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The understanding of the structural features within molecular compounds that facilitate 
their intermolecular assembly by hydrogen bonding, either with themselves or with 
complementary species, is important for the construction of functional co-crystallised 
systems and the development of rational methods for their synthesis. These multi-
component solids have potential applications in a variety of fields including 
pharmaceuticals, catalysis, and materials. While there has been plenty of study into purely 
organic co-crystals, those containing transition metal complexes are much less common. 
In particular, complex co-crystals with triple hydrogen bonding synthons are especially 
rare, with less 30 structures reported in the Cambridge Crystallographic Database 
(November 2018). This thesis introduces the background topics including supramolecular 
chemistry and intramolecular interactions as well as a summary of the potential hydrogen 
bonding tectons reported in the literature, before presenting the synthesis and 
characterisation of a series of transition metal complexes which are potential hydrogen 
bonding tectons containing primarily ADA or DAD type hydrogen bonding motifs. Finally 
the methods undertaken in an a attempt to co-crystallise the presented complexes with 
each other as well as complementary organic molecules are presented along with the 
results of these co-crystallisations, which include two co-crystal structures of DAD 
containing platinum(II) complexes with complementary ADA containing organic 
molecules,  as well as a novel co-crystal structure containing a cationic, DDD containing, 
platinum(II) complex hydrogen bonded to an anionic, AAA containing, barbitone moiety. 
Chapter 1 introduces the field of supramolecular chemistry, describing some of the major 
subfields with notable examples from each, as well as the field of crystal engineering, 
which is closely linked with supramolecular chemistry. A key part of understanding both 
fields is the variety of intermolecular interactions which occur between molecules, and 
these interactions as well as their relative strengths and how they occur is described, with 
particular focus given to hydrogen bonding interactions, as well as extended hydrogen 
bonding motifs, due to their key role in the work conducted. Hirshfeld surface analysis is 
introduced as a method for the analysis of intermolecular interactions in X-ray crystal 
structures. Transition metal chemistry is introduced with a focus on multimetallic 
transition metal catalysts, both synthetic and biological, and some of the various synthetic 
methods which have been reported for the synthesis of heterometallic species. Following 
this, a summary of the variety of triple hydrogen bond motif containing ligands and their 
transition metal complexes is presented, showing the variety of potential tectons which 
exist in the literature. The chapter ends with a brief outline of the proposed ligands and 
complexes which were planned for this project along with the reasoning behind the 
choices made with consideration to crystal engineering and co-crystallisation studies. 
Chapter 2 describes the synthesis and characterisation of a series of 2-phenylpyridine 
palladium(II) and platinum(II) complexes of substituted 1,5-diarylbiguanides, as well bis-
2,2’-bipyridine ruthenium(II) and bis-2-phenylpyridine iridium(III) complexes of 2,4-
diamino-1,3,5-triazine substituted 2-pyridyl-1,2,3-triazole ligands. X-ray crystal structures 
for four palladium(II) complexes, two ruthenium(II) complexes, and one of the 
platinum(II) complexes were also obtained and are reported along with Hirshfeld surface 
analysis of each structure. All of these complexes (excluding some of the palladium(II) 
complexes) potentially contain ADA type hydrogen bonding motifs, which are either 
incorporated proximal to the chelate ring, in the case of the diarylbiguanides, or more 
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isolated from the metal ion, as in the case of the pyridyl-triazole complexes. The 
diarylbiguanides complexes suffered from both poor solubility (particularly in the case of 
the palladium(II) complexes), as well as obfuscation of the potential ADA surface due to 
conformational position of the aryl rings.  
Chapter 3 describes the synthesis and characterisation of the bis-2,2’-bipyridine 
ruthenium(II) and bis-2-phenylpyridine iridium(III) complexes of orotic acid, the 
copper(II), zinc(II), bis-2,2’-bipyridine ruthenium(II) , and 2-phenylpyridine iridium(III) 
complexes of 2-pyridylmethylenehydantoin, as well as the bis(diphenylphosphino)ethane 
platinum(II) complex of biuret. X-ray crystal structures of both the ruthenium(II) 
complexes, one of iridium(III) complexes, as well as of the copper(II) and platinum(II) 
complexes were obtained and are reported along with the Hirshfeld surface analysis of 
each structure. 
Chapter 4 introduces the small collection of literature ADA:DAD hydrogen bond containing 
co-crystals which also contain at least one metal complex component. All of these 
structures were found to have non-planar geometries between the two hydrogen bonded 
moieties and a method for calculating the individual geometry components (θ1, θ2, τ) 
which describe the deviation from co-planar in three dimensions was developed. The 
methods utilised for co-crystallisations are described followed by the co-crystallisation 
combinations using the complexes reported in chapters 2 and 3, with the complementary 
organic molecules, 4-dimethylaminonaphthalimide, barbitone, phthalimide, and 6-phenyl-
2,4-diamino-1,3,5-triazine. From these crystal jars three complex-organic co-crystals were 
obtained; [(Pt(ppy)(tBubigu)):dmaNaph]·0.3CHCl3, [(Pt(ppy)2(diOMebigu)):dmaNaph], 
and [(Pt(ppy)(biguH)):(barb-H)]·CHCl3. The X-ray crystal structures, Hirshfeld analysis, 
and hydrogen bonding geometry of each structure is reported and discussed. The sum of 
the attempted complex-complex co-crystallisations along with the results of these 
attempts was then described. No complex-complex co-crystals were obtained from these 
co-crystallisation attempts and the likely reasons of this are discussed along with the 
suggestion of future methods, particularly the use of ligands with multiple hydrogen 
bonding motifs which favour the formation of larger or polymeric supramolecular 






A Hydrogen bond acceptor 
AA Acceptor-acceptor motif 
AAA Acceptor- acceptor- acceptor motif 
Ac Acetyl 
ADA Acceptor-donor-acceptor motif 
ADD Acceptor-donor-donor motif 
Anal. Analysis 
barb Barbitone (Barbital) 







cod Cyclooctadiene, typically as the η2η2- ligand 
COSY Homonuclear correlation spectroscopy 
CuAAC Copper(I)-catalysed azide alkyne cycloaddition 
D Hydrogen bond donor 
DA Donor-acceptor motif 
DAA Donor-acceptor-acceptor motif 
DAD Donor-acceptor-donor motif 
dapy 2,6-diaminopyridine 
DAT 2,4-diamino-1,3,5-triazine 
DD Donor-donor motif 
DDD Donor-donor-donor motif 
DH···A Hydrogen bond between atoms D and A, also refers to the angle formed 






dppeo 1,2-Bis(diphenylphosphino)ethane dioxide 
EDTA Ethylenediaminetetraacetic acid 
ESI-MS Electrospray ionization mass spectrum, shorthand for HRESI-MS 
Et Ethyl 
evap. Evaporation  
fc Ferrocene 
H···A Hydrogen bond to the atom A, also refers to the distance between the 
hydrogen and the atom A 
HMBCAD Heteronuclear multiple-bond correlation (adiabatic) 
HRESI-MS High resolution electrospray ionization mass spectrum, often shortened to 
ESI-MS 





nBu (normal) Butyl 
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NMR Nuclear magnetic resonance 
NOESY Nuclear Overhauser effect spectroscopy 
OAc Acetate 
orotH3 Orotic acid 
phen Phenanthroline 
pKa Acid dissociation constant 
ppm Parts per million  




𝑎(𝑛)  Graph set notation for cyclic hydrogen bond (a number of acceptors; d 
number of donors; n total number of atoms in ring) 
ROESY Rotating frame nuclear Overhauser effect spectroscopy 
S(n) Graph set notation for cyclic intramolecular bond (n total number of 




TMS Trimethylsilyl  
tz 1,2,3-Triazole 
vap. Vapour 
vdW Van der Waals 
Y^Z Chelating ligand with coordinating atoms Y and Z (Y and Z can be any of C, 
N, O, or S) 
ηn Ligand contains n continuous coordinating atoms (e.g. η5-) 
κn Ligand contains n separately coordinating atom (e.g. κ2-N,N) 
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1.1 Supramolecular Chemistry 
The field of supramolecular chemistry has been described in many different ways, such as 
“chemistry beyond the molecule”[1] or “chemistry of molecular assemblies and of the 
intermolecular bond,”[2] and generally involves the assembly (“complexation”) of 
molecular units into a larger system through a variety of interactions. The properties of 
individual units in the supramolecular assembly can be shared across or are still present 
within the ‘supramolecular complex’. The term supramolecular chemistry was coined by 
Jean-Marie Lehn,[2] with his description of the term marking the recognition of 
supramolecular chemistry as its own field during the 1970’s.[3] During this period the 
major focus of the field was on host-guest complexes, particularly macrocyclic compounds 
(Figure 1.1), where particular host molecules contained cavities which could be tuned 
through modification of their structural or electronic properties to selectively bind 
particular guest molecules. This work lead to Jean-Marie Lehn jointly receiving the 1987 
Nobel Prize in Chemistry alongside Donald J. Cram and Charles J. Pedersen "for their 
development and use of molecules with structure-specific interactions of high 
selectivity."[4]  
 
Figure 1.1 Complexation of 1-(2-aminioethyl)-pyridinium dication (blue) to the tetratryptophanate 
substituted 18-crown-6 ether macrocyclic compound.[2] 
Since then the field of supramolecular chemistry has continued to expand with a wider 
range of assemblies such as self-organising and self-assembling systems, as well as 
mechanically interlocked molecular architectures, being included under the umbrella of 
supramolecular chemistry. Self-organising systems are single (typically oligomeric) 
molecular units which will adopt discrete conformational structure which can be directed 
either by the preferential conformation that subunits of the molecule adopt or by 
intramolecular interactions between separate fragments of the molecule (or through a 
combination of both). This type of supramolecular self-organisation is prevalent in biology 
with proteins forming repeating secondary structures such as α-helices and β-sheets 
which then assemble together to give the protein its overall tertiary structure. This type of 
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self-organisation of a single molecular chain has also been replicated in synthetic systems 
(referred to as foldamers) utilising both biologically derived polypeptide sequences as 
well as synthetic oligomers and discrete chain molecules (Figure 1.2).[5] Foldamer systems 
have also been designed to fold/unfold upon the application of external stimuli.[6] 
 
Figure 1.2 X-ray crystal structure of the helical foldamer formed from a pyridine capped hydrazone-
pyrimidine oligomer strand 11.60 Å ‘tall’ (unfolded strand calculated to be ~80 Å long).[7] Solvent molecules  
hidden for clarity. 
Self-assembling systems are supramolecular assemblies where multiple complementary 
molecular units come together to form a larger structure. While host-guest complexes are 
included in self-assembled systems, other types of supramolecular complexes can also be 
classed as self-assembled systems, such as supramolecular coordination complexes. These 
systems utilise coordinate bonds formed between metal ions and bridging ligands with 
well-defined geometries.[8] Depending on the geometries of the components used 
supramolecular coordination complexes can either form discrete geometric structures 
(Figure 1.3)[8-10] or coordination polymers, including metal-organic frameworks 
(MOFs).[11-13] 
 
Figure 1.3 X-ray crystal structures of a [Pd2L4] type helicate with encapsulated PF6- anion (left)[9] and of a 
[Pd4L8] type tetrahedron (right).[10] Further anions and solvent molecules hidden for clarity. 
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Mechanically interlocked molecular architectures, MIMAs, are a series of supramolecular 
assemblies where (excluding molecular knots) two or more molecular units are held 
together by a “mechanical” bond rather than covalent, coordinate, or intermolecular 
bonds. Covalent bonds in one or more of the molecules must be broken to separate the 
interlocked system. MIMAs come in a variety of forms including catenanes, interlocked 
macrocyclic rings; rotaxanes, macrocycles threaded onto thin molecular axles; molecular 
knots, a singular macrocycle fixed in a knotted conformation; and molecular Borromean 
rings, three or more interlocked macrocycles which will come apart if any one ring is 
broken. MIMAs, particularly catenanes and rotaxanes, form the basis of many “molecular 
machines” due to the ability of their components to freely move relative to each-other 
without separating. Jean-Pierre Sauvage, Sir J. Fraser Stoddart and Bernard L. Feringa 
jointly received the 2016 Nobel Prize in Chemistry "for the design and synthesis of 
molecular machines."[14] 
 
Figure 1.4 X-ray crystal structure of [2]catenane involving the interlinked cyclobis(paraquat-p-phenylene) 
tetracation (pink) and 1,5-dinaphtho-38-crown-10 (light green) macrocyclic rings.[15] Anions and  
solvent molecules are hidden for clarity. 
The field of supramolecular chemistry considers assemblies that occur in a variety of 
states, from liquid (e.g. liquid crystals), solution state, and solid state, particularly 
crystalline structures. Supramolecular chemistry in one part considers the assembly of the 
discrete molecules (Figure 1.3), or polymeric structures that form from the creation of 
covalent or coordination bonds (e.g. MOFs). There is also the consideration of how 
discrete molecular (or even supramolecular) units assemble through intermolecular 
interactions to form crystalline solids. Study of this type of assembly is known as crystal 
engineering, and can be described as “The understanding of intermolecular interactions in 
the context of crystal packing and the utilization of such understanding in the design of 
new solids with desired physical and chemical properties.”[16] This understanding of the 
assembly of different molecules into solid state structures is important for a variety of 
different applications including pharmaceuticals, materials, and catalysis.[17-19] Co-
crystallisation of the anti-cancer drug hexamethylenebisacetamide (HMBA) with various 
dicarboxylic acids (COOH(CH2)nCOOH, n = 4, 6, 8, 10, 12) has been shown to modulate both 
the melting point and the solubility of the resulting co-crystallised solid (Figure 1.5).[20] 
The carboxylic acid moieties are hydrogen bonded to the pyridine moieties of HMBA 
forming chains of alternating dicarboxylic acids and HMBA molecules, which then pack 




Figure 1.5 X-ray crystal structure of HMBA:succinic acid[20] showing formation of chains through pyridine to 
carboxylic acid hydrogen bonds (blue) which then pack through weaker CH···O hydrogen bonds (magenta). 
The co-crystallisation of the very powerful, but extremely sensitive, explosive CL-20, with 
trinitrotoluene (TNT) has been shown to significantly reduce the kinetic sensitivity of CL-
20 to the point where it can be safely transported and handled as a practical explosive, 
then, with the application of heat, the TNT can be driven from the structure and the CL-20 
reactivated into its highly explosive form.[21] 
 
Figure 1.6 X-ray crystal structure of the 1:1 co-crystal of CL-20 and TNT,[21] with ionic interactions between 
adjacent nitro groups shown (blue). 
 
1.1.1 Intermolecular Interactions 
One of the key aspects of supramolecular chemistry is the understanding the 
intermolecular interactions that occur between different molecules and how molecules 
can be designed or modified to utilise these interactions in a systematic manner.[16, 22] 
Intermolecular interactions can occur through a variety of different mechanisms each with 
their own strength and directional preferences (Figure 1.7).[19, 23] These include dispersion 
forces (van der Waals), charge based interactions, hydrogen bonding, and interactions 
involving aromatic π systems.[3, 23] When molecular units which contain, or are designed 
with, discrete and/or well defined portions which facilitate intermolecular interactions 





Figure 1.7 Relative strengths of common intermolecular interactions, reproduced from Co-crystals: 
Preparation, Characterization and Applications.[19] 
1.1.1.1 Dispersion Forces 
Van der Waals interactions are individually the weakest of the intermolecular interactions 
although they are the most prevalent, occurring between all molecules. However these 
weak interactions scale with the size of the system and tend to dominate the 
intermolecular forces involved in assembling large biological systems.[3, 23, 26] Related to (or 
often included in) van der Waals, are the permanent dipole – induced dipole,  permanent 
dipole – permanent dipole, and the ion – dipole type interactions, which are stronger 
intermolecular interactions ranging up to 200 kJ mol-1 in interaction energies. The issue 
with the van der Waals based interactions is they lack much in the way of directionality, or 
specificity, with the strength of the interactions typically relying on the relative distance 
and collective number of interactions. This makes them generally unsuitable for designing 
synthetic systems, since it is difficult to predict how they will arrange based on the van der 
Waals forces alone, although for some uses, such as taking advantage of the hydrophobic 
effect with distinct hydrophilic and hydrophobic groups, these forces can be utilised.  
1.1.1.2 Aromatic π Stacking 
There are however intermolecular interactions which are much more specific, with the 
geometry between interacting moieties strongly influencing the interaction energies. 
These interactions include halogen and hydrogen bonding as well as the collection of π-
type interactions which are classically between two aromatic groups, but can also include 
chelate rings and other π-systems. Aromatic rings are often observed to ‘stack’ together, 
with this stacking typically occurring in either edge to face or as offset face to face type 
geometries which can be explained through the Hunter-Sanders rules.[27] These rules 
consider the interactions as electrostatic attractions or repulsions generated between the 
δ-π region, generated by the delocalised π-bond electrons, above and below each atom 
present in the aromatic system and the δ+ σ region (treated as the aromatic substituents) 
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around the edge of each atom in the aromatic system (note that each atom is considered 
rather than only the system as a whole). Rule one states that π-π repulsion dominates in 
face to face stacking geometry while rules two and three state that π-σ attraction will 
dominate in edge on or offset stacked geometries (Figure 1.8).  
 
Figure 1.8 Illustration of the attractive electrostatic interactions in edge to face (left) and offset face to face 
(right) geometries for the case of benzene, reproduced from New Aspects of Aromatic π . . .π and C-H. . .π 
Interactions in Crystal Engineering.[28] 
When aromatic systems are modified with polarizing groups, additional rules need to be 
considered due to changes to the partial charges in the π and σ regions. Rule four states 
that for interactions between highly charged atoms, charge-charge interactions dominate, 
while rules five and six define the π and σ polarizations, respectively, required to stabilise 
favourable interactions between neutral or weakly polarized sites in different geometries. 
In general these rules focus on maximising attractive and minimising repulsive 
electrostatic interactions in the overlapped atoms of offset stacking, or edge and face 
atoms in edge to face stacking, but also consider the location of the polarizing groups in 
relation to the stacking geometry (Figure 1.9). It can also be noted that face to face 
geometry can be favourable in certain cases, typically where one system contains π 
deficient atoms, which reduces the π-π repulsion enough for the van der Waals 
contribution (which is at its maximum with face to face geometry) to become significant. 
Face to face geometry can often be more favourable between two π deficient atoms than 
between π deficient and π rich atoms (Figure 1.9). Heteroaromatic systems also ‘stack’ in 
the same manner as aromatic systems, but the often observed offset or slipped 
(intermediate between offset and face to face) stacking geometries are consistent with the 
π-π and π-σ interactions predicted by Hunter-Sanders rules, rather than displaying unique 
behaviour.[29] The ability to tune aromatic systems through modification with electron 
withdrawing or donating groups has been utilised to create selective aromatic host-guest 
systems such as molecular tweezers (Figure 1.10) which when constructed with electron 
rich pincers will only bind electron poor aromatic molecules,[30] and vice versa,[31] by 




Figure 1.9 Reinforced attractive interactions in edge to face (left) and offset stacked (centre) substituted 
aromatic molecules, and face to face geometry observed in π deficient aromatic molecules such as nitro-
benzene (right) due to decreased electrostatic repulsion (which allows van der Waals interactions to 
dominate). 
 
Figure 1.10 Molecular tweezers with the electron rich acridines (green) pincers which preferentially bind 
electron poor aromatic molecules such as tri-nitro substituted permanent (blue) in the ~6.8 Å cavity formed 
between the two acridine moieties (left).[30] Molecular tweezers with electron poor terpy palladium(II) 
complexes (blue) which bind electron rich or neutral aromatic molecules such as anthracene (green)(right).[31] 
1.1.1.3 Chelate Stacking 
Stacking interactions analogous to face to face or offset stacked π stacking has also been 
observed to occur between the chelate rings of square planar metals and both aromatic 
moieties as well as other chelate rings (Figure 1.11).[32-33] While there aren’t currently a set 
of rules like the Hunter-Sander rules for π stacking, chelate stacking has been shown to be 
consistent with electrostatic models of the intermolecular interactions, in the same 




Figure 1.11 X-ray crystal structure of 2-pyridylpyrazole palladium(II) dichloride complex which packs 
through chel···chel (green) and offset π (light blue) interactions viewed side on (left) and from above 
(right).[35] 
1.1.1.4 Hydrogen Bonding 
Hydrogen bonding, while not the strongest of intermolecular forces, is one of the most 
utilised forces in supramolecular chemistry.[36] It can be described as “an attractive 
interaction between a hydrogen atom from a molecule or a molecular fragment, D-H, in 
which D is more electronegative than H, and an atom or group of atoms in the same or a 
different molecule, in which there is evidence of bond formation,”[16] although a more 
general description occurs which states “an D-H···A interaction is called a ‘hydrogen bond’, 
if 1. it constitutes a local bond, and 2. D-H acts as proton donor to A.”[37] In general 
hydrogen bonds are split into two components, the donor atom (or group) (D) to which 
the proton (H) is covalently bonded, and the acceptor atom (or group) (A) to which the 
hydrogen forms some sort of directional interaction. Although hydrogen bonding, by 
definition, involves, at least in part, some degree of proton transfer, in some cases the 
donor and acceptor are difficult to distinguish from each other resulting in a symmetrical 
hydrogen bond of the type X-H-X (vide infra). Classically, the donor can be any atom or 
group, whose electronegativity is greater than that of hydrogen, but in practice if the 
difference in electronegativity is too small the hydrogen bond will be too weak to 
differentiate from van der Waals interactions.  The heteroatoms nitrogen and oxygen are 
the most common donor atoms although halogens and other atoms such as sulfur 
commonly act as donor atoms. Electron poor atoms and those closely bonded to strongly 
electron withdrawing groups can also act as donor atoms with C-H and P-H hydrogen 
bond donors often encountered (these are commonly referred to as non-classical 
hydrogen bond donors).  
Energy Contributions of Hydrogen Bonds 
The attractive interaction which occurs from hydrogen bonding is composed of a variety 
of different components of varying natures and varying strengths, with most models 
partitioning the different components along the lines of equation 1.1.[38] The total energy 
of the interaction (Etotal) is the sum of the contributions from electrostatics (Eel), 
polarization (Epol), charge transfer (Ect), dispersion (Edisp), and exchange repulsion (Eer).  
 𝐸𝑡𝑜𝑡𝑎𝑙 =  𝐸𝑒𝑙 + 𝐸𝑝𝑜𝑙 + 𝐸𝑐𝑡 + 𝐸𝑑𝑖𝑠𝑝 + 𝐸𝑒𝑟  (1.1) 
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Typically the electrostatic term dominates the overall energy and drops off with r2 or r3 
(where r is proportional to the D···A distance), so is still significant at the longer distances 
in which hydrogen bonds occur. The electrostatic term is also directional as it due to 
dipole – dipole and dipole – monopole type interactions, and this leads to deviations from 
preferred hydrogen bonding geometry being directly proportional to a decrease in 
hydrogen bond strength. The polarization and charge transfer terms decreases much 
faster (r4 and er, respectively). The charge transfer (from bond orbital analysis)[39] occurs 
from lone pair electrons present at A to the antibonding orbital parallel to the D-H σ bond 
(nA → σ*DH), although only becomes significant in the edge cases of hydrogen bonds such 
as when ΔpKa†*between donor and acceptor is low (vide infra). The dispersion term 
decreases with r6 and is isotropic, so does not contribute to the directionality of the 
hydrogen bond. The exchange repulsion term decreases with r12 and can be considered the 
steric repulsion that only occurs during extremely close approaches. Overall electrostatic 
contributions to the overall interaction energy dominate, especially at increasing 
distances, while other terms (particularly charge transfer) tend to only have significant 
contributions in particular edge cases of hydrogen bonding interactions. 
Directional Preference of Donors and Acceptors 
Hydrogen bonds are highly directional interactions with both donor and acceptor 
components having preferred geometric arrangements which can vary due to a variety of 
different factors. Typically the donor component of a hydrogen bond prefer a linear 
geometry (D-H···A ≃ 180°) which directly arises from the electrostatic component of the 
interaction energy and maximises the δ+···δ- interaction between H and A while 
minimising δ-···δ- interaction between D and A (although deviation is common due to 
other geometric constrains, especially in crystalline structures). The degree of 
directionality depends on the polarity of the donor, with a decrease in the D-H polarisation 
directly proportional to a loss of directional preference in the hydrogen bond. This leads to 
a continuous transition from weak hydrogen bonds to van der Waals interactions which 
have no directional preference. The major exception to this linear preference is in the case 
of bifurcated and trifurcated hydrogen bonds (where one D-H interacts with multiple 
acceptor moieties). The linear geometry becomes unfavourable due steric repulsion 
between adjacent acceptor groups, and the loss of attractive energy from non-optimal 
geometry is made up for by the abundance of acceptor interactions. For these type of 
multifurcated hydrogen bonds to occur, a high density of local acceptors is critical.[37] The 
directionality preference of the acceptor (R-A···H) is not as straightforward as for the 
donor, although in general it will follow the geometry of lone pairs of electrons (for single 
atom acceptors) or the greatest electron density present (in π type acceptors). As the 
strength of hydrogen bond increases, the geometry at the acceptor will tend to the 
covalent geometry which would occur in the case of proton transfer, and can be 
considered the continuous transition to a covalent bond or to a hydrogen bond in the 
reverse direction (D-H···A ⇌ A*···H-D*, where D = A* and vice versa). 
Continuous Transition to Other Interaction Types 
As has been alluded to above, definite limits between hydrogen bonding interactions and 
other types of interactions do not exist and instead, continuous transitions occur as the 
                                                             
† ΔpKa refers to the absolute difference in acid dissociation constants between the donor and the conjugate 
acid of the acceptor.  
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major contribution of the interaction energy shifts between different terms (equation 1.1). 
The transition from hydrogen bonding to a pure van der Waals type interaction is very 
common as the polarities of the Dδ--Hδ+ or Aδ- can be reduced to zero in a continuous 
manner and is observed as both a weakening of the interaction and a loss of directionality. 
Conversely, there is a continuous transition to a covalent type interaction where the donor 
and acceptor cannot be distinguished from each other and the hydrogen is shared equally 
between the two (X-H-X) such that the hydrogen can be considered to be forming two 
covalent bonds of bond order ½. This case can only occur when both the donor and 
acceptor are chemically equivalent or when the ΔpKa between the two is sufficiently low. 
The exact value at which this occurs varies case by case and is also affected by state of the 
system. If the ΔpKa between donor and acceptor is large either a moderate hydrogen bond 
or an ionic type hydrogen bond will exist. Ionic type hydrogen bonds occur when the 
donor and acceptor moieties become formally charged (D+-H···A-) and the interaction 
energy is dominated by the Coulombic interaction between the two charges. This 
transition can occur either in a continuous manner (increasing partial charges to formal 
charges) or from a Brønsted-Lowry acid-base type reaction where the proton is 
transferred between donor and acceptor resulting in a hydrogen bond between the 
resulting conjugate base and acid formed. Closely related to the ionic edge case is the 
cation-π edge case where the donor also becomes formally positive, but is interacting with 
a π system rather than a formally negative acceptor. In both the ionic and cation-π edge 
systems the presence of the hydrogen atom continues to impart its directionality to the 
system, and therefore some of the hydrogen bond properties are maintained. 
Non-Additivity of Hydrogen Bonds 
In systems where there are multiple interconnected hydrogen bonds, the properties of 
these bonds are not simply the sum of the isolated bonds. Instead, mutual polarization 
occurs between the hydrogen bond donors and acceptors affecting the hydrogen bonding 
strength of further hydrogen bonds formed. The first mechanism through which this 
occurs is σ-bond cooperativity where the formation of a hydrogen bond increases the 
polarization of both the donor and acceptor groups which strengthens further hydrogen 
bonds formed to the same acceptor or donor. The σ-bond cooperativity drives the 
clustering of hydrogen bonding moieties as grouped hydrogen bonds can significantly 
increase the attractive energy of the system with model calculations suggesting typical 
gains, relative to isolated interactions, of around 20% are possible.[37] The other 
mechanism through which mutual polarization can occur is π-bond cooperativity, or 
resonance-assisted hydrogen bonding, in which the increased polarization from the 
formation of a hydrogen bond is transferred to other hydrogen bond donors or acceptors 
through either conjugated π-systems, resonance structures, or the formation of hydrogen 
bonded cyclic structures such as the common carboxylic acid dimer. Anti-cooperative 
interactions can also occur, either where the increased polarization from the formation of 
one hydrogen bond decreases the polarization of adjacent hydrogen bonds, or in the case 
where two near parallel donors interacting with single acceptor cause repulsive 
interactions due to their aligned dipoles. 
Practical Limits for Classifying Hydrogen Bonds 
Although hydrogen bonds continuously transition to other types of interactions and, 
depending on individual systems, can display a variety of properties, assigning some labels 
to associated properties is useful for comparing hydrogen bonds in similar systems or 
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states. Across different fields there are a variety of different definitions and limits assigned 
to hydrogen bonding interactions. In this work a set of definitions, variations of which are 
commonly utilised in X-ray crystallography and crystal engineering,[3, 22, 36] which classes 
hydrogen bonds as strong, moderate, and weak, based on the D···A and H···A distances, as 
well as the D-H···A angles observed in the crystal structure (Table 1.1) will be followed. It 
should be noted that these limits are not absolute and are treated more as guidelines for 
identifying hydrogen bonding interactions. 
Table 1.1 Typical bond lengths and angles observed in hydrogen bonding (D-H···A) interactions of varying 
strengths.[36] Bond energies are approximate and based on solution state studies. 
 D···A /Å H···A /Å D-H···A /° Bond Energy /kJ mol-1 
Strong 2.2 – 2.5 1.2 – 1.5 175 – 180 60 – 120 
Moderate 2.6 – 3.1 1.6 – 2.5 135 – 180  16 – 60  
Weak 3.0 – 4.0  2.0 – 3.0 110 – 180  < 12 
There are also limitations associated with locating and assigning the location of hydrogen 
atoms in solids state experiments (X-ray or neutron diffraction crystallography). Typically 
the centre of gravity of both the nucleus and the electrons of an atom coincide, so 
assignment of the atom location from either (X-ray diffraction giving electron density 
location vs neutron diffraction giving nucleus location) will agree. However in the case of 
hydrogen, especially strongly polarised hydrogens involved in hydrogen bonding, the bulk 
of electron density is centred away from the nucleus, leading to disagreements in the 
hydrogen location. Typically in X-ray crystallography hydrogens are placed with fixed or 
modelled bond lengths with the location of the associated electron density often defining 
the D-H bond vectors. Neutron diffraction data on the other hand gives reasonably 
accurate data on the location of the hydrogen nucleus and resulting structures will have 
hydrogens placed according to nucleus location. Neither method is wrong; instead both 
show different aspects of a complicated physical situation. 
1.1.1.5 Halogen Bonding 
Halogen bonding refers to the close interaction of organically bound halogen, X (F, Cl, Br, 
or I), with a nucleophilic atom or region of another molecule, A, which commonly refers to 
heteroatoms but also includes anions and π-systems.[23, 40-41] While halogens are typically 
considered to be nucleophilic, due to their high electronegativity, they contain a region of 
positive electrostatic potential which is trans to their R-X σ-bond which allows the halogen 
to act as a Lewis acid (in contrast to hydrogen bond donors acting as Brønsted acids).[42] 
This ‘σ-hole’ directs the X···A halogen bond to be co-linear to the R-X covalent bond 
although deviations from this linear geometry can often occur due to other effects such as 
crystal packing. While halogen bonds have comparable strengths to hydrogen bonds 
(Figure 1.7) it has recently been shown that the one type of interaction will be favoured 
over the other depending on the polarity of the solvent.[43] Generally halogen bonding will 
be favoured in polar solvents, while hydrogen bonding will be favoured in non-polar 
solvents, due to more polar solvents competing for the hydrogen bonding interactions. 
The increasing strength of the hydrogen bonding interaction has been shown to shift the 
point at which the system would transition from halogen bonding to hydrogen bonding by 




Table 1.2 Results from competitive co-crystallisation experiments involving 1:1:1 mixtures of 1,2-bis(4-
pyridyl)ethane (hydrogen and halogen bond acceptor), tetrafluro-1,4-diiodobenzene (halogen bond donor), 
and either hydroquinone(A), 2-fluorohydroquinone (B), or tetrafluorohydroquinone (C), in solvents of 
increasing polarity. HA, and XA refer to hydrogen bonded or halogen bonded co-crystals, respectively. 
Reproduced from Robertson et al.[43] 
Solvent System A System B System C 
Toluene HA HA HA 
Chloroform Mixed HA/XA HA HA 
Dichloromethane Mixed HA/XA Mixed HA/XA HA 
Acetone XA XA HA 
Acetonitrile XA XA HA 
Nitromethane XA XA HA 
iso-Propanol XA XA Mixed HA/XA 
 
1.1.2 Extended Hydrogen Bonding Motifs 
Hydrogen bonds can be used in tandem to create extended motifs with various 
combinations of donors and acceptors. These can occur as double, triple, or quadruple 
hydrogen bonding motifs, with even larger motifs possible but much less common. The 
double hydrogen bonding motifs have three different possible combinations of donors and 
acceptors, DD, AD, and AA, while triple hydrogen bonding motifs have six, AAA, AAD, ADA, 
DAD, DDA, and DDD, and so on for larger motifs. These different motifs are selective in 
which other motifs are complementary and will not engage with non-complementary 
motifs primarily due to steric repulsion between opposing protons. One of the most 
prevalent AD containing synthons is the carboxylic acid functional group which contains a 
hydroxyl donor and a carbonyl acceptor with lone pair of electrons oriented parallel to the 
O-H donor. AD motifs are also self-Complementary and are often observed to assemble 
into dimeric structures, or in species which contain two or more carboxylic acid groups 
assemble into larger supramolecular polymeric structures such as 1D hydrogen bonded 
chains (Figure 1.12).[35] 
 
Figure 1.12 Crystal structure of benezenedicarboxylic acid substituted pyridylpyrazole palladium(II) 
dichloride with 1D chains of palladium(II) complexes linked by double hydrogen bonding interactions 
between carboxylic acid groups which contain AD hydrogen bonding motifs.[35] 
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The organic molecules melamine and cyanuric acid are excellent examples of triple 
hydrogen bond motifs with each containing three DAD or ADA motifs, respectively. When 
melamine and cyanuric acid are co-crystallised in a 1:1 ratio they form hydrogen bonded 
sheets in which every melamine is triply hydrogen bonded to three separate cyanuric acid 
molecules and vice versa (Figure 1.13).[44] These molecular moieties, as well as related 
moieties (such as diaminopyridines and barbitones), have also been incorporated into 
larger host-guest type supramolecular structures (Figure 1.14).[45-46] 
        
Figure 1.13 X-ray crystal structure of co-crystallised melamine and cyanuric acid forming triple hydrogen 
bonded sheets.[44] 
 
Figure 1.14 Host-guest complex of barbitone and a macrocyclic tetraamide through triple hydrogen bonds 
between the DAD containing diaminopyridine moieties of the macrocycle and the ADA motifs contained in the 
barbitone molecule.[45] 
In biology the classic example of the selectivity of different hydrogen bonding motifs is 
DNA. All four nucleobases terminate in either double or triple hydrogen bonding motifs 
where adenine and thymine have the complementary AD motifs, while guanine and 
cytosine have complementary ADD and DAA motifs, respectively.[47] These complementary 
hydrogen bonding motifs help control the assembly of DNA with nucleobases only aligning 




Figure 1.15 Segment of DNA with the nucleobases Guanine and Thymine (green), and Adenine and Cytosine 
(blue) highlighted. 
1.1.2.1 Secondary Electrostatic Interactions  
With the increasing number of hydrogen bonds within a motif there is a corresponding 
increase in the interaction energy as would be expected. However this increase is not 
constant and the interaction energy between different complementary motifs can vary to a 
large degree. Looking at the three complementary pairs of triple hydrogen bonds DDD and 
AAA motifs have the highest interaction energies typically in the range of 28 to 59 kJ mol-1, 
while the DAD and ADA motifs have the lowest interaction energies in the range of 11 to 
17 kJ mol-1, with ADD and DAA hydrogen bonding motifs having intermediate interaction 
energies which fall between the other two ranges.[36] This difference in strength between 
the more mixed hydrogen bond motifs (i.e. ADA) and the more homogenous motifs (i.e. 
DDD) can be accounted for by secondary electrostatic interactions, which are typically 
considered as repulsive or attractive interactions between the δ+ and/or δ- charges of 
adjacent donors or acceptors across the hydrogen bonding motif (Figure 1.16).[3] 
 
Figure 1.16 Attractive (green) and repulsive (red) secondary electrostatic interactions between each of the 
different possible triply hydrogen bonded pairs. AAA:DDD pairs have the maximum attractive interactions 
while ADA:DAD pairs have the maximum repulsive interactions. 
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This view of secondary electrostatic interactions as interacting point charges is an 
oversimplification, however, with recent work showing that the arrangement of donors 
and acceptors within a motif give differing accumulations of charge from across the whole 
moiety with grouped donors (or acceptors) having a greater accumulation of charge when 
compared to alternating donors and acceptors (Figure 1.17).[48] These accumulation of 
charges affects the δ+ of donors and δ- of acceptors either enhancing or reducing both the 
electrostatic and covalent interactions of the hydrogen bonding and therefore affecting the 
overall interaction energies observed. While cognisant of this, the secondary electrostatic 
interactions model remains a useful as a predictive tool for the relative strength of 
different hydrogen bond motifs as it generally parallels the overall result observed in 
charge accumulation models. 
 
Figure 1.17 (a) Hydrogen bonded pairs guanidine and cytosine, and diaminopyridine and uracil with 
attractive (green) and repulsive (red) secondary electrostatic interactions shown. (b) Electrostatic potential 
surfaces (at 0.01 au) from -0.1 (red) to 0.1 au (blue) calculated (using BLYP-D3(BJ)/TZ2P) for the same 
hydrogen bonded pairs, reproduced from van der Lubbe et al.[48] 
1.1.2.2 Extended Hydrogen Bond Notation 
A systematic method for describing hydrogen bonding motifs based on graph theory, 
developed by Etter et al.[49] and expanded on by Bernstein et al.,[50] is useful for describing 
and comparing the variety of hydrogen bonding patterns which can occur in 3D structures. 
In the process of building a hydrogen bonding graph set descriptors are given to each 
motif, 𝐺𝑑
𝑎(𝑛), where G is the observed pattern and falls into one of four categories; C 
(infinite chain), R (ring), D (noncyclic dimer), or S (intramolecular), while a and d refer to 
the number of acceptors and donors, respectively, and n refers to the total number of 
atoms in the repeat unit (Figure 1.18).  
 
Figure 1.18 Graph set assignments for four different patterns of hydrogen bonding reproduced from 
Hydrogen Bonded Supramolecular Structures.[36] When no subscript and superscript are given, one donor and 
one acceptor are implied; n = 2 is the default value for a D pattern and is not specified. 
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There are a variety of rules for the assignment and combination of descriptors to build 
complete graph sets for structures (which are well described with exceptions and 
clarifications by Bernstein et al.[50]) but for the purpose of this work the ring motif 
descriptors, 𝑅𝑑
𝑎(𝑛), were exclusively used to compare different extended hydrogen 
bonding interactions, which always give ring type motifs, often with multiple rings 
adjacent to each other. Adjacent ring units which share a hydrogen bonding interaction 
have grouped descriptors of the form 𝑅𝑑
𝑎(𝑛)𝑅𝑑′
𝑎′(𝑛′) … where each ring is described in 
succession (Figure 1.19). In rare cases, an adjacent series of rings will repeat ad infimum, 
and are described in this work as {𝑅𝑑
𝑎(𝑛)𝑅𝑑′
𝑎′(𝑛′) … }∞ where each ring in the repeating 
unit is described by its respective R notation. By graph set nomenclature, however, this 
motif might be more correctly described as 𝐶𝑑∗
𝑎∗(𝑛∗)[𝑅𝑑
𝑎(𝑛)𝑅𝑑′
𝑎′(𝑛′) … ] where a*, d*, and n* 
refer to the sums of acceptors, donors, and atoms in the repeating unit, respectively.  
 
Figure 1.19 Graph set notation for the symmetrical triple hydrogen bonding between uracil and 
diaminopyridine (left) and for the asymmetric hydrogen bonding between a deprotonated  
1-phenylbiguanide complex and uracil (right). 
1.1.3 Hirshfeld Surface Analysis 
With the range and variety of intermolecular interactions that need to be considered for 
crystal engineering, a method for quantifying the relative contributions of the different 
intermolecular interactions in solid state structures as well as producing 2D visual 
representations of the intermolecular interactions around a 3D molecule for easier 
comparison of different structures is required. Hirshfeld surface analysis is a method of 
generating a surface around molecular units which is “… aesthetically appealing and offers 
some promise in routine partitioning of crystalline electron densities or in computer 
graphics to provide additional insight into molecular packing in crystals.”[51] The surface is 
generated from a weighting function, wA(r), which is a continuous function with 
0<wA(r)<1 that is dependent on the sum of the spherically averaged electron densities, 
𝑝𝑖
𝑎𝑡(𝒓), of each atom within the molecular fragment of interest (the promolecule), over the 
sum of the surrounding crystal (the procrystal).[52] 









The resultant 3D function exhausts all space around the molecular fragment with the 
atomic fragments overlapping. The contours of the weighting function are tightly spaced 
and surround the molecule near the van der Waals surface, while the function is extremely 
flat across the molecule itself, (wA(r) > 0.9 goes rapidly to < 0.1) and is also flat across the 
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remainder of the crystal (wA(r) < 0.1 goes rapidly to < 0.1). The Hirshfeld surface is 
defined as the iso-surface (wA(r) = 0.5) such that it “defines the volume of space where the 
promolecule electron density exceeds that from all neighbouring molecules,” and “it 
guarantees maximum proximity of neighbouring molecular volumes, but the volumes 
never overlap.”[52] 
 
Figure 1.20 (a) Contours of wA(r) surrounding a benzene molecule. (b) The Hirshfeld surface for benzene 
mapped with de plotted at the same size and orientation as the 0.5 contour in (a). From Spackman et al.[52] 
1.1.3.2 Interpretation of Hirshfeld Surfaces 
The primary functions mapped to the Hirshfeld surfaces which are useful in terms of 
crystal engineering are de and di which describe the distance from the Hirshfeld surface to 
the nearest nucleus outside (external, de) and inside (internal, di) as well as dnorm which 
calculates, using equation 1.3, a normalized contact distance with respect to the van der 
Waals radii (𝑟𝑣𝑑𝑊) between atoms inside and outside the surface. 










Each term of de has a paired di term (and vice versa) which can be collated into a 2D 
histogram which is coloured (dark blue through light blue to blue/white) with increasing 
density of points in each 0.01 Å ‘bin’. Such fingerprint plots provide a useful display from 
which to both interpret the mapping from the 3D surface and to compare surfaces from 
different crystal structures, as they are highly sensitive to the immediate environment of 
the molecular fragment of interest (Figure 1.21). Since de, and di do not take into account 
the varying size of atoms, features between different pairs of atoms are spread apart (with 
smaller atoms having closer de, and di values), allowing quick discrimination of different 
interactions from the fingerprint plots. Practically, Hirshfeld surfaces can be calculated 
from crystallographic information files (.cif), along with the related fingerprint plots using 





Figure 1.21 Example of different interactions observed in fingerprint plots of selected palladium(II) and 
platinum(II) complexes. Reproduced from McKay et al.[35] 
 
1.2 Transition Metal Complexes 
Transition metal chemistry makes up a large part of modern day inorganic and synthetic 
chemistry. Transition metals are involved in many areas of chemistry as a whole, as 
complexes and organometallic species, with applications in synthesis, catalysis, 
photochemistry, as well as other fields. This broad use of transition metal complexes 
comes from the wide range of properties they exhibit including their ability to adopt 
various oxidation states, adopt various (usually) discrete coordination geometries (i.e. 
octahedral, tetrahedral, and square planar), and in some cases display photoactive and 
catalytic properties. A myriad of properties can also be obtained from incorporation of the 
ligands into the overall complex and the effects they can have on the metal ions to which 
they are complexed.[36, 54] 
1.2.1 Transition Metal Based Catalysts 
A major application of transition metals is in the field of catalysis. Large scale industrial 
processes such as the production of ammonia as well as sulfuric and nitric acid rely on 
transition metal catalysts.[55] Catalysts are also important in the production of many 
organic compounds and petroleum derived products, particularly plastics,[56] which are 
key to many parts of modern life. The ability for transition metals to shift between various 
oxidation states with ease makes them ideal for the catalysis of oxidative addition and 
reductive elimination reactions. Typically metal based catalysts work through temporary 
coordination of one (or more) of the substrates to either the catalytic metal centre as part 
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of a coordination complex or on a solid surface. This coordination can provide electronic 
assistance to the reaction through the addition or removal of electrons or just by affecting 
the electron density of the coordinated substrate. Substrates can also be brought together 
with the metal centre providing a particular geometry that favours a certain reaction 
product or just a close enough approach for the substrates to react. A combination of all of 
these processes can also occur at catalytic metal sites.[54] 
1.2.1.1 Palladium Cross Coupling 
One group of catalytic process utilising transition metal catalysts are the series of 
palladium cross coupling reactions.[57-60] These are a range of similar reactions involving a 
variety of different palladium catalysts as well as substrates, but which all result in the 
formation of C-C bonds. The Negishi reaction is one of the classic palladium cross coupling 
reactions, and involves the reaction between organo-halide (or triflate) and organo-zinc 
substrates, catalysed by a palladium(0) species, typically with phosphine based ligands.[57] 
This reaction is quite powerful in generating a variety of C-C bonds between organic 
substrates which would usually be difficult to bring together, such as generating the bond 
between the two pyridine rings to form the now widely utilised 2,2’-bipyridine.[61-63] The 
catalytic cycle (Figure 1.22) begins with the oxidative addition of the organo-halide (or 
triflate) to the palladium(0), forming a square planar palladium(II) complex. This complex 
then undergoes a transmetalation with an organo-zinc species of the second substrate, 
with this second substrate displacing the halogen (or triflate) from the palladium ion. 
Finally the palladium(II) complex undergoes reductive elimination, reforming the Pd0 
complex and the product R-R’.  
 
Figure 1.22 The catalytic cycle of a generic Negishi cross coupling reaction. 
Another common palladium cross coupling reaction is the Sonogashira reaction, which is 
typically used to couple terminal alkynes to aromatic systems, although it also can be used 
to couple terminal alkynes to vinyl systems.[60] Unlike the Negishi reaction, the 
Sonogashira reaction contains both palladium and copper based catalytic cycles, which 
allow the reaction to proceed under much milder conditions, typically at room 
temperature under a nitrogen atmosphere.[60] The palladium cycle of the Sonogashira 
reaction is effectively identical to that of the Negishi reaction (Figure 1.22) where an 
organo-halide undergoes an oxidative addition to a palladium(0) catalyst and then the 
halide is exchanged for an alkyne through a transmetalation before the palladium(II) 
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complex undergoes reductive elimination to regenerate the palladium(0) catalyst and 
produce the coupled product (Figure 1.23). The difference from the Negishi reaction, is the 
additional copper cycle, where the alkyne substrate first reacts with a copper(I) halide to 
form the CuX(η2-HC≡CR’) complex which is then deprotonated with a mild base, typically 
a tertiary amine, to form the copper acetylide which then participates in the 
transmetalation with the palladium(II) complex (Figure 1.23). 
 
Figure 1.23 Simultaneous palladium and copper based catalytic cycles of the Sonogashira cross coupling 
reaction.  
1.2.2 Enzymes as Biological Catalysts 
Biological systems require much more mild conditions than the conditions under which 
most synthetic reactions are undertaken and many of the catalysts used in synthetic 
chemistry would be unsuitable due to their insolubility, toxicity, or lack of specificity. 
Nature instead utilises enzymes; large macromolecular systems usually comprised of 
proteins.[64-66] The largest part of enzymes is usually their protein scaffold which, while 
creating the ‘pocket’ where the reaction occurs (therefore giving the enzyme selectivity to 
particular substrates), are often not directly involved in the catalytic process itself. The 
reaction instead occurs at a particular active site which often contains metal ions acting in 
much the same way as their synthetic analogues do. An example of a metal containing 
enzyme is methyl-coenzyme M reductase which is able to anaerobically and reversibly 
produce methane from coenzyme bound methyl thioether and a thiol co-enzyme (Figure 
1.24) through the use of a nickel(I) ion in an enzyme active site.[67] The sulfur of the thio-
ether coordinates to the nickel(I) through which an electron is transferred to the methyl 
group oxidising the thiol, which is followed by transfer of the proton from the thiol to the 




Figure 1.24 General process by which methyl-coenzyme M reductase anaerobically generates methane. 
One of the most well-known metal containing active sites in biology is haemoglobin, the 
oxygen transport protein in all terrestrial vertebrates.[69] In haemoglobin, the active site 
contains an iron(II) ion within the 4-coordinate heme moiety with an additional histidine 
residue coordinating in an axial position (Figure 1.25). Since iron(II) prefers an octahedral 
geometry there is an unoccupied axial valence to which oxygen can reversibly coordinate 
giving the functionality of haemoglobin to act as an O2 transporter. 
 
Figure 1.25 Reversible coordination of O2 to the Fe(II) ion of deoxyhaemoglobin (left) to form  
oxyhaemoglobin (right).  
1.2.2.1 Multimetallic Enzymes  
Many enzyme active sites incorporate multiple metal ions which can exist as separate 
complexes in close proximity, bridged ions, or as metal clusters. Multimetallic systems 
often have properties similar to those of their monometallic counterparts, but also display 
unique or enhanced properties that arise from the cooperative interactions between the 
metal ions.[70] Many heme based systems have cooperative interactions with secondary 
metal centres such as cytochrome c oxidases,[71] and nitric oxide reductase.[72] Two 
bimetallic systems which have comparable oxygen binding functionality to haemoglobin 
(as biological oxygen transport protiens), but with very different structural arrangements 
at their active sites, are hemocyanin[73-74] and hemerythrin.[75] Hemocyanin contains two 
separate copper(I) ions each coordinated to three separate histidine residues (Figure 
1.26). On addition of O2 the protein undergo conformation changes to bring the two 
copper(I) ions into close proximity where they form a dinuclear complex with the 
dioxygen bridging the two copper atoms (Figure 1.26).  
 
Figure 1.26 Separate Cu(I) complexes within the active site of deoxyhemocyanin (left) come together through 
conformation changed of their protein scaffold, to form the O2 bridged complex in oxyhemocyanin (right). 
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Unlike hemocyanin, the two iron(II) ions in the active site of hemerythrin are held in close 
proximity through two bridging carboxylic acid residues, in addition to the five histidine 
residues which coordinate the two ions (three are coordinate to one iron(II) while two are 
coordinated to the other). The two metal ions are additionally bridged by a hydroxyl ion 
(Figure 1.27). Oxygen binds to hemerythrin through a reductive process forming 
protonated peroxide which is coordinated to the iron with only two coordinated histidine 
residues (Figure 1.27). While the reduction product is only coordinated to one iron ion, 
both metals donate a single electron each, both becoming oxidised to iron(III), rather than 
a localised two electron oxidation which would result in oxyhemerythrin containing both 
an iron(II) and an iron(IV) ion. This process is referred to as cooperative metal reduction. 
 
Figure 1.27 The dinuclear active site of deoxyhemerythrin (left) where the two Fe(II) ions are bridged by two 
carboxcylic acid residues and a hydroxyl ion. Oxygen preferentially binds to Fe(II) with only two coordinated 
histidine residues in oxyhemerythrin (right). 
1.2.2.2 Synthetic Multimetallic Analogues 
Building on the multimetallic systems observed in biology there has been much research 
into synthesising functional and structural analogues of these natural systems, in 
particular hemerythrin due to its interesting mode of oxidative addition.[70, 76-82] A 
functional structural analogue of the hemerythrin system was developed by Mizoguchi 
and Lippard which replicated the active site with two iron(II) ions bridged by two 
carboxylates and a hydroxyl ion (Figure 1.28).[83] It is a synthetically challenging system to 
construct Particularly the asymmetric addition of the ancillary ligand (L) to symmetrical 
complex where both iron(II) ions are five coordinate, since the product with an L 
coordinated to each iron ion would readily form.[83] 
 
Figure 1.28 Synthetic analogue of hemerythrin. 
24 
 
Another approach to synthesising analogues of enzyme active sites is to synthesise 
complexes which replicate the function without necessarily replicating the structure.[77-78, 
84] A series of binucleating ligands which contained both a six coordinate and a four 
coordinate site in close proximity were synthesised by Bosnich et al.  to replicate the 
function of binuclear enzymes like hemerythrin and hemocyanin.[85] The ligands were 
designed such that it contained a ‘closed’ six coordinate site, Ma, as well as an ‘open’ four 
coordinate site, Mb, which has open valence sites to which substrates can bind.[77] The 
ligands were able to coordinate a variety of octahedral transition metals, and sometimes 
two different metals, although the synthesis of both the ligands and their resulting 
complexes were challenging.[85] It was found with the first generation of ligands that while 
a substrate could oxidatively bind to Mb, as predicted, the change in the oxidation state of 
Mb, which generates a change in the M-L bond lengths, would put mechanical strain on Ma 
through the closely linked ligand system preventing oxidation of the second metal and 
excluding the possibility of cooperative metal reduction in the manner of hemerythrin.[75, 
84-85] Further work by Bosnich et al on second generation ligands where the two metal ions 
were bridged by an oxadiazole moiety and a separate hydroxyl ligand were able to obtain 
cooperative metal reduction without deactivation from mechanical coupling.[86] 
 
Figure 1.29 First generation (left) and second generation (right) binucleating ligands from Bosnich et al.[85-86] 
each coordinating two generic metals, Ma and Mb, in the closed six coordinate and open four/five coordinate 
sites, respectively.  
1.2.3 Approaches to Synthetic Heterometallic Systems 
The ability to create synthetic systems that contain multiple different metals that can act 
in a synergistic manner have great potential to provide enhanced catalytic activity.[70, 87-90] 
There are a variety of approaches to synthesising heterometallic systems each with its 
own advantages and also synthetic challenges. The simplest approach is through a 
bridging (or ditopic) ligand, which contains two separate coordination sites either in close 
proximity or electronically linked, like in the case of the tetrapyridophenazine ligand 
utilised by Rau et al. in the development of a ruthenium-palladium photocatalytic species 
(Figure 1.30) which was shown to give selective hydrogenation of toluene.[91] Selectively 
coordinating one metal to only one of the N^N coordination sites of the 
tetrapyridophenazine ligand is synthetically challenging and typically low yielding with 
the homobimetallic species forming the major product even when additional functional 




Figure 1.30 Ruthenium-palladium photocatalytic system developed by Rau et al.[91] 
1.2.3.1 Varied Denticity in Ditopic Ligands 
One way to improve the selectivity when coordinating different metals to a ditopic ligand 
is to vary the denticity of the coordination sites, i.e. by having separate three- and  two- 
coordinate sites, to which metal precursors with restricted valences (i.e. [Ru(bpy)2]2+) will 
selectively coordinate. Examples of ligands containing linked terpy and phen moieties 
have been reported by Sauvage et al. (Figure 1.31),[93-94] Schmittel et al.,[95] and Coronado 
et al.[96] While most of these ligands were used for homometallic supramolecular 
assemblies Coronado et al. reported a ruthenium-osmium complex of their linked phen-
terpy ligand (Figure 1.32). However this heterometallic complex was synthesised through 
addition of the terpy moiety to the phen moiety via a palladium cross coupling post-
complexation of the ruthenium(II) to the phen.[97] 
 
Figure 1.31 Ditopic ligand containing a three coordinate terpy moiety (red) and two coordinate phen moiety 
(blue) reported by Sauvage et al.[94] 
1.2.3.2 Post Synthetic Modification of Complexes 
The other approach to synthesising bridged heterometallic complexes mentioned above is 
to utilise a ligand which also has pro-ligand functionality such that once the ligand is 
coordinated to the first metal a post synthetic modification can be undertaken to generate 
the second coordination site of the bridging ligand to which a second metal can then be 
coordinated. Coronado et al. utilised this method in synthesising their ruthenium-osmium 
complex where the ruthenium(II) complex of the phen pro-ligand ligand was synthesised 
first before the terpy moiety was attached through a Suzuki cross-coupling reaction 





Figure 1.32 Synthesis of ruthenium-osmium heterometallic complex through post synthetic modification of 
coordinated phen moiety (blue) at the bromo- group (orange) to attach a terpy moiety (red), reported  
by Coronado et al.[97] 
Another example of this approach has been reported by Downward et al. to synthesise a 
ruthenium-cobalt based photo-ligand-ejection complexes.[87, 98] Their work showed that a 
preformed bis(bipyridine)phenanthrolinedione ruthenium(II) complex would react with 
hydrazidepyridinecarboximidic acid to modify the phenanthrolinedione ligand and 
generate a free bidentate coordination site (Figure 1.33) to which a variety of transition 
metals could be subsequently coordinated.[98] 
 
Figure 1.33 Post synthetic modification of a ruthenium(II) complex (left) at the dione portion of the 
phenanthrolinedione ligand (orange) to produce a second bidentate pocket (blue) reported by  




1.3 Approaches towards Non-covalent Heterometallic Systems 
While a number of general methods for synthesising heterometallic complexes were 
described above, they all relied on covalent connections between the coordination 
complexes. It should be possible, however, to create non-covalent heterometallic systems, 
where separate metal complexes interact through complementary motifs. While a number 
of intermolecular interactions could be utilised for this type of assembly, hydrogen 
bonding (and in particular triple hydrogen bonding motifs) is the focus of this work. There 
are six different possible triple hydrogen bonding motifs, which come in three 
complementary pairs, AAA and DDD, DAA and ADD, and ADA and DAD. As mentioned 
above (Subsection 1.1.1.4), the interaction energy varies between the different 
complementary pairs, with the homogenous motifs having the strongest interactions while 
the most mixed motifs have the weakest interactions (relatively).[36] A survey of the 
literature revealed a large number of ligands that contain triple hydrogen bonding 
synthons. The synthetic availability of ligands that contain different hydrogen bonding 
motifs seems to be inversely related to interaction strengths between the complementary 
motifs with ADA and DAD containing ligands being the most prevalent and synthetically 
available. The following sections are a summary of the coordination complexes of these 
triple hydrogen bond containing ligands which have the potential to act as supramolecular 
tectons. Complexes where the triple hydrogen bond motifs were obscured have been 
omitted for brevity. 
 
1.3.1 Complexes with Ligands Containing ADA and DAD Motifs 
1.3.1.1 Uracil Analogues 
The most prevalent ADA type motif is the imide, which consist of two acyl groups bridged 
by a nitrogen atom (Figure 1.34a). Imide containing organic molecules are used 
extensively for triple hydrogen bonding including molecules like cyanuric acid (Figure 
1.34b) which is a three-fold symmetric arrangement of imides within a six membered ring. 
While cyanuric acid can be directly coordinated to metal ions,[99] substituted uracil 
moieties (Figure 1.34c) are much more useful for creating ligands with appended imide 
motifs due to the variety of potential coordinating motifs as well as functional groups 
which can be attached. 
 
Figure 1.34 (a) General structure of an imide moiety. (b) Cyanuric Acid. (c) General structure of a uracil 




A variety of derivatives of uracil and their resulting complexes have been reported 
utilising various coordinating groups. A carboxylic acid at R2 gives the common ligand 
orotic acid, orotH3, for which a large variety of transition metal,[100-120] main group,[121-123] 
lanthanide,[124-126] and even actinide[127] complexes have been reported with the orotic acid 
able to coordinate in a variety of different modes (Figure 1.35) as either an anionic or 
dianionic ligand. Substitution of an amine at R1 in addition to the carboxylic acid at R2 
gives aminoorotic acid, which allows the ligand to coordinate through a six membered N,O 
chelate in addition to the existing five membered N,O chelate of orotic acid and various 
metal complexes,[126, 128-130] including dinuclear complexes,[100] have been reported.  
 
Figure 1.35 Different coordination modes of orotic acid to a generic metal. κ2-N,O (left), κ1-N (centre), or κ2-
O,O (right). κ1-O is also a possible coordination mode. 
 
Figure 1.36 X-ray crystal structures of [Ni(κ2-N,O-orotH)(H2O)4] (left),[131] and [Pt(κ1-N-orotH)(dapy)(PEt3)2] 
(right).[101] Additional solvent molecules and ethyl groups of PEt3 ligands are hidden for clarity. 
The nucleobase thymine is also a derivative of uracil with a methyl group at R1 and ligands 
and their resulting complexes have been reported either coordinating directly through the 
amide nitrogen,[132] or with further substation at R2 with either α-mercapto-acrylic acid[133] 
or porphyrins (Figure 1.37).[134] Alkyne substituted uracils have been shown to coordinate 
to rhodium(I)  in both a η2 manner and as carbenes.[135] Substituted alkynes opens up the 
addition of other coordinating moieties via cross-coupling type reactions, such as 
bisdimethylaminoethylene benzene.[136] Diphenylphosphino-substituted uracils have been 
shown to form gold(I) complexes,[137] while pyridine-substituted uracils have been shown 




Figure 1.37 Thymine (top left) and two ligand type derivatives, α-mercapto-β-thymine-acyrlic acid (bottom 
left) and tetrathymineporphyrin (right). 
 
Figure 1.38 X-ray crystal structure of [Rh(ppy)2(κ1-N-thymine)(EtOH)].[132] 
Barbiturates, a group of biologically active molecules, are another derivate of uracil 
containing an additional acyl group to have two adjacent ADA motifs at ~60° to each other. 
Barbiturates can have a variety of functional groups substituted at the six position carbon 
and a series of 2,2’-bipyridine substituted barbiturates (Figure 1.39) and their 
ruthenium(II) complexes have been reported along with their host-guest chemistry in 
solution.[139] 
 
Figure 1.39 Barbitone (far left) and a variety of 5-(2,2’-bipyridine) (bpy) substituted barbiturates. 
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1.3.1.2 Biurets  
Biuret is another imide based ligand containing only two amides incorporated adjacent to 
the imide moiety (Figure 1.40). Two closely related analogues of biuret are thiobiuret and 
dithiobiuret which involve substitution of one or both of the acyls for thioyls, respectively 
(Figure 1.40). Transition metal complexes of biuret have been reported typically 
coordinating κ2-N,N,[140-154] although some examples of thiobiuret coordinating κ2-S,O 
which gives a DDD type motif (vide infra). A variety of biuret ligands with additional 
functional groups attached to the amide nitrogens, including derivatives of 
ethylenebisbiuret, and their resulting complexes have also been reported.[154-161] 
 
Figure 1.40 Structures of the simple imide, biuret (left) and biuret analogues, thiobiuret (centre) and 
dithiobiuret (right). 
 
Figure 1.41 X-ray crystal structures of [Rh(η5-Me5Cp)(biuret)] (left),[162] and n-Bu4N[Cu(o-
phenylenebisbiuret)] (right).[154] Solvent molecules and counter-ions hidden for clarity. 
Thiobiuret can coordinate in two different modes either κ2-N,N like biuret or in a κ2-S,O 
manner (Figure 1.42). The κ2-N,N coordination is rare with only the Ni(II) and Pd(II) 
complexes reported[163-164] while a variety of transition metal complexes of thiobiuret 
coordinating κ2-S,O which gives a DAD hydrogen bonding motif when deprotonated at the 
imide nitrogen, have been reported.[165-167] Thiobiuret has also been shown to coordinate 
κ1-S to certain metals such as cobalt and mercury.[166] Dithiobiuret has no reported 
complexes where it has coordinated κ2-N,N and instead coordinates solely κ2-S,S which, on 
deprotonation of the imide nitrogen, gives DAD containing complexes.[168-186] Interestingly, 
even though dithiobiuret is extremely toxic,[187] especially in comparison to thiobiuret and 
biuret, its complexes have been used in a variety of hydrogen bonding studies.[168-172] 
Transition metal complexes where dithiobiuret coordinates κ1-S have also been reported 




Figure 1.42 Common coordination modes of biuret (left), thiobiuret (centre), and dithiobiuret (right) which 
give either ADA or DAD hydrogen bonding motifs. 
 
Figure 1.43 X-ray crystal structures of [Pt(dithiobiuret)2] (left),[175] and [Ni(i-Prdithiobiuret)2] (right).[190] 
Solvent molecules are hidden for clarity. 
1.3.1.3 Hydantoin and Maleimides 
The imide motif can also be incorporated into five-membered rings, with the two common 
parent moieties hydantoin and maleimide (Figure 1.44) which are both readily 
functionalised at their four and five positions. 
 
Figure 1.44 Hydantoin (left) and maleimide (right) moieties with readily functionisable position labelled R1 – 
R3.  
Unsubstituted hydantoin is able to coordinate through either the imide or amide nitrogens 
although doing so through the imide nitrogen would block the ADA hydrogen bonding 
motif (except in the case where R1/R2 = carbonyl).[191] Many transition metal complexes of 
substituted hydantoins coordinating through the amide nitrogen (i.e. R3 = M) with the 
groups substituted at R1 and R2 including four – seven membered alkane rings (Figure 
1.45)[192-194] as well as mixtures of methyl, phenyl, and α-hydroxybenzyl groups.[194-196] 
Hydantoin can also be readily functionalised with coordinating groups, the most common 
being pyridine, with complexes reported of the 2-, 3-, or 4-pyridyl, with additional 
substitutions at R2 and R3 (Figure 1.45) being a mixture of methyl, ethyl, phenyl, benzyl, or 
amino.[197-210] There is also the related 2-pyridylmethylenehydantoin (Figure 1.45), Hpyhy, 
which coordinates transition metals κ2-N,N with a six membered chelate.[211-213] 
Tetrahydrothiophene or thiane substituted hydantoins (Figure 1.46) have also been used 
to synthesis κ1-S complexes,[214-216] as well as carboxylate and hydroxyl (Figure 1.46) or 
acetic acid substituted hydantoin to obtain κ2-O,O or κ1-O based complexes.[196, 217] A 




Figure 1.45 Various substituted hydantoin including cycloalkanes (left), pyridyl (centre), and 
pyridylmethylene (right). 
 
Figure 1.46 Tetrahydrothiophene (n=1) or thiane (n=2) substituted hydantoins (left) and 5-carboxyl-5-
hydroxyl hydantoin (right). 
 
Figure 1.47 X-ray crystal structures of [Pt(Mepyhy)(dmso)Cl] (left),[207] hydantoin substituted ferrocene 
(centre),[219] and [Cu(pyhy)(H2O)Cl] coordination polymer (right).[211] Solvent molecules are hidden for clarity. 
Unsubstituted maleimide can coordinate in a η2 manner through the carbon-carbon 
double bond, with a variety of transition metal complexes reported.[191, 220-227] Further 
organometallic complexes of maleimide have been reported with the maleimide moiety 
fused to either ferrocene[228-229] or phenylpyridine type ligands.[230-233] Transition metal 
complexes of maleimide fused nitrogen based ligands such as pyridine,[234] 
phenanthroline,[235] prolinato,[236-249] 8,7-quinolindole,[250-259] and pyrazinobis-
benzimidazole (Figure 1.48).[260] Maleimide can also be substituted with various other 
groups with metal complexes of the dimercapto[261-262] and tricyano[263-264] substituted 
ligands (Figure 1.49) being reported. Additionally maleimide moieties have been 
incorporated into a variety of porphrins and phthalocyanines.[265-273] A large number of 
these complexes have biological relevance with much of the referenced literature 




Figure 1.48 Maleimide fused tautomers 8,7-quinolindole (left) and prolinato (centre), and maleimide fused 
pyrazinobisbenzimidazole (right) ligands. 
 
Figure 1.49 Dimercapto and tricyano substituted maleimide ligands. 
 
Figure 1.50 X-ray crystal structures of [Pt(η2-maleimide)(dippf)] (left),[229] and 
Ph4P[Ni(dimecaptomaleimide)2] (right).[261] Counter-ions and i-propyl groups of the dippf ligand hidden for 
clarity. 
1.3.1.4 Melamine and Diaminotriazines 
The most common DAD motif is that of two primary amines either side of a heterocyclic N 
atom with the classic example the threefold symmetric molecule melamine (Figure 1.51). 
Melamine can coordinate metals through the nitrogen atoms of the core 1,3,5-triazine ring, 
with a variety of metal complexes reported.[274-286] The closely related moiety that can be 
readily functionalised to ligands is 2,4-diamino-1,3,5-triazine, DAT (Figure 1.51), typically 
through a cyclisation reaction at a cyano[287] or formyl[288] group. Methyl substituted DAT 
forms transition metal complexes comparable to melamine,[289-290] while phenyl and para-
tolyl substituted DAT give κ2-C,N cyclometalated complexes.[291-293] Alkyne substituted 
DAT and the resulting organometallic complexes have also been reported.[294-295] 
 
Figure 1.51 DAD containing motifs melamine (left) and DAT (right). 
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Diaminotriazines can also be substituted with a variety of heteroaromatic groups (with 
and without spacing groups) with metal complexes reported for the ortho, meta, and para 
substituted pyridines,[296-308] quinoline and isoquinoline,[309] as well as a variety of other 
heteroaromatic groups (Figure 1.52),[310-317] including additional DAT moieties.[318] One or 
two DAT moieties have also been incorporated into terpy related ligands,[319] as well as 
appended to azamacrocycles.[320-325]  
 
Figure 1.52 2,4-diamino-1,3,5-triazine substituted ligands containing thiol, furan, or pyrole (left, X = S, O, or 
N), isoquinoline (centre), or 2,2-bipyridine (right). 
 
Figure 1.53 X-ray crystal structures of [Ru(bpy)2(isoquinolineDAT)](ClO4)2 (left),[309] and [Yb(DAT2py)(NO3)3] 
(right).[319] Counter-ions hidden for clarity. 
1.3.1.5 Biguanides and Guanidines 
Closely related to the diaminotriazines, but lacking the aromatic triazine ring, is the 
biguanide motif (Figure 1.54), which nominally contains a triple donor motif, but when 
complexed can either exist in a tautomeric form or readily deprotonate to give a DAD type 
motif (Figure 1.54). Much of the coordination chemistry of unsubstituted biguanides was 
researched in the first half of the 20th century with a wide variety of complexes 
reported.[326-327] Since then there has been an increasingly wide range of substituted 
biguanides reported which have displayed a variety of different κ2-N,N coordination 
geometries which result in DAD type hydrogen bonding motifs, as well as readily 
deprotonating to also give DAD motifs (Figure 1.55). It should be noted that while the 
deprotonated biguanides are drawn with a formal negative charge on the central amine, 




Figure 1.54 Free base form of biguanide (left), coordinated biguanide in DAD resulting tautomer (centre), and 
deprotonated form of coordinated biguanide which also gives a DAD type hydrogen bond motif (right). 
 
Figure 1.55 Various conformations of substituted biguanide complexes which contain DAD hydrogen bond 
motifs as well as the deprotonated biguanide complex (far left). 
 
Figure 1.56 X-ray crystal structures of [Cr(biguanide)3] (left),[329] and [Cu(1-methylbiguanide)2] (right).[330] 
Solvent molecules hidden for clarity. 
Asymmetrically substituted biguanide complexes are among the most numerous with a 
wide range of complexes of aryl,[331-350] alkyl,[330, 351-355] thiol,[356-357] amino,[358] and 
ketoxime[359] substituted biguanides reported, as well as complexes of the anti-malarial 
drug, palurdine (Figure 1.57),[338, 360-363] and the type 2 diabetes treating drug, 
metformin.[364] A range of alkyl bridged bisbiguanides (Figure 1.57) and their κ4-N,N,N,N 
coordination complexes,[365-376], as well as biguanide incorporating azamacrocyclic 
complexes[377-379] have been reported. These ligands are particularly notable for their 
strong σ-donor character which allows the formation of high oxidation number 
coordination complexes. A series of symmetrical, diaryl substituted, biguanides have also 
been reported[380] with only a couple of cobalt(III), copper(II) complexes reported,[157, 381] 
as well as a full range of nickel(II) complexes.[328] 
 
Figure 1.57 Substituted biguanides paludrine (left), bisbiguanide alkanes (centre, n = 2 – 8), and o-
toylbiguanide (right). 
Closely related to the biguanide ligands are the guanidine substituted imidazoles, 2-
guanidinobenzaimidazole and 5-oxo-4,4-diphenylimidazol-N-phenylguanidine (Figure 
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1.58) which readily deprotonate to give DAD type motifs. A wide variety of complexes of 
these guanidine ligands, particularly 2-guanidinobenzaimidazole, have been reported.[169, 
382-398] 
 
Figure 1.58 Deprotonated 2-guanidinobenzaimidazole (left) and 5-oxo-4,4-diphenylimidazol-N-
phenylguanidine (right) complexes (R1 = aryl or alkyl, R2 = H, or Me). 
 
Figure 1.59 X-ray crystal structures of [Ni(2-guanidinobenzaimidazole)2] (left),[390] and [Cu(5-oxo-4,4-
diphenylimidazol-N-phenylguanidine)2] (right).[389] Solvent molecules hidden for clarity. 
 
1.3.2 Complexes with Ligands Containing ADD and DAA Motifs 
1.3.2.1 Nucleobases 
The two complementary nucleobases guanine and cytosine contain ADD and DAA 
hydrogen bond motifs, respectively, both in closely related six membered rings containing 
adjacent imide and amidine moieties (Figure 1.60). Guanidine can coordinate κ-N through 
any of its nitrogen atoms, while having a variety (alkyl, ethers, carbohydrates, or PEG) of 
substituents at the amine nitrogen of the imidazole ring or through functionisation of 
ligand type moieties (i.e. 2,2’-bipyridines or carboxylic acids) to the imidazole ring with a 
large variety of metal complexes being reported.[399-426] Cytosine can also coordinate κ-N 
through its nitrogen atoms but only coordination through the imide nitrogen leaves the 
DAA motif intact with a small collection of complexes reported[427-429] as well as a number 
of complexes with cytosine coordinating η2-C,C also reported.[430-432] Cytosine can also be 
appended to coordinating moieties with complexes of cyclopentadiene and ferrocene,[433-
443] porphrin,[444] bipyridine,[425, 445-446] and carbohydrates[404, 447-448] with appended 
cytosine moieties reported. Complexes of substituted (aryl, nitroso, aldyl, and amino) 




Figure 1.60 Triple hydrogen bond motif containing nucleobases guanine (left) and cytosine (right), as well as 
their variably substituted analogues (centre left and centre right). 
 
Figure 1.61 X-ray crystal structure of [Ir(η5-Me5Cp)(ppy)(N-Et-guanine) (left),[426] and cytosine substituted 
ferrocene (right).[435] Solvent molecules hidden for clarity. 
1.3.2.2 Amidino-O-Alkylurea and Pseudothiohydantoin 
Structurally and chemically similar to biguanide is the amidino-O-alkylurea group of 
ligands which have an ether group replacing one of the amine groups of biguanide (Figure 
1.72). Amidino-O-alkylureas coordinate κ2-N,N in the same manner as biguanides and can 
also deprotonate at the secondary amine to switch from a ADD motif to a DAA one, and a 
large collection of transition metal complexes,[330, 345, 462-500] and a handful of lanthanide 
complexes[501-502] have been reported. Pseudothiohydantoin (Figure 1.72) is a DDA 
containing moiety which is structurally related to hydantoin and can coordinate κ1-S or be 
functionalised with other coordinating groups in the same manner as hydantoin, although 
not many coordination compounds have been reported which preserve the triple 
hydrogen bond motif.[503]  
 
Figure 1.62 Amindino-O-alkylurea (left) which contains a ADD motif (though can be DAA when deprotonated) 




Figure 1.63 X-ray crystal structure of [Cu(1-ethoxybiguanide)2].[500] Anion hidden for clarity. 
1.3.2.2 Guanidine Derivatives 
Unlike the series of 2-guanidinobenzaimidazole ligands, the similar 2-
guanidinopyrimidine ligands contain an ADD hydrogen bonding motif (Figure 1.64), 
rather than the DAD motif observed in the 2-guanidinobenzaimidazole ligands and 
complexes. A series of transition metal complexes of (primarily chloro) substituted 2-
guanidinobenzaimidazole have been reported.[504-510] Like with other biguanide and 
guanidine complexes, 2-guanidinopyrimidine should be able to form DAA hydrogen 
bonding motifs on deprotonation, but no complexes of the deprotonated ligand have been 
reported. 
 
Figure 1.64 Substituted 2-guanidinopyrimidine complex with an ADD motif (left) and the potential DAA motif 
which could be formed on deprotonation (right). 
 
1.3.3 Complexes with Ligands Containing DDD and AAA Motifs 
1.3.3.1 Biguanides, Guanidines, and Thiobiurets 
Many of the reported biguanide and guanidine complexes exist in the tautomeric form 
where the C-N double bonds of the guanidine moieties are localised adjacent to the 
coordinated nitrogen atoms (Figure 1.65) giving DDD type hydrogen bond motifs.[326, 328, 
330, 333-334, 356, 360, 368, 394, 421, 505, 511-521] Similarly complexes of thio- and dithiobiuret which 
coordinate in κ2-S,O and κ2-S,S manners, respectively (Figure 1.65), contain the same DDD 




Figure 1.65 DDD motif containing complexes of substituted biguanides (far left), 2-guanidinobenzimidazole 
(centre left), thiobiuret (centre right), and dithiobiuret (far right). 
 
Figure 1.66 X-ray crystal structures of [Ni(paludrine)2]Cl2 (left),[527] and [Ni(dithiobiuret)2](ClO4)2 (right).[183] 
Solvent molecules and anions hidden for clarity.  
1.3.3.2 Heterocycle Fused Uracil Analogues 
Ligands which contain AAA triple hydrogen bond motifs are rare with very few examples 
of AAA containing complexes reported. All of the examples present in the literature 
contain deprotonated heterocycle (pyrazine or imidazole) fused uracil analogues (Figure 
1.67) lumazine,[528-529] 6-thioxanthine,[461] and uric acid.[530] 
 
Figure 1.67 AAA motif containing complexes of deprotonated lumazine (left), 6-thioxanthine (centre), and 




1.4 Project Outline 
This project intends to synthesise a collection of ADA and DAD triple hydrogen bond motif 
containing transition metal complexes using existing 1,5-diarylbiguanide, biuret, orotic 
acid, and 5-(2-pyridylmethylene)-hydantoin ligands, as well as new 6-(2,4-diamino-1,3,5-
triazine) functionalised 5-(2-pyridyl)-1,2,3-triazine based ligands. These complexes are 
designed such that they should typically contain a single, well defined, hydrogen bonding 
motif, and, where possible, are neutral complexes, or if they are charged, have non-
hydrogen bonding counter-ions. The focus on synthesising neutral complexes is to limit 
potential complications and competing interactions when observing the hydrogen 
bonding. Neutral complexes are ideal for quantifying the strength of hydrogen bonding 
interactions between complexes since overall charge-charge interactions between the 
interacting molecules have been eliminated, and there are no counter-ions present which 
could compete for hydrogen bonding interactions. The particular metal ions used (Pd(II), 
Pt(II), Ru(II), Ir(III), Cu(II), and Zn(II)) were selected both for their potential as catalytic 
and/or photoactive centres, as well as for their coordination chemistry properties 
(generally non-labile, stable, and have well defined coordination geometries). 
1.4.1 Palladium(II) and Platinum(II) Diarylbiguanides and Biurets 
1.4.1.1 Diarylbiguanides 
The first series of complexes to be synthesised was a collection of palladium(II) and 
platinum(II) 2-phenylpyridine 1,5-diarylbiguanides using the range of substituted  
1,5-diarylbiguanide ligands previously reported in the literature.[328, 380] These ligands are 
ideal since they are straightforward to synthesise (Scheme 1.1) and by varying the initial 
aniline used, can add a variety of substituents which should be electronically linked to the 
hydrogen bonding motif. 
 
Scheme 1.1 Synthesis of hydrochloride salt of 1,5-diarylbiguanide ligands from two equivalents of 
appropriately substituted aniline and sodium dicyanamide. 
The diarylbiguanide ligands will be complexed with the Pd(II) and Pt(II) 2-phenylpyridine 
dimers[531-532] to give the DDD containing complex which, upon deprotonation of the 
biguanide moiety, should give neutral molecules containing a single DAD type hydrogen 
bonding motif. The varying substituents on the aryl rings of the diarylbiguanide may have 
electronic effects on the hydrogen bonding motif which should be observable when 
comparing hydrogen bonding interactions between the different complexes. 
1.4.1.2 Biurets 
For complementary complexes for co-crystallisation with the diarylbiguanide complexes, 
palladium(II) and platinum(II) biuret complexes with neutral, and solubilising ancillary 
ligands would be ideal. Bis(diphenylphosphino)ethane (dppe) was chosen as the ancillary 
ligand since it should improve the solubility in organic solvents, and the ethylene protons 




Figure 1.68 Proposed ADA containing complexes [Pd(dppe)(biuret)] (left) and [Pt(dppe)(biuret)] (right). 
1.4.2 Ruthenium(II) and Iridium(III) Bis-bipyridine/phenylpyridine 
Complexes 
The octahedral metal complexes ruthenium(II) bis-2,2’-bipyridine and iridium(III) bis-2-
phenylpyridine both have two free coordination sites which are ideal for coordinating 
bidentate type ligands and these complexes should be readily synthesised from the 
ruthenium(II) dichloride complex, [Ru(bpy)2Cl2], and the iridium(III) dimer fac-[(Ir(ppy)2-
μ-Cl2], respectively.[533] The ligands orotic acid, orotH3, and 2-pyridylmethylenehydantoin, 
pyhyH,[213] both contain ADA hydrogen bonding motifs and should coordinate as dianions 
and monoanions, respectively, giving neutral complexes with ruthenium(II) bis-2,2’-
bipyridine and iridium(III) bis-2-phenylpyridine, respectively. For a DAD hydrogen bond 
motif containing ligand for the octahedral complexes, 2,4-diamino-1,3,5-triazine 
substituted 2-pyridyl-1,2,3-triazole type ligands were proposed, due to recent work 
showing the usefulness of pyridyltriazoles as synthetically available and readily 
functionisable alternatives to substituted 2,2’-bipyridine, or phenanthroline ligands.[33, 534] 
The proposed benzyl and hexyl substituted ligands BtpD and HtpD should be able to be 
synthesised in three to four steps utilising well known and robust reactions such as 
Sonogashira cross couplings,[60] and copper catalysed azide-alkyne cycloadditions.[33]  
 
Figure 1.69 Proposed octahedral ruthenium(II) (M = Ru(II), E = N) and iridium(III) (M = Ir(III), E = C) 
complexes of orotH (left), pyhy (centre), and BtpD and HtpD (R = Bn or Hex) (right).  
1.4.2.1 Ruthenium(II) Bis-bipyridine Complexes 
The ruthenium(II) bis-2,2’-bipyridine moiety has an overall charge of 2+, so will only form 
neutral complexes with dianionic ligands, such as orotic acid (in its dianoinc κ2-N,O 
coordination mode), and would still give cationic complexes with monoanionic ligands, 
like pyhy, or neutral ligands like BtpD and HtpD. With these complexes anion choice 
becomes important due to some anions competing with other species for hydrogen 
bonding interactions; therefore fluorinated anions like hexafluorophosphate would be 
used where possible. Complexation of the hydrogen bonding ligands to the ruthenium(II) 
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would be done under microwave assisted conditions, which would initially produce the 
chloride salts (except for the orotic acid complex which would be neutral), and then 
precipitated from the crude solution by addition of an aqueous solution saturated with the 
desired anion (likely saturated NH4PF6 solution). 
 
Figure 1.70 Proposed synthesis of ruthenium(II) bis-2,2’-bipyridine complexes through microwave assisted 
complexations (L = orotH, pyhy, BtpD, or HtpD; n = 0 – 2). Intermediate complexes will only be present in 
crude reaction solution and won’t be isolated. 
1.4.2.2 Iridium(III) Bis-phenylpyridine Complexes 
The iridium(III) bis-2-phenylpyridine moiety has an lower overall charge than its 
ruthenium(II) counterpart due to the two anionic 2-phenylpyridine ligands and therefore 
forms neutral complexes with monoanionic ligands, such as pyhy, and will form cationic 
complexes with neutral ligands like BtpD and HtpD, while the dianionic ligand orotH will 
give an overall anionic complex. Once again counter-ion is an important consideration to 
avoid competition for hydrogen bonding interactions with hexafluorophosphate the 
primary anion to be used for the cationic complexes while tetra-alkyl ammonium cations, 
such as tetra-n-butyl ammonium, being used for the anionic complexes. The complexation 
would be done through heating of a solution of the iridium(III) dimer with two equivalents 
of ligand and an excess of inorganic base such as sodium carbonate. The complex would 
then initially be formed as either the sodium or the chloride salts (except for the pyhy 
complex which would be neutral) and would be precipitated from solution as the desired 
salts by addition of saturated aqueous solution of the desired counter-ions (saturated n-
Bu4NCl, or NH4PF6 solutions). 
 
Figure 1.71 Proposed synthesis of iridium(III) bis-2-phenylpyridine complexes from the fac-[(Ir(ppy)2-μ-Cl2]  
iridium(III) dimer (L = orotH, pyhy, BtpD, or HtpD). Intermediate complexes will only be present in crude 




1.4.3 Copper(II) and Zinc(II) Hydantoin Complexes 
While all the complexes proposed above contain only a single triple hydrogen bond motif, 
complexes which contain two or more hydrogen bond motifs are not uncommon and could 
be useful for creating larger assemblies, either as trimers, tetramers,† larger discrete units, 
or as supramolecular polymers (for infinitely repeating units). Complexation of two 
monoanonic pyhy ligands to 2+ metal ions should give neutral complexes containing two 
ADA triple hydrogen bond motifs. Square planar metals such as Pd(II) and Pt(II) would not 
be suitable since the carbonyls of one ligand would be brought into close proximity to 
either the hydantoin or pyridine moieties (for cis or trans conformations, respectively) of 
the adjacent ligand resulting in steric repulsion. Metals with tetrahedral, or more flexible 
four coordinate spheres, such as Zn(II) or Cu(II) should readily form complexes. These 
complexes when mixed with the single DAD containing platinum and palladium biguanide 
complex or ruthenium and iridium DAT containing complexes would be expected to form 
2:1 trimers, or if mixed with complexes like the previously reported bis-1,5-
diarylbiguanide nickel(II) complexes,[328] could form 1D hydrogen bonded polymer chains 
(Figure 1.72). 
 
Figure 1.72 Potential hydrogen bonded assemblies that could be formed by bis-pyhy complexes. Discrete 
trimers should be formed when mixed with octahedral DAT containing complexes (top) while 1D  
polymeric chains should be formed when mixed with complexes like [Ni(bigu)2] (bottom). 
  
                                                             
† In this context trimer refers to a discrete supramolecular unit composed of three molecules while a tetramer 
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containing ADA and DAD triple hydrogen bonding motifs: Potential tectons for the 




2.1 Biguanide Based Synthons 
2.1.1 Introduction 
Unsubstituted biguanides are excellent hydrogen bond donors, to the point of detriment to 
other properties. The large range of hydrogen bond donors supplied by biguanides 
seriously reduces the solubility of biguanide complexes and they lack the selectivity 
offered by other hydrogen bonded moieties. A partial solution to this is substitution of the 
biguanide at the 1 and 5 positions with aryl substituents (Scheme 2.1), which firstly 
reduces the number of hydrogen bond donors as well as breaking up the potential 
hydrogen bonding surfaces. The aryl arms also offer increased organic solubility, as well as 
further substitutions for modulating both the solubility and electronics of the ligands and 
their resulting complexes.[1-2] 
 
Scheme 2.1 1,5-diarylbiguanide ligands discussed in this work. 
2.1.1.1 1,5-Diarylbiguanide Ligands 
For this work a series of six differently substituted 1,5-diarylbiguanides were prepared as 
previously described by reacting two equivalents of the appropriate aniline with sodium 
dicyanamide in aqueous HCl solution to give the hydrochloride salt which was then 
treated with sodium methoxide to obtain the free base of the ligand  
(Scheme 2.2).[1, 3] The aryl components of the ligands were substituted with a range of 
electron donating and withdrawing substituents including halides, methoxy and tert-butyl 
moieties as detailed in Scheme 2.1.  
 
Scheme 2.2 Synthesis of hydrochloride salt of 1,5-diarylbiguanide ligands from two equivalents of 




The free base of the ligands can exist in various possible tautomeric forms due to the 
acidic nature of the biguanide protons and their ready transfer between the nitrogen 
atoms of the biguanide. Solid state structures of the biguH, BrbiguH, diClbiguH, and 
diFbiguH ligands and the hydrochloride salt biguH·HCl, have been obtained by X-ray 
crystallography (Figure 2.1).[1-3]  The structures of biguH, Brbigu, and diClbiguH are 
observed to have the expected tautomer (Scheme 2.3a), with a pattern of short and long C-
N bonds supported by an intramolecular, S(6) type, hydrogen bond (Figure 2.1). The 
structure of diFbiguH exists in another tautomeric form where the double bonds are 
located on the arylated nitrogens (Scheme 2.3b), giving an N=C-NH-C=N pattern through 
the biguanide (Figure 2.1). The structure of diFbiguH still contains a supporting S(6) 
intramolecular hydrogen bond. Formally the structure of the protonated biguH.HCl ligand 
is comparable to the tautomer observed in biguH, albeit with the protonated cationic 
nitrogen. The structure however has intermediate bond lengths through the biguanide 
(Figure 2.1), characteristic of delocalised π-bonds (Scheme 2.3c), and lacking the 
intramolecular hydrogen bond observed in the other structures.  
 
Scheme 2.3 Tautomeric forms of free base 1,5-diarylbiguanide ligands. (a) Formal expected tautomer with 
alternating single and double bonds between the aryl- substituents. (b) Alternative tautomer where double 
bonds are nearest aryl- substituents. (c) Delocalised π-bond form with no supporting S(6) hydrogen bond. 
Free base has a proton at either H* location while HCl salt is protonated at both sites.  
 
Figure 2.1 X-ray crystal structures of various 1,5-diarylbiguanide ligands. Ellipsoids are drawn at 50% and the 
Cl- anion of biguH·HCl hidden for clarity. Bond lengths of biguanide moieties shown in Å. 
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2.1.1.2 Nickel(II) bis-1,5-Diarylbiguanides 
A series of nickel(II) complexes of the type [Ni(biguH)2](BF4)2 utilising the 1,5-
diarylbiguanide ligands biguH, tBubiguH, BrbiguH, diOMebiguH, and diMebiguH (the 
last of which was not used in this work) were prepared from the addition of two 
equivalents of the appropriate ligand to an acetone solution of Ni(BF4)2·6H2O, and 
precipitated as pure solids by addition of excess diethyl ether (except in the case of the 
bromo substituted complex).[2] The corresponding deprotonated complexes of the type 
[Ni(bigu)2] were also prepared from addition of two equivalents of the appropriate ligand 
to a methanol solution of Ni(BF4)2·6H2O, and precipitated as pure solids by addition of two 
equivalents of trimethylamine (except in the case of the bromo substituted complex once 
again).[2] Upon complexation with a metal ion, the neutral biguanide ligands were 
observed to convert to another of their tautomeric forms, where the double bonds were 
localised adjacent to the two coordinating nitrogens (Scheme 2.4a). This tautomer would 
be expected to give a triple hydrogen bond donor, DDD, surface but the aryl groups are 
free to rotate around the biguanide C-N bond between the depicted anti-anti 
conformations (Scheme 2.4a) and the alternate syn-syn conformations (Scheme 2.4b) 
which exposes two DD surfaces instead. The deprotonated biguanide ligands were 
observed to contain a delocalised π-system within the chelate ring (confirmed from solid 
state bond lengths, vide infra) and a DAD surface when the aryl groups are in the anti-anti 
conformation (Scheme 2.4c), but still retained two DD surfaces in the folded syn-syn 
conformation (Scheme 2.4d).  
 
Scheme 2.4 Hydrogen bonding options for complexes containing neutral and deprotonated biguanide ligands. 
(a) anti-anti conformation for neutral ligand with DDD surface, (b) syn-syn conformation for neutral ligand 
with two DD surfaces, (c) anti-anti conformation for deprotonated ligand with DAD surface, (d) syn-syn 
conformation for deprotonated ligand with two DD surfaces. 
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X-ray crystal structures of the complexes [Ni(diOMebiguH)2](BF4)2 and 
[Ni(diMebiguH)2](ClO4)2 (which were prepared from Ni(ClO4)2 rather than Ni(BF4)2) 
(Figure 2.2) were reported.[2] The complex [Ni(diOMebiguH)2](BF4)2 crystallised in the 
triclinic space group 𝑃1̅ with the asymmetric unit containing a Ni atom positioned on a 
centre of inversion, one diOMebiguH ligand, a BF4- anion, and an acetone solvent. The 
diOMebiguH ligand is in the syn-syn conformation with the BF4- anion in a hydrogen 
bonded position with NH···F hydrogen bonds from H1 and H4 to F3 and from H1 and the 
symmetry related H3 to F4 (H···F 2.42, 2.16, 2.46, and 2.13 Å, NH···F 138°, 149°, 165°, and 
160°, respectively), forming two adjacent 𝑅2
1(6) hydrogen bonding motifs. In contrast the 
structure of [Ni(diMebiguH)2](ClO4)2 (which still crystallises in the triclinic space group 
𝑃1̅ with the asymmetric unit containing a Ni atom positioned on a centre of inversion, one 
diMebiguH ligand, a ClO4- anion, and an acetonitrile solvent) has the biguanide ligand in 
its anti-anti conformation, exposing the DDD hydrogen bonding surface to which both the 
perchlorate anion and the acetonitrile solvent are hydrogen bonded; with H4 and H2 
forming NH···O hydrogen bonds to O1 and O3, respectively (NH···O 2.08 and 2.12 Å, NH···O 
157° and 171°, respectively), while H14 forms a NH···N hydrogen bond to N20 (H···N 2.49 
Å, NH···N 129°). 
 
Figure 2.2 X-ray crystal structures of [Ni(diOMebiguH)2](BF4)2·Acetone (left) and [Ni(diMebiguH)2](ClO4)2 
·CH3CN  (right) from McMorran et al.[2] Ellipsoids are drawn at 50% and disorder (excepting acetonitrile 
solvent) is hidden for clarity. 
X-ray crystal structures of the neutral complexes [Ni(bigu)2] and [Ni(diMebigu)2] (Figure 
2.3) with deprotonated biguanide ligands were also reported.[2] The complex [Ni(bigu)2] 
crystallised in the monoclinic space group C2/c with the asymmetric unit containing a Ni 
atom positioned on a two-fold axis, one bigu ligand, and an acetonitrile solvent. The 
biguanide ligand is in the anti-anti conformation with N2 and H9 forming NH···N hydrogen 
bonds to H9 and N2 of adjacent complexes (H···N 2.20 Å, NH···N 174°) via 𝑅2
2(8) motifs. 
The complex [Ni(diMebigu)2] crystallised in the triclinic space group 𝑃1̅ with the 
asymmetric unit containing a Ni atom positioned on a centre of inversion, one diMebigu 
ligand, and two DMSO solvent molecules. The biguanide ligand is in the mixed syn-anti 
conformation which presents a DD type surface on one side of biguanide moiety, to which 
one of the DMSO solvent molecules is strongly hydrogen bonded with H3 and H1 forming 
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NH···O hydrogen bonds to O1 (NH···O 2.00 and 2.25 Å, NH···O 164° and 154°, respectively) 
via a 𝑅2
1(6) motif, while having a single exposed NH donor on the other side of the 
biguanide moiety, to which the other DMSO solvent is hydrogen bonded with H13 forming 
a NH···O hydrogen bond to O2 (NH···O 2.13 Å, NH···O 159°). There is also a S(6) 
intramolecular hydrogen bond from the ortho proton, H4, of the syn aryl ring to N2 of the 
biguanide (NH···O 2.36 Å, NH···O 119°). 
 
Figure 2.3 X-ray crystal structures of [Ni(bigu)2]·CH3CN (left) and [Ni(diMebigu)2]·2DMSO (right) from 
McMorran et al.[2] Ellipsoids are drawn at 50% and disordered and acetonitrile solvent molecules are hidden 
for clarity. 
 
2.1.2 Palladium(II) Complexes 
In this work a series of complexes of the type [Pd(ppy)(biguH)]OAc were synthesised by 
addition of two equivalents of the appropriate ligand to a solution of [Pd(ppy)μ-OAc]2 in 
dichloromethane which, after stirring overnight at room temperature was added to an 
excess of diethyl ether which precipitated pure complexes as light yellow or cream solids 
(Scheme 2.5).   These charged palladium complexes were then deprotonated to the neutral 
complexes of the type [Pd(ppy)(bigu)] by addition of sodium methoxide (as a methanol 
solution) to a suspension of the complex in acetone (Scheme 2.5). Typically upon addition 
of the methoxide to the acetone suspension the complex would dissolve forming a light 
yellow solution which was stirred overnight at room temperature. Reduction of the 
volume of the solvent through rotary evaporation followed by addition of excess diethyl 
ether precipitated pale yellow solids which were collected via filtration and dried in vacuo 
to give the corresponding neutral complex. Occasionally the pure neutral complex would 





Scheme 2.5 Synthesis of the palladium(II) phenylpyridine 1,5-diarylbiguanide complexes. 
2.1.2.1 Characterisation 
The compositions of both the six charged complexes and six neutral complexes were 
confirmed by elemental analysis, HR-ESIMS, and IR, 1H, and 13C NMR spectroscopies. As a 
group the complexes displayed limited solubility in common organic solvents so DMSO-d6 
was used for NMR characterisation. Pairs of the charged and neutral complexes share the 
same mass spectrum peak of the corresponding 1+ complex (), which occurs either 
through loss of the acetate anion or through protonation under mass spectrum conditions. 
Peaks corresponding to pairs of complexes, one in neutral form and one charged (), also 
appear in the spectrum. Due to this, mass spectra cannot be used to confirm the formation 
of the neutral complexes. However, elemental analysis shows the absence of the acetate 
anion in the analysis of the neutral complexes. 
 
Figure 2.4 HRESI-MS spectra of [Pd(ppy)(diOMebigu)] (left) and [Pd(ppy)(diOMebiguH)]OAc (right) with 




In the IR spectra of all the complexes, a series of weak peaks ca. 3430 – 3250 cm-1 were 
observed corresponding to N-H stretches. In the charged complexes strong C=N and 
medium to strong C-N stretches were observed ca. 1680-1550 cm-1 and 1100 – 900 cm-1, 
respectively, although these are overlapped with various aromatic stretches. In the neutral 
complexes there is a reduction in the number and intensity of bands in these regions with 
increase in the intensity of bands ca. 1500 – 1300 cm-1 consistent with delocalisation of C-
N π-bonds.[2] The 1H NMR of the charged complexes also contained a peak at about 1.91 
ppm (Figure 2.5) which had an integration of 3H which corresponds to the acetate anion. 
The shift of 1.91 would usually be more characteristic of acetic acid in DMSO-d6,[4] 
suggesting the acetate anion is very strongly hydrogen bonded or involved in some type of 
proton transfer with the biguanide. In the neutral complexes the peak at 1.91 ppm is 
absent and a peak at around 1.7 ppm sometimes appears, likely corresponding to a 
impurity of NaOAc (pure NaOAc in DMSO-d6 appears as a singlet at 1.71 ppm), and was 
removed through suspension of the solid in water followed by filtration, washing with 
solvents (typically ethanol then diethyl ether), and finally drying in vacuo. It was 
determined (by solid state analysis, vide infra) that the charged complexes are 
preferentially in the anti-anti conformation with the acetate anion hydrogen bonded to the 
DDD surface, while upon deprotonation the conformation shifts to the syn-syn 
conformation where the ortho protons of the aryl- groups are involved in intramolecular 
interactions with the deprotonated N, and solvent molecules (DMF or DMSO) can be 
involved in hydrogen bonding interactions to the exposed DD surfaces. There is little 
difference, however, between the 1H NMR spectra of a charged complex and its neutral 
counterpart (Figure 2.5), meaning conformations cannot be readily distinguished using 
NMR spectroscopy and likely exist in some equilibrium in solution.
 
Figure 2.5 1H NMR (500 MHz) spectra of [Pd(ppy)(tBubiguH)]OAc (top) and [Pd(ppy)(tBubigu)] (bottom) in 
DMSO-d6 with the acetate peak highlighted in green. 
The palladium complexes gave 1H NMR spectra with sharp, well resolved signals in DMSO-
d6 including those of the NH protons, which are often broadened or even absent in other 
solvents. Due to the unsymmetrical nature of the complexes from the ppy ligand, the 1H 
NMR spectrum contains individual peaks for all the protons present. Confirmation of the 
solution state structures was achieved through a series of NMR experiments including 1H 
and 13C 1D spectra as well as COSY, ROSEYAD, HSQCAD, and HMBCAD 2D spectra. Cross 
peaks in the 1H COSY spectrum (Figure 2.6) group the signals of the ppy ring systems, 
which appear as two 1H doublets and two 1H triplets each. In the spectrum of 
[Pd(ppy)(tBubigu)] there are multiplets that involve an overlapping doublet and triplet 
signal, and another where another doublet and triplet pair overlap with an additional 1H 
signal (from integration). One of the triplets is also overlapping with addition proton 
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signals from the aryl rings. The HSQCAD spectrum (Figure 2.7) showed two cross peaks 
for each of the multiplets containing a doublet and a triplet, allowing the additional proton 
in the 3H multiplet to be assigned as a NH. It also helps with identifying the ab system of 
the para-substituted aryl rings. The ab system is split due to the lack of internal symmetry 
in the complex and is further complicated by overlapping with one of the triplets of the 
ppy ring. The HMBCAD spectrum (Figure 2.8) firstly confirms the ring groupings assigned 
from the COSY. In the spectra of [Pd(ppy)(tBubigu)] the 13C signal at 160.4 ppm, which has 
no directly associated hydrogen signal (Figure 2.7), has cross peaks with the protons He, 
Hf, and Hh, as well as the most upfield shifted NH proton. Therefore this carbon signal was 
assigned as the metalated carbon, which allowed the two sets of ring protons to be 
assigned to the pyridine and phenyl rings. The only other carbon to show cross peaks 
across both rings in the HMBCAD was at 165.6 ppm, which showed cross peaks with 
protons Ha, Hc, Hd, and He. When this carbon is assigned as the carbon adjacent to the 
heterocyclic N and the phenyl ring it gives the ordering of the protons around both rings, 
since Hb would then need to be para- to this carbon and He the closest proton of the 
phenyl portion of the ligand. A cross peak between Hd and He would be expected in 1H 
NOESY or ROESYAD experiments and while these were not conclusive in the spectra of 
[Pd(ppy)(tBubigu)], a ROESYAD spectrum of [Pd(ppy)(Brbigu)] was obtained and 
supported this assignment. These assignments also allowed the NH proton at 5.28 ppm to 
be assigned as NH1 from the cross peak with the metalated carbon (this was also 
confirmed with the Hh to NH1 cross peak in the ROESYAD spectrum of 
[Pd(ppy)(Brbigu)]). From there the remaining NH proton signals could be assigned as the 
two carbon signals at 157.7 and 156.9 ppm show strong cross peaks each with two of the 
NH proton signals and a weaker signal with the other downfield shifted NH proton, 
therefore they could assigned as the coordinated NHs (upfield) and arylated NHs  
(downfield) for either side of the biguanide, although when compared with the ROESYAD 
for [Pd(ppy)(Brbigu)] the weaker cross peaks correspond to the closer (2 bond distance) 




Figure 2.6 1H COSY NMR (500 MHz) spectrum of [Pd(ppy)(tBubigu)] in DMSO-d6. Cross peaks identify the 
two ppy ring systems in blue and green while those identifying the ab system of the para-substituted aryl 
groups are shown in orange. 
 
Figure 2.7 HSQCAD NMR (500 MHz) spectrum of [Pd(ppy)(tBubigu)] in DMSO-d6. Cross peaks identify carbon 




Figure 2.8 HMBCAD NMR (500 MHz) spectrum of [Pd(ppy)(tBubigu)] in DMSO-d6. Cross peaks in green and 
yellow are associated with the biguanide carbons and pair the NH peaks together. Cross peaks in blue are 
associated with the coordinated carbon and differentiate the phenyl from the pyridyl rings of the ppy ligand 
and allow absolute assignment of the biguanide. 
2.1.2.2 Concentration Dependence in Solution State 
In the 1H NMR spectra of the neutral complexes the NH signals showed a concentration 
dependence with shifts up to 0.39 ppm observed for NH4 over the ranges of 10-2 to 10-5 
mol L-1 and smaller shifts observed in the other NH signals with NH1 barely moving 
(Figure 2.9). As the concentration of the solutions is increased the NH signals move 
downfield with NH3 and NH5 having significant downfield shifts while NH1 and NH4 have 
smaller downfield shifts. The signal corresponding to Ha also is observed to shift 
downfield. This shifting of peaks rather than peaks increasing/decreasing in size with 
concentration is indicative of rapid exchange of species as would be expected from 
intermolecular interactions. The NH5 peak is shifting downfield towards the NH4 with 
increasing concentration, suggesting the two protons are shifting towards more similar 
environments which are consistent with an increase in complexes in the anti-anti 
conformation forming dimers where the protons are in an environment more dominated 
by the hydrogen bonding interaction instead of the asymmetric ppy ligand. On the other 
side, the NH1/NH3 peaks can be considered to be sharing more of their environment with 
the NH4/NH5 protons in the low concentration situation where the aryl arms are more 
likely in syn- conformations where DMSO solvent molecules can hydrogen bond across the 
two protons in a 𝑅2
1(6) type motif (as shown in X-ray crystallographic structures, vide 





Figure 2.9 1H NMR (400 MHz) concentration type titration of [Pd(ppy)(diFbigu)] in DMSO-d6 at 20 °C from 
1.8 x 10-4 to 1.4 x 10-2 mol L-1. NH peaks and Ha are highlighted as per the structure. 
NMR titrations were performed on all complexes in DMSO-d6 (although the Br and Cl 
substituted complexes repeatedly gave poor data) and the binding constants were 
calculated using supramolecular.org’s bindfit v0.5 function for NMR dimer aggregation 
running the Nelder-Mead method assuming a 1:1 style dimerisation.[5] This gave binding 
constants ranging from 77 to 330 L mol-1 (Table 2.1) which is within the range expected 
from hydrogen bonding interactions.[6] The charged complexes were also checked for NMR 
concentration dependence but had observed shifts of less than 0.02 ppm over the same 
range as the neutral complexes were tested. This is likely due to the acetate strongly 
hydrogen bonding to the DDD surface of the biguanide as suggested by more acetic acid 
like shift of the acetate signal in the NMR as well as the NH2 proton either being absent or 
as a diminished peak at high (>12) ppm. Another piece of evidence for this very strong 
hydrogen bonding is the ability for the charged fluoro- and chloro- substituted complexes 
to crystallise as their neutral counterparts from DMF without the presence of a strong 
base (vide infra). The process occurring on change of the concentration therefore must 




Table 2.1 Binding constants for self dimerisation of neutral palladium biguanide complexes 
 Ke (L mol-1) 
[Pd(ppy)(bigu)] 177 ± 6 
[Pd(ppy)(tBubigu)] 330 ± 20 
[Pd(ppy)(Brbigu)] - 
[Pd(ppy)(diClbigu)] - 
[Pd(ppy)(diFbigu)] 300 ± 10 
[Pd(ppy)(diOMebigu)] 77 ± 8 
  
2.1.2.3 X-ray Crystallography 
Structure of [Pd(ppy)(tBubiguH)]OAc 
The only X-ray quality crystals obtained of a charged complex, were of 
[Pd(ppy)(tBubiguH)]OAc, which was grown by diffusion of diethyl ether into an 
acetonitrile solution of the complex. The complex crystallises in the triclinic space group 
𝑃1̅ with the asymmetric unit containing a single molecule of the complex with the acetate 
anion (Figure 2.10). The palladium anion is a slightly distorted square planar geometry 
with the biguanide coordinating through the N1 and N3 donors and the ppy ligand 
coordinating C^N. The phenyl and pyridyl rings of the ppy ligand are slightly twisted at an 
8.8° angle relative to each other, while the biguanide is 19.2° relative to the plane of the 
ppy chelate. The donor atoms of the ppy are substitutionaly disordered and were refined 
with shared position and displacement parameters using the EXYZ and EADP functions of 
SHELX. The ratio of the disorder was found through a floating refinement to be 81:19. The 
biguanide is in an anti-anti conformation with the plane of the two aryl rings at a 55.5° 
angle relative to each other and at 63.9° and 72.8°, respectively, to the plane of the PdN3C 
core. The C1-N1 and C2-N3 bond lengths (1.288(2) and 1.299(3)) Å are shorter than those 
of C1-N2 and N2-C2 bonds (1.366(3) and 1.379(3) Å) which suggests the double bonds are 
localised to the coordinating nitrogens rather than delocalised as would be expected if N2 
had been deprotonated by the acetate. With N2 protonated and the aryl arms in their anti-
anti conformation the acetate anion is observed to strongly hydrogen bond to the NH2 and 
NH5 donors (H···O 1.91 and 1.97 Å, NH···O 167° and 176° for H2 and H5, respectively), 
with a weaker hydrogen bond to NH4 (H···O 2.44 Å, NH···O 139°), forming a 𝑅2
2(8)𝑅2
1(6) 
motif. Pairs of molecules form head-to-tail offset dimers through chelate-chelate π-
stacking interactions between the ppy chelate rings (Figure 2.11) with a centroid to 
centroid distance of 3.55 Å. These dimers then assemble into chains down the 
crystallographic b axis via a series of weak non-classical CH···O hydrogen bonds (H···O 
2.72-2.82 Å, CH···O 142-175°) and a CH···π interaction (CH···cent 2.705 Å, 140.2°). These 
chains are then further assembled into sheets via a second weak CH···O hydrogen bond 
(H···O 2.79 Å, CH···O 172°) and the overall structure is supported by further weak CH···π 




Figure 2.10 X-ray crystal structure of [Pd(ppy)(tBubigu)]OAc. Ellipsoids are drawn at the 50% level and only 
the major component of the disordered ppy is shown. 
 
Figure 2.11 (top) Side on view of the π stacked dimer of [Pd(ppy)(tBubiguH)]OAc with chel-chel interaction 
shown in green. (bottom) Top down view of [Pd(ppy)(tBubiguH)]OAc dimer with Pd(ppy) chelate centroids 




Figure 2.12 Hirshfeld fingerprint plots of the intermolecular interactions in [Pd(ppy)(tBubiguH)]OAc: 
(top left) H-H interactions, 60.5%; (top right) H-C interactions, 21.3%; (bottom left) H-N interactions, 5.5%; 
(bottom right), H-O interactions, 5.7%. 
Structure of [Pd(ppy)(tBubigu)] 
Crystals of the neutral complex [Pd(ppy)(tBubigu)]·2DMF were obtained from a DMF 
solution of the complex. The complex crystallised in the orthorhombic space group 𝑃21212 
with the asymmetric unit containing one complex and two DMF solvent molecules (Figure 
2.13). The palladium ion is square planar with the biguanide coordinating through N1 and 
N3 as expected. The chelate ring of the biguanide is planar with the C-N bond lengths 
around the biguanide being of similar length (1.32(1) Å – 1.340(9) Å), consistent with the 
previously observed bond delocalisation that occurs upon deprotonation of N2,[2] rather 
than the mix of longer (~1.38 Å) and shorter (~1.29 Å) bonds that are observed in the 
chelate ring of the [Pd(ppy)(tBubiguH)]OAc complex. The ppy ligand shows the same 
substitutional disorder as the charged complex was refined in the same manner with 
EADP and EXYZ functions and the ratio of disorder was found to be 90:10. Unlike 
[Pd(ppy)(tBubiguH)]OAc, the aryl groups were in their syn-syn conformations with the 
two aryl rings 78.1° relative to each other and 34.6° and 43.7° relative to the plane of the 
PdN3C core. The syn-syn conformation is supported by a weak non-classical S(6) hydrogen 




Figure 2.13 X-ray crystal structure of [Pd(ppy)(tBubigu)]·2DMF. Ellipsoids are drawn at the 50% level and 
only the major component of the disordered ppy is shown. 
The complex is chiral due to perpendicular dissymmetric planes (in the same manner as 
chiral ortho substituted biphenyl molecules) generated due to the conformation of the t-
butylaryl rings as well as the DMF solvent molecules perpendicular or co-planar to the 
plane of the PdCN3 core. While nominally molecules which are chiral in this manner can be 
named using the S and R notation for axially chiral molecules (when viewing down the 
axis, around which the chirality occurs, label groups using the Cahn–Ingold–Prelog 
priority rules used for tetrahedral stereocentres, with the additional rule that “near” 
(darker) groups have priority over “far” (lighter) groups),[7] the structure of 
[Pd(ppy)(tBubigu)]·2DMF contains only subtle conformational differences, therefore is 
only tentatively given R designation (Figure 2.14).  
 
Figure 2.14 Assignment of the different moieties within the structure of [Pd(ppy)(tBubigu)]·2DMF starting 




The syn-syn conformation exposes the sides of the biguanide as two DD type hydrogen 
bond motifs involving N1 and N4, and N3 and N5. Each of these pairs is strongly hydrogen 
bonded to a DMF solvent with the N1/N4 pair binding to O1 (H···N 2.31 and 2.13 Å, NH···O 
148° and 161°, respectively) with an additional supporting interaction from H32 (H···O 
2.56 Å, CH···O 166°) to give a 𝑅2
1(6)𝑅2
1(7) motif, while the N3/N5 pair binds to O2 (H···N 
2.33 and 2.04 Å, NH···O 152° and 163°, respectively) with no additional interactions giving 
a 𝑅2
1(6) motif. With the biguanide engaged in hydrogen bonding with the DMF solvent, and 
the syn-syn conformation of the aryl arms disrupting the planarity of the complex, there is 
little functionality left to facilitate the long range packing of the molecules in the crystal 
structure. The molecules are observed to pack into chains along the crystallographic c axis 
through a variety of weak CH···N hydrogen bonds between the DMF solvent molecules and 
the biguanide moieties of adjacent complexes as well as weak CH···π interactions. These 
chains then pair up through weak hydrogen bonding and van der Waals interactions, with 
pairs of chains then assembling into the overall structure with each lying at 87.1° to the 
next. This weak set of interactions is exemplified in the Hirshfeld analysis (Figure 2.15) 
where the fingerprint plot is more diffuse than the [Pd(ppy)(diClbigu)]·2DMF and 
[Pd(ppy)(diFbigu)]·DMF structures (vide infra) with no tight groupings and the H-H and 
C-H interactions making up 61.3% and 24.1% of the total Hirshfeld surface area. 
 
Figure 2.15 Hirshfeld fingerprint plots of the intermolecular interactions in [Pd(ppy)(tBubigu)]·2DMF:  
(top left) all interactions; (top right) H-H interactions, 61.3%; (bottom left), H-C interactions, 24.1%;  
(bottom right) H-N interactions, 7.1%. 
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Structures of [Pd(ppy)(diClbigu)] and [Pd(ppy)(diFbigu)] 
Colourless crystals of both [Pd(ppy)(diClbigu)]·2DMF and [Pd(ppy)(diFbigu)]·DMF were 
grown from DMF solutions of [Pd(ppy)(diClbiguH)]OAc and [Pd(ppy)(diFbiguH)]OAc, 
respectively. The deprotonation of the biguanide was likely facilitated by the acetate anion 
as the NMR spectra were already suggestive of the acetate anion having a more acetic acid 
like shift. The strong electron withdrawing properties of the chloro and fluoro 
substituents also likely contributed to this and is why the same process did not occur 
during crystallisation of the charged tert-butyl substituted complex under the same 
conditions. Both complexes crystallise in the triclinic space group 𝑃1̅ and in each case the 
asymmetric unit containes one complex with two DMF solvent molecules (Figure 2.16 and 
Figure 2.17). In both complexes the palladium ion is square planar with the biguanide 
coordinating through N1 and N3 as expected and with the similar C-N bond lengths 
around the biguanide chelate ring consistent with delocalisation of the double bonds 
associated with the deprotonation at N2. The ppy ligands also show the same 
substitutional disorder and were once again refined with the EADP and EXYZ functions 
with the ratio of disordered atoms being 87:13 and 89:11, respectively.  
Like in the structure of [Pd(ppy)(tBubigu)], both structures have the biguanide ligand in 
the syn-syn conformation, but the extent to which the aryl rings are twisted in relation to 
each other is much less at 31.2° and 37.8°, and the angles between the aryl rings and the 
PdN3C core are 24.4° and 13.3°, and 25.5° and 23.4°  for [Pd(ppy)(diClbigu)] and 
[Pd(ppy)(diFbigu)], respectively. The syn-syn conformation is stabilised by weak non-
classical S(6) hydrogen bonding interactions between the ortho protons of both aryl rings 
and the N2 nitrogen (H···N 2.37 and 2.28 Å, CH···N 117° and 119° for [Pd(ppy)(diClbigu)], 
and H···N 2.32 and 2.34 Å, CH···N 118° and 118° for [Pd(ppy)(diFbigu)]). As for 
[Pd(ppy)(tBubigu)] this conformation of the biguanide allows DMF solvent molecules 
hydrogen bond to the pairs of NH donors. In [Pd(ppy)(diClbigu)] H1A and H4A hydrogen 
bonding to O1 (H···O 2.46 and 2.13 Å, NH···O 150° and 170° respectively) with an 
additional weak supporting interaction from C24 (H···O 2.74 Å, CH···O 159°) to give a 
𝑅2
1(6)𝑅2
1(7) motif, while the H3A and H5A binds to O2 (H···O 2.34 and 2.11 Å, NH···O 157° 
and 157°, respectively) with an additional weak supporting interaction from H15 (H···O 
2.83 Å, CH···O 173°) to give an overall  𝑅2
1(6)𝑅2
1(7) motif. The same structure is observed 
in the structure of [Pd(ppy)(diFbigu)] with H1A and H4A hydrogen bonding to O1 (H···O 
2.35 and 2.02 Å, NH···O 152° and 168° respectively) with the weak supporting interaction 
from C24 (H···O 2.81 Å, CH···O 169°) while H3A and H5A hydrogen bond to O2 (H··O 2.17 
and 2.33 Å, NH···O 154° and 152°, respectively) with the weak supporting interaction from 
H15 (H···O 2.39 Å, CH···O 169°) giving a pair of 𝑅2
1(6)𝑅2




Figure 2.16 X-ray crystal structure of [Pd(ppy)(diClbigu)]·2DMF. Ellipsoids are drawn at the 50% level and 
only the major component of the disordered ppy is shown. 
 
Figure 2.17 X-ray crystal structure of [Pd(ppy)(diFbigu)]·2DMF. Ellipsoids are drawn at the 50% level and 




The structure of [Pd(ppy)(diClbigu)] is observed to pack into offset stacks via weak 
CH···Cl hydrogen bonds (H···Cl 2.918 Å, 124.9°) between the Cl2 chloride substituent of a 
biguanide aryl ring and H17 on the ppy ligand of an adjacent molecule, and weak CH···O 
hydrogen bonds (H···O 2.65 Å, 166.1°) between the C30 methyl of a DMF solvent to O1 of 
the DMF solvent hydrogen bonded to an adjacent molecule. These offset stacks also 
involve weak π-π stacking (cent···cent 3.728 Å) between the ppy of one molecule and the 
biguanide aryl ring of another (Figure 2.18). These stacks are further assembled into 
sheets via weak CH···Cl interactions between Cl2 and the methyl of a DMF solvent involved 
in an adjacent stack, and Cl···Cl interactions (3.258 Å) involving Cl1. These sheets are 
incorporated into the overall three-dimensional structure via weak CH···π type 
interactions. This dominance of H···Cl intermolecular interactions in the packing of 
[Pd(ppy)(diClbigu)] molecules can be observed in the Hirshfeld analysis (Figure 2.19) 
where H-Cl interactions make up 22.7% of the overall intermolecular interactions, while 
H-H and H-C interactions make up 32.3% and 18.0%, respectively. 
 
Figure 2.18 Packing of [Pd(ppy)(diClbigu)]·2DMF with ellipsoids drawn at the 50% level. Separate complex 
molecules are coloured light green, and pink, respectively, with DMF solvent molecules coloured light blue. 




Figure 2.19 Hirshfeld fingerprint plots of the intermolecular interactions in [Pd(ppy)(diClbigu)]·2DMF: 
(top left) H-C interactions, 18.0%; (top right) H-Cl interactions, 22.7%; (bottom left) H-N interactions, 7.5%; 
(bottom right), H-O interactions, 3.0%. 
Instead of packing into offset stacks, [Pd(ppy)(diFbigu)] is observed to pack into offset, 
head-to-tail dimers via a weak CH···F hydrogen bond (H···F 2.63 Å, CH···F 128°) between 
the F2 fluoride substituent of a biguanide aryl ring and H16 on the ppy ligand of an 
adjacent molecule, and weak CH···O hydrogen bonds (H···O 2.64 Å, 166°) between the C31 
methyl of a DMF solvent to O1 of the DMF solvent hydrogen bonded to an adjacent 
molecule (Figure 2.20). These dimers are further assembled into the overall three-
dimensional structure by a series of CH···F hydrogen bonds (H···F 2.48-2.63 Å, CH···F 139-
153°) between fluoride substituted aryl rings of adjacent molecules and to DMF solvent 
molecules hydrogen bonded to adjacent molecules (Figure 2.21). As with the structure of 
[Pd(ppy)(diClbigu)], the Hirshfeld analysis (Figure 2.22) exemplifies the importance of 
the hydrogen to halide intermolecular interactions in the packing of [Pd(ppy)(diFbigu)] 





Figure 2.20 Packing of [Pd(ppy)(diFbigu)]·2DMF with ellipsoids drawn at the 50% level. Separate complex 
molecules are coloured light green, and pink, respectively, with DMF solvent molecules coloured light blue. 
Interactions within the asymmetric unit are coloured blue while packing interactions are coloured magenta. 
 
Figure 2.21 Packing of [Pd(ppy)(diFbigu)]·2DMF with ellipsoids drawn at the 50% level. Interactions within 




Figure 2.22 Hirshfeld fingerprint plots of the intermolecular interactions in [Pd(ppy)(diFbigu)]·2DMF:  
(top left) H-C interactions, 19.1%; (top right) H-F interactions, 19.0%; (bottom left) H-N interactions, 7.0%; 
(bottom right) H-O interactions, 2.7%. 
2.1.2.4 Bis-biguanide Complexes 
Like the previously reported nickel(II) complexes, palladium should be able to form bis-
biguanide complexes. Complexation of biguH with [Pd(CH3CN)4](BF4)2 in a solution of 
DCM gave a bright yellow solid upon workup. 1H NMR spectra in both CD3CN and DMSO-d6 
(Figure 2.23) had two or three broadened singlets, characteristic of NH protons, and tight 
groupings of aromatic protons between 7.5 and 6.8 ppm.  
 
Figure 2.23 1H-NMR (400 MHz) of isolated product from biguH and [Pd(CH3CN)4](BF4)2 in DMSO-d6. 
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X-ray quality crystals of the complex were obtained from diffusion of diethyl ether into an 
acetonitrile solution of the complex. The crystal structure obtained from these crystals 
revealed why the 1H NMR contained more peaks than expected; instead of coordinating 
N^N through N1 and N3, like the nickel(II) complexes and the palladium(II) and 
platinum(II) complexes, the biguanide has coordinated N^N through N1 and N5 (Figure 
2.24), placing the aryl- groups in different electronic environments. Even though X-ray 
quality crystals of the complex were obtained, repeated attempts to purify the bulk solid 
continually gave inconsistent elemental analysis which did not correspond to the expected 
complexes as well as giving mass spectral data with no discernible peaks.  
Attempts to synthesise the neutral palladium(II) bis-diarylbiguanide were also made by 
addition of solutions of biguH type ligands to acetone solutions of [Pd(CH3CN)4](BF4)2  
which were then treated with sodium methoxide, but workup of these solutions often 
resulted in oily or very impure solids, which gave poor analyses, with only the product of 
the diOMebiguH ligand giving mass spectrum data that could be resolved (Figure 2.25). 
Due to these repeated issues this group of complexes was left in the interest of perusing 
other potential ligands and complexes. 
 
Figure 2.24 X-ray crystal structure of [Pd(biguH)2](BF4)2. Ellipsoids are drawn at 50% and BF4 anions are 




Figure 2.25 HRESI-MS spectra of crude isolated [Pd(diOMebigu)2] with calculated isotope patterns shown 
next to major peaks. 
 
2.1.3 Platinum(II) Complexes 
The analogous [Pt(ppy)μ-OAc]2 dimer is not easily accessible like the palladium precursor 
used in the synthesis of the palladium diarylbiguanides therefore the [Pt(ppy)μ-Cl]2 
precursor was synthesised from K2PtCl4 and 2-phenylpyridine in a solution of tBuOH in 
water following literature procedures.[8] The cationic biguanide complex does not readily 
form even under forcing conditions or with the addition of a silver(I) salt to remove 
chloride ions as AgCl(s). In light of this neutral complexes were prepared directly from the 
free ligands and metal dimer. The first methods tested used excesses of inorganic (Na2CO3) 
or organic (Et3N) bases in ethoxyethanol. Use of these bases and solvent has precedent in 
the literature for forming similar platinum complexes.[8-12] These reactions were low 
yielding (<10%) with pure product practically impossible to isolate from the crude. 
Switching the reaction solvent to a more coordinating solvent, such as DMF, and having 
the reactions proceed under dry, inert conditions in the presence of an inorganic base, 
gave the neutral platinum complexes in good yields (Scheme 2.6). Interestingly the 
platinum complexes show some chloroform solubility (except for the dichloro substituted 




Scheme 2.6 Synthesis of the platinum(II) phenylpyridine 1,5-diarylbiguanide complexes.  
2.1.3.1 Characterisation 
The compositions of all six complexes were confirmed by elemental analysis, HRESI-MS, 
and IR, 1H, and 13C NMR spectroscopies. The major peak observed in all ESI-MS spectra, 
was of the complete protonated complex, similar to what was observed for the palladium 
complexes, as well as in some cases another major 1+ peak corresponding to two 
complexes, one protonated, and one deprotonated was also observed (Figure 2.26). Other 
major peaks corresponding to ligand fragments were also typically observed.  
 
Figure 2.26 HRESI-MS of [Pt(ppy)(diOMebigu)] with calculated isotope patterns shown next to major peaks. 
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Similar to the IR spectra of the neutral palladium(II) complexes, weak bands ca. 3420 – 
3360 cm-1 corresponding to N-H stretches were observed, and strong bands ca. 1600 – 
1420 cm-1, characteristic of the delocalised C-N π-bonds, were also observed with the 
absence of  strong C=N stretches. Some medium bands ca. 1170 – 1010 cm-1 were also 
observed corresponding to C-N stretches. Due to the unsymmetrical nature of the 
complexes arising from the ppy ligand the 1H NMR spectrum contains individual peaks for 
all the protons present although the peaks corresponding to protons on the aryl groups 
are typically tightly grouped. As a group the complexes displayed limited solubility in 
common organic solvents (although most are reasonably soluble in solvents such as 
chloroform) so DMSO-d6 was used for NMR characterisation and all the peaks were fully 
assigned by means of COSY, HSQCAD, and HMBCAD 2D spectroscopic experiments in the 
same manner as their palladium counterparts (Subsection 2.2.1.1). The 1H COSY spectrum 
(Figure 2.27) shows cross-peaks which allow assignment of the ring groups of the ppy 
ligand and the aryl groups of the biguanide ligand, which in the case of di-substituted aryl 
groups like [Pt(ppy)(diOMebigu)] appear as singlets with integrations of either 1 or 2H. 
The HSQCAD spectrum (Figure 2.28), like with the palladium complexes, allowed both the 
confirmation of the NH proton assignment from their lack of cross peaks with carbon 
signals as well as identification of which carbon signals correspond to carbons with 
protons, which is useful when comparing to the HMBCAD spectrum (Figure 2.29) 
 
Figure 2.27 1H COSY NMR (500 MHz) spectrum of [Pd(ppy)(diOMebigu)] in DMSO-d6. Cross peaks identify 





Figure 2.28 HSQCAD NMR (500 MHz) spectrum of [Pd(ppy)(diOMebigu)] in DMSO-d6. Cross peaks identify 
carbon signals with associated protons (black dots) and lack of cross peaks confirms NH peak assignments. 
 
Figure 2.29 HMBCAD NMR (500 MHz) spectrum of [Pd(ppy)(diOMebigu)] in DMSO-d6. Cross peaks in green 
and yellow are associated with the biguanide carbons and pair the NH peaks together. Cross peaks in blue are 
associated with the coordinated carbon and differentiate the phenyl from the pyridyl rings of the ppy ligand 
and allow absolute assignment of the biguanide. 
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2.1.3.2 Concentration Dependence 
Unlike the complexes of the type [Pd(ppy)(bigu)], the platinum complexes did not show 
significant concentration dependence in DMSO-d6 (Figure 2.30), while in CDCl3 the spectra 
show significant overlap of peaks as well as loss of resolution of peak groups (likely due to 
free rotation of the aryl arms without the presence of hydrogen bond accepting solvent).  
 
Figure 2.30 1H NMR (400 MHz) concentration type titration of [Pt(ppy)(diOMebigu)] in DMSO-d6 from 2.5 x 
10-4 to 1.9 x 10-2 mol L-1. NH peaks and Ha are highlighted. 
2.1.3.3 X-ray Crystallography 
The only X-ray quality crystals of a platinum diarylbiguanide complex obtained were of 
the complex [Pt(ppy)(diFbigu)]·2DMF which were grown from a solution of DMF in the 
same manner as the crystals of [Pd(ppy)(tBubigu)]·2DMF, and although the resulting 
structure seems to be isostructural with [Pd(ppy)(diFbigu)]·2DMF, the two complexes 
pack together slightly differently, therefore the structure of [Pt(ppy)(diFbigu)]·2DMF will 
be described here in full. Crystallisation was attempted through a variety of methods for 
the other platinum complexes but none yielded X-ray quality crystals. The complex 
crystallises in the triclinic space group 𝑃1̅ with the asymmetric unit containing one 
complex and two DMF solvent molecules (Figure 2.31). The platinum anion is square 
planar with the biguanide coordinating through N1 and N3 as expected, and the C-N bond 
lengths around the biguanide ring are similar and consistent with delocalisation of the 
double bonds around the chelate ring from deprotonation at N2 in the same way as was 
observed in the neutral palladium complexes and in previously reported complexes.[2] The 
ppy ligand coordinates C^N in the same manner as in the palladium complexes with the 
same substitutional disorder of the coordinating C and N atoms of the ppy ligand which 
was also refined with the EADP and EXYZ functions with the ratio of disordered atoms 
being 90:10. The aryl rings are in the same syn-syn conformation as the palladium 
analogue with the angle between the rings at 38.5° and the angle between the rings and 
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the PtN3C core being 26.9° and 23.9°, respectively. This conformation is stabilised by non-
classical S(6) type hydrogen bonds between the H4 and H10 ortho protons of the aryl 
rings and N2 of the biguanide (H···N 2.32 and 2.33 Å, CH···N 117.8° and 117.8°, 
respectively). This conformation of the biguanide allows DMF solvent molecules to come 
in and hydrogen bond to the pairs of NH donors with H1A and H5A hydrogen bonding to 
O1 (H···O 2.21 and 1.88 Å, NH···O 156° and 166°, respectively) with an additional weak 
supporting interaction from H24 (H···O 2.80 Å, CH···O 162.4°) to give a 𝑅2
1(6)𝑅2
1(7) motif, 
while H3A and H5A hydrogen bond to O2 (H···O 2.13 and 2.31 Å, NH···O 166° and 155°, 
respectively) with an additional supporting interaction from H15 (H···O 2.38 Å, CH···O 
168.9°) to give a 𝑅2
1(6)𝑅2
1(7) motif also.  
 
Figure 2.31 X-ray crystal structure of [Pt(ppy)(diFbigu)]·2DMF. Ellipsoids are drawn at the 50% level and 
only the major component of the disordered ppy is shown. 
The structure of [Pt(ppy)(diFbigu)]·2DMF is arranged into offset head-to-tail stacks with 
the hydrogen bonded O2 DMF solvent over the chelate ring of one adjacent molecule with 
H30B and H31B of the methyl groups involved in CH···Pt anagostic interaction[13] (H···Pt 
2.873 Å, CH···Pt 148.1° for H30B) and a CH···chelate interaction to the biguanide (H···cent. 
2.634 Å, CH···cent. 176.9° for H31B), respectively, while to the other adjacent molecule it is 
involved in a weak CH···O interaction (H···O 2.637 Å, CH···O 166.6°) to O1 of the hydrogen 
bonded DMF solvent (Figure 2.32). These stacks also are supported by a CH···F hydrogen 
bond (H···F 2.62 Å, CH···F 127.2°) to the ppy ligand. These stacks then interdigitate (Figure 
2.33) through a variety of CH···F hydrogen bonds, from both DMF methyl groups and 
aromatic CH groups with distances ranging from 2.473 – 2.667 Å and angles between 
127.3° and 152.9° (Table 2.5), to form the overall three dimensional structure. Hirshfeld 
analysis (Figure 2.34) of the packing highlights how important the CH···F hydrogen bonds 
are to the packing of the complex beyond the strongly hydrogen bonded DMF solvent 




Figure 2.32 Packing of [Pt(ppy)(diFbigu)]·2DMF with ellipsoids drawn at the 50% level. Separate complex 
molecules are coloured light green, and pink, respectively, with DMF solvent molecules coloured light blue. 
Interactions within the asymmetric unit are coloured blue while packing interactions are coloured magenta. 
 
Figure 2.33 Packing of [Pt(ppy)(diFbigu)]·2DMF with ellipsoids drawn at the 50% level. Interactions within 
the asymmetric unit are coloured blue while packing interactions are coloured magenta. 
 
Figure 2.34 Hirshfeld fingerprint plots of the intermolecular interactions in [Pt(ppy)(diFbigu)]·2DMF: (left) 
all interactions, (right) H-F interactions, 19.1%. 
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2.2 Melamine Based Synthons 
2.2.1 Introduction 
A large range of different DAT containing ligands exist in the literature, including those 
with pyridyl, 2,2’-bipyridinyl and phenanthroline substituents. The new DAT containing 
pyridyl-triazole ligands BtpD and HtpD (Scheme 2.7), which can readily coordinate κ2-N,N 
in the same manner as bpy and phen based ligands were developed due to recent interest 
in functionalised pyridyl-triazole ligands as readily available alternatives to bpy and phen 
analogues.[14-15] 
 
Scheme 2.7 Diaminotriazine containing pyridyl-triazole ligands BtpD, and HtpD. which have their synthesis 
and complexation with Ru(II) and Ir(III) reported in this work. 
The pyridyl-triazole core is easily modifiable at N3 of the triazole and depends on the 
azide precursor used for the click reaction. Substitution at this position can improve the 
physical properties (i.e. solubility or crystallisation ability) of the ligand and resulting 
complexes. Going forward substitution at this position can also be used to tune complexes 
for applications, e.g. a triphenylamine moiety which is known to be photochemically active 
when incorporated into pyridyl-triazole complexes.[16-17]  
2.2.2 Ligand Synthesis 
The starting material, 2-bromo-5-cyanopyridine, is readily available and has the two 
separate functional groups required for both the formation of the pyridyl-triazole (at the 
bromo substituted position) and the DAT moiety (at the cyano substituted position). 
Initially the formation of the DAT moiety was attempted following literature preparations 
for a variety of substituted pyridines that had been shown to undergo cycloaddition with 
dicyandiamide in solutions of KOH in 2-methoxyethanol under standard reflux 
conditions.[18] The 2-bromo substituted pyridine however repeatedly gave starting 
material under these conditions and when the same reaction was attempted on the parent 
substrate, 5-cyanopyridine, this also gave the corresponding starting material (5-
cyanopyridine). A different preparation, using the same substrates (cyano substituted 
pyridine and dicyandiamide) but done as a pseudo melt under microwave conditions had 
been reported to work on a range of heterocycles. This method was tested on 5-
cyanopyridine and was found to give the diaminotriazine substituted product at very good 
yield (>98%). With the cycloaddition conditions chosen and tested it was left for the final 
reaction of the synthesis due to the DAT moiety significantly reducing organic solubility of 
the molecule which would cause multiple issues during workup and purification during 
the synthesis of the remaining portions of the ligand, especially in terms of performing 
column chromatography.  
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2.2.2.1 Acetylene Precursor  
 
Scheme 2.8 Synthesis of 2-(2-trimethylsilyl)acetyl-5-cyanopyridine from 2-bromo-5-cyanopyridine via a 
Sonogashira type reaction. 
In light of this, the synthesis of the pyridyl-triazole moiety was undertaken, starting with 
the substitution of the bromo group on the 2-bromo-5-cyanopyridine for TMS protected 
acetylene through a standard Sonogashira cross-coupling reaction,[19] with 5% CuI and 2% 
[Pd(PPh3)2Cl2] catalysts  in a 4:1 solution of THF and i-Pr2NH under N2 (Scheme 2.8). The 
crude reaction solution was filtered through Celite with CHCl3 to remove the solid 
palladium. The copper catalyst was removed by addition of EDTA:NH4OH(aq) and the 
remaining organic (CHCl3) phase was collected and washed repeatedly with water then 
brine, giving the crude product as an off white/brown solid. This crude contained some 
deprotected acetylene product as well as other impurities giving the brown 
discolouration. A silica column eluting with dichloromethane followed by recrystallisation 
from petroleum ether gave the product as pure colourless crystals in good yield. The 
product was confirmed using 1H NMR spectroscopy and elemental analyses and was found 
to be consistent with reported spectra in the literature.[20] 
2.2.2.2 Pyridyl-triazole Formation 
 
Scheme 2.9 Synthesis of the substituted pyridyl-triazole precursors first through deprotection of the 
acetylene then via a CuAAC ‘click’ reaction with the organo-azide which is formed in situ.  
The acetylene was deprotected with an excess of sodium carbonate in a solution of 
methanol while the organo-azide for the CuAAC “click” reaction was pre-formed from 
either benzyl or hexyl bromide and sodium azide in a solution of DMF through a 
microwave assisted reaction. Once the DMF solution had cooled it was added directly to 
the solution of deprotected acetylene, copper sulfate hexahydrate, and sodium ascorbate 
in 4:1 DMF and water. After stirring overnight at room temperature the copper was 
removed by addition of EDTA:NH4OH(aq). The product was extracted from the resulting 
solution with CHCl3 and the resulting combined organic phases were repeatedly washed 
with water before drying over magnesium sulfate and removal of the solvent to give the 
crude product. The crude pyridyl-triazole product was purified via flash chromatography 
on silica eluting with a 1:1 solution of ethyl acetate and petroleum ether to give either 
BtpCN or HtpCN as white crystalline solids. The composition of the compounds was 
confirmed using 1H NMR spectroscopy. 
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2.2.2.3 Diaminotriazine Cycloaddition 
 
Scheme 2.10 Synthesis of the final ligand via microwave assisted cyclisation of dicyandiamide and the cyano- 
group of the ligand precursor.  
The final step of the ligand synthesis is the conversion of the cyano- group to the 
diaminotriazine moiety. This is done via a microwave assisted cycloaddition with 
dicyandiamide as a pseudo melt using a minimum amount of dry DMSO. The resulting oil 
is poured into boiling water to produce an off white precipitate. For the BtpD product, this 
white precipitate was washed with ice cold methanol before drying in vacuo to give the 
pure product as a cream solid. For the HtpD product, purification by column 
chromatography on silica eluting with a 1:1 solution of CHCl3 and acetone, was required to 
obtain the pure product as a yellow solid. The formation of the DAT group lowers the 
solubility of both ligands to some extent but they both remain soluble in common organic 
solvents such as acetonitrile. The composition of the ligands was confirmed using 
elemental analysis, HRESI-MS (Figure 2.36), and 1H NMR spectroscopy (Figure 2.35). 
When the cycloaddition reaction was performed on the benzyl substituted precursor in 
deuterated solvent (DMSO-d6), the resulting ligand, BtpD-d3, was found to be deuterated 
at the triazole and at the methylene, as could be readily observed when comparing the 1H 
NMR spectra of the two complexes (Figure 2.35), and further confirmed through HRESI-
MS. Issues with collecting consistent elemental analysis were repeatedly encountered with 
all three ligands, with the closest analysis reporting much lower (>2 %) nitrogen content. 
This was proposed to be due to incomplete combustion of the nitrogen rich heterocycles 
under the analysis conditions. 
 
Figure 2.35 1H NMR (400 MHz) spectra of BtpD (top) and BtpD-d3 (bottom) showing the reduction of triazole 
(tz) and methylene (CH2) signals in the deuterated ligand (small peaks are present due to proton/deuteron 




Figure 2.36 HRESI-MS of BtpD-d3 with calculated isotope patterns shown next to major peaks. 
 
2.2.2 Ruthenium(II) Complexes 
Complexes of the type [Ru(bpy)2(RtpD)](PF6)2 (where R = B or H) were synthesised 
through microwave assisted complexations of the appropriate ligands with [Ru(bpy)2Cl2] 
in a solution of ethanol at 125°C for 2 hours. The microwave assisted reaction was used to 
avoid the use of silver(I) salts to extract the chloride ions (as AgCl) before complexation of 
the desired ligand. On cooling, the addition of saturated aqueous ammonium 
hexafluorophosphate solution gave a dark red precipitates although removal of the 
ethanol via rotary evaporation was required to ensure complete precipitation. The solids 
were collected by filtration and washed with water, ice cold methanol, and diethyl ether to 
give the respective products as dark red solids. Recrystallisation from diethyl ether into 
acetonitrile solutions of the complexes gave pure products, often as X-ray quality crystals. 
Due to the octahedral geometry of ruthenium(II), Λ and Δ enantiomers of the complexes 
are produced as racemic mixtures from the complexation reactions. The enantiomers are 
not separated for the characterisation nor crystallisation studies. The deuterated ligand 
BtpD-d3 was also complexed with [Ru(bpy)2Cl2] in the exact same manner as the non-
deuterated ligand BtpD, to give the complex [Ru(bpy)2(BtpD-d3)](PF6)2 and gave dark red 
crystals from recrystallisation of diethyl ether into an acetonitrile solution.  
2.2.2.1 Characterisation 
The compositions of all three complexes were confirmed by elemental analysis, HRESI-MS, 
and IR, 1H, and 13C NMR spectroscopies. Like the ligands, there were issues with collecting 
consistent and accurate analysis data of the complexes which was likely due to the 
incomplete combustion of the nitrogen rich triazole ring(s), even when X-ray quality 
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crystals were submitted for analysis. The HRESI-MS of both [Ru(bpy)2(BtpD)](PF6)2 and 
[Ru(bpy)2(BtpD-d3)](PF6)2 contained two major 1+ peaks corresponding to the complex 
with one PF6 anion and a fragment of the complex with one PF6 anion, as well as a major 
2+ peak corresponding to the complex with no anions (Figure 2.37). The ESI-MS of 
[Ru(bpy)2(HtpD)](PF6)2 contained the 2+ and 1+ peaks corresponding to the lone complex 
and the complex with a single anion, respectively. The IR spectra of all three complexes 
contained weak bands ca. 3500 – 3400 cm-1 and strong bands ca. 1610 – 1390 cm-1 
corresponding to the N-H and aromatic N-C stretches of the DAT moiety, respectively. 
Strong bands ca. 840 – 830 cm-1 were also observed characteristic of the C=CH bending of 
the triazole. 
 
Figure 2.37 HRESI-MS of [Ru(bpy)2(BtpD)](PF6)2 (left) and [Ru(bpy)2(BtpD-d3)](PF6)2 (right) with calculated 
isotope patterns shown next to major peaks. 
Due to the asymmetrical nature of the pyridyl-triazole ligand the 1H NMR spectrum 
contains individual peaks for all the protons present though the two bipyridine ligands are 
in very similar environments and cannot be distinguished from each other and so, beyond 
identifying the appropriate number of doublets and triplets expected from a bipyridine, 
are assigned purely as ‘bpy’ protons. The 1H peaks of the RtpD ligands were assigned with 
assistance from the COSY, HSQCAD, and HMBCAD 2D spectroscopic experiments. The 
triazole proton, Hd, appears as a sharp singlet at 8.67 and 8.72 ppm, for the benzyl and 
hexyl substituted complexes, respectively, and is absent in the spectrum of the deuterated 
complex. The triazole peaks are adjacent, or overlapping (in the case of the HtpD complex) 
with the 1H double doublets which are observed at around 8.70 ppm, which in the 1H 
COSY spectra (Figure 2.38) show a single cross peak with doublets which are incorporated 
as part of multiplets around 8.15 ppm. These peaks correspond to Hb and Hc, respectively, 
with the double doublets showing a weak cross peak to lone doublets at 8.30 ppm which 
can only correspond to the Ha proton of the coordinating pyridines. In all complexes the 
NH signals of the DAT moiety appear as broadened singlets at around 5.55 ppm. In the 1H 
NMR spectrum of the complex [Ru(bpy)2(BtpD)](PF6)2 the methylene signal overlaps the 
broad NH singlet as a sharp singlet, while the corresponding deuterated complex 
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[Ru(bpy)2(BtpD-d3)](PF6)2  has a much smaller peak in its place, suggesting there may be 
some deuteron/proton exchange occurring on the methylene carbon. In both complexes 
the signals corresponding to the ring of the benzyl group are overlapped with bipyridine 
signals but the multiplets they occur in could be assigned using a combination of the 
HSQCAD and HMBCAD spectra looking for cross peaks from the methylene carbon to the 
connecting ring carbon and on to the protons. Splitting of the triazole and methylene 
carbon signals in the 13C NMR spectrum should be expected due to coupling with the 2D 
nuclei but is not observed for either signal. The triazole carbon appears as a slightly 
broadened peak at 127.25 ppm and the 13C signal corresponding to the methylene carbon 
(which appears at 56.57 ppm in [Ru(bpy)2(BtpD)](PF6)2)  is not visible above the baseline, 
although a cross peak to the partial 1H signal is observed in the HSQCAD. The 13C signal for 
the methylene carbon of [Ru(bpy)2(BtpD-d3)](PF6)2  (which occurs at 56.57 ppm in 
[Ru(bpy)2(BtpD)](PF6)2) is lost in the baseline noise of the spectrum, although a weak 
cross peak can be observed in the HSQCAD spectrum.  The COSY spectra seemed to 
support the assignment but it was hard to confirm due to the large overlap with bipyridine 
associated signals. In the spectrum of the complex [Ru(bpy)2(HtpD)](PF6)2 the hexyl 
group was much easier to identify and assign since the signals were below 5 ppm and had 
no overlap with the aromatic protons of the bipyridine ligands. The terminal methyl and N 
adjacent methylene protons of the hexyl- were easily identified as triplets of 3H and 2H 
integrations, respectively, with the N adjacent methylene the most downfield shifted at 
4.35 ppm. This assignment was confirmed through use of the HSQCAD and HMBCAD 
spectra (Figure 2.39 and Figure 2.40) with the signal at 4.35 being the only alkyl type 
signal to show cross peaks to the triazole. The remaining hexyl signals were assigned 
through the COSY spectrum (Figure 2.38) from end to end, with confirmation coming from 
the HSQCAD and HMBCAD spectra.  
 
Figure 2.38 1H COSY NMR (500 MHz) spectrum of [Ru(bpy)2(HtpD)](PF6)2 in CD3CN. Cross peaks identifying 





Figure 2.39 HSQCAD NMR (500 MHz) spectrum of [Ru(bpy)2(HtpD)](PF6)2 in CD3CN. The lack of cross peaks 
for the NH protons is shown in grey. Carbons with hexyl assigned protons are labelled with green dots while 
carbons with pyridyl-triazole protons are labelled with blue dots. 
 
Figure 2.40 HMBCAD NMR (500 MHz) spectrum of [Ru(bpy)2(HtpD)](PF6)2 in CD3CN. 
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2.2.2.2 X-ray Crystallography 
X-ray quality crystals of [Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN and [Ru(bpy)2- 
(HtpD)](PF6)2·CH3CN were both grown by diffusion of diethyl ether into acetonitrile 
solutions of the appropriate complex. Crystals of [Ru(bpy)2(BtpD)](PF6)2 were obtained 
by the same method with similar unit cells to the deuterated complex but repeatedly gave 
lower quality data sets and heavily disordered structures. The complex  
[Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN crystallises in the triclinic space group 𝑃1̅ with the 
asymmetric unit containing one complex with its two anions and a single acetonitrile 
solvent (Figure 2.41). The ruthenium ion is octahedral with the BtpD-d3 coordinating N^N 
through the pyridine and triazole as expected. The crystal contains a racemic mixture of 
the Λ and Δ enantiomers which form hydrogen bonded pairs through the NH···N hydrogen 
bonding between H9A and N7 (H···N 2.24 Å, NH···N 165°) of adjacent diaminotriazine 
moieties via a 𝑅2
2(8) motif (Figure 2.42). This hydrogen bonding interaction is supported 
by weaker NH···F hydrogen bonding interactions to F10 and F9 of a PF6 anion from N8 and 
N9 respectively (H···F 2.17 and 2.36 Å, NH···F 158° and 125° respectively) to give an 
overall   𝑅3
3(10)𝑅2
2(8)𝑅3
3(10) motif. These hydrogen bonded pairs then pack into chains 
down the crystallographic b axis (Figure 2.43).  
 
Figure 2.41 X-ray crystal structure of [Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN. Ellipsoids are drawn at 50% level 
and acetonitrile solvent is hidden for clarity and hydrogen bonding interactions shown in blue. 
This packing is facilitated by offset π-π interactions between the coordinating pyridines of 
the BtpD-d6 ligands on adjacent molecules (cent···C 3.62 Å) and between the benzyl ring 
of one molecule and the triazine ring of the molecule hydrogen bonding to the first 
adjacent molecule (which is involved in the pyridine-pyridine interaction) (cent···N 3.50 
Å). The packing into chains is also supported by a variety of weak CH···F and CD···F 
hydrogen bonds between the PF6 anions supporting the triazine hydrogen bonding 
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interaction and the adjacent molecules involving H26 and F12 (H···F 2.55 Å, CH···F 127°), 
H17 and F9 (H···F 2.91 Å, CH···F 113°), and D11B and F7 (D···F 2.91 Å, CD···F 122°). There 
is a supporting CD···N hydrogen bond between the N8 amino group of one triazine and the 
triazole of an adjacent hydrogen bonded pair (D···N 2.62(4) Å, CD···N 152(3)°). Chains 
then pack into the overall 3D structure through further weak CH···F and CH···N 
interactions with the acetonitrile filling space between chains with a hydrogen bonded 
position to C28 of a bipyridine ligand (H···N 2.45 Å, CH···N 157°). The Hirshfeld surface 
analysis of [Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN (Figure 2.44) showed the majority of the 
intermolecular interactions present are H-F, which make up 38.8% of the total surface and 
include both tight close approaches, indicative of strong hydrogen bonding, and more 
diffuse longer distance interactions which are more of a van der Waals character. H-N 
interactions made up a significant portion of the intermolecular interactions at 10.0% with 
sharp peaks related to the NH···N hydrogen bonding observed in the structure. H-C and C-
C interactions also made up a combined 19.0% of the overall surface interactions (14.2% 
and 4.8%, respectively) and supported the observation of π-stacking interactions between 
the pyridine and benzyl moieties of adjacent BtpD-d6 ligands. 
 
Figure 2.42 Packing of [Ru(bpy)2(BtpD-d6)] complexes with supporting PF6 anions into hydrogen bonded 
pairs via  𝑹𝟑
𝟑(𝟏𝟎)𝑹𝟐
𝟐(𝟖)𝑹𝟑
𝟑(𝟏𝟎) motifs. Hydrogen bonding interactions shown in blue. 
 
Figure 2.43 Pairs of [Ru(bpy)2(BtpD-d6)] molecules (green or pink, with PF6 anions in blue) pack into chains 
down the crystallographic b axis via a variety of non-classical CH···N and CH···F hydrogen bonding interactions 
(magenta) and offset π-π stacking (dark blue) between coordinated pyridines of adjacent molecules and 




Figure 2.44 Hirshfeld fingerprint plots of the intermolecular interactions in [Ru(bpy)2(BtpD-
d3)](PF6)2·CH3CN: (top left) H-C interactions, 14.2%; (top right) C-C interactions, 4.8%; (bottom left) H-N 
interactions, 10.0%; (bottom right), H-F interactions, 38.8%. 
The complex [Ru(bpy)2(HtpD)](PF6)2·CH3CN also crystallises in the triclinic space group 
𝑃1̅ with the asymmetric unit containing one complex with its two anions and a single 
acetonitrile solvent (Figure 2.45). One of the PF6 anions is disordered with the major 
component present 70% of the time. Like in the structure of [Ru(bpy)2(BtpD-
d6)](PF6)2·CH3CN,  the ruthenium ion is octahedral with the HtpD ligand coordinating N^N 
through the pyridine and triazole as expected and the crystal once again contains a 
racemic mixture of the Λ and Δ enantiomers forming hydrogen bonded pairs through the 
NH···N hydrogen bonding between N6 and N9 (H···N 2.17 Å, NH···N 157°) of adjacent 
diaminotriazine moieties via a 𝑹𝟐
𝟐(𝟖) motif (Figure 2.46). This hydrogen bonding is 
supported by NH···F hydrogen bonds with PF6 anions like in the BtpD-d6 structure, 
although the anion is in a closer position to diaminotriazine moieties with N8 hydrogen 
bonding to both N7A and F8A (H···F 2.37 and 2.39 Å, NH···F 134° and 161° respectively) 










Figure 2.45 X-ray crystal structure of [Ru(bpy)2(HtpD)](PF6)2·CH3CN. Ellipsoids are drawn at 50% level and 
only major components of disorder are shown. Hydrogen bonding interactions shown in blue. 
The hydrogen bonded pairs of [Ru(bpy)2(HtpD)](PF6)2 also pack into chains, in this case 
down the crystallographic a axis (Figure 2.47). Unlike the BtpD-d6 structure the pairs are 
not packed as tightly together and no π-stacking interactions are observed. Instead, the 
packing is primarily facilitated by weak CH···F type interactions between the bipyridine 
aromatic protons H24 and H25 with F11A (H···F 2.67 and 2.89 Å, CH···F 129° and 119° 
respectively), the hexyl protons H11B and H14B with F12A (H···F 2.48 and 2.49 Å, CH···F 
180° and 147° respectively), and the triazole H7 with F9A (H···F 2.93 Å, CH···F 159°). 
Similar interactions also occur with the corresponding atoms of the minor component of 
the disordered PF6 at similar lengths and angles. There is also weak supporting CH···N 
interactions between H12A and H14A of a hexyl group and N9 and N7 respectively of the 
triazine of an adjacent molecule (H···N 2.93 and 2.82 Å, CH···N 173° and 140° 
respectively), and also between the aromatic proton H26 and N7 of an adjacent molecule 










𝟐(𝟒) motifs. Hydrogen bonding interactions are shown in blue. 
 
Figure 2.47 Pairs of [Ru(bpy)2(HtpD)] molecules (green or pink, with PF6 anions in blue) pack into chains 
down the crystallographic a axis via a variety of non-classical CH···N and CH···F hydrogen bonding interactions 
shown in magenta. 
The Hirshfeld surface analysis of [Ru(bpy)2(HtpD)](PF6)2·CH3CN (Figure 2.48) was similar 
to the surface observed in [Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN although with a few 
significant differences. Firstly H-F interactions, which make up only 30.6% (compared to 
38.8%) show two pairs of strong close approaches rather than the single pair observed in 
the BtpD-d3 structure, suggesting there is two different types of strong H···F interactions 
present in the structure, although is actually due to the disordered (and therefore parted) 
PF6- anion. H-N interactions make up 14.0% of the total surface interactions with a 
fingerprint plot more than was observed in the BtpD-d3 structure. H-C and C-C make up a 
combined 17.6% of the total surface interactions (15.5% and 2.1%, respectively) although 
the C-C interactions are much weaker than those observed in [Ru(bpy)2(BtpD-
d3)](PF6)2·CH3CN (which contains significant π-stacking) and the H-C fingerprint plot has 
sharp peaks which look closer to hydrogen bonding interactions rather than  π-stacking 





Figure 2.48 Hirshfeld fingerprint plots of the intermolecular interactions in [Ru(bpy)2(HtpD)](PF6)2·CH3CN: 
(top left) H-C interactions, 15.5%; (top right) C-C interactions, 2.1%; (bottom left) H-N interactions, 14.0%; 
(bottom right), H-F interactions, 30.6%. 
 
2.2.3 Iridium(III) Complexes 
Cyclometalated complexes of the type fac-[Ir(ppy)2(RtpD)]PF6 (where R = B or H) were 
synthesised from the iridium(III) dimer fac-[Ir(ppy)2-μ-Cl]2 with two and a half 
equivalents of the appropriate ligand and an excess of sodium carbonate in a dry DMSO 
solution under Ar(g) at 125°C for 6 hours. After cooling, the slow addition of aqueous 
NH4PF6 precipitated the crude product which was purified by filtration through 
CeliteCelite as a dichloromethane solution and then addition of excess diethyl ether to give 






The composition of both complexes was confirmed by elemental analysis, HRESI-MS, and 
1H and 13C NMR spectroscopies. Like with the ligands, there were issues with collecting 
consistent and accurate analysis data of the complexes likely due to the incomplete 
combustion of the nitrogen rich triazole ring(s). The ESI-MS of both fac-
[Ir(ppy)2(BtpD)]PF6 and fac-[Ir(ppy)2(HtpD)]PF6 contain major 1+ peaks corresponding 
to the respective complexes without their PF6 anions. The IR spectra of the iridium(III) 
complexes was very similar to those of the ruthenium(II) complexes. 
 
Figure 2.49 HRESI-MS of [Ir(ppy)2(BtpD)]PF6 (left) and [Ir(ppy)2(HtpD)]PF6 (right) with calculated isotope 
patterns shown next to the major peaks. 
Due to the asymmetric nature of both the RtpD and the ppy ligands, the 1H NMR spectrum 
contains individual peaks for all the protons present. Unlike the ruthenium complexes 
where the bipyridine ligands are difficult to assign, the asymmetry of the phenylpyridine 
ligands allows assignment of all proton signals; although the two ligands have their proton 
signals paired and cannot be differentiated from each other. The 1H protons of the 
complexes were fully assigned by means of COSY, ROSEYAD, HSQCAD, and HMBCAD 2D 
spectroscopic experiments. The triazole proton appears as a sharp singlet at either 9.35 or 
9.44 ppm for the benzyl and hexyl substituted complexes, respectively, and the NH amines 
of the DAT moiety appear as a broadened singlet at around 6.4 ppm in both complexes. 
The 1H COSY spectrum (Figure 2.50) allowed the identification of three different ring 
systems through their cross peaks, and the benzyl ring protons (as well as giving the 




Figure 2.50 1H COSY NMR (500 MHz) spectrum of fac-[Ir(ppy)2(BtpD)]PF6 in DMSO-d6. Cross peaks identify 
pyridyl-triazole (blue), benzyl (green), cyclometalated phenyl (orange), and pyridyl (purple) ring groupings.  
 
Figure 2.51 1H ROSEYAD NMR (500 MHz) spectrum of fac-[Ir(ppy)2(BtpD)]PF6 in DMSO-d6. Cross peaks 




Figure 2.52 HSQCAD NMR (500 MHz) spectrum of fac-[Ir(ppy)2(BtpD)]PF6 in DMSO-d6. Cross peaks link 
pyridyl-triazole (blue), benzyl (green), cyclometalated phenyl (orange), and pyridyl (purple) protons to their 
respective carbon signals. Broad NH singlet has no directly associated carbon as expected. 
 
Figure 2.53 HMBCAD NMR (500 MHz) spectrum of fac-[Ir(ppy)2(BtpD)]PF6 in DMSO-d6. Metalated carbons 
are highlighted in orange and yellow while the carbons between the phenyl and pyridine rings of the ppy 
ligands are  
highlighted in blue and purple. 
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2.3 Conclusions  
A series of cationic palladium(II) complexes of the type [Pd(ppy)(biguH)]OAc, the neutral 
palladium(II) and platinum(II) analogues of these complexes, which were of the type 
[M(ppy)(bigu)], as well as the cationic ruthenium(II) and iridium(III) complexes 
[Ru(bpy)2(BtpD)](PF6)2, [Ru(bpy)2(BtpD-d3)](PF6)2, [Ru(bpy)2(HtpD)](PF6)2, 
[Ir(ppy)2(BtpD)](PF6)2, and [Ir(ppy)2(HtpD)](PF6)2,  were synthesised and characterised 
through a variety of techniques including elemental analysis, ESI-MS, X-ray 
crystallography, and a collection of 1D and 2D 1H and 13C NMR experiments. Many of the 
complexes suffered from limited solubility in common organic solvents especially the 
neutral palladium(II) complexes which were only soluble in strongly hydrogen bonding 
solvents such as DMF and DMSO leading to competition for hydrogen bonding 
interactions. The charged palladium(II) complexes nominally contain DDD type hydrogen 
bond motifs and one crystal structure of [Pd(ppy)(tBubiguH)]OAc was obtained. The 
neutral palladium(II) and platinum(II) complexes contain potential DAD motifs with 
crystal structures of [Pd(ppy)(tBubigu)]·2DMF, [Pd(ppy)(diClbigu)]·2DMF, 
[Pd(ppy)(diFbigu)]·2DMF, and [Pt(ppy)(diFbigu)]·2DMF all being obtained, although 
conformational changes in the diarylbiguanide complexes was found to obscure the DAD 
motif (vide infra). The ruthenium(II) and iridium(III) complexes also contain DAD type 
motifs, although only structures of [Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN and  
[Ru(bpy)2(HtpD)](PF6)2·CH3CN were obtained. 
Of the five diarylbiguanide crystal structures obtained, only in the structure of the charged 
[Pd(ppy)(tBubiguH)]OAc was the diarylbiguanide ligand found to be in its syn-syn 
conformation, which enabled the acetate anion to be involved in NH···O hydrogen bonds to 
the resultant DDD surface via a 𝑅2
2(8)𝑅2
1(6) motif. In the structures of [Pd(ppy)(tBubigu)] 
and [Pt(ppy)(diFbigu)], which were obtained from solutions of the respective complexes 
in DMF, as well as the structures of [Pd(ppy)(diFbigu)] and [Pd(ppy)(diClbigu)], which 
were obtained from DMF solutions of their respective charged acetate complexes, the 
diarylbiguanide ligands were observed to be their anti-anti conformations. In this 
conformation the biguanide presents two DD type hydrogen bonding surfaces to which 
DMF solvent molecules were positioned with NH···O hydrogen bonds with supporting 
CH···O hydrogen bonds, from the ppy ligand, to give two pairs of 𝑅2
1(6)𝑅2
1(7) motifs in all 
four structures, except for one DMF solvent in the structure of [Pd(ppy)(tBubigu)] which 
was positioned too far from the ppy ligand to engage in the additional CH···O interaction. 
In all four structures the ortho protons of the aryl groups were also involved in S(6) 
intramolecular hydrogen bonds to the deprotonated N2, which also likely helped drive the 
adoption of the anti-anti conformation, along with the presence of the DMF solvent 
molecules which act as good hydrogen bond acceptors for the DD motifs. 
Beyond the conformational geometries the different diarylbiguanide complexes adopt in 
their crystalline structures, the different complexes pack together in variety of different 
ways relying on different weaker intermolecular interactions (due to the DMF solvent 
molecules or acetate anion monopolising the strong hydrogen bonding interactions). 
While the square planar metal ions with the flat aromatic ppy ligand and biguanide with 
delocalised π-bonds would be considered ideal to pack through π-stacking or chelate 
stacking interactions, only in the structure of [Pd(ppy)(tBubiguH)]OAc are complexes 
observed to pack in this way forming head-to-tail pairs (Figure 2.11) through chel···chel 
interactions (cent···cent 3.55 Å). In the structures of [Pd(ppy)(diClbigu)]·2DMF, 
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[Pd(ppy)(diFbigu)]·2DMF, and [Pt(ppy)(diFbigu)]·2DMF, the complexes are observed to 
form either offset head-to-tail stacks or dimers where the hydrogen bonded DMF solvent 
molecules engage in interactions with the adjacent complex or its hydrogen bonded 
solvent molecules, while the fluoro or chloro atoms act as hydrogen bond acceptors for 
CH···X hydrogen bonds from the ppy ligand of adjacent complexes. The packing of both 
[Pd(ppy)(diClbigu)]·2DMF and [Pd(ppy)(diFbigu)]·2DMF  primarily rely on the CH···Cl  
or CH···F  hydrogen bonds, as well as weak offset π-stacking interactions between the 
biguanide aryl groups and the ppy ligand of the adjacent complex, while the DMF solvent 
molecules only engage in weak CH···O hydrogen bonds to the hydrogen bonded solvent of 
an adjacent complex (Figure 2.18 and Figure 2.20).  
In the structure of [Pt(ppy)(diFbigu)]·2DMF, there is an greater offset between adjacent 
complexes, compared to the structure of [Pd(ppy)(diClbigu)]·2DMF and 
[Pd(ppy)(diFbigu)]·2DMF, such that the DMF solvent molecules are positioned that they 
are involved in CH···Pt and CH···π interactions with the metal ion, and delocalised 
biguanide π-bonds of an adjacent complex. No CH···F interaction between these adjacent 
complexes occurs (although they are present in the further packing of the stacks formed), 
nor do the DMF solvent molecules hydrogen bond to the DMF solvent molecules of 
adjacent complexes. In the structure of [Pd(ppy)(tBubigu)]·2DMF chains of complexes 
down the crystallographic c axis are formed by weak CH···N hydrogen bonds between the 
strongly hydrogen bonded solvent molecules and the biguanide moieties of adjacent 
complexes, as well as weak CH···π interactions. These chains then pack together through a 
variety of weak hydrogen bonding and van der Waals interactions to form the overall 
structure. Hirshfeld analysis of [Pd(ppy)(tBubigu)]·2DMF supported the lack of strong 
intermolecular interactions involved in the packing with H-N interactions, while making 
up 7.1% of the total surface being more diffuse than would normally be observed for 
hydrogen bonding interactions, while H-H interactions make up 61.3% of the total surface. 
H-C interactions, which make up 24.1% of the surface, do have somewhat sharp peaks, 
supporting the assignment of CH···π type interactions assisting the packing of the 
complexes. 
The head-to-tail pairs of complexes in the structure of [Pd(ppy)(tBubiguH)]OAc pack 
together through a variety of weak CH···O and CH···π hydrogen bonds to form the overall 
3D structure. Hirshfeld analysis of [Pd(ppy)(tBubiguH)]OAc showed C-C, C-N, and C-Pd 
make up a combined 4.7% of the total surface (1.9%, 1.6%, and 1.2%, respectively), and 
are clustered tightly around 3.1 – 3.5 Å and are related to the chelate stacking interactions, 
although this is not much more than the percentage interactions observed in the other 
structures where chelate or large areas of π-stacking are not observed. C-H interactions 
make up 21.3% of the Hirshfeld surface and highlight the importance of the CH···π 
interactions in the packing of the complex. H-H made up 60.5% of the total surface, like in 
the structure of [Pd(ppy)(tBubigu)]·2DMF, highlighting how the packing of the tBu 
substituted complexes is significantly supported by dispersion interactions.  
All three of the halogen substituted complexes, [Pd(ppy)(diClbigu)]·2DMF, 
[Pd(ppy)(diFbigu)]·2DMF, and [Pt(ppy)(diFbigu)]·2DMF, have their secondary packing 
supported by CH···X hydrogen bonds. These types of hydrogen bonds are important in the 
packing of all three structures with Hirshfeld surface analysis showing H-Cl or H-F 
interactions making up 22.7%, 19.0%, and 19.1% of the total surface interactions of each 
complex, respectively. Stacks of complexes in the structure of [Pd(ppy)(diClbigu)]·2DMF 
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pack together into sheets through the CH···Cl hydrogen bonds as well as CH···π 
interactions, with Cl···Cl interactions (Cl···Cl 3.26 Å, C-Cl···Cl 154°) also being observed 
between adjacent complexes. In the structures of both [Pd(ppy)(diFbigu)]·2DMF and 
[Pt(ppy)(diFbigu)]·2DMF, interdigitated stacks of complexes form through a variety of 
CH···F hydrogen bonds between both adjacent aryl groups (forming twisted 𝑅2
2(8) dimers) 
and DMF solvent molecules. 
The complexes in both structures of [Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN and  
[Ru(bpy)2(HtpD)](PF6)2·CH3CN were observed to form hydrogen bonded pairs where the 
DAT moieties of each of the adjacent complexes would form NH···N hydrogen bonds 
forming  𝑅2
2(8) motifs. PF6- anions in both structures were located either side of the 𝑅2
2(8) 
motifs and involved in various NH···F hydrogen bonding interactions with the amines of 
the DAT moieties to give a 𝑅3
3(10)𝑅2
2(8)𝑅3
3(10) motif in the case of [Ru(bpy)2(BtpD-





2(4) motif in the case of 
[Ru(bpy)2(HtpD)](PF6)2·CH3CN, due to slightly different positioning of the anions. In both 
structures, pairs of complexes form chains down the crystallographic b and a axis, 
respectively. Although the arrangement of the hydrogen bonded pairs into chains is 
similar, in the structure of [Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN the complexes are arranged 
through π-stacking interactions between the benzyl ring and the triazine ring of the 
adjacent complex (cent···N 3.50 Å) as well as between the pyridine rings of the adjacent 
BtpD-d3 ligands (cent···C 3.62 Å). In the structure of [Ru(bpy)2(HtpD)](PF6)2·CH3CN, no 
clear π-stacking arangments are observed and instead the packing into chains is facilitated 
by a series of weak CH···F and CH···N hydrogen bonds involving the triazine, and hexyl 
moieties as well as PF6- anions. Comparing Hirshfeld surface analysis between the two 
structures is not exactly clear since C-H and C-C interactions make up 19% and 17.6%, 
respectively (14.2% and 4.8%, and 15.5% and 2.1%), although the fingerprint plots of the 
C-H and C-C interactions do differ with the structure of [Ru(bpy)2(HtpD)](PF6)2·CH3CN 
having sharper (more hydrogen bond like) C-H interactions, while the structure of 
[Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN has more condensed central C-C interactions 
(characteristic of π-stacking interactions). In both structures H-F make up a significant 
(38.8% and 30.6% for BtpD-d3 and HtpD structures, respectively) portion of the 
interactions, highlighting the importance of the anions in the packing of the complexes, 




2.4 Experimental Supplemental 
Unless otherwise stated, all reagents were purchased from commercial sources and used 
without further purification. Diarylbiguanide ligands, biguH,[1-3] and the cyclometalated 
complexes [Pt(ppy)μ-Cl]2,[8] [Pd(ppy)μ-OAc]2,[21] and fac-[(Ir(ppy)2-μ-Cl2],[22] were 
prepared by literature methods. Solvents used were laboratory grade, with petroleum 
ether referring to the fraction of petroleum ether boiling in the range 40-60 °C. All NMR 
spectra were recorded on either a 400 MHz Varian 400 MR, or Varian 500 MHz VNMRS 
spectrometer at 298 K. Chemical shifts are reported in parts per million, referenced to 
residual solvent peaks (CDCl3: 1H 7.26, 13C 77.23; CD3CN: 1H 1.96, 13C 118.69; dmso-d6: 1H 
2.50, 13C 39.52 ppm), and analysed using MestReNova 9.0. IR spectra were recorded on a 
Bruker ALPHA FT-IR spectrometer using a diamond surface. Hirshfeld surfaces[23] were 
calculated to high resolution using the complete asymmetric units of the respective 
structures in the CrystalExplorer software package.[24] High resolution electrospray mass 
spectra (HRESI-MS) were collected on a Bruker micro-TOF-Q spectrometer. UV-vis spectra 
were collected by either Dr Georgina Shillito or Joseph Mapley in collaboration with the 
KCG research group at the University of Otago. Microanalyses were conducted at the 
Campbell Microanalytical Laboratory at the University of Otago. 
2.4.1 Pyridyl-triazole Based Ligands and Precursors 
2-(TMS-acetylene)-5-cyanopyridine was prepared through typical Sonogishira methods 
from 2-bromo-5-cyanopyridine and TMS-acetylene in a 1:4 solution of diisopropylamine 
in THF with 5% and 2% of copper iodide and [Pd(dppe)Cl2], respectively. The prepared  






A suspension of 2-(TMS-acetylene)-5-cyanopyridine (609.5 mg, 3.04 mmol) and sodium 
carbonate (645.0 mg, 6.09 mmol) in methanol (15 mL) was stirred at room temperature 
for 2 hours before filtration through Celite followed by removal of the methanol through 
rotary evaporation. The resulting residue was taken up by chloroform (20 mL) and filtered 
through Celite again before removal of the solvent again to give the deprotected acetylene 
as a white solid which was not purified further. This was dissolved in a 4:1 mix of 
DMF:H2O (5 mL) and added to a stirring mixture of copper sulfate pentahydrate (381.5 
mg, 1.53 mmol), sodium ascorbate (604.8 mg, 3.05 mmol), sodium azide (196.0 mg, 3.02 
mmol), and benzyl bromide (360 μL, 3.03 mmol) in a 4:1 mix of DMF:H2O (20 mL), 
resulting in a cloudy orange solution which was stirred at room temperature overnight. An 
aqueous 1:1 solution of EDTA:NH4OH (0.1 M, 25 mL) was added to the orange solution and 
stirred for a further 2 h at room temperature, resulting in a green/blue solution from 
which the product was extracted with chloroform (50 mL). The yellow organic phase was 
washed with water (6 x 80 mL) before drying over magnesium sulfate, filtration and 
removal of solvent via rotary evaporation. The crude product was purified via flash 
column chromatography on silica eluting with 1:1 ethyl acetate:petroleum ether to yield a 
white crystalline solid (199.4 mg, 25%). 1H NMR (400 MHz, CDCl3) δ 8.78 (s, 1H, Ha), 8.30 
(d, J = 8.3 Hz, 1H, Hc), 8.11 (s, 1H, Hd), 8.02 (dd, J = 8.3, 2.1 Hz, 1H, Hb), 7.42 – 7.31 (m, 5H, 






A solution of 2-(3-benzyl-1,2,3-triazol-5-yl)-5-cyanopyridine (131.4 mg, 0.501 mmol), 
dicyandiamide (75.9 mg, 0.908 mmol) and potassium hydroxide (10.1 mg, 0.180 mmol) in 
dry DMSO-d6 (0.7 mL) was heated under sealed tube microwave conditions at 195 °C for 
10 min. After cooling to approx. 30 °C the resulting dark orange oil was poured into boiling 
H2O (100 mL) to give a cream precipitate. After cooling the aqueous suspension to room 
temperature, the precipitate was collected via filtration, washed with ice cold methanol 
and air dried to give the product as a cream solid which was deuterated at d, and e. (120.4 
mg, 70%). Anal. Calc. for C17H12D3N9·0.5H2O: C, 57.62; H, 4.55; N, 35.57. Found: C, 57.38; H, 
4.44; N, 32.67. 1H NMR (400 MHz, DMSO-d6) δ 9.32 (d, J = 2.1 Hz, 1H, Ha), 8.56 (dd, J = 8.3, 
2.2 Hz, 1H, Hb), 8.12 (d, J = 8.3 Hz, 1H, Hc), 7.42 – 7.29 (m, 5H, Ph), 6.84 (s, 4H, NH2) (trace 
amounts of the non-deuterated ligand observed in solution likely through further proton 
exchange). ESIMS (m/z) (DMSO/MeOH): [C17H12D3N9Na]+ expected 371.1531, found 
371.1570.  
 
The non-deuterated complex was prepared through the same method with dry DMSO (1 
mL) used as the solvent. (110.1 mg, 64%). 1H NMR (400 MHz, DMSO-d6) δ 9.35 (s, 1H, Hd), 
8.78 (s, 1H, Ha), 8.59 (d, J = 8.3 Hz, 1H, Hb), 8.14 (d, J = 8.3 Hz, 1H, Hc), 7.54 – 7.22 (m, 5H, 






A suspension of 2-(TMS-acetylene)-5-cyanopyridine (610.0 mg, 3.05 mmol) and sodium 
carbonate (754.5 mg, 7.12 mmol) in methanol (25 mL) was stirred at room temperature 
for 2 hours before filtration through Celite and removal of the methanol through rotary 
evaporation to give the deprotected acetylene as a white solid which was not purified 
further. This solid was dissolved in a 3:1 mix of DMF:H2O (20 mL) and added to a stirring 
mixture of copper sulfate pentahydrate (382.2 mg, 1.53 mmol), and sodium ascorbate 
(616.7 mg, 3.11 mmol). The n-hexyl azide was pre-formed by heating a solution of sodium 
azide (2395 mg, 3.68 mmol), and n-hexyl bromide (520 μL, 3.66 mmol) in DMF (5 mL) 
under sealed tube microwave conditions at 150 ºC for 1 h and then added dropwise to the 
deprotected acetylene solution, resulting in a dark orange solution which was stirred at 
room temperature overnight. An aqueous 1:1 solution of EDTA:NH4OH (0.1 mol L-1, 25 
mL) was added to the red solution and stirred for a further 2 h. at room temperature, 
resulting in a green/blue solution from which the product was extracted with chloroform 
(2 x 45 mL). The yellow organic phase was washed with water (6 x 100 mL) and brine (2 x 
60 mL) before drying over magnesium sulfate, filtration and removal of solvent via rotary 
evaporation. The crude product was purified via column chromatography on silica eluting 
with 1:1 ethyl acetate:petroleum ether to give an off white solid. (638.4 mg, 82%). 1H NMR 
(400 MHz, CDCl3) δ 8.83 (d, J = 2.1 Hz, 1H, Ha), 8.31 (d, J = 8.3 Hz, 1H, Hc), 8.20 (s, 1H, Hd), 
8.03 (dd, J = 8.3, 2.1 Hz, 1H, Hb), 4.44 (t, J = 7.2 Hz, 2H, He), 1.97 (quintet, J = 7.2 Hz, 2H, 







A solution of 2-(3-hexzyl-1,2,3-triazol-5-yl)-5-cyanopyridine (182.9 mg, 0.72 mmol), 
dicyandiamide (108.6 mg, 1.29 mmol) and potassium hydroxide (21.7 mg, 0.39 mmol) in 
dry DMSO (1 mL) was heated under sealed tube microwave conditions at 195 °C for 10 
min. After cooling to approx. 30 °C the resulting dark orange oil was poured into boiling 
H2O (120 mL) to give an orange precipitate. After cooling the aqueous suspension to room 
temperature, the precipitate was collected via filtration, washed with additional water 
before being taken up in methanol and the resulting solution dried over magnesium 
sulfate, filtered and the solvent removed via rotary evaporation. The resulting dark yellow 
solid was purified by column chromatography on silica, eluting with 1:1 mixture of 
chloroform and acetone to give a pure yellow solid (58.7 mg, 24%). Anal. Calc. for 
C16H21N9·0.33CHCl3: C, 51.74; H, 5.67; N, 33.24. Found: C, 52.01; H, 5.44; N, 28.85. 1H NMR 
(400 MHz, DMSO-d6) δ 9.35 (dd, J = 2.2, 0.9 Hz, 1H, Ha), 8.74 (s, 1H, Hd), 8.59 (dd, J = 8.3, 
2.2 Hz, 1H, Hb), 8.15 (dd, J = 8.3, 0.9 Hz, 1H, Hc), 6.86 (s, 4H, NH2), 4.43 (t, J = 7.0 Hz, 2H, 
He), 1.88 (quintet, J = 6.9 Hz, 2H, Hf), 1.27 (s, 6H, Hg, Hh, Hi), 0.85 (t, J = 6.8 Hz, 3H, Hj). ESI-
MS (m/z) (DMSO/CH3OH): [C16H21N9Na]+ expected 362.1812, found 362.1811; 







2.4.2 Diarylbiguanide Complexes 
2.4.2.1 Palladium(II) Complexes 
Charged 1,5-diarylbiguanide 2-phenylpyridine palladium(II) acetate complexes of the type 
[Pd(ppy)(biguH)]OAc were prepared through the following general method using the 
appropriately substituted 1,5-diarylbiguanide: To a solution of [Pd(ppy)μ-OAc]2 (64.1 mg, 
0.10 mmol) in dichloromethane (15 mL), two equivalents of the ligand (0.20 mmol) was 
added and the resulting solution stirred at room temperature overnight, during which 
time a pale yellow or cream precipitate formed. The suspension was poured into an excess 
of diethyl ether (80 mL) and stirred for a further 10 min. The resulting yellow or cream 
precipitates were filtered and washed with diethyl ether before being dried in vacuo to 
give the corresponding complex. 
Neutral 1,5-diarylbiguanido 2-phenylpyridine palladium(II) complexes of the type 
[Pd(ppy)(bigu)] were prepared from the corresponding acetate complex through the 
following general method: To a suspension of the charged palladium(II) complex (0.075 
mmol) in acetone (10 mL), a solution of sodium methoxide (17 μL, 25 wt%) was added 
and the resulting solution was stirred at room temperature overnight. Reduction of the 
solvent (to approx. 2 mL) and addition of diethyl ether gave pale yellow solids which were 
collected via filtration and washed with diethyl ether before being dried in vacuo to give 







Pale cream product (92.8 mg, 81%). Anal. Calc. for C27H26N6O2Pd: C, 56.60; H, 4.57; N, 
14.67; Found: C, 56.76; H, 4.69; N, 14.81. 1H NMR (500 MHz, DMSO-d6) δ 11.95 (s, 1H, 
NH2), 8.60 (s, 1H, NH5), 8.48 (d, J = 5.6 Hz, 1H, Ha), 8.18 (s, 1H, NH4), 8.12 – 8.01 (m, 2H, 
Hc, Hd), 7.75 (dd, J = 7.7, 1.4 Hz, 1H, He), 7.45 – 7.35 (m, 6H, Hb, Hh, Hk, Hl), 7.22 – 7.12 (m, 
5H, Hf, Hj, Hm), 7.09 (t, J = 7.3 Hz, 1H, Hg), 6.95 – 6.86 (m, 2H, Hi, Hn), 5.87 (s, 1H, NH3), 
5.37 (s, 1H, NH1), 1.91 (s, 3H, OAc). 13C NMR (126 MHz, DMSO-d6) δ 171.99, 165.57, 
160.13, 157.50, 156.70, 147.26, 145.53, 141.15, 141.06, 138.83, 130.96, 128.42 (3C), 
123.75, 123.50, 122.33, 121.17, 120.85, 120.63, 120.13, 119.37, 21.08. IR υ max/cm-1 
3401, 3362, 3273, 3056, 2981, 2673, 1683, 1630, 1596, 1562, 1493, 1483, 1449, 1397, 
1303, 1262, 1219, 1200, 1004, 857, 747, 728, 711, 695, 671, 643, 595, 519, 491, 472, 416. 
UV-vis (DMSO): λmax (ε/M-1cm-1) = 380 (3700) nm. ESI-MS (m/z) (DMSO/MeOH): 








Cream solid (86.3 mg, 63%). Anal. Calc for C35H42N6O2Pd·0.5H2O: C, 60.56; H, 6.24; N, 
12.11. found C, 60.55; H,6.39; N, 12.20. 1H NMR (500 MHz, DMSO-d6) δ 8.52 – 8.47 (m, 2H, 
Ha, NH4), 8.10 – 8.01 (m, 3H, Hc, Hd, NH5), 7.74 (dd, J = 7.7, 1.5 Hz, 1H, He), 7.44 – 7.35 (m, 
2H, Hh, Hb), 7.32 – 7.26 (m, 4H, Hi, Hl), 7.21 – 7.06 (m, 6H, Hf, Hg, Hj, Hk), 5.79 (s, 1H, 
NH3), 5.28 (s, 1H, NH1), 1.91 (s, 3H, OAc), 1.27 (d, J = 4.5 Hz, 18H, tBu). 13C NMR (126 MHz, 
DMSO-d6) δ 165.58, 160.37, 157.63, 156.87, 147.26, 145.52, 143.38, 142.99, 138.77, 
138.54, 138.50, 138.45, 131.03, 128.29, 124.90, 124.88, 123.70, 123.43, 122.29, 120.79, 
120.23, 119.34, 33.83, 33.78, 31.31 (6C). IR υ max/cm-1 3382, 2961, 2866, 1671, 1622, 
1600, 1577, 1556, 1511, 1402, 1360, 1267, 1224, 848, 748, 748, 727, 645. UV-vis (DMSO): 
λmax (ε/M-1 cm-1) = 364 (3600) nm. ESI-MS (m/z) (DMSO/MeOH): [C33H39N6Pd]+ expected 








Cream solid (81.8 mg, 56%). Anal. Calc. for C27H24Br2N6O2Pd·0.5H2O: C, 43.84; H, 3.41; N, 
11.36. Found: C, 43.72; H, 3.08; N, 11.24. 1H NMR (500 MHz, DMSO-d6) δ 8.75 (s, 1H, NH4), 
8.48 (d, J = 5.7 Hz, 1H, Ha), 8.30 (s, 1H, NH5), 8.11 – 8.00 (m, 2H, Hc, Hd), 7.74 (d, J = 7.5 Hz, 
1H, He), 7.44 – 7.37 (m, 2H, Hb, Hh), 7.33 – 7.25 (m, 8H, Hi-l), 7.16 (t, J = 7.3 Hz, 1H, Hf), 
7.10 (t, J = 7.5 Hz, 1H, Hg), 5.95 (s, 1H, NH3), 5.42 (s, 1H, NH1), 1.90 (s, 3H, OAc). 13C NMR 
(126 MHz, DMSO-d6) δ 171.99, 165.55, 159.79, 157.20, 156.41, 147.36, 145.54, 140.49, 
138.89, 131.05, 131.02, 130.98, 128.38, 123.76, 123.58, 122.51, 122.39, 122.33, 119.38, 
112.56, 112.43, 21.09. IR υmax/cm-1 3277, 2622, 1723, 1684, 1626, 1585, 1555, 1486, 1199, 
1068, 1007, 857, 750, 729, 644. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 385 (3200) nm. ESI-MS 








Cream product (96.7 mg, 68%). Anal. Calc. for C27H22N6O2Cl4Pd·0.5H2O: C, 45.06; H, 3.22; 
N, 11.68. Found: C, 45.22; H, 3.17; N, 11.73. 1H NMR (500 MHz, DMSO-d6) δ 11.94 (s, 1H, 
NH2), 9.12 (s, 1H, NH4), 8.62 (s, 1H, NH5), 8.50 (d, J = 5.7 Hz, 1H, Ha), 8.15 – 8.01 (m, 2H, 
Hc, Hd), 7.76 (dd, J = 7.8, 1.4 Hz, 1H, He), 7.47 – 7.37 (m, 6H, Hb, Hh, Hj, Hk), 7.19 (td, J = 
7.3, 1.4 Hz, 1H, Hf), 7.13 (t, J = 7.4, 1H, Hg), 6.98 (dt, J = 3.5, 1.9 Hz, 2H, Hi, Hl), 6.21 (s, 1H, 
NH3), 5.63 (s, 1H, NH1), 1.91 (s, 3H, OAc). 13C NMR (126 MHz, DMSO-d6) δ 165.55, 159.22, 
156.34, 155.61, 147.42, 145.58, 143.31, 143.28, 139.08, 133.85, 133.84, 130.95, 128.44, 
123.86, 123.77, 122.44, 119.56, 119.51, 119.48, 117.25, 21.05. IR υ max/cm-1 3390, 3375, 
3326, 3063, 2626, 1720, 1679, 1627, 1607, 1580, 1524, 1485, 1439, 1410, 1330, 1315, 
1302, 1223, 1114, 1093, 997, 866, 835, 811, 742, 724, 689, 665, 650, 611, 576, 474, 433, 
410. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 385 (2100) nm. ESI-MS (m/z) (DMSO/MeOH): 








Pale cream solid (98.0 mg, 76%). Anal. Calc. for C27H23F4N6O2Pd.H2O: C, 48.92; H, 3.65; N, 
12.68. Found: C, 48.84; H, 3.60; N, 12.80. 1H NMR (500 MHz, DMSO-d6) δ 11.94 (s, 1H, 
NH2), 9.13 (s, 1H, NH4), 8.64 (s, 1H, NH5), 8.50 (d, J = 5.6 Hz, 1H, Ha), 8.12 – 8.01 (m, 2H, 
Hc, Hd), 7.76 (d, J = 7.5 Hz, 1H, He), 7.46 – 7.42 (m, 2H, Hh, Hb), 7.21 – 7.02 (m, 6H, Hi, Hj, 
Hk, Hl), 6.67 – 6.57 (m, 2H, Hf, Hg), 6.19 (s, 1H, NH3), 5.62 (s, 1H, NH1), 1.91 (s, 3H, OAc). 
13C NMR (126 MHz, DMSO-d6) δ 172.02, 165.56, 163.56 (d, J = 5.2 Hz), 163.43 (d, J = 5.6 
Hz), 161.64 (d, J = 5.5 Hz), 161.51 (d, J = 5.3 Hz), 159.33, 159.25, 145.57, 143.55 (td, J = 
13.9, 3.5 Hz), 139.06, 131.00, 128.42, 123.82, 123.75, 122.46, 122.40, 119.47, 116.45, 
103.57, 103.37, 102.13, 101.92. IR υmax/cm-1 3391, 3357, 3084, 2652, 1682, 1647, 1607, 
1589, 1564, 1482, 1458, 1411, 1220, 1182, 1120, 981, 856, 747, 729, 653. UV-vis (DMSO): 
λmax (ε/M-1 cm-1) = 384 (3900) nm. ESI-MS (m/z) (DMSO/MeOH): [C25H19F4N6Pd]+ 








Pale cream solid (101.2 mg, 73%). Anal. Calc. for C31H34N6O6Pd: C, 53.72; H, 4.94; N, 12.13. 
Found: C, 53.59; H, 4.82; N, 12.05. 1H NMR (500 MHz, DMSO-d6) δ 8.63 (s, 1H, NH4), 8.48 
(d, J = 5.6 Hz, 1H, Ha), 8.22 (s, 1H, NH5), 8.12 – 8.01 (m, 2H, Hc, Hd), 7.75 (dd, J = 7.7, 1.5 
Hz, 1H, He), 7.46 – 7.34 (m, 2H, Hh, Hb), 7.18 – 7.06 (m, 2H, Hf, Hg), 6.72 – 6.62 (m, 4H, Hj, 
Hk), 6.03 (t, J = 2.2 Hz, 1H, Hi/l), 6.00 (t, J = 2.3 Hz, 1H, Hi/l), 5.96 (s, 1H, NH3), 5.47 (s, 1H, 
NH1), 3.59 – 3.52 (m, 12H, OMe), 1.90 (s, 3H, OAc). 13C NMR (126 MHz, DMSO-d6) δ 165.58, 
160.45 (4C), 159.96, 157.13, 156.30, 147.26, 145.56, 142.97, 142.85, 138.91, 130.93, 
128.36, 123.80, 123.57, 122.35, 119.42, 97.76, 97.33, 93.74, 93.44, 54.67, 54.65, 21.11. IR υ 
max/cm-1 3360, 2940, 2841, 1718, 1683, 1587, 1475, 1424, 1407, 1362, 1205, 1181, 1158, 
1070, 1051, 929, 811, 739, 724, 709, 649, 608, 539, 510, 461, 407. UV-vis (DMSO): λmax 
(ε/M-1 cm-1) = 374 (5400) nm. ESI-MS (m/z) (DMSO/MeOH): [C29H31O4N6Pd]+ expected 








Pale yellow solid (38.5 mg, 74%). Anal. Calc. for C25H22N6Pd: C, 58.54; H, 4.32; N, 16.39; 
Found: C, 58.60; H, 5.26; N, 16.37. 1H NMR (500 MHz, DMSO-d6) δ 8.60 (s, 1H, NH4), 8.49 
(d, J = 5.6 Hz, 1H, Ha), 8.20 (s, 1H, NH5), 8.10 – 8.01 (m, 2H, Hc, Hd), 7.74 (dd, J = 7.7, 1.4 
Hz, 1H, He), 7.44 – 7.36 (m, 6H, Hh, Hk, Hl, Hm/Hn), 7.23 – 7.12 (m, 5H, Hi, Hj, Hm/Hn), 
7.09 (t, J = 7.4 Hz, 1H, Hb), 6.96 – 6.86 (m, 2H, Hf, Hg), 5.88 (s, 1H, NH3), 5.38 (s, 1H, NH1). 
13C NMR (126 MHz, DMSO-d6) δ 165.57, 160.14, 157.52, 156.71, 147.29, 145.53, 141.17, 
141.07, 138.81, 130.97, 128.41, 123.74, 123.48, 122.34, 121.15, 120.82, 120.62, 120.13, 
119.35, 79.16. IR υ max/cm-1 3420, 3395, 3356, 3173, 3039, 1612, 1601, 1580, 1514, 
1498, 1478, 1448, 1423, 1229, 1194, 1178, 1057, 1025, 1001, 979, 899, 837, 788, 744, 
727, 670, 628, 585, 490, 469, 446, 410. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 384 (4200) nm. 








Yellow crystalline solid (28.2 mg, 48%). Anal. Calc. for C33H38N6Pd·0.5H2O: C, 62.50; H, 
6.20; N, 13.25. Found: C, 62.55; H, 6.16; N, 13.34. 1H NMR (500 MHz, DMSO-d6) δ 8.53 – 
8.44 (m, 2H, Ha, NH4), 8.10 – 7.99 (m, 3H, Hc, Hd, NH5), 7.74 (d, J = 7.5 Hz, 1H, He), 7.45 – 
7.36 (m, 2H, Hb, Hh), 7.33 – 7.25 (m, 4H, Hk, Hj), 7.22 – 7.11 (m, 5H, Hg, Hi, Hl), 7.09 (t, J = 
7.3 Hz, 1H, Hf), 5.79 (s, 1H, NH3), 5.28 (s, 1H, NH1), 1.27 (d, J = 4.4 Hz, 18H, tBu). 13C NMR 
(126 MHz, DMSO-d6) δ 160.38, 157.65, 156.88, 147.25, 143.36, 142.98, 138.76, 138.55, 
138.46, 131.03, 128.28, 124.89, 124.87, 123.69, 123.42, 122.28, 120.78, 120.22, 119.33, 
33.82, 33.78, 31.31 (6C). IR υmax/cm-1 3427, 2959, 2865, 1602, 1506, 1471, 1431, 1233, 
743, 722, 570. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 384 (3800) nm. ESI-MS (m/z) 








Cream solid (39.7 mg, 79%) Anal. Calc. for C25H20Br2N6Pd·NaOAc: C, 43.08; H, 3.08; N, 
11.16. Found: C, 42.64; H, 3.06; N, 10.58. 1H NMR (500 MHz, DMSO-d6) δ 8.81 (s, 1H, NH4), 
8.56 (d, J = 5.2 Hz, 2H, NH5, Ha), 8.08 – 8.01 (m, 2H, Hc, Hd), 7.74 (d, J = 7.6 Hz, 1H, He), 
7.43 – 7.39 (m, 2H, Hb, Hh), 7.37 – 7.21 (m, 8H, Hi-l), 7.16 (t, J = 7.3 Hz, 1H, Hg), 7.09 (t, J = 
7.4 Hz, 1H, Hf), 6.11 (s, 1H, NH3), 5.43 (s, 1H, NH1). 13C NMR (126 MHz, DMSO-d6) δ 
165.52, 159.88, 157.24, 156.40, 147.64, 145.56, 140.65, 140.55, 138.84, 131.03, 131.00, 
130.97, 128.37, 123.73, 123.55, 122.51, 122.39, 122.29, 119.31. IR υmax/cm-1 3400, 3275, 
1685, 1627, 1604, 1585, 1555, 1487, 1399, 1220, 1068, 1007, 837, 750, 729, 644. UV-vis 
(DMSO): λmax (ε/M-1 cm-1) = 386 (2400) nm. ESI-MS (m/z) (DMSO/MeOH): 









Pale yellow solid (18.5 mg, 38%). Anal. Calc. for C25H18Cl4N6Pd.H2O: C, 44.77; H, 3.31; N, 
12.53. Found C, 44.96; H, 3.24; N, 12.31. 1H NMR (500 MHz, DMSO-d6) δ 9.12 (s, 1H, NH4), 
8.63 (s, 1H, NH5), 8.50 (d, J = 5.6 Hz, 1H, Ha), 8.08 (dd, J = 15.9, 7.7 Hz, 2H, Hc, Hd), 7.76 (d, 
J = 7.6 Hz, 1H, He), 7.49 – 7.36 (m, 6H, Hb, Hh, Hj, Hk), 7.19 (t, J = 7.4 Hz, 1H, Hf), 7.12 (t, J = 
7.4 Hz, 1H, Hg), 6.98 (dt, J = 3.2, 1.6 Hz, 2H, Hi, Hl), 6.21 (s, 1H, NH3), 5.62 (s, 1H, NH1). 13C 
NMR (126 MHz, DMSO-d6) δ 165.55, 159.22, 156.35, 155.60, 147.45, 145.58, 143.33, 
143.29, 139.08, 133.85, 133.84, 130.96, 128.44, 123.86, 123.77, 122.45, 119.55, 119.49, 
119.48, 117.24. IR υmax/cm-1 3413, 3050, 1629, 1572, 1544, 1518, 1492, 1469, 1437, 1419, 
1301, 1234, 1113, 1067, 827, 796, 743, 727, 656. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 384 








Pale yellow solid (28.5 mg, 74%). Anal. Calc. for C25H18F4N6Pd.H2O.0.5CH3OH: C, 49.49; H, 
3.58; N, 13.58. Found C, 49.71; H, 3.21; N, 13.23. 1H NMR (500 MHz, DMSO-d6) δ 9.33 (s, 
1H, NH4), 9.29 (s, 1H, NH5), 8.70 (d, J = 5.6 Hz, 1H, Ha), 8.12 – 7.94 (m, 2H, Hc, Hd), 7.75 (d, 
J = 7.6 Hz, 1H, He), 7.46 (d, J = 7.5 Hz, 1H, Hh), 7.39 (t, J = 6.5 Hz, 1H, Hb), 7.22 – 7.03 (m, 
6H, Hg, Hf, Hj, Hk), 6.65 – 6.47 (m, 3H, Hi, Hl, NH3), 5.64 (s, 1H, NH1). 13C NMR (126 MHz, 
DMSO-d6) δ 173.32, 165.49, 163.53, 163.40, 161.48, 156.63, 155.74, 148.09, 145.62, 
143.83, 138.91, 131.08, 128.36, 123.75, 123.66, 122.41, 119.28, 102.09, 101.98, 101.89, 
101.75, 95.25, 95.15, 95.04, 94.93. IR υ max/cm-1 3419, 3394, 3376, 3219, 3057, 1625, 
1599, 1580, 1556, 1532, 1510, 1453, 1424, 1408, 1304, 1249, 1214, 1169, 1155, 1115, 
1076, 1006, 995, 978, 826, 808, 744, 731, 714, 700, 670, 647, 590, 561, 551, 526, 506, 478, 
412. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 384 (2800) nm. ESI-MS (m/z) (DMSO/MeOH): 








Pale yellow solid (47.5 mg, 34%). Anal. Calc. for C29H30N6O4Pd·0.5NaOAc: C, 53.46; H, 4.71; 
N, 12.47. Found C, 53.42; H, 4.66; N, 12.13. 1H NMR (500 MHz, DMSO-d6) δ 8.67 (s, 1H, 
NH4), 8.56 (d, J = 5.6 Hz, 1H, Ha), 8.46 (s, 1H, NH5), 8.11 – 7.98 (m, 2H, Hc, Hd), 7.74 (d, J = 
7.5 Hz, 1H, He), 7.45 – 7.34 (m, 2H, Hb, Hh), 7.19 – 7.05 (m, 2H, Hf, Hg), 6.68 (dd, J = 6.7, 2.2 
Hz, 4H, Hj, Hk), 6.11 (s, 1H, NH3), 6.00 (dt, J = 19.0, 2.3 Hz, 2H, Hi, Hl), 5.48 (s, 1H, NH1), 
3.55 (d, J = 4.8 Hz, 12H, OMe). 13C NMR (126 MHz, DMSO-d6) δ165.58, 160.44 (4C), 159.96, 
157.13, 156.30, 147.24, 145.55, 142.97, 142.85, 138.91, 130.93, 128.36, 123.79, 123.57, 
122.35, 119.42, 97.75, 97.32, 93.73, 93.44, 54.66, 54.64. IR υ max/cm-1 3361, 2931, 2836, 
1716, 1682, 1591, 1527, 1447, 1421, 1305, 1236, 1193, 1148, 1061, 927, 816, 745, 727, 
660, 605, 536, 460, 444, 410. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 378 (29100) nm. ESI-MS 






2.4.2.2 Platinum(II) Complexes 
Neutral 1,5-diarylbiguanido 2-phenylpyridine platinum(II) complexes of the type 
[Pt(ppy)(bigu)] were prepared through the following general method using the 
appropriately substituted 1,5-diarylbiguanide: A solution of [Pt(ppy)μ-Cl]2 (76.8 mg, 0.10 
mmol), 1,5-diarylbiguanide ligand (0.20 mmol), and sodium carbonate (42.4 mg, 0.40 
mmol) in dry N,N-dimethylformamide, was stirred for 48 hours at room temperature 
under an argon atmosphere. The resulting solution was taken up in a mixture of 
chloroform (30 mL) and water (80 mL) which was separated and an extraction of 
chloroform (30 mL) performed on the aqueous phase. The combined organic phases were 
then washed with water (5 x 80 mL) before being dried over magnesium sulfate* before 
filtration and reduction of the solvent to ~10 mL on a rotary evaporator not exceeding 
40°C. Immediate addition of excess petroleum ether precipitated the complex which was 
then collected via filtration after cooling to room temperature and washed with petroleum 
ether before being dried in vacuo to give the corresponding complex.** 
* Due to much lower chloroform solubility the complex [Pt(ppy)(diClbigu)] began to 
precipitate during the washing of the organic phase so the undried chloroform solution 
was reduced in volume and the precipitate directly collected via filtration and washed 
with a minimum of cold chloroform then petroleum ether before drying in vacuo.  
** The complex [Pt(ppy)(Brbigu)] required  additional purification via column 
chromatography on silica eluting with a 5:1 mixture of ethyl acetate and 40-60 petroleum 







Bright yellow solid (91.4 mg, 76%). Anal. Calc. for C25H22N6Pt.0.5H2O: C, 49.18; H, 3.80; N, 
13.76; Found: C, 48.93; H, 3.75; N, 13.67. 1H NMR (500 MHz, DMSO-d6) δ 8.84 – 8.72 (m, 
2H, Ha, NH4), 8.36 (s, 1H, NH5), 8.05 – 7.99 (m, 2H, Hc, Hd), 7.72 (d, 1H, He), 7.52 (d, J = 
7.5 Hz, 1H, Hh), 7.44 – 7.37 (m, 4H, Hl, Hk), 7.35 (td, J = 6.0, 2.6 Hz, 1H, Hb), 7.24 – 7.10 (m, 
5H, Hg, Hm, Hj), 7.05 (t, J = 7.4 Hz, 1H, Hf), 6.98 – 6.89 (m, 2H, Hn, Hi), 6.85 (s, 1H, NH3), 
6.39 (s, 1H, NH1). 13C NMR (126 MHz, DMSO-d6) δ 167.19, 155.05, 153.48, 151.28, 146.11, 
144.75, 140.98, 140.82, 137.87, 129.45, 128.69, 128.47 (4C), 124.06, 124.02, 122.16, 
122.11, 121.87, 121.33, 121.04, 120.69, 120.27, 119.37. IR υmax/cm-1 3358, 3039, 1607, 
1582, 1522, 1480, 1453, 1425, 1305, 1235, 1178, 1158, 1065, 1032, 746, 728, 696, 667, 
630, 584, 473, 449, 414. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 398 (8200) nm. ESI-MS (m/z) 








Bright yellow solid (108.5 mg, 76%). Anal. Calc. for C33H38N6Pt: C, 55.53; H, 5.37; N, 11.77; 
Found: C, 55.53; H, 5.49; N, 11.68. 1H NMR (500 MHz, DMSO-d6) δ 8.80 (d, J = 5.9 Hz, 1H, 
Ha), 8.68 (s, 1H, NH4), 8.26 (s, 1H, NH5), 8.06 – 7.98 (m, 2H, Hc, Hd), 7.71 (dd, 1H, He), 
7.53 (d, J = 7.7 Hz, 1H, Hh), 7.36 – 7.27 (m, 5H, Hb, Hj, Hk), 7.22 – 7.11 (m, 5H, Hi, Hl, Hg), 
7.05 (t, J = 7.4 Hz, 1H, Hf), 6.79 (s, 1H, NH3), 6.31 (s, 1H, NH1), 1.30 – 1.26 (m, 18H, tBu). 
13C NMR (126 MHz, DMSO-d6) δ 167.24, 155.26, 153.70, 146.15, 144.76, 143.56, 143.23, 
138.41, 138.26, 137.80, 129.50, 128.67, 124.97, 124.04, 122.10, 121.80, 120.85, 120.40, 
119.36, 33.88, 33.85, 31.35, 31.33, 31.32 (6C). IR υmax/cm-1 3421, 3039, 2955, 2902, 2866, 
1607, 1507, 1480, 1426, 1392, 1362, 1306, 1264, 1238, 1190, 1112, 1063, 1014, 823, 811, 
743, 727, 658, 415. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 400 (10000) nm. ESI-MS (m/z) 








Yellow solid (27.3 mg, 18%). Anal. Calc. for C25H20N6Br2Pt.0.5EtOAc.0.3NaCl: C, 39.50; H, 
2.95; N, 10.24; Found: C, 39.46; H, 2.51; N, 10.36. 1H NMR (400 MHz, DMSO-d6) δ 8.91 (s, 
1H, NH4), 8.77 (dd, J = 5.7, 1.2 Hz, 1H, Ha), 8.46 (s, 1H, NH5), 8.05 – 7.99 (m, 2H, Hc, Hd), 
7.72 (dd, J = 7.8, 1.3 Hz, 1H, He), 7.53 (dd, J = 7.6, 1.1 Hz, 1H, Hh), 7.38 – 7.25 (m, 9H, Hb, Hi, 
Hj, Hk, Hl), 7.17 (td, J = 7.3, 1.3 Hz, 1H, Hg), 7.10 – 7.02 (m, 1H, Hf), 6.93 (s, 1H, NH3), 6.44 
(s, 1H, NH1). 13C NMR (101 MHz, DMSO-d6) δ 167.16, 154.72, 153.18, 146.20, 144.76, 
140.32, 140.23, 137.96, 131.10, 131.07, 129.45, 128.69, 122.66, 122.52, 122.17, 121.97, 
112.80, 112.67. IR υmax/cm-1 3357, 3271, 3058, 2964, 1607, 1575, 1477, 1419, 1389, 1304, 
1284, 1233, 1066, 1006, 810, 745, 727, 657, 487, 451, 438, 411. UV-vis (DMSO): λmax  
(ε/M-1 cm-1) = 390 (6500) nm. ESI-MS (m/z) (DMSO/MeOH): [C25H21N6Br2Pt]+ expected 









Bright yellow solid (44.1 mg, 30%). Anal. Calc. for C25H18N6Cl4Pt.1.5H2O: C, 39.18; H, 2.76; 
N, 10.97. Found: C, 39.15; H, 2.64; N, 10.82. 1H NMR (500 MHz, DMSO-d6) δ 9.27 (s, 1H, 
NH4), 8.82 – 8.72 (m, 2H, NH5, Ha), 8.08 – 8.00 (m, 2H, Hc, Hd), 7.74 (dd, J = 7.8, 1.3 Hz, 1H, 
He), 7.54 (d, J = 7.4 Hz, 1H, Hh), 7.45 – 7.34 (m, 5H, Hb, Hj, Hk), 7.23 – 7.15 (m, 2H, Hg, 
Hi/Hl), 7.07 (td, J = 7.4, 1.1 Hz, 1H, Hf), 7.04 – 7.00 (m, 2H, NH3, Hi/Hl), 6.65 (s, 1H, NH1). 
13C NMR (126 MHz, DMSO-d6) δ 167.16, 153.66, 152.20, 146.31, 143.13, 143.02, 138.23, 
133.96, 133.93, 129.48, 128.73, 124.11, 122.24, 119.79, 119.76, 119.74, 119.47, 117.42, 
117.41, 117.39, 117.36, 117.32. IR υmax/cm-1 3413, 3391, 3378, 3334, 3046, 1625, 1583, 
1573, 1547, 1523, 1495, 1475, 1441, 1421, 1389, 1303, 1250, 1236, 1114, 1097, 1071, 
991, 938, 849, 827, 800, 742, 727, 688, 658, 627, 569, 556, 529, 488, 412. UV-vis (DMSO): 









Dark yellow solid (75.6 mg, 56%). Anal. Calc. for C25H18N6F4Pt.0.2NaCl: C, 43.82; H, 2.65; N, 
11.09; Found: C, 43.66; H, 2.85; N, 11.46. 1H NMR (400 MHz, DMSO-d6) δ 9.28 (s, 1H, NH4), 
8.78 (d, J = 10.2 Hz, 2H, NH5, Ha), 8.08 – 8.00 (m, 2H, Hc, Hd), 7.74 (dd, 1H, He), 7.55 (d, J = 
7.5 Hz, 1H, Hh), 7.37 (td, J = 5.6, 3.1 Hz, 1H, Hb), 7.22 – 7.02 (m, 7H, NH3, Hi, Hj, Hk, Hl), 
6.69 – 6.56 (m, 3H, NH1, Hf, Hg). 13C NMR (101 MHz, DMSO-d6) δ 163.83, 161.49, 161.42, 
161.33, 161.27, 153.87, 152.40, 150.26, 146.31, 143.37, 138.20, 129.51, 128.72, 124.09, 
122.21, 119.46, 102.33, 102.06, 95.63. IR υmax/cm-1 3053, 2185, 1587, 1456, 1424, 1256, 
1168, 1115, 982, 830, 750, 729, 651, 593, 508, 415. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 389 









Bright yellow solid (73.6mg, 51%). Anal. Calc. for C28H30N6O4Pt.0.2NaCl: C, 47.50; H, 4.12; 
N, 11.46; Found: C, 47.73; H, 4.04; N, 11.36. 1H NMR (500 MHz, DMSO-d6) δ 8.80 (s, 1H, 
NH4), 8.76 (d, J = 5.9 Hz, 1H, Ha), 8.38 (s, 1H, NH5), 8.07 – 7.99 (m, 2H, Hc, Hd), 7.72 (dd, J 
= 7.8, 1.4 Hz, 1H, He), 7.51 (d, J = 7.5 Hz, 1H, Hh), 7.35 (td, J = 5.9, 2.8 Hz, 1H, Hb), 7.15 (td, 
1H, Hf), 7.06 (t, J = 7.4 Hz, 1H, Hg), 6.92 (s, 1H, NH3), 6.70 – 6.62 (m, 4H, Hj, Hk), 6.48 (s, 
1H, NH1), 6.05 (t, J = 2.2 Hz, 1H, Hl/Hi), 6.02 (t, J = 2.2 Hz, 1H, Hl/Hi), 3.56 – 3.52 (m, 12H, 
OMe). 13C NMR (126 MHz, DMSO-d6) δ 167.20, 160.48, 154.56, 152.98, 151.04, 146.08, 
144.77, 142.76, 142.58, 137.97, 129.39, 128.69, 124.06, 122.17, 121.96, 119.42, 97.79, 
97.76, 97.42, 97.39, 93.91, 93.84, 93.61, 93.54, 54.67, 54.62. IR υmax/cm-1 3406, 3305, 
3181, 2933, 1666, 1598, 1580, 1547, 1495, 1481, 1450, 1414, 1374, 1349, 1302, 1231, 
1205, 1192, 1176, 1161, 1122, 1096, 1047, 1032, 982, 944, 829, 816, 761, 739, 660, 629, 
439, 418. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 396 (10500) nm. ESI-MS (m/z) 
(DMSO/MeOH): [C29H31N6O4Pt]+ expected 722.2051, found 722.2087; [C58H61N12O8Pt2]+ 







2.4.3 Diaminotriazine Pyridyl-triazole Complexes 
 2.4.3.1 Ruthenium(II) Complexes 
Octahedral bis-bipyridine diaminotriazine pyridyl-triazole ruthenium(II) complexes of the 
type [Ru(bpy)2(RtpD)](PF6)2 were prepared through the following general method using 
the appropriately substituted RtpD ligand: A purple solution of [Ru(bpy)2Cl2]·2H2O (52.6 
mg, 0.100 mmol) and RtpD (0.100 mmol) in ethanol (7 mL) was heated under sealed tube 
microwave conditions at 125°C for 2 hours. The resulting red solution was cooled to room 
temperature and saturated aqueous solution of NH4PF6 (10 mL) was added and the 
solution stirred overnight. Removal of the ethanol via rotary evaporation and cooling of 
the solution resulted in a dark red precipitate which was collected via filtration. 
Recrystallisation from diethyl ether into an acetonitrile solution gave the resulting 






Red crystalline solid (40.3 mg, 39%). Anal. Calc. for C37H31N13F12P2Ru: C, 42.38; H, 2.98; N, 
17.36. Found: C, 38.04; H, 2.96; N, 15.51. 1H NMR (500 MHz, CD3CN) δ 8.70 (dd, J = 8.3, 1.7 
Hz, 2H, Hb), 8.67 (s, 1H, Hd), 8.56 (d, J = 8.1 Hz, 1H, bpy), 8.52 (d, J = 8.1 Hz, 1H, bpy), 8.45 
(t, J = 8.2 Hz, 2H, Hg), 8.29 (d, J = 1.6 Hz, 1H, Ha), 8.19 – 8.09 (m, 2H, Hc, bpy), 8.11 – 7.99 
(m, 3H, Hh, bpy), 7.92 (dd, J = 4.5, 2.7 Hz, 2H, bpy), 7.84 (dd, J = 5.7, 1.4 Hz, 1H, bpy), 7.79 
(dd, J = 5.7, 1.6 Hz, 1H, bpy), 7.52 – 7.42 (m, 2H, bpy), 7.43 – 7.33 (m, 5H, Hf, bpy), 7.21 – 
7.15 (m, 2H, bpy), 5.53 (m, 6H, NH2, He). 13C NMR (126 MHz, CD3CN) δ 168.57, 158.65, 
158.35, 158.20, 157.86, 153.50, 153.21, 153.13, 152.96, 151.67, 148.54, 139.18, 138.85, 
138.83, 138.67, 137.85, 135.55, 134.57, 130.13, 130.06, 129.22, 128.68, 128.61, 128.46, 
127.76, 127.71, 127.26, 125.22, 125.21, 124.80, 124.54, 123.28, 56.57. IR / cm-1 3481, 
3396, 3117, 1609, 1576, 1534, 1443, 1398, 1243, 1128, 830, 761, 727, 552. UV-vis 
(DMSO): λmax (ε/M-1 cm-1) = 440 (10200) nm.  ESI-MS (m/z) (CH3CN): [C37H31N13Ru]2+ 
expected 379.5929, found 379.5924; [C25H23N7F6PRu]+ expected 668.1312, found 









Red crystalline solid (52.6 mg, 50%). Anal. Calc. for C37H27D3N13F12P2Ru·C2H3N: C, 42.86; H, 
3.41; N, 17.94. Found: C, 42.62; H, 3.16; N, 18.56. 1H NMR (500 MHz, CD3CN) δ 8.70 (dd, J = 
8.3, 1.7 Hz, 2H, Hb), 8.67 (d, J = 8.1 Hz, 1H, bpy), 8.52 (d, J = 8.1 Hz, 1H, bpy), 8.45 (t, J = 8.2 
Hz, 2H, Hg), 8.29 (d, J = 1.6 Hz, 1H, Ha), 8.19 – 8.09 (m, 2H, Hc, bpy), 8.11 – 7.99 (m, 3H, Hh, 
bpy), 7.92 (dd, J = 4.5, 2.7 Hz, 2H, bpy), 7.84 (dd, J = 5.7, 1.4 Hz, 1H, bpy), 7.79 (dd, J = 5.7, 
1.6 Hz, 1H, bpy), 7.52 – 7.42 (m, 2H, bpy), 7.43 – 7.33 (m, 5H, Hf, bpy), 7.21 – 7.15 (m, 2H, 
bpy), 5.53 (s, 4H, NH2,). 13C NMR (126 MHz, CD3CN) δ 168.57, 158.65, 158.35, 158.20, 
157.86, 153.50, 153.21, 153.13, 152.96, 151.67, 148.54, 139.18, 138.85, 138.83, 138.67, 
137.85, 135.55, 134.57, 130.13, 130.06, 129.22, 128.68, 128.61, 128.46, 127.76, 127.71, 
127.26, 125.22, 125.21, 124.80, 124.54, 123.28, 56.57. IR / cm-1 3481, 3396, 3117, 1609, 
1576, 1534, 1443, 1398, 1243, 1128, 830, 761, 727, 552. ESI-MS (m/z) (CH3CN): 
[C37H27D3N13Ru]2+ expected 380.5989, found 380.5973; [C25H17D3N7F6PRu]+ expected 










Red crystalline solid (23.4 mg, 23%). Anal. Calc. for C36H37N13F12P2Ru: C, 41.47; H, 3.58; N, 
17.46. Found: C, 38.13; H, 3.64; N, 16.02. 1H NMR (500 MHz, Acetonitrile-d3) δ 8.76 – 8.70 
(m, 2H, Hb, Hd), 8.55 (d, J = 8.1 Hz, 1H, bpy), 8.51 (d, J = 8.1 Hz, 1H, bpy), 8.50 – 8.42 (m, 
2H, bpy), 8.30 (d, J = 1.5 Hz, 1H, Ha), 8.19 – 8.11 (m, 2H, Hc, bpy), 8.10 – 7.99 (m, 3H, bpy), 
7.94 – 7.84 (m, 3H, bpy), 7.78 (dd, J = 5.7, 1.6 Hz, 1H, bpy), 7.49 (ddd, J = 7.3, 5.7, 1.2 Hz, 
1H, bpy), 7.45 (ddd, J = 7.3, 5.6, 1.2 Hz, 1H, bpy), 7.40 (ddd, J = 7.3, 5.7, 1.2 Hz, 1H, bpy), 
7.36 (ddd, J = 7.3, 5.7, 1.3 Hz, 1H, bpy), 5.55 (s, 4H, NH2, NH2), 4.35 (t, J = 7.0 Hz, 2H, He), 
1.80 (p, J = 7.3 Hz, 2H, Hf), 1.23 – 1.15 (m, 4H, Hh, Hi), 1.11 – 1.04 (m, 2H, Hg), 0.83 (t, J = 
7.0 Hz, 3H, Hj). 13C NMR (126 MHz, CD3CN) δ 168.56, 168.45, 158.64, 158.38, 158.20, 
157.88, 153.64, 153.19, 153.16, 153.08, 152.95, 151.69, 148.16, 139.15, 138.82, 138.80, 
138.62, 137.88, 135.46, 128.66, 128.62, 128.48, 127.75, 127.12, 125.20, 125.19, 124.78, 
124.50, 123.12, 53.22, 31.52, 30.09, 26.28, 23.09, 14.22. IR / cm-1 3506, 3473, 3401, 3137, 
2931, 2860, 1613, 1572, 1531, 1443, 1394, 1318, 1243, 1121, 830, 763, 731, 553, 512. UV-
vis (DMSO): λmax (ε/M-1 cm-1) = 440 (10600) nm. ESI-MS (m/z) (CH3CN): [C36H37N13F6PRu]+ 





2.4.2.2 Iridium(III) Complexes 
Octahedral bis-phenylpyridine diaminotriazine pyridyl-triazole iridium(III) complexes of 
the type fac-[Ir(ppy)2(RtpD)]PF6 were prepared through the following general method 
using the appropriately substituted RtpD ligand: A yellow solution of dry Na2CO3 (60 mg, 
0.6 mmol), fac-[(Ir(ppy)2)2-μ-Cl2] (43.9 mg, 0.040 mmol), and RtpD, in dry DMSO (1.5 mL) 
under Ar(g) was heated at 125°C for 6 hours. After cooling the resulting orange solution to 
room temperature, an aqueous saturated solution of NH4PF6 (20 mL) was added dropwise, 
giving a yellow precipitate which was collected via filtration and washed with water 
before being taken up in dichloromethane (10 mL) and filtered through Celite. Addition of 
excess diethyl ether to the yellow solution gave the product as a dark yellow solid which 






Yellow solid (66.6 mg, 84%). Anal. Calc. for C39H31N11F6PIr.2H2O: C, 45.61; H, 3.43; N, 
14.99. Found: C, 45.92; H, 3.13; N, 12.12. 1H NMR (500 MHz, DMSO-d6) δ 9.35 (s, 1H, Hd), 
8.71 (dd, J = 8.1, 2.0 Hz, 1H, Hb), 8.57 – 8.48 (m, 2H, Ha, Hc), 8.24 (d, J = 8.3 Hz, 2H, Hm, 
Hm’), 8.00 – 7.92 (m, 2H, Hn, Hn’), 7.90 (d, J = 7.8 Hz, 1H, Hl), 7.84 (d, J = 7.8 Hz, 1H, Hl’), 
7.76 – 7.70 (m, 2H, Hp, Hp’), 7.44 – 7.35 (m, 3H, Hg, Hh), 7.23 (dd, J = 6.7, 2.9 Hz, 2H, Hf), 
7.19 (t, J = 6.7 Hz, 1H, Ho), 7.14 (t, J = 6.7 Hz, 1H, Ho’), 7.06 (t, J = 7.5 Hz, 1H, Hk), 7.00 – 
6.84 (m, 2H, Hj, Hk’), 6.80 (t, J = 7.4 Hz, 2H, Hj’), 6.43 (s, 2H*, NH2), 6.22 (d, J = 7.6 Hz, 1H, 
Hi), 6.16 (d, J = 7.6 Hz, 1H, Hi’), 5.78 (s, 2H, He). 13C NMR (126 MHz, DMSO-d6) δ 167.11, 
166.91, 166.85, 166.78, 150.51, 149.38, 149.29, 149.24, 149.22, 149.21, 148.01, 146.25, 
144.08, 143.74, 138.81, 138.63, 138.26, 135.10, 134.06, 131.37, 131.01, 130.40, 129.41, 
129.00 (2C), 128.73, 128.10 (2C), 127.53, 125.12, 124.53, 123.73, 123.67, 122.53, 121.78, 
120.00, 119.73, 54.74. IR / cm-1 3689, 3501, 3403, 3337, 3044, 1607, 1583, 1538, 1479, 
1440, 1422, 1398, 1347, 1315, 1269, 1255, 1227, 1164, 1129, 1105, 1064, 1031, 997, 983, 
837, 819, 757, 737, 731, 718, 695, 670, 655, 630, 557, 525, 451, 416. UV-vis (CH2Cl2): λmax 
(ε/M-1 cm-1) = 376 (7400) nm. ESI-MS (m/z) (CH2Cl2/CH3OH): [C39H31N11Ir]1+ expected 







Yellow solid (26.8 mg, 62%). Anal. Calc. for C39H37N11F6PIr: C, 45.61; H, 3.43; N, 14.99. 
Found: C, 45.92; H, 3.13; N, 12.12. 1H NMR (500 MHz, DMSO-d6) δ 9.44 (s, 1H, Hd), 8.74 
(dd, J = 8.3, 1.9 Hz, 1H, Hb), 8.52 (d, J = 1.8 Hz, 1H, Ha), 8.46 (d, J = 8.3 Hz, 1H, Hc), 8.27 – 
8.20 (m, 2H, Ho, Ho’), 7.97 – 7.90 (m, 2H, Hp, Hp’), 7.89 (d, J = 7.8 Hz, 1H, Hn), 7.83 (d, J = 
7.9 Hz, 1H, Hn’), 7.75 – 7.68 (m, 2H, Hr, Hr’), 7.21 – 7.11 (m, 2H, Hq, Hq’), 7.06 (t, J = 7.6 Hz, 
1H, Hm), 6.98 – 6.89 (m, 2H, Hm’ Hl), 6.79 (t, J = 7.3 Hz, 1H, Hl’), 6.43 (s, 4H), NH), 6.21 (d, J 
= 7.5 Hz, 1H, Hk), 6.15 (d, J = 7.5 Hz, 1H, Hk’), 4.49 (t, J = 7.1 Hz, 2H, He), 1.87 – 1.74 (m, 2H, 
Hf), 1.22 – 1.14 (m, 4H, Hg, Hh), 1.11 (s, 2H, Hi), 0.83 – 0.74 (m, 3H, Hj). 13C NMR (126 MHz, 
DMSO-d6) δ 166.93, 166.85 (2C), 166.82, 150.61, 149.45, 149.38, 149.26, 149.17, 147.61, 
146.30, 144.05, 143.76, 138.79, 138.66, 138.57, 138.37, 135.06, 131.32, 131.00, 129.37, 
127.13, 125.11, 124.47, 123.69, 123.63, 122.52, 122.25, 121.73, 119.98, 119.68, 69.77, 
51.51, 30.28, 28.87, 25.04, 21.80, 13.74. IR / cm-1 3794, 3403, 3115, 3045, 2931, 2861, 
1607, 1583, 1539, 1478, 1439, 1421, 1398, 1316, 1269, 1227, 1163, 1126, 1108, 1064, 
1031, 839, 757, 736, 670, 630 ,621, 557, 528, 420. UV-vis (CH2Cl2): λmax (ε/M-1 cm-1) = 376 






2.5 X-ray Crystallography Supplemental  
Yellow crystals of [Pd(ppy)(tBubiguH)]OAc were grown from diffusion of diethyl ether 
into an acetonitrile solution of [Pd(ppy)(tBubiguH)]OAc. Yellow crystals of 
[Pd(ppy)(tBubigu)]·2DMF were grown from the partial evaporation of a DMF solution of 
[Pd(ppy)(tBubigu)]. Yellow/green crystals of [Pd(ppy)(diClbigu)]·2DMF and 
[Pd(ppy)(diFbigu)]·2DMF were both grown from the vapour diffusion of diethyl ether 
into DMF solutions of [Pd(ppy)(diClbigu)]OAc and [Pd(ppy)(diFbigu)]OAc, respectively. 
X-ray data for these complexes were collected at 100 K on an Agilent Technologies 
Supernova system using Cu Kα radiation with exposures over 1.0°, and data were treated 
using CrysAlisPro[25] software. The structures were solved using SIR-97[26] and weighted 
full-matrix refinement on F2 was carried out using SHELXL-2014[27] running within the 
WinGX[28] package. All non-hydrogen atoms were refined anisotropically. Non N-H 
hydrogen atoms were placed in calculated positions and refined using a riding model. 
Where possible, the N-H hydrogens (those on N1, N2, N4, and N5 of tBubiguH, on the 
biguanide of [Pd(ppy)(diClbigu)]·2DMF, and on N1, N4, and N5 of 
[Pd(ppy)(diFbigu)]·2DMF) were assigned from electron density maps and refined as 
floating atoms. Otherwise N-H hydrogens were placed in calculated positions and refined 
using a riding model 
Yellow/green crystals of [Pt(ppy)(diFbigu)]·2DMF were grown from the partial 
evaporation of a DMF solution of [Pt(ppy)(diFbigu)]. Orange crystals of [Ru(bpy)2(BtpD-
d3)](PF6)2·CH3CN and [Ru(bpy)2(HtpD)](PF6)2.CH3CN were both grown by vapour 
diffusion of diethyl ether into a acetonitrile solutions of [Ru(bpy)2(BtpD-d3)](PF6)2 and 
[Ru(bpy)2(HtpD)](PF6)2, respectively. X-ray data for these complexes were collected at 
100 K on an Agilent Technologies Supernova system using Cu Kα radiation with exposures 
over 1.0°, and data were treated using CrysAlisPro[25] software. The structures were solved 
using SHELXT[27] and weighted full-matrix refinement on F2 was carried out using SHELXL-
2014[27] running within the WinGX[28] package. All non-hydrogen atoms were refined 
anisotropically. Non N-H hydrogen atoms were placed in calculated positions and refined 
using a riding model. Where possible, the N-H hydrogens (those on the nitrogen atoms of 
the biguanide of [Pt(ppy)(diFbigu)]·2DMF) were assigned from electron density maps 
and refined as floating atoms. Otherwise N-H hydrogens were placed in calculated 
positions and refined using a riding model. The deuterium atoms on C7 and C11 
[Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN were also assigned from electron density maps. 
Crystallographic data relevant for all structures reported in this chapter are summarised 
in Table 2.2 and Table 2.3, with selected bond lengths and angles, as well as hydrogen 
bonding metrics reported in Table 2.4 and Table 2.5. Hirshfeld surface analysis for each 
structure is summarised in Table 2.6 with fingerprint plots shown in Section 2.5.2. All 
structures reported have been validated using checkCIF,[29] with any and all level A and B 






2.5.1 Crystallographic Data Tables 










Formula C35H42N6O2Pd C39H52N8O2Pd C31H32N8O2F4Pd C31H32N8O2Cl4Pd 
FW 685.15 771.28 731.04 796.84 
Crystal 
System 
Triclinic Orthorhombic Triclinic Triclinic 
Space Group P -1 P 21212 P -1 P -1 
a / Å 10.6109(3) 27.8757(8) 7.3941(2) 10.3997(3) 
b / Å 12.3786(3) 15.985(5) 14.4709(2) 12.5486(4) 
c / Å 13.1939(4) 8.7370(3) 15.6155(3) 14.9232(5) 
α / ° 79.325(2) 90 116.540(2) 67.212(3) 
β / ° 77.329(3) 90 92.067(2) 87.641(2) 
γ / ° 73.188(3) 90 90.431(2) 68.071(3) 
V / Å3 1604.70(8) 3893.2(2) 1493.28(6) 1653.4(1) 
Z 2 4 2 2 
T / K 100.0(1) 100.0(1) 100.0(1) 100.0(1) 
μ / mm-1 4.999 4.185 5.624 7.858 
Refls. coll. 22434 16783 22094 24219 
Ind.Refls. 
(Rint) 
6361 (0.0489) 7804 (0.0586) 6231 (0.0380) 6889 (0.0462) 
R1 (I>2σ(I))a 0.0368 0.0558 0.0337 0.0451 
wR2 
(I>2σ(I))a 
0.1015 0.1462 0.0920 0.1208 
R1 (all data)a 0.0373 0.0586 0.0341 0.0458 
wR2 (all 
data)a 
0.1023 0.1527 0.0951 0.1238 























Formula C31H32N8O2Pt C39H31D3N14F12P2Ru C31H25N14F12P2Ru 
FW 819.73 1092.83 1083.85 
Crystal System Triclinic Triclinic Triclinic 
Space Group P -1 P -1 P -1 
a / Å 7.4546(1) 12.5859(3) 12.6434(4) 
b / Å 14.4536(3) 13.9533(3) 13.1692(5) 
c / Å 15.5267(3) 14.3594(5) 14.8178(6) 
α / ° 116.599(2) 61.231(3) 74.796(3) 
β / ° 91.786(2) 74.581(3) 67.386(4) 
γ / ° 90.113(2) 78.342(2) 82.470(3) 
V / Å3 1494.91(5) 2122.7(2) 2196.6(2) 
Z 2 2 2 
T / K 100.0(1) 100.0(1) 100.0(1) 
μ / mm-1 9.391 4.634 4.471 
Refls. coll. 15036 31665 24566 
Ind.Refls. (Rint) 5870 (0.0345) 8473 (0.0743) 8710 (0.0389) 
R1 (I>2σ(I))a 0.0267 0.0479 0.0456 
wR2 (I>2σ(I))a 0.0719 0.1212 0.1118 
R1 (all data)a 0.0281 0.0603 0.0529 
wR2 (all data)a 0.0801 0.1336 0.1184 















Table 2.4 Selected bond lengths (Å) and angles (°). 
[Pd(ppy)(tBubiguH)]OAc [Pd(ppy)(tBubiguH)]OAc 
 C1-N1 1.288(3)  C1-N1 1.323(9) 
 C1-N2 1.366(3)  C1-N2 1.340(9) 
 C2-N2 1.379(3)  C2-N2 1.328(10) 
 C2-N3 1.299(3)  C2-N3 1.321(10) 
 C34-O1 1.264(3)  Pd1-C33A 2.029(8) 
 C34-O2 1.255(3)  Pd1-N1 2.023(7) 
 Pd1-C33A 2.001(2)  Pd1-N3 2.014(6) 
 Pd1-N1 2.009(2)  Pd1-N6A 2.029(8) 
 Pd1-N3 2.085(2)  N1-Pd1-N3 85.5(3) 
 Pd1-N6A 2.0398(2)  C33A-Pd1-N6A 80.7(3) 
 N1-Pd1-N3 86.09(9) [Pd(ppy)(diFbigu)]·2DMF 
 C33A-Pd1-N6A 81.2(1)  C1-N1 1.324(3) 
[Pd(ppy)(diClbigu)]·2DMF  C1-N2 1.337(3) 
 C1-N1 1.316(6)  C2-N2 1.346(3) 
 C1-N2 1.339(4)  C2-N3 1.308(3) 
 C2-N2 1.337(4)  Pd1-C25A 2.003(2) 
 C2-N3 1.317(4)  Pd1-N1 1.989(2) 
 Pd1-C25A 2.011(3)  Pd1-N3 2.048(2) 
 Pd1-N1 1.998(3)  Pd1-N6A 2.047(2) 
 Pd1-N3 2.053(3)  N1-Pd1-N3 86.68(9) 
 Pd1-N6A 2.044(3)  C25A-Pd1-N6A 81.33(9) 
 N1-Pd1-N3 86.6(2) [Pt(ppy)(diFbigu)]·2DMF 
 C25A-Pd1-N6A 81.5(2)  C1-N1 1.333(4) 
[Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN  C1-N2 1.325(5) 
 Ru1-N1 2.088(3)  C2-N2 1.349(4) 
 Ru1-N2 2.030(3)  C2-N3 1.314(4) 
 Ru1-N10 2.050(3)  Pt1-C25A 2.004(4) 
 Ru1-N11 2.055(3)  Pt1-N1 1.985(3) 
 Ru1-N12 2.047(3)  Pt1-N3 2.054(3) 
 Ru1-N13 2.045(3)  Pt1-N6A 2.028(3) 
 N1-Ru1-N2 78.3(2)  N1-Pt1-N3 86.6(2) 
 N10-Ru1-N11 78.9(2)  C25A-Pt1-N6A 81.1(2) 
 N12- Ru1-N13 79.0(2)    
[Ru(bpy)2(HtpD)](PF6)2·CH3CN    
 Ru1-N1 2.082(3)    
 Ru1-N2 2.043(3)    
 Ru1-N10 2.061(3)    
 Ru1-N11 2.061(3)    
 Ru1-N12 2.053(3)    
 Ru1-N13 2.047(3)    
 N1-Ru1-N2 78.0(1)    
 N10-Ru1-N11 79.1(2)    




Table 2.5 Hydrogen bond metrics. 
  d(H···A)/Å d(D···A)/Å <(DH···A)/° 
[Pd(ppy)(tBubiguH)]OAc    
 N2-H2A···O1 1.91 2.703(3) 167(3) 
 N5-H5A···O2 1.97 2.720(3) 176(3) 
 N4-H4A···O1 2.44 2.994(3) 139(4) 
[Pd(ppy)(tBubigu)]·2DMF    
 N1-H1···O1 2.31 3.093(8) 148.3 
 N4-H4···O1 2.13 2.970(8) 160.5 
 C32-H32···O1 2.56 3.488(11) 166.0 
 N3-H3···O2 2.33 3.132(12) 152.0 
 N5-H5···O2 2.04 2.891(14) 162.5 
 C8-H8···N2 2.48 2.981(10) 113.1 
 C4-H4···O1#1 2.44 3.358(9) 163.3 
[Pd(ppy)(diClbigu)]·2DMF    
 N1-H1A···O1 2.46(5) 3.175(4) 150(5) 
 N4-H4A···O1 2.13(5) 2.848(4) 170(4) 
 N3-H3A···O2 2.34(5) 3.150(4) 157(4) 
 N5-H5A···O2 2.11(5) 2.900(4) 157(4) 
 C24-H24···O1 2.74 3.643(4) 159.2 
 C15-H15···O2 2.83 3.770(4) 172.9 
 C8-H8···N2 2.37 2.928(4) 116.9 
 C10-H10···N2 2.28 2.847(4) 118.8 
 C16-H16···Cl2#2 2.98 3.872(3) 122.1 
 C27-H27C···O2#3 2.65 3.552(4) 153.2 
 C31-H31A···Cl#4 2.78 3.642(6) 147.5 
[Pd(ppy)(diFbigu)]·2DMF    
 N1-H1A···O1 2.35(4) 3.209(3) 152(3) 
 N4-H4A···O1 2.02(5) 2.908(3) 168(4) 
 N3-H3A···O2 2.17 2.972(3) 154.1(5) 
 N5-H5A···O2 2.33(4) 3.040(3) 152(4) 
 C24-H24···O1 2.81 3.712(3) 162.8 
 C15-H15···O2 2.39 3.306(3) 168.8 
 C10-H10···N2 2.34 2.890(3) 117.8 
 C4-H4···N2 2.32 2.878(3) 118.0 
 C10-H10···F1#5 2.48 3.186(3) 132.8 
 C16-H16···F2#6 2.63 3.277(3) 127.6 
 C31-H31C···F1#7 2.57 3.358(3) 139.7 
 C31-H31A···O1#6 2.64 3.574(3) 166.1 
[Pt(ppy)(diFbigu)]·2DMF    
 N1-H1A···O1 2.21(5) 3.183(4) 156(3) 
 N4-H4A···O1 1.88(6) 2.892(4) 166(5) 
 N3-H3A···O2 2.13(6) 2.949(4) 166(5) 
 N5-H5A···O2 2.31(5) 3.021(4) 155(4) 
 C24-H24···O1 2.80 3.700(4) 162.4 
 C15-H15···O2 2.38 3.295(4) 168.9 
 C10-H10···N2 2.33 2.889(5) 117.8 
 C4-H4···N2 2.32 2.877(4) 117.8 
 C8-H8···F3#8 2.63 3.389(4) 139.6 
 C10-H10···F1#8 2.47 3.179(3) 132.7 
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 C16-H16···F2#9 2.62 3.265(4) 127.2 
 C31-H31C···F1#7 2.58 3.368(4) 138.9 
 C31-H31A···O1#9 2.64 3.578(4) 166.6 
[Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN    
 C4-H4···F5#9 2.32 3.201(5) 158.2 
 C28-H28···N14 2.45 3.321(6) 156.7 
 N8-H8B···F10#10 2.17 2.982(4) 158.2 
 N8-H8A···F1#11 2.50 3.350(4) 158.2 
 N9-H9A···N6#10 2.24 3.080(4) 165.0 
 N9-H9B···F9 2.36 2.939(5) 124.9 
 C7-D7···N8#12 2.62(4) 3.437(5) 152(3) 
[Ru(bpy)2(HtpD)](PF6)2·CH3CN    
 C4-H4···F1#9 2.38 3.224(4) 150.4 
 C7-H7···F9A 2.42 3.305(5) 159.1 
 C11-H11B···F12A 2.48 3.454(5) 179.5 
 C17-H17···N14#13 2.50 3.199(8) 131.7 
 C23-H23···F6#14 2.27 3.195(5) 171.7 
 C36-H36···F6 2.45 3.135(5) 131.1 
 N8-H8A···F7A#9 2.37 3.030(5) 134.4 
 N8-H8A···F8A#9 2.39 3.217(8) 160.9 
 N8-H8A···F8B#9 2.50 3.308(13) 156.6 
 N8-H8A···F9B#9 2.51 3.012(11) 117.7 
 N8-H8B···F1 2.64 3.201(4) 124.2 
 N8-H8B···F3 2.43 3.291(4) 176.6 
 N9-H9A···N6#15 2.17 2.985(4) 156.9 
 N9-H9B···F8A#16 2.42 2.913(7) 116.8 
 N9-H9B···F8B#16 2.58 3.046(12) 114.8 
Symmetry codes: #1 –x+2, -y+2, z  #2 –x, -y+1, -z  #3 –x+1, -y, -z  #4 x, y, z+1  #5 –x+1, -y+2, -z+1  #6 –x+1, -
y+1, -z  #7 x-1, y-1, z-1  #8 –x+1, -y+2, -z+2  #9 –x+1, -y+1, -z+1  #10 –x, -y, -z+1  #11 x-1, y, z  #12 -x, -y+1, -z+1  




2.5.2 Hirshfeld Surface Analysis 
Table 2.6 Percentage of total Hirshfeld surface interactions (including reciprocals) between internal and 
external atoms. 
 H-H H-C H-N H-O H-X C-C C-N C-O C-X X-X Other 
[Pd(ppy)(tBubiguH)]OAc 60.5 21.3 5.5 5.7 N/A 1.9 1.6 0.8 N/A N/A 2.7 
[Pd(ppy)(tBubigu)] 61.3 24.1 7.1 2.6 N/A 0.4 0.4 0.4 N/A N/A 3.7 
[Pd(ppy)(diClbigu)] 32.3 18.0 7.5 3.0 22.7 4.3 1.3 0.3 5.6 1.5 5.0 
[Pd(ppy)(diFbigu)] 35.7 19.1 7.0 2.7 19.0 5.0 1.7 0.9 3.5 1.5 5.4 
[Pt(ppy)(diFbigu)] 35.5 19.2 7.3 2.9 19.1 4.9 1.6 1.0 3.5 1.5 5.0 
[Ru(bpy)2(BtpD-d3)](PF6)2 25.3 14.2 10.0 N/A 38.8 4.8 1.9 N/A 4.1 0.2 0.9 
[Ru(bpy)2(HtpD)](PF6)2 30.9 15.5 14.0 N/A 30.6 2.1 1.7 N/A 3.7 0.4 1.5 
 
 





Figure 2.55 Hirshfeld fingerprint plots of intermolecular interactions in [Pd(ppy)(diClbiguH)]·2DMF (left) 




Figure 2.56 Hirshfeld fingerprint plots of intermolecular interactions in [Ru(bpy)2(BtpD-d3)](PF6)2·CH3CN 
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Transition Metal Complexes 
Containing ADA Synthons 
 
 
Portions of the research presented in this chapter have been published in the following 
paper; 
McKay, A. P.; Mapley, J. I.; Gordon, K. C.; McMorran, D. A. Ru(II) and Ir(III) complexes 
containing ADA and DAD triple hydrogen bonding motifs: Potential tectons for the 




3.1 Uracil Based Synthons 
3.1.1 Introduction 
Uracil is one of the four nucleobases of RNA. It consists of a six membered, pseudo 
aromatic ring with two carbonyls at the 3 and 5 positions and two nitrogen atoms at the 4 
and 6 positions (Figure 3.1). Common substitutions occur at the 1, 2, 4, and 6, positions 
with the ADA motif only disrupted when there is substitution at the 4 position. Orotic acid, 
orotH3, is a derivative of uracil containing a carboxylic acid substituted at the 1 position 
(Figure 3.1). Orotic acid has a variety of potential coordinating modes involving 
deprotonated N and O atoms. The chelating N^O form, where the ligand coordinates 
through N6 and the carboxylic acid as a dianion, orotH, is the most commonly observed 
motif although structures involving the ligand coordinating through N4 or through the 
carboxylate,  as a monoanionic, orotH2, ligand have been observed (Subsection 1.3.1.1).  
 
Figure 3.1 The uracil moiety (left) and orotic acid (right). 
Due to the commercial availability of orotic acid a wide variety of orotH3 complexes have 
been reported in the literature with over 200 reported transition metal complexes 
reported and over 100 structures in the CSD containing the dianionic orotH ligand 
coordinating N^O to a transition metal (Subsection 1.3.1.1). These include examples such 
as bisphosphino orotic acid platinum(II)[1-2] and tetraaqua orotic acid nickel(II) 
complexes,[3] which among others show how readily orotic acid will form complexes with 
metal ions containing a variety of ancillary ligands. Orotic acid containing complexes have 
also already been utilised in triple hydrogen bonding interactions between complexes and 
complementary species (Subsection 4.1.2.2).[4] However, only a small collection of 
iridium(III)[5-6] and iridium(I)[7] complexes of orotic acid have been reported while no 
ruthenium(II) complexes of orotic acid have been reported. 
3.1.2 Ruthenium Orotic Acid Complex 
In this work a neutral bis-bipyridine ruthenium(II) complex of orotic acid, 
[Ru(bpy)2(orotH)], was synthesised through a microwave assisted complexation of 
orotH3 with [Ru(bpy)2Cl2] in a solution of ethanol at 125°C for 2 hours. The reaction 
solvent was removed via rotary evaporation and the crude dark red solid was 
recrystallized from hot methanol/water solution to give X-ray quality dark purple crystals 
of the hydrate of the complex. Due to the octahedral geometry of ruthenium(II), Λ and Δ 
enantiomers of the complexes are produced as racemic mixtures from the complexation 





The composition of the [Ru(bpy)2(orotH)] complex was confirmed by elemental analysis,  
HRESI-MS, and IR, 1H, and 13C NMR spectroscopies. The HRESI-MS contains a major 1+ 
peak corresponding to the complex with a sodium ion. The IR spectrum contained strong 
bands ca. 1640 – 1600 cm-1 and 1600 – 1560 cm-1 corresponding to the C=O stretches and 
N-H bends of the orotic acid amides. A strong band at 760 cm-1 was also observed, 
corresponding to the C=CH bend of the uracil moiety. The complex has limited solubility in 
organic solvents likely due to the extended hydrogen bonding in the solid state (vide infra) 
and so NMR analysis was performed in DMSO-d6. Due to the asymmetrical nature of the 
orotic acid ligand the 1H NMR spectrum contains individual peaks for all the protons 
present, though the two bipyridine ligands are in very similar environments and therefore 
cannot be distinguished from each other and so, beyond identifying the appropriate 
number of doublets and triplets expected from a bipyridine, these are assigned purely as 
‘bpy’ protons. The 1H spectrum of the complex was assigned by means of COSY, HSQCAD, 
and HMBCAD 2D spectroscopic experiments. The orotic acid ligand only contains two 1H 
signals which both appear as tight doublets at 9.76 and 5.68 ppm, respectively. Their 
assignments were confirmed through their cross peak present in the 1H COSY spectrum 
(Figure 3.3). The lack of an associated carbon signal for the 9.76 ppm proton signal in the 
HSQCAD spectrum (Figure 3.4) supported the peak’s assignment as the NH signal. The 
HSQCAD spectrum was also used to confirm that the appropriate number of signals were 
present for the bipyridine ligands. 
 
Figure 3.2 HRESI-MS of [Ru(bpy)2(orotH)] from a DMSO/MeOH solution, with calculated isotope pattern 




Figure 3.3 1H COSY NMR (500 MHz) spectrum of [Ru(bpy)2(orotH)] in DMSO-d6. Cross peaks linking orotH 
(blue) and bipyridine (orange and green) protons are highlighted. 
 
Figure 3.4 HSQCAD NMR (500 MHz) spectrum of [Ru(bpy)2(orotH)] in DMSO-d6. Cross peaks link orotH 
(blue) and bipyridine (orange) protons to their respective carbon signals. Sharp singlet at 9.76 ppm has no 




Figure 3.5 HMBCAD NMR (500 MHz) spectrum of of [Ru(bpy)2(orotH)] in DMSO-d6. 
3.1.2.2 X-ray Crystallography 
X-ray quality crystals of [Ru(bpy)2(orotH)]·2.4H2O were grown from a solution of the 
crude product in water and methanol. The complex crystallises in the monoclinic space 
group P21/n with the asymmetric unit containing one complex, two full occupancy water 
solvent molecules, and one partial (40%) occupancy water solvent (Figure 3.6). The 
ruthenium ion is octahedral with the dianionic orotH ligand coordinating N^O through the 
amide nitrogen N1 and the carboxylic acid oxygen O3. The crystal contains a racemic 
mixture of the Λ and Δ enantiomers located in symmetry related positions which are 
hydrogen bonded to each other through H2 and O2 (H···O 2.15 Å, NH···O 157°) via a 𝑅2
2(8) 
type motif. This motif forms part of a larger, extended, hydrogen bonding motif where H3 
is involved in a weak non-classical CH···O hydrogen bond to O4 of another adjacent 
molecule (H···O 2.73 Å, CH···O 162°), and the two full occupancy water molecules, O5 and 
O6, form bridging hydrogen bonds to O1, O2, O4, and O5 (H···O 2.07, 1.89, 2.10, and 2.05 Å, 
167°, 163°, 171°, and 174° for H5A···O2, H5B···O4, H6A···O1, and H6B···O5, respectively) 







3(10)}∞ motif which links complexes into chains down 
the crystallographic a axis (Figure 3.7). These hydrogen bonded chains then stack together 
through various weak CH···O hydrogen bonds (H···O 2.42 – 2.66 Å, CH···O 118° - 174°) to 
form the overall 3D structure. Hirshfeld analysis of the crystal structure shows the 
dominance of the H···O intermolecular interactions, with H-O contacts making up 32.2% of 
the overall intermolecular contacts (Figure 3.8). The majority of the remaining 
intermolecular contacts are H-H at 39.4%, and C-H and C-C together at 20.7% which are 




Figure 3.6 X-ray crystal structure of [Ru(bpy)2(orotH)]·2.4H2O. Ellipsoids are drawn at 50% and hydrates are 
hidden for clarity. 
 
Figure 3.7 Packing of [Ru(bpy)2(orotH)]·2.4H2O into hydrogen bonded chains down the crystallographic a 












Figure 3.8 Hirshfeld fingerprint plots of the intermolecular interactions in [Ru(bpy)2(orotH)]·2.4H2O: (top 
left) H-H interactions, 39.4%; (top right) H-O interactions, 32.2%; (bottom left) C-C interactions, 8.6%;  
(bottom right) H-C interactions, 12.1%; Partial hydrate removed from Hirshfeld analysis. 
 
3.1.3 Iridium Orotic Acid Complex 
An anionic bis-2-phenylpyridine iridium(III) complex of orotic acid, fac-
(nBu4N)[Ir(ppy)2(orotH)], was synthesised by heating orotH3 with the iridium(III) dimer, 
fac-[(Ir(ppy)2)2-μ-Cl2], in a solution of Na2CO3 in DMSO at 125°C for six hours. After cooling 
a two-fold excess of nBu4NCl in water was added to the reaction solution and after stirring 
for 30 min. the product, as a bright yellow solid, was precipitated by the addition of an 
excess of acetone. The fac geometry of the nBu4N[Ir(ppy)2(orotH)] complex was expected 
due to the well-established propensity for cyclometallating carbons of the ppy ligands to 
occupy mutually cis positions, which are trans to the nitrogen atoms of the N^N 
coordinating ligand,[8] and was confirmed through NMR spectroscopy and X-ray 





The composition of the complex was confirmed by elemental analysis, HRESI-MS, and IR, 
1H, and 13C NMR spectroscopies. Elemental analysis is consistent for the complex as a 
monohydrate, and the HRESI-MS contains a major 1- peak corresponding to the complex 
without its cation (Figure 3.9). The IR spectrum was similar to that of the ruthenium(II) 
complex, although the C=O stretching and N-H bending bands were grouped into a strong 
slightly broadened band around 1620 cm-1. 
 
Figure 3.9 HRESI-MS of fac-nBu4N[Ir(ppy)2(orotH)] from a solution of CHCl3, with calculated isotope pattern 
shown next to the major peak. 
Due to the asymmetrical nature of the ligands the 1H NMR spectrum contains individual 
peaks for all the protons present, and unlike with bipyridine ligands, the asymmetry of the 
2-phenylpyridine allows assignment of all protons present although the signals of the two 
ppy ligands are paired and cannot be differentiated from each other. The 1H spectrum of 
the complex was fully assigned by means of COSY, NOESY, HSQCAD, and HMBCAD 2D 
spectroscopic experiments. The orotic acid only contains two 1H signals which appear as a 
singlet and a tight doublet at 9.52 and 5.67 ppm, respectively, while the 2-phenylpyridine 
peaks appear as a series of doublets and triplets between 8.46 and 5.94 ppm. The n-butyl 
ammonium peaks appear between 3.17 and 0.92 ppm. The 1H COSY spectrum (Figure 
3.10) confirmed Ha and Hb being from the orotic acid ligand due to their lack of cross 
peaks with other protons. It also allowed the grouping of two pairs of aromatic protons 
corresponding to the two 2-phenylpyridine ligands. Cross peaks between Hg and Hf, and 
Hg’ and Hf’ in the 1H NOESY spectrum (Figure 3.11) gave the arrangement of the protons 
around the ring groups.  
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The pyridine protons of the ppy ligands can be differentiated from the phenyl protons 
through use of the HSQCAD spectrum (Figure 3.12) to identify which carbons have 
substituted protons and then locating the metalated carbons and phenyl-pyridine bridging 
carbons in the HMBCAD spectrum (Figure 3.13). The metalated carbons in particular show 
cross peaks with Hf, Hd, and Hc (and Hf’, Hd’, and Hc’) while not showing any cross peaks 
across to the pyridine ring (unlike the bridging carbons), nor to He (and He’) which is 
ortho to the metalated carbon. The two distinct sets of 2-phenylpyridine peaks that share 
similar but slightly different environments, supporting the assignment of the complex 
conformation as fac- since the two ligands are arranged similarly but adjacent to different 
portions of the orotH ligand. If the complex was in a mer- conformation then it would 
expected to observed a less clear splitting of the proton signals since the phenyl of one 
ligand would be axial in relation to the orotH ligand while the phenyl of the other would 
be equatorial (and vice versa for the pyridine portions of the ligands).  
 
Figure 3.10 1H COSY NMR (500 MHz) spectrum of fac-nBu4N[Ir(ppy)2(orotH)] in DMSO-d6. Cross peaks 





Figure 3.11 1H NOESY NMR (500 MHz) spectrum of fac-nBu4N[Ir(ppy)2(orotH)] in DMSO-d6. Cross peaks 
identify ortho-ortho interaction between phenyl and pyridine rings (light purple).  
 
Figure 3.12 HSQCAD NMR (500 MHz) spectrum of fac-nBu4N[Ir(ppy)2(orotH)] in DMSO-d6. Cross peaks link 
orotic acid (blue), phenyl (orange) and pyridine (green) protons to their respective carbon signals. Sharp 




Figure 3.13 HMBCAD NMR (500 MHz) spectrum of fac-nBu4N[Ir(ppy)2(orotH)] in DMSO-d6. Metalated 
carbons are highlighted in purple while the carbons between the phenyl and pyridine rings of the ppy ligands 
are highlighted in light green and yellow, respectively.  
 
3.2 Hydantoin Based Synthons 
3.2.1 Introduction 
Hydantoin is a five membered ring analogous to uracil, containing two carbonyls and two 
amide nitrogens (Figure 3.14). The five membered ring pulls the carbonyl oxygen atoms 
back relative to the central nitrogen atom with an ONO angle across the imide moiety of 
162°, compared to the ~175° angle observed in the orotic acid moiety (measured from 
crystal structures of orotH and pyhy complexes)[9]. The hydantoin moiety can be readily 
substituted at the 5 position with a wide variety of functionality (Subsection 1.3.1.3).  
 
Figure 3.14 Hydantoin moiety 
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Hydantoin can be reacted with 2-pyridinecarboxaldehyde in the organic base piperidine 
under reflux to form the ligand 2-pyridylmethylenehydantoin, pyhyH, in reasonable yield  
(Scheme 11).[10] The ligand is then isolated from an aqueous solution in its protonated 
form by treating with concentrated hydrochloric acid. The free ligand is soluble in a good 
range of common organic solvents and readily chelates to transition metals in a N^N 
manner as a monoanion.  
 
Scheme 11 Preparation of pyhyH from 2-pyridinecarboxaldehyde and hydantoin. 
Two complexes of pyhy have been previously reported, both of which were prepared by 
addition of aqueous solutions of the appropriate metal salts (Ni(ClO4)2 and CuCl2) to 
methanolic solutions of pyhyH.[11] Crystal structures of both complexes have also been 
reported and in both structures adjacent hydantoin moieties are observed to strongly 
hydrogen bond (H···O 1.93 and 1.98 Å, NH···O 171° and 172°, respectively) in an offset 
manner via 𝑅2
2(8) motifs (Figure 3.15). No pyhy complexes of the interesting metal ions 
ruthenium(II) or iridium(III) have been reported in the literature. 
 
Figure 3.15 X-ray crystal structures of [Ni(pyhy)(OH2)4]+ (left) and polymeric [CuCl(pyhy)(OH2)] (right) 
showing hydrogen bonding between adjacent hydantoin moieties via 𝑹𝟐
𝟐(𝟖) motifs.[11] 
3.2.2 Ruthenium(II) Complex  
A cationic bis-bipyridine ruthenium(II) complex of pyhy, [Ru(bpy)2(pyhy)]PF6, was 
synthesised through a microwave assisted complexation of pyhyH with [Ru(bpy)2Cl2] in a 
solution of ethanol at 125°C for 2 hours. Addition of a saturated aqueous solution of 
ammonium hexafluorophosphate to the reaction solution followed by removal of the 
ethanol via rotary evaporation precipitated a dark red solid which was then recrystallised 
by addition of diethyl ether to an acetonitrile solution to give the pure product as a dark 
red crystalline solid. Due to the octahedral geometry of ruthenium(II), Λ and Δ 
enantiomers of the complexes are produced as a racemic mixture from the complexation 
reactions. The enantiomers were not separated for the characterisation nor crystallisation 
studies, although the complex was found to crystallise in chiral space group with the Δ 




The composition of the [Ru(bpy)2(pyhy)]PF6 complex was confirmed by elemental 
analysis, HRESI-MS, and IR, 1H, and 13C NMR spectroscopies. The HRESI-MS contains a 
single 1+ peak corresponding to the complex without its PF6 anion (Figure 3.18). The IR 
spectra contained strong bands ca. 1740 – 1700 cm-1 and 1630 – 1600 cm-1 corresponding 
to the C=O stretches and N-H bends of the hydantoin moiety. A strong band at 830 cm-1 
was also observed, corresponding to the C=CH bend of the methylene bridge. The complex 
has reasonable solubility in polar organic solvents, such as acetonitrile and DMSO, but is 
insoluble in common chlorinated solvents, such as chloroform and dichloromethane. 
Therefore NMR analysis was done in CD3CN. Also, due to the asymmetrical nature of the 
pyhy ligand, the 1H NMR spectrum contains individual peaks for all the protons present, 
though the two bipyridine ligands are in very similar environments and therefore cannot 
be distinguished from each other and so, beyond identifying the appropriate number of 
doublets and triplets expected from a bipyridine, these are assigned purely as ‘bpy’ 
protons. The 1H spectrum of the complex was assigned by means of COSY, HSQCAD, and 
HMBCAD 2D spectroscopic experiments. The 1H COSY spectrum (Figure 3.16) was used to 
tease the pyhy protons signals away from the bipyridine signals by looking for cross peaks 
between the isolated doublet and triplet signals, at 8.88 and 6.56 ppm, with the other 
signals of the pyridine portion of the ligand. The single proton of the methylene bridge, He, 
appears as a singlet at 6.09 ppm and has no related cross peaks. The NH signal appears as 
a slightly broadened singlet at 8.11 ppm and its assignment was confirmed through use of 
the HSQCAD spectrum (Figure 3.17) as it was overlapped with two additional signals. The 
ordering of the proton assignments around the pyridine portion of the pyhy ligand was 
confirmed through observing a cross peaks from Hd through to He via their respective 
carbons in the HMBCAD spectrum.  
 
Figure 3.16 1H COSY NMR (500 MHz) spectrum of [Ru(bpy)2(pyhy)]PF6 in CD3CN. Cross peaks link the signals 




Figure 3.17 HSQCAD NMR (500 MHz) spectrum of [Ru(bpy)2(pyhy)]PF6 in CD3CN. Cross peaks link pyhy 
(blue) and bipyridine (black) protons to their respective carbons. Singlet under the multiplet at  8.03 ppm has 
no associated carbon indicative of a NH proton. 
 
Figure 3.18 HRESI-MS of [Ru(bpy)2(pyhy)]PF6 from a solution of MeCN/MeOH, with calculated isotope 
pattern shown next to the major peak. 
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3.2.2.2 X-ray Crystallography 
X-ray quality crystals of [Ru(bpy)2(pyhy)]PF6·CH3CN were grown by diffusion of diethyl 
ether into an acetonitrile solution of [Ru(bpy)2(pyhy)]PF6. The complex crystallises in the 
monoclinic space group P21 with the asymmetric unit containing one complex with its PF6 
anion and one acetonitrile solvent molecule (Figure 3.19). The ruthenium ion is octahedral 
with the monoanionic pyhy ligand coordinating N^N through the pyridine nitrogen, N1, 
and the hydantoin nitrogen, N2. Although the complex was synthesised as a racemic 
mixture, it crystallised in a chiral space group with the structure collected containing the Δ 
enantiomer. Surprisingly the structure lacks any extended hydrogen bonding motifs, with 
the hydantoin moiety involved in a single NH···N hydrogen bond to N8 of an acetonitrile 
solvent (H···N 2.25 Å, NH···N 163°). The remaining intermolecular interactions are non-
classical CH···O and CH···F interactions. Each hexafluorophosphate anion is involved in 
weak interactions with different parts of different complexes; to H6 of the methylene 
bridge of a pyhy ligand (H···F 2.44 Å, CH···F 153°), to H2 of the pyridine portion of a pyhy 
ligand (H···F 2.47 Å, CH···F 142°), to H18 (H···F 2.60 Å, CH···F 164°), and via a 𝑅1
2(4) motif 
to H29 (H···F 2.63 and 2.60 Å, CH···F 127° and 163°, respectively) of a bipyridine ligand.  
These complexes are linked together through CH···O interactions (H···O 2.41, 2.54, and 
2.35 Å, CH···O 138°, 142°, and 174°) and weak bridging CH···N interactions through 
acetonitrile solvent molecules (H···N 2.50 and 2.63 Å, CH···N 119° and 118°). The 
fingerprint plots from the Hirshfeld analysis of [Ru(bpy)2(pyhy)]PF6 (Figure 3.20) are 
more diffuse than those for [Ru(bpy)2(orotH)] (Figure 3.8), with the total intermolecular 
interactions spread more evenly between the H-C, H-F, H-N, and H-O with each interaction 
having 19.9%, 25.6%, 6.3%, and 11.7% of the total interactions, respectively. H-H 
interactions make up 29.5% of the total interactions. 
 
Figure 3.19 X-ray crystal structure of Δ-[Ru(bpy)2(pyhy)]PF6·CH3CN. Ellipsoids are drawn at 50% and 




Figure 3.20 Hirshfeld fingerprint plots of intermolecular interactions in [Ru(bpy)2(pyhy)]PF6·CH3CN: (top 
left) H-C interactions, 19.9%; (top right) H-F interactions, 25.6%; (bottom left) H-N interactions, 6.3%;  
(bottom right) H-O interactions, 11.7%. 
 
3.2.2 Iridium(III) Complex 
A neutral bis-phenylpyridine iridium(III) complex of pyhy, fac-[Ir(ppy)2(pyhy)], was 
synthesised by heating pyhyH with the iridium(III) dimer, fac-[(Ir(ppy)2)2-μ-Cl2], in a 
solution of Na2CO3 in DMSO at 125°C for six hours. The resulting solution was taken up in a 
1:10 solution of brine in water and the product extracted with chloroform, with the 
combined organic phase then being washed repeatedly with brine before being dried over 
magnesium sulfate and the chloroform solvent removed via rotary evaporation. The 
resulting oil was taken up in a minimum solution of chloroform before the pure solid 
precipitated with an excess of petroleum ether, collected via filtration, and dried in vacuo 





The composition of the complex was confirmed by elemental analysis, HRESI-MS, and IR, 
1H, and 13C NMR spectroscopies. Elemental analysis is consistent for the complex as a 
monohydrate, and the HRESI-MS contains three major 1+ peaks corresponding to one and 
two complexes, each with a sodium ion, and a singly protonated complex (Figure 3.21). 
The IR spectra of the iridium(III) complex was similar to that of the ruthenium(II) complex 
although the band corresponding to the methylene C=CH bend was observed at 753 cm-1. 
Due to the asymmetrical nature of the pyhy ligand, the 1H NMR spectrum contains 
individual peaks for all the protons present, and unlike with bis-bipyridine complexes, the 
asymmetry of the 2-phenylpyridine allows assignment of all protons present, although the 
signals of the two ppy ligands are paired and cannot be differentiated from each other. The 
1H spectrum of the complex was fully assigned by means of COSY, NOESY, HSQCAD, and 
HMBCAD 2D spectroscopic experiments. The methylene proton, He, was identified as a 
large singlet at 6.01 ppm, and the NH proton of the hydantoin, Hf, was identified as a 
slightly broadened singlet at 10.17 ppm with no associated cross peaks in the COSY 
spectrum (Figure 3.22), although this did show a cross peak with the water present in the 
solvent in the NOESY spectrum (Figure 3.23), suggesting that a strong hydrogen bonding 
interaction is occurring in solution, which is not unexpected given the crystal structure 
where the hydantoin is involved in a strong hydrogen bonding interaction to the oxygen 
atom of a diethyl ether solvate (vide infra).† Using the HSQCAD spectrum (Figure 3.24), the 
13C signal associated with He was identified at 99.48 ppm, which in the HSQCAD spectrum 
(Figure 3.25) was found to have a single cross peak to a proton doublet at 7.55 ppm which 
was assigned as Hd. From there the remaining protons of the pyhy pyridine ring were 
identified through the COSY spectrum (Figure 3.22). The pyridine and phenyl protons of 
the ppy ligands where differentiated in the same manner as in the NMR spectra of fac-
nBu4N[Ir(ppy)2(orotH)], by identifying the metalated carbons through use of the HSQCAD 
and HMBCAD spectra while using the COSY spectrum to collect proton signals into four 
groups of four for each ring system of the two ppy ligands. While the two ppy ligands 
cannot be differentiated they do have significantly different chemical shifts for some of the 
related protons, particularly Hg and Hg’, as well as Hn and Hn’, which are separated by 
0.77 and 1.67 ppm, respectively. Most paired protons were separated by <0.10 ppm. 
 
                                                             




Figure 3.21 HRESI-MS of [Ir(ppy)2(pyhy)] from a solution of CH2Cl2/MeOH, with calculated isotope patterns 
shown next to major peaks. 
 
Figure 3.22 1H COSY NMR (500 MHz) of [Ir(ppy)2(pyhy)] in DMSO-d6. Cross peaks link the signals associated 




Figure 3.23 1H NOESY NMR (500 MHz) of [Ir(ppy)2(pyhy)] in DMSO-d6. 
 
Figure 3.24 HSQCAD NMR (500 MHz) spectrum of [Ir(ppy)2(pyhy)] in DMSO-d6. Cross peaks link pyhy (blue) 




Figure 3.25 HMBCAD NMR (500 MHz) spectrum of [Ir(ppy)2(pyhy)] in DMSO-d6.   
3.2.2.2 X-ray Crystallography 
X-ray quality crystals of fac-[Ir(ppy)2(pyhy)]·0.5Et2O were grown by diffusion of diethyl 
ether into a chloroform solution of fac-[Ir(ppy)2(pyhy)]. The complex crystallises in the 
monoclinic space group C2/c with the asymmetric unit containing the complex and half a 
disordered diethyl ether solvent (Figure 3.26). The iridium(III) ion is octahedral with the 
monoanionic pyhy ligand coordinating N^N through the pyridine N1 and hydantoin N2 
nitrogens. The two monoanionic 2-phenylpyridine ligands coordinate C^N with the 
metalated carbon atoms in the same plane of the iridium octahedron as the pyhy ligand 
confirming the fac geometry assigned to the complex. The crystal contains a racemic 
mixture of the Λ and Δ enantiomers in symmetry related positions. The diethyl ether 
solvent, which is centred on a two-fold rotation axis, is strongly hydrogen bonded to the 
hydantoin moiety with H3A hydrogen bonding to the oxygen atom of the ether (H···O 1.99 
Å, NH···O 175°) with a weak supporting CH···O interaction between H33C and O1 (H···O 
2.64 Å, CH···O 134°). This hydrogen bonding continues through to a symmetry related 
complex of the same ‘handedness’ with the angle between the complexes, through the 
oxygen atom of the ether, at 113°. These hydrogen bonded molecules then form stacks 
down the crystallographic b axis (Figure 3.27) through weak CH···O interactions between 
H18 and H19 of a 2-phenylpyridine ring to O1 of the pyhy ligand of an adjacent molecule 
(H···O 3.00 and 2.97 Å, CH···O 126° and 127°, respectively). Stacks then pack together 
through weak CH···O interactions between H2 and O1 (H···O 2.53 Å, CH···O 134°), and 
weak π-π interactions (Figure 3.28). The intermolecular interactions observed from the 
Hirshfeld analysis (Figure 3.29) show that the majority of the intermolecular interactions 
are H-H and H-C, making up 53.2% and 31.6% of the total interactions, respectively. These 
are characteristic of van der Waals and π-type interactions which are involved in the 
packing of the hydrogen bonded pairs into stacks and these stacks together into the 
overall 3D structure. Unusually some of the H-H interactions are observed to be very close, 
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at less than 2.0 Å, which is likely a complication from the disordered nature of the diethyl 
ether solvent. H-O interactions only make up 9.6% of the overall interactions but show a 
couple of concentrated peaks in the fingerprint plot, which correspond to the close 
approach in the NH···O hydrogen bonding and its supporting CH···O interactions. 
 
Figure 3.26 X-ray crystal structure of fac-[Ir(ppy)2(pyhy)]·0.5Et2O. Ellipsoids are drawn at 50% and 
symmetry related portions of the disordered diethyl ether solvent are shown. 
 
Figure 3.27 Packing of hydrogen bonded complex pairs, via the diethyl ether solvent, form stacks down the 




Figure 3.28 Packing of adjacent Δ (light green) and Λ (light blue) stacks of fac-[Ir(ppy)2(pyhy)]·0.5Et2O along 




Figure 3.29 Hirshfeld fingerprint plots of intermolecular interactions in [Ir(ppy)2(pyhy)]·0.5Et2O: (top left) all 
interactions; (top right) H-H interactions, 53.2%; (bottom right) H-C interactions, 31.6%; (bottom right) H-O 
interactions, 9.6%.  
 
3.2.3 Copper(II) Complex 
The bis-pyhy complex of copper(II) has been previously reported, but only prepared as a 
co-crystal structure with melamine and lacking any other analysis beyond the X-ray 
crystal structure.[12] The neutral copper(II) complex of pyhy, [Cu(pyhy)2], was synthesised 
by slow addition of an acetonitrile solution of two equivalents of  pyhyH to an acetonitrile 
solution of copper(II) acetate hydrate. The solution turns purple after 30 min. at room 
temperature and addition of diethyl ether precipitated the product as a purple solid, which 





The composition of the complex was confirmed with elemental analysis, HRESI-MS, and IR 
and UV-vis spectroscopies. The paramagnetic nature of the copper(II) ion precludes NMR 
analysis of the complex. Elemental analysis was found to be consistent with one complex 
with 0.2 water solvent molecules, likely carried over from the hydrate present in the 
copper(II) acetate starting material, and the HRESI-MS contained a major peak 
corresponding to the complex with a sodium ion (Figure 3.30). The IR spectrum contains 
medium bands ca. 1740 – 1700 cm-1 and 1630 – 1600 cm-1 corresponding to the C=O 
stretches and N-H bend of the hydantoin moiety, as well as a medium band at 912 cm-1 and 
weak bands ca. 3250 cm-1 corresponding to the C=CH bend of the methylene bridge and N-
H stretches, respectively. The complex has limited solubility in most solvents, severely 
limiting solution state analysis. In light of this, the UV-vis spectrum was obtained in DMF 
and was found to have a maximum absorption at 531.7 nm with a molar absorptivity of 
844 L mol-1 cm-1.  
 
Figure 3.30 HRESI-MS of [Cu(pyhy)2] from a solution of DMF, with calculated isotope pattern shown next to 
major peak. 
3.2.3.2 X-ray Crystallography 
During attempted co-crystallisation experiments, X-ray quality crystals of [Cu(pyhy)2] 
were grown by diffusion of water into a 2:1 mixed solution of [Pt(ppy)(diOMebigu)] and 
[Cu(pyhy)2] in DMSO. The complex crystallises in the monoclinic space group P 2/n with 
the asymmetric unit containing two ligands each coordinated to a half occupancy 
copper(II) ion (Figure 3.31). The copper ions are four coordinate with the pyhy ligands 
coordinating N^N through N1 and N2, and N4 and N5, respectively. Each complex has C2 
symmetry with the coordination geometry of the copper intermediate between square 
planar and tetrahedral. Angles around Cu1 ranged from 93° to 146°, while around Cu2 the 
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angles ranged from 93° to 147°. Structural parameters τ4 and τ4’ were calculated†[13-14] to 
be 0.60 and 0.55, and 0.61 and 0.54, for Cu1 and Cu2, respectively, supporting the 
assignment of coordination geometries as intermediate between tetrahedral and square 
planar.  
 
Figure 3.31 X-ray crystal structure of [Cu(pyhy)2]. Ellipsoids are drawn at 50%. 
The two complexes within the asymmetric unit are involved in very strong NH···O 
hydrogen bonds via a 𝑅2
2(8) motif from H3A to O3 and H6A to O2 (H···O 1.99 and 2.20 Å, 
NH···O 175° and 169°, respectively). This hydrogen bonding forms chains of complexes 
down the crystallographic c axis (Figure 3.32). These chains are then linked together into 
sheets across the crystallographic b axis via a series of non-classical CH···O interactions 
H1, H4, H10, and H13 with O4, O3, O2, and O1 (H···O 2.46, 2.43, 2.60, and 2.43 Å, CH···O 
160°, 126°, 149°, and 127°, respectively). This sheets then stack together up the b axis 
(Figure 3.33) via weak CH···N interactions (H···N 2.62 Å, CH···N 117°) to form the overall 
3D structure. A Hirshfeld surface generated from the completed asymmetric unit 
fragments (Figure 3.31) showed that H-O interactions make up 33.7% of the overall 
interactions (Figure 3.34) which is consistent with the large number of H···O interactions 
observed in the structure. While it is not immediately clear from the crystal structure, C-C 
and H-C fingerprints from the Hirshfeld analysis show close approaches of 3.2 Å and 2.8 Å, 
respectively, suggesting that there are also π-π stacking interactions supporting the 
packing of the [Cu(pyhy)2] molecules. 











 where α and β are the two greatest coordination angles (β>α) and θ 




Figure 3.32 Hydrogen bonding of complexes via 𝑹𝟐
𝟐(𝟖) motifs into chains down the crystallographic c axis as 
viewed down the crystallographic a axis (top) and b axis (bottom). 
 




Figure 3.34 Hirshfeld fingerprint plots of intermolecular interactions in [Cu(pyhy)2]: (top left) H-H 
interactions, 19.4%; (top right) C-C interactions, 9.1%; (bottom left) H-C interactions, 18.5%;  
(bottom right) H-O interactions, 33.7%. 
 
3.2.4 Zinc(II) Complex 
A neutral zinc(II) complex of pyhy, [Zn(pyhy)], was synthesised by slow addition of an 
acetonitrile solution of two equivalents of  pyhyH to an acetonitrile solution of zinc(II) 
acetate dihydrate. After one hour at room temperature the product precipitated as a 
yellow solid and was collected via filtration and was washed with cold acetonitrile and 
diethyl ether.  
3.2.4.1 Characterisation 
The composition of the [Zn(pyhy)2] complex was confirmed by elemental analysis, HRESI-
MS, and IR and 1H NMR spectroscopies. Elemental analysis was consistent with the 
expected bis pyhy complex, while the ESI-MS contains a major 1+ peak corresponding to 
the complex with a sodium ion (Figure 3.35). The ESI-MS also contains a series of peaks 
likely corresponding to decomposition products of the complex under mass spectrum 
conditions. The IR spectrum is very similar to that of copper(II) complex, suggesting both 
complexes are adopting similar geometries. 1H NMR spectrum was also consistent with 
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the expected complex with a single set of peaks directly comparable to the ligand with Hb, 
Hc, and Hd shifted downfield by 0.21, 0.04, and 0.25 ppm, respectively, while Ha and He 
have shifted upfield by 0.50 and 0.16 ppm respectively (Figure 3.36).  
 
Figure 3.35 HRESI-MS of [Zn(pyhy)2] from a solution of DMSO, with calculated isotope pattern shown next to 
major peak.  
 
Figure 3.36 1H NMR (400 MHz) spectra of pyhyH (top) and [Zn(pyhy)2] (bottom) in CD3CN, showing shifting 




3.3 Biuret Synthons 
3.3.1 Introduction 
An alternative dianionic ADA containing ligand is biuret which coordinates N^N from 
amines directly adjacent to the imide motif. A wide array of transition metal complexes of 
biurets have been reported (Subsection 1.3.1.2), but those synthesised without ancillary 
groups tended to suffer from poor solubility. The palladium(II) and platinum(II) biuret 
containing complexes synthesised and used in this work utilised dppe as the ancillary 
ligand, as a neutral and solubilising ligand, which had precedence in the literature with 
dppe and other similar phosphine ligands used for complexes with dianionic hydrogen 
bonding ligands.[15] The complex [Pd(dppe)(biuret)] can be synthesised (Scheme 12) first 
by treating a dichloromethane solution of [Pd(dppe)Cl2] with two equivalents of a silver(I) 
salt (e.g. AgPF6), followed by filtration to remove the precipitated silver chloride, and 
removal of the solvent via rotary evaporation before taking up the resulting residue in 
methanol. A solution of one equivalent of biuret in methanol was treated with two 
equivalents of base (sodium methoxide) before being added to the palladium containing 
methanol solution and stirred at room temperature. Removal of the methanol via rotary 
evaporation gave a crude yellow solid which was purified by recrystallisation (diethyl 
ether into a chloroform solution).[16]  
 
Scheme 12 Synthesis of [Pd(dppe)(biuret)] through addition of a solution of biuret treated with sodium 
methoxide to a methanol solution of [Pd(dppe)]2+ which was produced by treating [Pd(dppe)Cl2] with AgPF6. 
A X-ray crystal structure of [Pd(dppe)(biuret)]·DMF has been obtained[16] with the 
complex crystallising in monoclinic space group C2/c with the asymmetric unit containing 
one complex and a disordered DMF solvent (Figure 3.37). The biuret ligands of adjacent 
complexes strongly hydrogen bond to each other through NH···O hydrogen bonds between 
H2 and O1 (H···O 2.03 Å, NH···O 174°) via 𝑅2




Figure 3.37 X-ray crystal structure of [Pd(dppe)(biuret)]·DMF.[16] Ellipsoids are drawn at 50% and 
disordered DMF solvent is hidden for clarity. 
 
Figure 3.38 Hydrogen bonded pairs of [Pd(dppe)(biuret)]. 
3.3.2 Platinum(II) Complex 
Attempts to synthesise the platinum(II) analogue of the palladium(II) biuret complex 
through the same method (vide supra) repeatedly yielded starting materials or their 
decomposition products. An alternative method for synthesising platinum(II) bis-
phosphines with chelating dianionic ligands, such as orotH, from [Pt(cod)Cl2] in the 
presence of silver oxide has been reported.[15] Following this method, the neutral 
platinum(II) complex, [Pt(dppe)(biuret)], was synthesised by refluxing a solution of 
[Pt(cod)Cl2], bis(diphenylphosphino)ethane, biuret, and silver oxide in dichloromethane 
for 6 hours. The resulting solution was filtered through Celite to remove remaining silver 
oxide before the solvent was removed via rotary evaporation. This gave an off white solid 
which was recrystallised by diffusion of diethyl ether into a dichloromethane solution to 




The composition of the [Pt(dppe)(biuret)] complex was confirmed by elemental analysis, 
HRESI-MS, and IR and 1H NMR spectroscopies. Elemental analysis was consistent with the 
expected complex with a single dichloromethane solvent. The ESI-MS (Figure 3.39) 
contains a major 2+ peak corresponding to [Pt(dppe)2]2+ and a major 1+ peak 
corresponding to [Pt(dppe)(C2H7N2O2)] which contains a fragment of the biuret ligand. 
The IR spectrum contained weak bands ca. 3370 cm-1, as well as strong bands ca 1640 – 
1600 cm-1 and 1600 – 1570 cm-1 corresponding to N-H stretches, C=O stretches, and N-H 
bends of the biuret, respectively. The 1H NMR spectrum showed a grouping of aromatic 
protons as multiplets from 7.80 and 7.34 ppm and an ab quartet at 2.61 ppm with the 
relative peak integrations corresponding to the dppe ligand. There is also a slightly 
broadened doublet at 7.22 ppm and a multiplet at 4.24 ppm which peak integrations of 1H 
and 2H respectively (to the 4H of the dppe ab quartet) which correspond to the NH 
protons of the biuret ligand.  
 
Figure 3.39 HRESI-MS of [Pt(dppe)(biuret)] from a solution of DMSO, with calculated isotope patterns shown 
next to major peaks. 
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3.3.2.1 X-ray Crystallography 
X-ray quality crystals of [Pt(dppe)(biuret)]·CHCl3 were grown from diffusion of diethyl 
ether solution of [Pt(dppe)(biuret)] in chloroform. The complex crystallises in the 
monoclinic space group I2/a with the asymmetric unit containing one complex with a 
chloroform solvent (Figure 3.40).  The platinum ion is square planar with the dianionic 
biuret ligand coordinating N^N through N1 and N2. As in the structure of 
[Pd(dppe)(biuret)], complexes form hydrogen bonded pairs through a NH···O between H2 
and O1 (H···O 1.97 Å, NH···O 174°) via a 𝑅2
2(8) motif. Chloroform solvent molecules are 
involved in CH···O hydrogen bonding bridging positions between O1 and O2 (H···O 2.37 
and 2.65, CH···O 124° and 130°, respectively) of the two hydrogen bonded complexes 
making an overall 𝑅2
2(6)𝑅2
2(8)𝑅2
2(6) motif (Figure 3.41). Hydrogen bonded pairs then 
assemble via offset π-π stacking between adjacent dppe ligands (cent···C 3.452 Å) into 1D 
zig-zag chains down the crystallographic a axis, which then pack together through further 
π-π interactions as well as weak CH···O and CH···N hydrogen bonds to form the overall 
packing structure (Figure 3.42).  
 
Figure 3.40 X-ray crystal structure of [Pt(dppe)(biuret)]·CHCl3. Ellipsoids are drawn at 50%. 
 




Figure 3.42 Packing of pairs of hydrogen bonded [Pt(dppe)(biuret)] complexes into  1D chains (light blue and 
light green) down the crystallographic a axis  which then pack into the overall 3D structure through weak 
CH···N and CH···O interactions (magenta). Chloroform solvent molecules hidden for clarity. 
Fingerprint plots of the H-O interactions from the Hirshfeld analysis (Figure 3.43) support 
the strong H···O hydrogen bonds present in the structure with these interactions making 
up 10.1% of the overall surface. However, H-H interactions make up 40.5% of the overall 
intermolecular interactions, due to the addition of the bulky dppe ligands. Some H-H 
distances are observed to be as low as 2.0 Å, with H14 and H3B (of an adjacent dppe 
ligand), due to forced close proximity from π-stacking interactions between phenyl groups 
of adjacent complexes. Hirshfeld analysis also revealed that weak H···Cl interactions make 
up a significant portion of the packing in the structure, which, in concert with CH···O 
hydrogen bonds from the chloroform solvents, stabilise the positioning of said solvents in 




Figure 3.43 Hirshfeld fingerprint plots of intermolecular interactions in [Pt(dppe)(biuret)]·CHCl3]: (top left) 
H-H interactions, 40.5%; (top right) H-C interactions, 19.3%; (bottom left) H-O interactions, 10.1%; (bottom 
right) H-Cl interactions, 18.5%. 
 
3.4 Conclusions 
Octahedral ruthenium(II) and iridium(III) complexes, [Ru(bpy)2(pyhy)](PF6), 
[Ru(bpy)2(orotH)], fac-[Ir(ppy)2(pyhy)], and fac-nBu4N[Ir(ppy)2(orotH)] were 
synthesised and had overall charges ranging from 1- to 1+ with the charged complexes 
isolated as either the hexafluorophosphate or tetra-n-butylammonium salts. The neutral 
zinc(II) and copper(II) complexes [Zn(pyhy)2] and [Cu(pyhy)2] were also synthesised, 
along with the neutral platinum(II) complex [Pt(dppe)(biuret)]. All the complexes were 
characterised through a variety of techniques including elemental analysis, HRESI-MS, and 
a collection of 1D and 2D 1H and 13C NMR experiments. Crystal structures of 
[Ru(bpy)2(pyhy)](PF6)·CH3CN, [Ru(bpy)2(orotH)]·2.4H2O, as well as fac-
[Ir(ppy)2(pyhy)]·0.5Et2O, [Cu(pyhy)2], and [Pt(dppe)(biuret)]·CHCl3 were also obtained, 




The most extensive hydrogen bonding was observed in the structure of 
[Ru(bpy)2(orotH)]·2.4H2O, in which the orotic acid ligand was involved in a variety of 
strong OH···O and CH···O hydrogen bonds to adjacent orotic acid ligands with the two full 
occupancy water solvent molecules in bridging, hydrogen bonding positions. Unlike the 
other structures (except the bis-pyhy copper(II) complex) the hydrogen bonds link 







3(10)}∞ motifs (Figure 3.7). This extensive 
hydrogen bonding is likely the cause of the insolubility of [Ru(bpy)2(orotH)]·2.4H2O in 
most common organic solvents, with solvents which can readily compete for the hydrogen 
bonding interactions, such as DMF or DMSO, required to break up the hydrogen bonding 
between complexes and provide an adequate solvation of the separate complexes.  
Complexes present in the structure of [Cu(pyhy)2] are also observed to pack into 1D 
chains (down the crystallographic c axis in this case). These chains, however, do not occur 
through continuous hydrogen bonding motifs, and instead the hydantoin moiety of each 
ligand, hydrogen bonds via discrete 𝑅2
2(8) motifs to the hydantoin moiety of an adjacent 
complex. The creation of the 1D chains are facilitated by the coordination of two pyhy 
ligands, which are orientated in opposing directions, to each copper ion (Figure 3.31). 
[Cu(pyhy)2] shares the poor solubility of [Ru(bpy)2(orotH)] however this is likely also, in 
part, due to the lack of ancillary ligands or groups attached to the pyhy ligands which 
could potentially provide additional solubility. Hydrogen bonds via discrete 𝑅2
2(8) motifs 
are also observed in the structure of [Pt(dppe)(biuret)]·CHCl3, however with each 
complex only containing a single biuret ligand, adjacent complexes form discrete dimers 
with chloroform solvent molecules providing bridging hydrogen bonding interactions 
between the biuret ligands to give overall 𝑅2
2(6)𝑅2
2(8)𝑅2
2(6) motifs (Figure 3.41).  
While containing hydantoin based ligands, which are often observed to hydrogen bond to 
each other via 𝑅2
2(8) motifs, as was observed in the case of [Cu(pyhy)2]). Crystal 
structures of [Ru(bpy)2(pyhy)]PF6·CH3CN, and fac-[Ir(ppy)2(pyhy)]·0.5Et2O show that in 
neither case that 𝑅2
2(8) motifs between adjacent hydantoin moieties are present. Instead, 
in the case of fac-[Ir(ppy)2(pyhy)]·0.5Et2O, adjacent hydantoin moieties are bridged by a 
disordered diethyl ether solvent, through single strong NH···O hydrogen bonds from the 
imides of the hydantoin moieties to the oxygen atom of diethyl ether (Figure 3.26). In the 
case of [Ru(bpy)2(pyhy)]PF6·CH3CN, the hydantoin moiety is involved in a NH···N 
hydrogen bond to the acetonitrile solvent, as well as weak CH···O hydrogen bonds to the 
2,2’-bipyridine ligands of two adjacent complexes. The structure of 
[Ru(bpy)2(pyhy)]PF6·CH3CN actually lacks any distinct hydrogen bond motifs, unlike the 
other four structures, and instead the majority of intermolecular interactions are a variety 
of moderate or weak CH···N, CH···F, or CH···O hydrogen bonds between adjacent 
complexes, solvent molecules, and anions, which directly contribute to the overall packing 
structure. Hirshfeld analysis of [Ru(bpy)2(pyhy)]PF6·CH3CN showed hydrogen bonding 
related contacts, H-O, H-N, and H-F, to make up 43.6% of the overall surface interactions 
(11.7%, 6.3%, and 25.6%, respectively) while contacts more indicative of π-π interactions 





The hydrogen bonded 1D chains formed in the structure of both 
[Ru(bpy)2(orotH)]·2.4H2O and [Cu(pyhy)2] pack together through a variety of moderate-
weak CH···O hydrogen bonds and π-π interactions, with the secondary packing in the 
copper(II) structure also facilitated by weak CH···N interactions (Figure 3.33). Hirshfeld 
analysis showed that H-O interactions make up roughly equal amounts of the surface 
interactions (32.2% and 33.7% for the ruthenium(II) and copper(II) structures, 
respectively), while the copper(II) structure has the additional H-N hydrogen bonding 
interactions bringing its total hydrogen bonding surface type interactions to 43.6% 
(33.7% and 9.9% for H-O and H-N interactions, respectively). The combined H-C and C-C 
contacts also made up a significantly larger proportion in the structure of [Cu(pyhy)2] at 
27.6% (18.5% and 9.1%, respectively), when compared to the structure of 
[Ru(bpy)2(orotH)]·2.4H2O where they made up only 20.7% (12.1% and 8.6%, 
respectively), with the difference in remaining surface contacts being made up by H-H 
interactions.  
The hydrogen bonded pairs (of complexes) formed in the structures of 
[Pt(dppe)(biuret)]·CHCl3 and fac-[Ir(ppy)2(pyhy)]·0.5Et2O each form into 1D secondary 
structures which then further pack together to form the overall packing structures. How 
the two different hydrogen bond pairs pack into these secondary structures is different, 
with the pairs in the platinum(II) structure forming zig-zag chains (Figure 3.42) through 
offset π-π stacking interactions between adjacent dppe ligands while the pairs in the 
iridium(III) structure form stacks through weak CH···O interactions between the 2,2’-
bipyridine ligands and the hydantoin moieties of an adjacent pairs (Figure 3.27). In the 
structure of fac-[Ir(ppy)2(pyhy)]·0.5Et2O, stacks of alternating orientations pack together 
through π-π interactions as well as weak CH···O hydrogen bonds. Hirshfeld analysis of the 
structure reveals that the π-π interactions between stacks is likely much more important 
to the packing of the complexes with H-C and C-C contacts making up 33.0% of the total 
surface interactions (31.6% and 1.4%, respectively). H-O contacts only make up 9.6% of 
the total surface, which does include the strong hydrogen bonding interaction between the 
hydantoin moieties and the diethyl ether solvent. H-O contacts drop to the relative 4.6% 
when accounting for the additional complex added (9.1% without) when surface is 
recalculated around the strongly hydrogen bonded ‘pair’. In the structure of 
[Pt(dppe)(biuret)]·CHCl3 the zig-zag chains pack together through a variety of weak 
CH···N and CH···O as well as additional π-π interactions. While H-O and H-N contacts make 
up 14% of the contacts in the Hirshfeld analysis (10.1% and 3.9%, respectively), much of 
this would be accounted for in the strong hydrogen bonds between the platinum(II) 
complexes. H-C and C-C contacts, on the other hand, only make up 20.9% of the total 
surface interactions (19.3% and 1.6%, respectively), which a significant amount of the 
remaining surface (18.5%) being involved in H-Cl contacts. These interactions relate to 
packing of the chloroform solvent molecules tightly into the overall structure, resulting in 
their well resolved ellipsoids and lack of any disorder which would be observed in less 




3.5 Experimental Supplemental 
Unless otherwise stated, all reagents were purchased from commercial sources and used 
without further purification. 2-pyridylmethylenehydantoin,[10] and the cyclometalated 
complex fac-[(Ir(ppy)2-μ-Cl2],[17] were prepared by literature methods. Solvents used were 
laboratory grade, with petroleum ether referring to the fraction of petroleum ether boiling 
in the range 40-60 °C. All NMR spectra were recorded on either a 400 MHz Varian 400 MR, 
or Varian 500 MHz VNMRS spectrometer at 298 K. Chemical shifts are reported in parts 
per million, referenced to residual solvent peaks (CDCl3: 1H 7.26, 13C 77.23; CD3CN: 1H 
1.96, 13C 118.69; dmso-d6: 1H 2.50, 13C 39.52 ppm), and analysed using MestReNova 9.0. IR 
spectra were recorded on a Bruker ALPHA FT-IR spectrometer using a diamond surface. 
High resolution electrospray mass spectra (HR SI-MS) were collected on a Bruker micro-
TOF-Q spectrometer. Hirshfeld surfaces[18] were calculated to high resolution using the 
complete asymmetric units of the respective structures in the CrystalExplorer software 
package.[19] UV-vis spectra were collected by Joseph Mapley in collaboration with the KCG 
research group at the University of Otago. Microanalyses were conducted at the Campbell 





3.5.1 Orotic Acid Complexes 
[Ru(bpy)2(orotH)] 
 
A purple solution of [Ru(bpy)2Cl2]·2H2O (52.6 mg, 0.101 mmol) and HtpD (33.5 mg, 0.099 
mmol) in EtOH (7 mL) was heated under sealed tube microwave conditions at 125 °C for 2 
h. The resulting red solution was cooled to room temperature before removal of the 
solvent via rotary evaporation. The dark red precipitate recrystallized from a 
methanol:water solution (1:5, 30 mL) to give black/purple crystals which were collected 
via filtration and washed with water (75.5 mg, 89%). Anal. Calc. for C25H18N6O4Ru·2H2O: C, 
49.75; H, 3.67; N, 13.92. Found C, 49.48; H, 3.60; N, 14.41. 1H NMR (500 MHz, DMSO-d6) δ 
9.76 (d, J = 2.4 Hz, 1H, Hb), 8.76 – 8.71 (m, 2H, bpy), 8.65 (t, J = 8.6 Hz, 2H, bpy), 8.58 (dd, J 
= 5.5, 1.3 Hz, 1H, bpy), 8.45 (d, J = 8.1 Hz, 1H, bpy), 8.14 – 8.02 (m, 2H, bpy), 7.88 (td, J = 
7.8, 1.5 Hz, 1H, bpy), 7.79 – 7.73 (m, 2H, bpy), 7.68 (td, J = 7.7, 1.4 Hz, 1H, bpy), 7.62 – 7.57 
(m, 1H, bpy), 7.48 (dd, J = 5.6, 1.3 Hz, 1H, bpy), 7.27 (ddd, J = 7.3, 5.7, 1.3 Hz, 1H, bpy), 7.08 
(ddd, J = 7.3, 5.8, 1.4 Hz, 1H, bpy), 5.68 (d, J = 2.3 Hz, 1H, Ha). 13C NMR (126 MHz, DMSO-d6) 
δ 173.29, 165.97, 158.72, 158.67, 158.51, 158.12, 157.90, 157.83, 152.43, 151.79, 151.28, 
149.23, 135.13, 134.91, 134.80, 133.01, 126.79, 126.13, 126.12, 124.78, 123.19, 123.16, 
122.61, 122.50, 99.82. IR υmax/cm-1 3562, 3178, 3163, 3071, 1638, 1597, 1555, 1461, 1443, 
1420, 1383, 1360, 1321, 1263, 1155, 1019, 942, 851, 799, 760, 725, 675, 656, 636, 586, 
437, 423. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 382 (16200), 547 (12900) nm. ESI-MS (m/z) 








A yellow solution of dry Na2CO3 (60 mg, 0.6 mmol), fac-[(Ir(ppy)2-μ-Cl2] (43.7 mg, 0.041 
mmol) and anhydrous orotic acid (16.9 mg, 0.108 mmol) in dry DMSO (1.5 mL) under Ar(g 
was heated at 125 °C for 6 h. After cooling the yellow solution to room temperature a 
solution of tetra-n-butylammonium chloride (31.2 mg, 0.113 mmol) in water (20 mL) was 
added and stirred for 30 min before the addition of acetone (25 mL), and the resulting 
yellow solution was stirred at room temperature overnight. The bright yellow precipitate 
was collected via filtration and dried in vacuo to give pure product, 41.5 mg (78 %). Anal. 
Calc. for C43H54N5O4Ir·H2O: C, 56.43; H, 6.17; N, 7.65. Found: C, 56.65; H, 6.00; N, 7.62. 1H 
NMR (500 MHz, DMSO-d6) δ 9.52 (s, 1H, Hb), 8.45 (d, J = 5.7 Hz, 1H, Hj), 8.36 (dd, J = 5.7, 
1.5 Hz, 1H, Hj’), 8.09 (d, J = 8.1 Hz, 1H, Hg’), 8.02 (d, J = 8.2 Hz, 1H, Hg), 7.87 (td, J = 7.7, 1.7 
Hz, 1H, Hh’), 7.80 (td, J = 7.8, 1.6 Hz, 1H, Hh), 7.67 (d, J = 7.8 Hz, 1H, Hf’), 7.54 (d, J = 7.6 Hz, 
1H, Hf), 7.32 – 7.29 (m, 2H, Hi, Hi’), 6.75 (t, J = 7.5 Hz, 1H, He’), 6.60 – 6.56 (m, 2H, Hd’, He), 
6.43 (t, J = 7.3 Hz, 1H, Hd), 6.06 (d, J = 7.6 Hz, 1H, Hc), 5.95 (d, J = 7.5 Hz, 1H, Hc’), 5.67 (d, J 
= 2.3 Hz, 1H, Ha), 3.19 – 3.12 (m, 8H, Hk), 1.56 (p, J = 15.6, 6.9 Hz, 8H, Hl), 1.30 (h, J = 7.2 
Hz, 8H, Hm), 0.93 (t, J = 7.3 Hz, 12H, Hn). 13C NMR (126 MHz, DMSO-d6) δ 174.13, 168.44, 
168.27, 166.25, 157.26, 156.59, 153.27, 152.23, 149.82, 146.88, 145.04, 142.78, 136.91, 
136.46, 131.90, 131.78, 128.36, 127.65, 123.65, 123.39, 122.44, 121.21, 120.03, 118.47, 
118.06, 117.92, 99.53, 57.53, 57.50, 57.48, 23.04, 19.20, 13.48. IR υmax/cm-1 3413, 3038, 
2960, 2871, 1747, 1623, 1469, 1417, 1360, 1267, 1158, 1060, 1025, 796, 759, 730, 668, 
628, 428. UV-vis (CH2Cl2): λmax (ε/M-1 cm-1) = 337 (14000), 458 (2700) nm. ESI-MS (m/z) 





3.5.2 2-Pyridylmethylenehydantoin Complexes 
[Ru(bpy)2(pyhy)]PF6 
 
A purple solution of [Ru(bpy)2Cl2]·2H2O (75.4 mg, 0.145 mmol) and 2-methinehydantoin 
pyridine (30.8 mg, 0.163 mmol) in EtOH (7 mL) was heated under sealed tube microwave 
conditions at 125 °C for 2 hours. The resulting red solution was cooled to room 
temperature and saturated NH4PF6(aq) (10 mL) was added and the solution stirred 
overnight. Removal of the ethanol via rotary evaporation and cooling of the solution 
resulted in a dark red precipitate which was collected via filtration. Recrystallization from 
diethyl ether into acetonitrile solution yielded a black/red crystalline solid (34.3 mg, 30 
%). Anal. Calc. for C29H22N7O2F6PRu: C, 46.66; H, 2.97; N, 13.13. Found: C, 46.63; H, 3.16; N, 
13.41. 1H NMR (500 MHz, CD3CN) δ 8.88 (dd, J = 5.7, 1.5 Hz, 1H, Ha), 8.44 (d, J = 8.2 Hz, 1H, 
bpy), 8.39 (m, 2H, bpy), 8.31 (d, J = 5.5 Hz, 1H, bpy), 8.23 (d, J = 8.1 Hz, 1H, bpy), 8.11 – 
7.97 (m, 3H, Hf, bpy), 7.87 (td, J = 7.9, 1.5 Hz, 1H, bpy), 7.75 (td, J = 7.8, 1.5 Hz, 1H, bpy), 
7.65 (d, J = 5.6 Hz, 1H, bpy), 7.59 – 7.49 (m, 3H, Hb, bpy), 7.45 (ddd, J = 7.3, 5.6, 1.3 Hz, 1H, 
bpy), 7.36 – 7.26 (m, 2H, Hd, bpy), 7.22 (ddd, J = 7.3, 5.7, 1.3 Hz, 1H, bpy), 7.03 (ddd, J = 7.3, 
5.7, 1.4 Hz, 1H, bpy), 6.56 (t, J = 6.7 Hz, 1H, Hc), 6.09 (s, 1H, He). 13C NMR (126 MHz, 
CD3CN) δ 168.56, 162.33, 159.26, 158.95, 158.49, 156.50, 154.12, 153.59, 153.36, 152.66, 
152.41, 143.42, 137.53, 137.32, 137.21, 136.71, 136.64, 128.32, 127.99, 127.51, 127.14, 
126.07, 124.96, 124.70, 124.09, 123.29, 121.18, 100.88. IR υmax/cm-1 3381, 3078, 1740, 
1706, 1628, 1599, 1539, 1465, 1439, 1359, 1310, 1273, 1240, 1186, 1159, 1131, 1065, 
1006, 831, 763, 737, 647, 551, 455, 423. UV-vis (DMSO): λmax (ε/M-1 cm-1) = 346 (15900), 








A yellow solution of dry Na2CO3 (60 mg, 0.6 mmol), [(Ir(ppy)2-μ-Cl2] (42.9 mg, 0.040 
mmol) and 1,5-di(4-tertbutylphenyl)biguanide (36.7 mg, 0.100 mmol) in dry DMSO (1.5 
mL) under Ar(g) was heated at 125 °C for 6 hr. After cooling the orange solution to room 
temperature water (15 mL) was added resulting in a cloudy orange solution, which was 
taken up in water/brine (50 mL). This solution was extracted with CHCl3 (4 x 25 mL) and 
the combined organic extracts washed with brine (5 x 15 mL) before drying over 
magnesium sulfate and removal of the solvent under reduced pressure. The resulting 
orange oil was taken up in minimum CHCl3 and the addition of excess PET gave an orange 
precipitate which was collected via filtration and washed with additional PET before 
drying in vacuo to give a bright orange solid (31.6 mg, 56%). Anal. Calc. for 
C31H22N5O2Ir·0.5C4H10O·H2O: C, 53.29; H, 3.93; N, 9.42. Found: C, 53.22; H, 3.93; N, 9.39. 1H 
NMR (500 MHz, DMSO-d6) δ 10.17 (s, 1H, Hf), 8.69 (dd, J = 6.3, 1.3 Hz, 1H, Hg), 8.18 (d, J = 
8.1 Hz, 1H, Hj), 8.08 (dd, J = 8.3, 1.3 Hz, 1H, Hj’), 7.96 – 7.87 (m, 2H, Hi, Hg’), 7.85 (ddd, J = 
8.4, 7.5, 1.6 Hz, 1H, Hi’), 7.79 (dd, J = 7.9, 1.3 Hz, 1H, Hk), 7.70 (td, J = 7.7, 1.7 Hz, 1H, Hc), 
7.65 (dd, J = 5.9, 1.7 Hz, 1H, Hn), 7.60 – 7.50 (m, 2H, Hk’, Hd), 7.31 (td, J = 7.3, 5.8, 1.4 Hz, 
1H, H), 7.16 (td, J = 7.3, 5.8, 1.4 Hz, 1H, H’), 6.86 (td, J = 7.5, 1.3 Hz, 1H, Hl), 6.77 – 6.68 (m, 
2H, Hb, Hm), 6.65 (td, J = 7.5, 1.2 Hz, 1H, Hl’), 6.50 (td, J = 7.4, 1.3 Hz, 1H, Hm’), 6.03 (dd, J = 
7.4, 1.1 Hz, 2H, Ha), 6.01 (s, 2H, He), 5.98 (dd, J = 7.8, 1.2 Hz, 1H, Hn’). 13C NMR (126 MHz, 
DMSO-d6) δ 168.51, 168.03, 167.42, 160.33, 156.63, 152.55, 152.40, 150.14, 149.13, 
148.74, 144.53, 143.01, 142.16, 137.90, 137.42, 136.87, 132.16, 131.17, 129.78, 127.77, 
126.79, 124.87, 123.42, 122.82, 122.10, 121.18, 120.79, 119.75, 119.47, 119.00, 99.48. IR 
υmax/cm-1 3046, 1713, 1628, 1601, 1549, 1475, 1432, 1344, 1270, 1184, 1160, 1127, 1060, 
1026, 1008, 909, 754, 732, 675, 645, 456. UV-vis (CH2Cl2): λmax (ε/M-1 cm-1) = 404 (10200), 
474 (4900) nm. ESI-MS (m/z) (CH2Cl2/CH3OH): [C31H23N5O2Ir]1+ expected 690.1476, found 
690.1462; [C31H22N5O2IrNa]1+ expected 712.1295, found 712.1288; [(C31H22N5O2Ir)2Na]1+ 







A yellow solution of pyhyH (197.4 mg, 1.048 mmol) in warm acetonitrile (20 mL) was 
added dropwise to a dark blue solution of [Cu(OAc)2]·H2O (102.2 mg, 0.510 mmol) in 
acetonitrile (10 mL) and the resulting light blue solution was stirred at room temperature 
for 30 min. over which time the product precipitated as a purple solid. Diethyl ether (30 
mL) was added to ensure full precipitation. The solid was collected via filtration and 
washed with diethyl ether before air drying to give the product as a purple solid (195.5 
mg, 85%). Anal. Calc. for C18H12N6O4Cu·0.2H2O: C, 48.75; H, 2.82; N, 18.95. Found: C, 48.51; 
H, 2.71; N, 18.98. IR υmax/cm-1 3135, 3041, 2737, 1735, 1706, 1632, 1599, 1551, 1479, 
1436, 1390, 1349, 1308, 1269, 1245, 1180, 1154, 1126, 1035, 1018, 912, 863, 844, 778, 
769, 746, 721, 681, 652, 639, 596, 486, 471, 424. ESI-MS (m/z) (DMF): [C18H12N6O4CuNa]1+ 






A yellow solution of pyhyH (202.1 mg, 1.05 mmol) in acetonitrile (20 mL) was added 
dropwise to a colourless suspension of [Zn(OAc)2]·2H2O (112.6 mg, 0.513 mmol) in warm 
acetonitrile (10 mL). The resulting solution was stirred at room temperature for 1 hour 
from which a yellow solid precipitated. The solid was collected via filtration and washed 
with acetonitrile and diethyl ether before air drying to give the pure product as a yellow 
solid (212.7 mg, 91%). Anal. Calc. for C18H12N6O4Zn: C, 48.95; H, 2.74; N, 19.03. Found: C, 
48.94; H, 2.65; N, 19.05. 1H NMR (400 MHz, DMSO-d6) δ 8.12 (dd, J = 5.5, 1.9 Hz, 1H), 8.02 
(ddd, J = 8.1, 7.5, 1.8 Hz, 1H), 7.83 (dt, J = 8.2, 1.1 Hz, 1H), 7.30 (ddd, J = 7.5, 5.4, 1.3 Hz, 1H), 
6.31 (s, 1H). IR υmax/cm-1 3266, 3069, 3034, 2996, 2758, 1749, 1719, 1696, 1632, 1600, 
1552, 1486, 1439, 1408, 1395, 1368, 1343, 1315, 1274, 1244, 1188, 1158, 1129, 1038, 
1015, 915, 863, 842, 782, 771, 748, 733, 715, 656, 673, 651, 601, 590, 474, 459, 413. ESI-






3.5.3 Biuret Complexes 
[Pt(dppe)(biuret)] 
 
A solution of [Pt(cod)Cl2] (96.2 mg, 0.26 mmol), bis(diphenylphosphino)ethane (105.0 mg, 
0.26 mmol), biuretH2 (26.9 mg, 0.26 mmol), and silver oxide (145.0 mg, 0.44 mmol) in 
dichloromethane (40 mL) was refluxed for 6 hours.  After cooling to room temperature the 
black solution was filtered through Celite to obtain a yellow solution. The solvent was 
removed via rotary evaporation and the resulting solid was suspended in petroleum ether 
before being collected via filtration and air dried. The crude off white solid was 
recrystallised by diffusion of diethyl ether into a dichloromethane solution to obtain the 
pure product as silver grey crystals (61.4 mg, 34%). Anal. Calc. for 
C28H27N3O2P2Pt·0.2CH2Cl2: C, 47.60; H, 3.88; N, 5.91. Found: C, 47.58; H, 4.20; N, 5.51. 1H 
NMR (400 MHz, DMSO-d6) δ 7.80 – 7.71 (m, 7H), 7.67 – 7.56 (m, 11H), 7.53 – 7.34 (m, 2H), 
7.22 (d, J = 2.7 Hz, 1H), 4.24 (dd, J = 5.7, 2.8 Hz, 2H), 2.72 – 2.54 (m, 4H). IR υmax/cm-1 3373, 
3051, 1636, 1596, 1572, 1481, 1435, 1413, 1366, 1309, 1268, 1185, 1103, 1073, 1027, 
997, 967, 882, 824, 751, 716, 706, 692, 535, 486, 448. ESI-MS (m/z) (DMSO): 
[C28H31N2O2P2Pt]1+ expected 684.1503, found 684.1194; [C52H48P4Pt]2+ expected 495.6172, 






3.6 Crystallography Supplemental 
Purple/black crystals of [Ru(bpy)2(orotH)]·2.4H2O were grown from an aqueous solution 
of crude [Ru(bpy)2(orotH)]. Red crystals of [Ru(bpy)2(pyhy)]PF6·CH3CN were grown by 
diffusion of diethyl ether into an acetonitrile solution of [Ru(bpy)2(pyhy)]PF6. Orange 
crystals of fac-[Ir(ppy)2(pyhy)]·0.5Et2O were grown by diffusion of diethyl ether into a 
chloroform solution of fac-[Ir(ppy)2(pyhy)]. Dark purple crystals of [Cu(pyhy)2] were 
grown by diffusion of water into a 2:1 solution of [Pt(ppy)(diOMebigu)] and [Cu(pyhy)2] 
in DMSO. Colourless crystals of [Pt(dppe)(biuret)]·CHCl3 were grown by diffusion of 
petroleum ether into a chloroform/acetonitrile solution of [Ru(bpy)2(BtpD)](PF6)2 and 
[Pt(dppe)(biuret)]. X-ray data for these complexes were collected at 100 K on an Agilent 
Technologies Supernova system using Cu Kα radiation with exposures over 1.0°, and data 
were treated using CrysAlisPro[20] software. The structures were solved using SHELXT[21] 
and weighted full-matrix refinement on F2 was carried out using SHELXL-2014[21] running 
within the WinGX[22] package. All non-hydrogen atoms were refined anisotropically. Non 
N-H hydrogen atoms were placed in calculated positions and refined using a riding model. 
Where possible, the N-H hydrogens (those on N2 of [Ru(bpy)2(orotH)]·2.4H2O, on the N3 
of fac-[Ir(ppy)2(pyhy)]·0.5Et2O, as well as on N3 and N6 of [Cu(pyhy)2]) were assigned 
from electron density maps and refined as floating atoms. Otherwise N-H hydrogens were 
placed in calculated positions and refined using a riding model. The hydrogen atoms on 
the water solvent molecules O5 and O6 of [Ru(bpy)2(orotH)]·2.4H2O were also assigned 
from electron density maps. 
Crystallographic data relevant for all structures reported in this chapter are summarised 
in Table 3.1 and Table 3.2, with selected bond lengths and angles, as well as hydrogen 
bonding metrics reported in Table 3.3 and Table 2.5. Hirshfeld surface analysis for each 
structure is summarised in Table 3.5 with fingerprint plots shown in Section 3.6.2. All 
structures reported have been validated using checkCIF,[23] with any and all level A and B 





3.6.1 Crystallographic Data Tables 








Formula C25H22N6O6.4Ru C31H25N8O2F6PRu C66H53.41N10O5Ir2 
FW 609.95 787.63 1450.99 
Crystal System Monoclinic Monoclinic Monoclinic 
Space Group P 21/n P 21 C 2/c 
a / Å 11.7983(4) 8.9678(2) 34.3923(4) 
b / Å 14.0016(5) 17.4041(4) 9.03470(10) 
c / Å 14.9397(5) 10.2184(3) 17.6240(2) 
α / ° 90 90 90 
β / ° 91.840(3) 96.685(2) 100.6810(10) 
γ / ° 90 90 90 
V / Å3 2466.7(2) 1584.01(7) 5381.3(2) 
Z 4 2 4 
T / K 100.0(2) 100.0(2) 100.0(2) 
μ / mm-1 5.634 0.625 9.962 
Refls. coll. 56176 12880 18248 
Ind.Refls. (Rint) 5168(0.0747) 5690(0.0297) 5359(0.0402) 
R1 (I>2σ(I))a 0.0630 0.0266 0.0320 
wR2 (I>2σ(I))a 0.1497 0.0746 0.0836 
R1 (all data)a 0.0700 0.0287 0.0327 
wR2 (all data)a 0.1545 0.0777 0.0845 
GOF 1.120 0.791 0.855 
a  𝑅1 =
∑‖𝐹𝑜|−|𝐹𝑐‖
∑|𝐹𝑜|










Table 3.2 Crystallographic data for X-ray structures of the copper(II) and platinum(II) complexes. 
 [Cu(pyhy)2] [Pt(dppe)(biuret)]·CHCl3 
Formula C18H12N6O4Cu C29H28N3O2P2Cl3Pt 
FW 439.88 813.92 
Crystal System Monoclinic Monoclinic 
Space Group P 2/n I 2/a 
a / Å 13.0118(5) 18.0729(4) 
b / Å 7.6714(3) 13.0172(2) 
c / Å 17.9358(8) 26.9598(6) 
α / ° 90 90 
β / ° 104.590(4) 106.859(2) 
γ / ° 90 90 
V / Å3 1732.6(2) 6069.9(2) 
Z 4 8 
T / K 100.0(2) 100.0(2) 
μ / mm-1 2.159 12.340 
Refls. coll. 16523 18523 
Ind.Refls. (Rint) 3124(0.0942) 6328(0.0477) 
R1 (I>2σ(I))a 0.0755 0.0533 
wR2 (I>2σ(I))a 0.2014 0.1442 
R1 (all data)a 0.0856 0.0560 
wR2 (all data)a 0.2077 0.1475 














Table 3.3 Selected bond lengths (Å) and angles (°). 
[Ru(bpy)2(orotH)]·2.4H2O [Cu(pyhy)2] 
 Ru1-N1 2.106(5)  Cu1-N1 2.004(4) 
 Ru1-N3 2.057(5)  Cu1-N2 1.924(4) 
 Ru1-N4 2.058(5)  Cu2-N4 2.014(4) 
 Ru1-N5 2.047(5)  Cu2-N5 1.924(5) 
 Ru1-N6 2.029(5)  N1-Cu1-N2 93.1(2) 
 Ru1-O3 2.098(4)  N1-Cu1-N1#1 129.7(3) 
 O3-C5 1.277(7)  N1-Cu1-N2#1 101.3(2) 
 O4-C5 1.239(7)  N2-Cu1-N2#1 145.8(3) 
 N1-Ru1-O3 78.3(2)  N4-Cu2-N5 93.4(2) 
 N3-Ru1-N4 79.3(2)  N4-Cu2-N4#2 127.3(3) 
 N5-Ru1-N6 79.6(2)  N4-Cu2-N5#2 101.1(2) 
fac-[Ir(ppy)2(pyhy)]·0.5Et2O  N5-Cu2-N5#2 146.9(3) 
 Ir1-N1 2.228(3) [Pt(dppe)(biuret)]·CHCl3 
 Ir1-N2 2.1463(3)  Pt1-N1 2.092(5) 
 Ir1-N4 2.043(3)  Pt1-N3 2.030(5) 
 Ir1-N5 2.040(3)  Pt1-P1 2.236(2) 
 Ir1-C10 2.010(3)  Pt1-P2 2.243(2) 
 Ir1-C21 2.014(4)  C1-N1 1.233(9) 
 N1-Ir1-N2 88.3(2)  C1-O1 1.263(8) 
 N4-Ir1-C10 80.6(2)  C2-N3 1.330(8) 
 N5-Ir1-C21 80.2(2)  C2-O2 1.253(8) 
[Ru(bpy)2(pyhy)]PF6·CH3CN  N1-Pt1-N3 86.8(2) 
 Ru1-N1 2.118(5)  P1-Pt1-P2 84.60(5) 
 Ru1-N2 2.068(5)    
 Ru1-N4 2.063(5)    
 Ru1-N5 2.042(5)    
 Ru1-N6 2.051(5)    
 Ru1-N7 2.044(5)    
 N1-Ru1-N2 89.3(2)    
 N4-Ru1-N5 78.9(2)    
 N6-Ru1-N7 79.1(2)    




Table 3.4 Hydrogen bond metrics. 
  d(H···A)/Å d(D···A)/Å <(DH···A)/° 
[Ru(bpy)2(orotH)]·2.4H2O    
 N2-H2···O6#3 2.15(7) 2.943(7) 157(6) 
 O5-H5A···O2#4 2.07(8) 2.767(7) 167(8) 
 O5-H5B···O4 1.89(9) 2.775(7) 163(8) 
 O6-H6A···O1#3 2.10(12) 2.928(8) 171(11) 
 O6-H6B···O5#4 2.05(10) 2.782(9) 174(10) 
[Ru(bpy)2(pyhy)]PF6·CH3CN    
 C2-H2···F3#5 2.48 3.256(8) 141.4 
 C11-H11···O2#6 2.40 3.458(8) 138.1 
 C21-H21···O1#7 2.55 3.331(8) 141.9 
 C26-H26···O2#8 2.34 3.270(8) 174.6 
 C29-H29···F6#9 2.59 3.492(8) 162.5 
 N3-H3A···N8#10 2.25 3.083(8) 162.4 
fac-[Ir(ppy)2(pyhy)]·0.5Et2O    
 C2-H2···O1#11 2.53 3.251(4) 134.4 
 C18-H18···O1#12 3.00 3.623(6) 126.0 
 C19-H19···O1#12 2.97 3.603(6) 127.1 
 N3-H3A···O3 1.99(6) 2.889(4) 175(5) 
[Cu(pyhy)2]    
 C1-H1···O4#13 2.46 3.348(7) 160.2 
 C4-H4···O3#14 2.43 3.075(7) 126.0 
 C10-H10···N5#2 2.62 3.151(7) 116.8 
 C10-H10···O2#15 2.60 3.424(7) 148.6 
 C13-H13···O1#16 2.43 3.078(7) 126.7 
 N3-H3A···O3 1.99(7) 2.765(6) 175(7) 
 N6-H6A···O2 2.20(7) 3.049(6) 169(6) 
[Pt(dppe)(biuret)]·CHCl3    
 C28-H28···O2#17 2.42 3.274(9) 152.0 
 C29-H29···O1 2.37 3.030(9) 123.8 
 C29-H29···O2#18 2.65 3.356(9) 129.6 
 N2-H2···O1#18 1.97 2.827(7) 174.2 
Symmetry codes: #1 –x,+½, y, -z+1½  #2 –x+½, y, -z+½  #3 –x+1, -y+1, -z+1  #4 –x+1, -y+1,-z+1  #5 –x+1, y-½, 
-z+1  #6 x-1, y, z  #7 –x+1, y-½, -z  #8 –x+2, y-½, -z  #9 x+1, y, z  #10 –x+2, y+½, -z  #11 x, -y+1, z+½  #12 x, 
y+1, z  #13 x-½, -y+1, z+½  #14 x+½, -y+1, z+½  #15 x-½, -y, -z-½,  #16 x+½, -y, z-½  #17 x-½, -y+1, z  #18 –




3.6.2 Hirshfeld Surface Analysis 
Table 3.5 Percentage of total Hirshfeld surface interactions (including reciprocals) between internal and 
external atoms. 
 H-H H-C H-N H-O H-X C-C C-N C-O C-X X-X Other 
[Ru(bpy)2(orotH)] 39.4 12.1 2.1 32.2 N/A 8.6 1.0 2.5 N/A N/A 2.1 
[Ru(bpy)2(pyhy)]PF6 29.5 19.9 6.3 11.7 25.6 1.5 0.1 0.2 2.7 0.0 2.5 
[Ir(ppy)2(pyhy)] 53.2 31.6 2.8 9.6 N/A 1.4 0.0 1.1 N/A N/A 0.3 
[Cu(pyhy)2] 19.4 18.5 9.9 33.7 N/A 9.1 0.6 2.8 N/A N/A 6.0 
[Pt(dppe)(biuret)] 40.5 19.3 3.9 10.1 18.5 1.6 0.0 0.0 4.0 0.0 2.1 
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Portions of the research presented in this chapter have been published in the following 
paper; 
McKay, A. P.; Shillito, G. E.; Gordon, K. C.; McMorran, D. A., Cyclometallated platinum(II) 
and palladium(II) complexes containing 1,5-diarylbiguanides: synthesis, characterisation 




While there exists a large range of potential ligands containing triple hydrogen bond 
motifs, and a correspondingly large collection of metal complexes (Section 1.3.1), there are 
only 22 crystal structures present in the CSD[1] in which these complexes have been co-
crystallised with complementary molecules via ADA and DAD type hydrogen bond motifs. 
The majority of the co-crystallised complexes found in the CSD which contain DAD type 
motifs have been co-crystallised primarily with imide containing organic molecules, while 
the few complexes which contain ADA type motifs have been co-crystallised with 
melamine or melamine analogue organic molecules. There is only one published structure 
which contains two complementary metal complexes (vide infra).  
4.1.1 Literature DAD Containing Complexes 
4.1.1.1 Co-crystals Containing Dithiobiuret Complexes 
While there are no examples of biuret containing complexes that display DAD type motifs, 
there are six nickel(II) structures[3-6] and one platinum(II)[7] co-crystal structure 
containing the thiolated, and much more toxic form, of biuret, dithiobiuretH. The 
complexes within these structures take the form [M(dithiobiuret)2] (where M is Ni or Pt), 
where the sulfur atoms are coordinated to the metal ion, resulting in a DAD motif (Figure 
4.1), analogous to the DAD motif observed in biguanide. The platinum complex was co-
crystallised with thymine, in a 1:2 ratio, while the nickel complex was co-crystallised with 
a variety of ADA containing organic molecules including thymines (Figure 4.1), uracil, 
naphthalimide, substituted piperidinone, and iminosioindolinone, all in a 1:2 ratio. All 
seven co-crystals display strong hydrogen bonding (H···O 1.93 – 2.18 Å, NH···O 160° – 
177°; H···N 2.03 – 2.35 Å, NH···N 160° – 178°) between the complex and complementary 
organic molecules via 𝑅2
2(8)𝑅2
2(8) motifs, forming trimers,† with additional hydrogen 
bonding interactions, particularly NH···S and NH···O hydrogen bonds, packing the trimers 
together.  
 
Figure 4.1 X-ray crystal structure of the [(Ni(dithiobiuret)2):(thymine)2] hydrogen bonded (blue) trimer 
from G. Kociok-Kohn et al.[3] Ellipsoids are drawn at 50%. 
4.1.1.2 Co-crystals Containing Biguanide Complexes 
A deprotonated bis-biguanide complex of nickel(II), [Ni(big)2], was co-crystallised with 
dimethoxy-quinazolinedione, in a 1:2 ratio.[6]  The quinzolinedione molecules are strongly 
hydrogen bonded (H···O 2.07 and 2.17 Å, NH···O 173° and 163°; H···N 2.10 Å, NH···N 177°) 
to the biguanide ligands via 𝑅2
2(8)𝑅2
2(8) motifs, forming trimers much like the dithiobiuret 
                                                             
† In this context trimer refers to a discrete supramolecular unit composed of three molecules. A dimer would 
consist of two molecular units while a tetramer would consist of four, etcetera. 
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complexes. A deprotonated bis-1,5-diarylbiguanide complex of nickel(II), 
[Ni(diOMebigu)2], was co-crystallised with a complementary organic molecule, in this 
case naphthalimide, Naph, also in a 1:2 ratio (Figure 4.2).[8] The naphthalimide molecules 
are strongly hydrogen bonded (H···O 2.03 and 2.07 Å, NH···O 165° and 158°; H···N 2.17 Å, 
NH···N 168°) to the DAD surface of the diarylbiguanide ligands via 𝑅2
2(8)𝑅2
2(8) motifs, 
forming trimers. The hydrogen bonding between the biguanide and naphthalimide is 
supported by additional, weak CH···O hydrogen bonds (H···O 2.53 and 2.67 Å, CH···O 137° 
and 129°) from the ortho protons of the aryl groups due to their rotated angle relative to 




1(6) motif.  
 
Figure 4.2 X-ray crystal structure of the [(Ni(diOMebigu)2):(Naph)2] hydrogen bonded (blue) trimer from D. 
A. McMorran et al.[8] Ellipsoids are drawn at 50%. 
4.1.1.3 Co-crystals Containing Guanidine Based Complexes 
The ligand 2-guanidinobenzimidazole is similar to biguanide, with both containing the 
same C2N5 motif, but differs with 2-guanidinobenzimidazole in having a fused 
benzaimidazole ring incorporating part of the C2N5 motif. Two co-crystal structures of the 
nickel(II) and one of the copper(II) bis-2-guanidinobenzimidazole complexes, [M(2-
guanidinobenzimidazole)2] (M = Ni or Cu), with the complementary organic molecules 
phthalimide or naphthalimide, have been reported.[9-10] All three structures show the 
imide containing molecules strongly hydrogen bonding (H···O 2.01 – 2.63 Å, NH···O 170° – 
177°; H···N 1.89 – 2.08 Å, NH···N 168° – 178°) to the guanidine ligands via 𝑅2
2(8)𝑅2
2(8) 
motifs, forming 1:2 trimers. A similar ligand to 2-guanidinobenzimidazole is 5-oxo-4,4-
diphenylimidazol-N-phenylguanidine which has the same imidazole-guanidine moiety as 
2-guanidinobenzimidazole but also contains three phenyl rings one of which is in a 
position comparable to the aryl rings of the 1,5-diarylbiguanides. A single co-crystal 
structure of bis-5-oxo-4,4-diphenylimidazol-N-phenylguanidine copper(II) with the 
complementary organic molecule, naphthalimide, has been reported (Figure 4.3),[10] and 
shows the same strong hydrogen bonding (H···O 1.95 and 2.07 Å, NH···O 162° and 168°; 
H···N 2.14 Å, NH···N 177°) between the imide and guanidine moieties via 𝑅2
2(8)𝑅2
2(8) 
motifs to form 1:2 trimers. The ortho proton of the N-phenyl ring of the ligand might be 
able to provide a supporting CH···O hydrogen bond to the naphthalimide, similar to the 
nickel(II) biguanide structure (Figure 4.2) but due to the rotation of the aryl group relative 




Figure 4.3 X-ray crystal structure of the [Cu(5-oxo-4,4-diphenylimidazol-N-phenylguanidine)2:(Naph)2] 
hydrogen bonded (blue) trimer from M. M. Bishop et al.[10] Ellipsoids are drawn at 50%. 
4.1.1.4 Co-crystals Containing Diaminotriazine Based Complexes 
As discussed in Chapter 1, the 2,4-diamino-1,3,5-triazine moiety is readily appended to a 
variety of coordinating ligands. In terms of co-crystallised structures there are two 
copper(II) complexes of DAT appended azocyclam, [Cu(azaDAT)(H2O)2]2+ and 
[(Cu(azaDAT)(ClO4))2-μ-I]+, with the complementary organic species, barbiturate and 
barbitone.[11] The first co-crystal contains [Cu(azaDAT)(H2O)2]2+ the barbiturate anion 
strongly hydrogen bonded to the DAT moiety (H···O 2.09 and 2.04 Å, NH···O 177° and 
178°; H···N 2.03 Å, NH···N 175°) via a 𝑅2
2(8)𝑅2
2(8) motif forming 1:1 dimers, which then 
pack together through various strong hydrogen bonds involving the hydrates present in 
the crystal. The second co-crystal, [((Cu(azaDAT)(ClO4))2-μ-I):(barb)2]ClO4,  contains two 
copper cyclam units bridged by an iodide which gives a dimeric complex with two DAT 
units facing in opposite directions. Each DAT unit is strongly hydrogen bonded to a 
barbitone molecule (H···O 2.22 and 2.12 Å, NH···O 157° and 168°; H···N 2.05 Å, NH···N 
161°) via  𝑅2
2(8)𝑅2
2(8) motifs to form 1:2 trimers (Figure 4.4).  
 
Figure 4.4 X-ray crystal structure of the [((Cu(azaDAT)(ClO4))2-μ-I):(barb)2]ClO4 hydrogen bonded (blue) 
trimer from P. V. Bernhardt et al.[11] Ellipsoids are drawn at 50%, barbitone ethyl groups and perchlorate  
anion hidden for clarity. 
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Barbitone molecules strongly hydrogen bond (H···O 2.00 Å, NH···O 172°) to the barbitone 
molecules of adjacent trimer units (Figure 4.5) via 𝑅2
2(8) motifs to form hydrogen bonded 
polymer chains down the crystallographic bc axis. Another way this can be conceptualised 
is as hydrogen bonded “tetrameric” units containing two barbitone molecules between 
two copper(II) cyclam units. These “tetramers” are then linked into chains through 
bridging iodide anions connecting adjacent copper complexes.  
 
Figure 4.5 Hydrogen bonding between adjacent barbitone molecules in the structure of 
[((Cu(azaDAT)(ClO4))2-μ-I):(barb)2]ClO4 from P. V. Bernhardt et al.[11] Ellipsoids are drawn at 50%, barbitone 
ethyl groups and perchlorate anion omitted for clarity. 
 
4.1.2 Literature ADA Containing Complexes 
4.1.2.1 Co-crystals Containing Biuret Based Complexes 
A bis-biuret nickel(II) complex, (Et4N)2[Ni(biuret)2], has been reported co-crystallised 
with two molecules of 6-phenyl-2,4-diamino-1,3,5-triazine, PhDAT.[6] The DAT moieties 
are strongly hydrogen bonded (H···O 2.20 and 2.05 Å, NH···O 152° and 171°; H···N 2.16 Å, 
NH···N 174°) to the biuret ligands via  𝑅2
2(8)𝑅2
2(8) motifs, to form 1:2 trimers (Figure 4.6). 
These trimers then pack together through additional NH···N hydrogen bonds as well as 
through weak offset π-π stacking (cent···N 3.74 Å) to form the overall structure. 
 
Figure 4.6 X-ray crystal structure of the [(Ni(biuret)2):(PhDAT)2] hydrogen bonded (blue) trimer from M. M. 
Bishop et al.[6] Ellipsoids are drawn at 50% and Et4N cations hidden for clarity. 
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4.1.2.2 Co-crystals Containing Orotic Acid Based Complexes 
Structures of platinum(II) and rhodium(I) complexes of orotic acid, co-crystallised with 
2,6-diaminopyridine, dapy, have been reported.[12-13] The platinum(II) complex, cis-
[Pt(dppe)(orotH):(dapy)]·2CHCl3, has the dianionic orotic acid ligand coordinating κ-N 
from the deprotonated imide nitrogen. Since the imide moiety of the orotic acid is blocked 
due to the coordination with the platinum ion, the dapy molecule strongly hydrogen bonds 
(H···O 2.06 and 2.02 Å, NH···O 154° and 159°; H···N 2.58 Å, NH···N 160°) to the side of the 
orotic acid (more typically involved in N^O type chelating) via a 𝑅2
2(8)𝑅2
2(9) motif. The 
rhodium(I) complex, Bu4N[Rh(cod)(orotH)]·CHCl3, has the orotic acid coordinating in the 
more typical N^O chelate, with the dapy molecule strongly hydrogen bonded (H···O 2.33 
and 2.08 Å, NH···O 131° and 161°; H···N 2.14 Å, NH···N 175°) to the imide portion of the 
orotic acid via a 𝑅2
2(8)𝑅2
2(8) motif (Figure 4.7). These dimers pack together through 
various hydrogen bonding interactions (H···O 2.05 and 2.11 Å, NH···O 154° and 165°; H···O 
2.72 Å, CH···O 157°).  
 
Figure 4.7 X-ray crystal structure of the [(Rh(cod)(orotH)):dapy]·2CHCl3 hydrogen bonded (blue) dimer from 
S. L. James et al.[13] Chloroform solvent molecules are hidden for clarity. 
4.1.2.3 Co-crystals Containing Maleimide and Hydantoin Based Complexes 
While most other ligands incorporate the triple hydrogen bonding motif into six 
membered rings (or six membered chelates), examples of ADA motifs in five membered 
rings are not uncommon with the maleimide and hydantoin moieties both containing 
imide like functional groups in planar five membered rings which are readily substituted 
to create ADA containing ligands like 2,3-dimercapto-maleimide or 2-pyridyl-
methylenehydantoin. A gold(III) complex of bis-2,3-dimercaptomaleimide, (melH)[Au(2,3-
dimercapto-maleimide)2], co-crystallised with the complementary organic molecule 
melamine has been reported.[14] Instead of forming 1:2 trimers, as is observed in the other 
co-crystallised bis complexes or the hydrogen bonded supramolecular hexagons 
predicated by the authors, one melamine hydrogen bonds (H···O 2.37 and 2.33 Å, NH···O 
165° and 169°; H···N 1.96 Å, NH···N 172°) to one of the maleimide ligands, while the other 
is involved in various NH···O hydrogen bonds to other melamine molecules, melamine 
cations, and hydrates present in the structure which, along with DMF solvent molecules, 




A copper(II) complex of bis-pyhy, [Cu(pyhy)2], also co-crystallised with melamine, has 
been reported.[15] Unlike the copper(II) bis-pyhy complex reported in Chapter 3, the co-
crystallised compound was obtained straight from a one pot mixture of melamine and free 
pyhyH with copper chloride in methanol. The co-crystal [(Cu(pyhy)2):(mel)2]·H2O, similar 
to the structure of the component copper complex, the copper(II) ion has a coordination 
geometry intermediate between tetrahedral and square planar (τ4 = 0.52, τ4’ = 0.46) and 
the pyhy ligands coordinating N^N through the pyridine and hydantoin nitrogens, with 
the imide free to engage in hydrogen bonding. The melamine units are strongly hydrogen 
bonded (H···O 2.23 and 2.32 Å, NH···O 167° and 178°; H···N 1.87 Å, NH···N 171°) to the 
ADA surface of the hydantoin via 𝑅2
2(8)𝑅2
2(8) motifs, forming the typical 1:2 trimers 
(Figure 4.8).  Adjacent melamine molecules form hydrogen bonded chains (H···N 2.14 Å, 
NH···N 173°) via 𝑅2
2(8) motifs along the crystallographic a axis. These chains are bridged 
by the copper(II) complexes via 𝑅2
2(8)𝑅2
2(8) hydrogen bonding motifs of the trimer units, 
forming corrugated sheets across the ac plane (Figure 4.9). These sheets then stack 
together through weaker NH···N and CH···N interactions, with channels of water 
molecules between the sheets down the crystallographic a axis. 
 
Figure 4.8 X-ray crystal structure of the [(Cu(pyhy)2):(mel)2] hydrogen bonded (blue) trimer from  
M. M. Chowdhry et al.[15] Water molecules hidden for clarity. 
 
Figure 4.9 Packing of hydrogen bonded [(Cu(pyhy)2):(mel)2] trimers (light green or pink copper complexes) 
into sheets across the ac plane via 𝑹𝟐
𝟐(𝟖) motif hydrogen bonding (magenta) between adjacent melamine 
molecules (light blue). Water molecules hidden for clarity. 
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The structures containing the five membered maleimide and hydantoin based ligands have 
longer NH···O hydrogen bonds (H···O 2.23 – 2.33 Å) and much shorter central NH···N 
hydrogen bonds (H···N 1.87 and 1.96 Å), to the complementary organic molecule, than in 
the structures of comparable compounds with six membered rings which tended to have 
NH···O and NH···N hydrogen bonds of more similar lengths around 2.0 – 2.1 Å. The 
different shape of the ADA motif due to the five membered ring is the major contributor to 
this difference in hydrogen bonding lengths but does not hinder their ability to engage in 
extended hydrogen bonding interactions. 
4.1.3 Complex:Complex Co-crystal Structures 
In terms of co-crystals containing two, triply hydrogen bonded, complexes, only one 
example is present in the CSD.[1] This structure is a co-crystal of two nickel(II) complexes, 
(Et4N)2[Ni(biuret)2], and [Ni(2-guanidinobenzimidazole)2], which was prepared by 
addition of a twofold excess of 2-guanidinobenzimidazole to a warm solution of 
(Et4N)2[Ni(biuret)2] in methanol, which was then left to evaporate.[9] Both complexes are 
square planar with the ADA or DAD hydrogen bonding motifs pointing in opposing 
directions. The two complexes strongly hydrogen bond (H···O 1.98 and 1.90 Å, NH···O 160° 
and 176°; H···N 2.13 Å, NH···N 173°) to each other via 𝑅2
2(8)𝑅2
2(8) motifs to form hydrogen 
bonded chains of alternating complexes (Figure 4.10). These chains then link together 
through NH···O hydrogen bonds (H···O 2.01 – 2.40 Å, NH···O 160° – 165°) from the 
guanidine and biuret ligands to the carbonyls of biuret ligands in adjacent chains, creating 
2D sheets. These sheets then pack together with the t-butyl ammonium ions creating 
layers between the sheets of hydrogen bonded nickel(II) complexes. 
 
Figure 4.10 X-ray structure of [(Et4N)2(Ni(biuret)2):(Ni(2-guanidinobenzimidazole)2)] from M. M. Bishop et 
al.[9] showing the hydrogen bonded 1D chains formed by alternating complexes. Ellipsoids drawn at 50% and  
Et4N+ anions hidden for clarity. 
A structure containing the complexes [Cu(bigu)2] and (PPh4)[Co(o-phenylenebisbiuret)(4-
phpy)2] obtained from an equimolar mixture of the two complexes in chloroform has been 
reported,[16] although the structure present in the CSD[1] lacked 3D coordinates. The co-
crystallised complexes were reported to form 1D chains through ADA:DAD hydrogen 




Figure 4.11 Hydrogen bonded 1D chains formed from a 1:1 mixture of [Cu(bigu)2] and (PPh4)[Co(o-
phenylenebisbiuret)(4-phpy)2] reported by Kitamura et al.[16] R = 4-phenylpyridine. 
There is also an unpublished structure of a triply hydrogen bonded complex:complex co-
crystal from D. A. McMorran,[17] which unlike the structure from Bishop et al., is both a 
discrete 1:2 trimer and heterometallic, with the co-crystal containing a bis-diarylbiguanide 
nickel(II) complex, [Ni(bigu)2], and two biuret palladium(II) complexes, 
[Pd(dppe)(biuret)], complexes (Figure 4.12). The co-crystal was obtained from an 
equimolar DMSO-d6 solution of the two complex components. Similar to the co-crystal of 
[(Ni(diOMebigu)2):(naph)2], the biuret moieties are strongly hydrogen bonded to the 
biguanide through NH···O and NH···N bonds (H···O 2.12 and 1.98 Å, NH···O 139° and 172°; 
H···N 1.85 Å, NH···N 179°) with weaker supporting CH···O interactions from the ortho 





1(6) motif.  
 
Figure 4.12 X-ray structure of [(Ni(bigu)2):(Pd(dppe)(biuret))2] from D. A. McMorran[17] showing the trimer 
formed through hydrogen bonding between the biuret and biguanide. Ellipsoids are drawn at 50%  
and solvents are hidden for clarity. 
4.1.4 Quantitative Analysis of Hydrogen Bond Geometry 
The geometry between two triply hydrogen bonded organic molecules is typically 
expected to be planar or close to planar. However it has been observed that when metal 
complexes are involved in triply hydrogen bonded co-crystals the geometry between the 
complementary moieties is non-planar, often to quite a large extent. While an angle can be 
readily calculated between the planes of the ADA and DAD motifs, this number is a 
combination of different distortions. To understand why these triply hydrogen bonded 
complexes have non-planar interactions, the distortion from planarity first needs to be 
calculated in both direction and magnitude.  
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4.1.4.1 Calculation of Geometry Terms 
To define the geometry between the two moieties, a method to represent the distortion 
from co-planar with four terms, τ, θ1, θ2, and φ was developed. The first three terms 
represent the distortion along three perpendicular axes, the twist (or torsion) between the 
moieties, the direct bend of one moiety out of the plane of the other, and the bend of one 
moiety within the plane of the other moiety, respectively. The final term represented the 
direct offset between the moieties. These terms were calculated through a variety of 
measurements made between specific atoms involved in the hydrogen bonding (Figure 
4.13) as well as a single plane, and single centroid, calculated from the hydrogen bonding 
moieties. 
 
Figure 4.13 Diagram of hydrogen bonding between a generic DAD moiety, A, (left) and ADA moiety, B, (right) 
with the objects (plane and centroid) and atoms key to calculating triple hydrogen bond geometry. 
The term φ is simply defined by equation 4.1, as the distance (in Å) from the central donor 
atom of the B moiety, to the plane that best represents the DAD motif of the A moiety. This 
gives a good gauge of how the two moieties are offset from each other, but will give larger 
than expected values if a large bend, θ1, is present. 
 𝜑 =  |𝑃𝑙𝑎𝑛𝑒𝐴 ⋯ 𝐵2| (4.1) 
To calculate the term θ1, which is the bend between the planes of moieties A and B (in °), 
without including the contribution from the twist, τ, equation 4.2 is used, which assumes 
any twist will be centred down the middle of the moiety B. A centroid, CentB, is generated 
behind atom B, such that a line drawn between B2 and CentB is perpendicular to a line 
drawn between B1 and B3. A right angle triangle can then be formed where θ1 is located at 
B2 and B2···CentB is the hypotenuse. The adjacent side is parallel to a line traced across 
PlaneA from the closest points of B2 and CentB, so cannot be readily measured. However 
this means the opposite side is the difference between the distances of B2 and CentB from 
the PlaneA which is easily calculated from the crystal structure. These values can then be 
applied to an inverse sine equation to calculate θ1.  
 𝜃1 =  sin
−1 (





To calculate the term θ2 (which is perpendicular to θ1), the bend within the planes of A and 
B (in °), equation 4.3 can be used. The difference is the distance between A1 and B1, and A3 
and B3, creates the opposite side, while the distance between A1 and A3 creates the 
adjacent side of a right angle triangle, where the angle formed represents the bend 
between A and B within the planes of the respective moieties. These values can then be 
applied to an inverse tan equation to calculate θ2.  
 𝜃2 = tan
−1 (
|(𝐴1 ⋯ 𝐵1) − (𝐴3 ⋯ 𝐵3)|
(𝐴1 ⋯ 𝐴3)
) (4.3) 
The term, τ, which is the twist between the planes of the moieties A and B (in °), can be 
calculated using equation 4.4, which compares the distances of B1 and B2 from the plane of 
A (where one term is negative if they are on opposite sides of PlaneA). The difference 
between these distances forms the opposite side of a right angle triangle where the 
distance between B1 and B3 forms the hypotenuse. Substituting these terms into an inverse 
sine equation, τ is calculated. 
 𝜏 = sin−1 (




4.1.4.2 Hydrogen Bond Geometries Observed in Literature Structures 
When applying equations 4.1 - 4.4 to the reported triply hydrogen bonded complex 
structures, values of up to 39.8° and 26.1° for θ1 and τ, respectively, are observed while θ2 
and φ are generally no higher than 1.5° and 0.60 Å, respectively. There are a few 
exceptions where θ2 and φ reach 4.4° and 1.50 Å, respectively (Table 4.9). A scatter plot of 
θ1 against τ (Figure 4.14) shows that the majority of structures have a mix of bending and 
twisting to a small (<5°) to moderate (<15°) degree, while the structures with a large bend 




Figure 4.14 Plot of the twists, τ, and bends, θ1, observed in the crystal structures of literature co-crystallised 
compounds. Complex:complex co-crystals from Bishop et al. and McMorran are shown in purple.  
An extreme case of a bent, θ1, geometry is the  structure of [(Ni(diOMebigu)2):(naph)2][8] 
in which the bend of 39.8° is clearly visible when observing the trimer from the side of the 
biguanide complex (Figure 4.15). The naphthalimide unit also has a moderate twist of 7.5° 
and a large offset of 1.50 Å although the large offset is actually an artefact of the extreme 
bend between the naphthalimide and biguanide units. In contrast, the structure of 
[(Ni(biuret)2):(PhDAT)2][6] has a large twist of 17.3° between the biuret and DAT moieties 
combined with a large bend of 15.0° both of which are visible when observing the trimer 
from the side of the bis-biuret complex (Figure 4.16).  There is also a small bend, θ2, of 1.2° 




Figure 4.15 X-ray crystal structure of [(Ni(diOMebigu)2):(naph)2] from D. A. McMorran et al.[8] showing the 
bend (θ1) of the naphthalimide units relative to the biguanide complex. Ellipsoids are drawn at 50%, 
methoxide groups hidden for clarity. 
 
Figure 4.16 4.17 X-ray crystal structure of [(Ni(biuret)2):(PhDAT)2] M. M. Bishop et al.[6] showing the twist 
(τ) and bend (θ1) of the DAT units relative to the biuret complex. Ellipsoids are drawn at 50% and Et4N cations 
hidden for clarity. 
Although the DAT moiety in the crystal structure of [((Cu(azaDAT)(ClO4))2-μ-
I):(barb)2]ClO4[11] is not directly coordinated to the copper(II), there is still a moderate 
twist of 12.7° between the DAT and the barbitone (Figure 4.18). When compared to the 
platinum(II) biguanide barbitone co-crystal (vida infra) the twisting is much less. There is 
also a small bend, θ1, of 5.0° and an offset of 0.21 Å between the two moieties. Adjacent 
barbitone molecules, which are hydrogen bonded via 𝑅2
2(8) motifs, are practically co-
planar.   
 
Figure 4.18 X-ray crystal structure of [((Cu(azaDAT)(ClO4))2-μ-I):(barb)2]ClO4 from P. V. Bernhardt et al.[11] 
showing the twist (τ) of the barbitone relative to the DAT unit while the two barbitone units are co-planar. 
Ethyl groups of the barbitone and the perchlorate anions are hidden for clarity. 
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The biuret and guanidine moieties of the complex:complex co-crystal 
[(Et4N)2(Ni(biuret)2):(Ni(guanibenzaimidazole)2][9] are relatively co-planar (Figure 4.19), 
especially when compared to similar complex:organic co-crystals (Figure 4.14), with θ1 
and τ of 4.9° and 2.9°, respectively. However, there is significant distortion between the 
nickel(II) and the coordinating nitrogens of the guanibenzaimidazole ligands likely due to 
steric repulsion between the ortho proton of the benzene ring and the guanidine of the 
other ligand. On the other hand, the unpublished structure of 
[(Ni(bigu)2):(Pd(dppe)(biuret))2][17] has a twist of 39.1°, more than 10° greater that the 
next closest structure (Table 4.9). This twist is clearly visible when viewing the trimer 
from the side of nickel(II) complex (Figure 4.20) with the aryl rings turned to optimise the 
CH···O interactions from the ortho aryl protons to the carbonyls of the biuret, much in the 
same manner as [(Ni(diOMebigu)2):(naph)2]  (Figure 4.15). The structure shows little in 
the way of other distortions with θ1, θ2, and φ of 3.2°, 0.0°, and 0.20 Å, respectively.  
 
Figure 4.19 X-ray structure of [(Et4N)2(Ni(biuret)2):(Ni(guanibenzaimidazole)2)] from M. M. Bishop et al.[9] 
showing the slight bend between adjacent complexes, and distortion around the nickel(II) ions. Ellipsoids 
drawn at 50% and Et4N+ anions hidden for clarity. 
 
Figure 4.20 X-ray structure of [(Ni(bigu)2):(Pd(dppe)(biuret))2] from D. A. McMorran[17] showing the 
significant twist between the biuret and biguanide units. Ellipsoids are drawn at 50% and solvents  
are hidden for clarity. 
This non-planarity between complexes (containing ADA or DAD type hydrogen bond 
motifs) and complementary species, both organic and complex, is likely due to a couple of 
factors. Preliminary calculations indicate that the planar geometry is also not optimal for 
the three simultaneous hydrogen bonds, and that the maximum attractive interactions of 
the hydrogen bonding occurs at geometries offset from co-planar.[18] In part the non-
planarity could also be attributed to crystal packing forces, which can variety greatly 
depending on the coordination of complex(s) present in the structure as well as the 
different ancillary ligands and/or counter ions. 
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4.2 Organic-Complex Assemblies 
4.2.1 Introduction 
The series of ADA and DAD containing complexes discussed in chapters two and three 
were designed to form triply hydrogen bonded co-crystals with complementary organic 
molecules in the same manner as the co-crystals that have been previously reported in the 
literature, as well as with each other (vide infra). The organic molecules with ADA motifs 
which were chosen were 4-dimethyl-aminonaphthalimide, dmaNaph; barbitone, barb; 
and phthalimide (Figure 4.21). While naphthalimide was present in a number of reported 
co-crystals, it suffers from low solubility in many common organic solvents which limits 
the variety of solvent combinations which can be used for crystallisation. Instead, the 
dimethylamino substituted form, dmaNaph, was synthesised from napthalic anhydride 
following a two-step literature procedure.[19] This substituted form of naphthalimide has 
much better solubility giving a better range of solvents to choose from for co-
crystallisation processes. Phthalimide was chosen given its comparable structure to 
naphthalimide, but with the imide ADA motif contained within a five membered ring, 
rather than a six membered ring, hopefully to observe any difference, or lack thereof, 
between the co-crystals. Barbitone was chosen due to its presence of two ADA motifs at 
~60° to each other, which could either bridge two DAD containing complexes forming 
trimers, or, like in the case of [((Cu(azaDAT)(ClO4))2-μ-I):(barb)2]ClO4, could hydrogen 
bond to an adjacent barbitone:complex pair, forming tetrameric units. Both phthalimide 
and barbitone were commercially available and used as purchased.  
 
Figure 4.21 Organic molecules containing ADA triple hydrogen bonding motifs used for co-crystallisation with 
complementary DAD containing complexes in this work. 
Organic molecules with DAD hydrogen bonding motifs that have been observed to co-
crystallise with complementary, ADA containing, complexes, have been limited to 
melamine, mel, or the melamine like molecules 6-phenyl-2,4-diamino-1,3,5-triazine, 
PhDAT; and 2,6-diaminopyridine, dapy (Figure 4.22). Melamine suffers from a lack of 
solubility in most organic solvents which can make it troublesome for readily co-
crystallising with complementary complexes. In this work only PhDAT was used due to its 
similarity to melamine, but was preferable since it only contained a single DAD motif 
(compared to melamine’s three) and had reasonable solubility due to the phenyl group, 




Figure 4.22 Organic molecules containing ADA triple hydrogen bonding motifs used for co-crystallisation with 
complementary DAD containing complexes. Only PhDAT was used in this work. 
4.2.2 Attempted Organic-Complex Co-crystallisations 
Crystallisation, of even a single species, is still largely a process of trial and error, with co-
crystallisation of two different compounds being even more so. Obtaining X-ray quality 
crystals is dependent on a large variety of factors including the method, solvent and anti-
solvent choice, rate of diffusion or solvent mixing, concentration of compounds, and the 
molar ratio of the complementary species. Solvents typically used were chloroform or 
acetonitrile but included other solvents such as DMF and DMSO (among others), while 
typical anti-solvents were diethyl or diisopropyl ether but included other solvents from 
petroleum ether to butanol.  
4.2.2.1 Co-crystallisation Methods 
There were a few different methods used for attempting co-crystallisations between 
complementary organic and complex molecules. The major method used was vapour 
diffusion, where the two complementary compounds were mixed together into a single 
solution (either equimolar or with the organic species in excess), which a more volatile 
anti-solvent, which is miscible with the initial solvent, diffuses into (Figure 4.23). The 
initial solvent is usually placed in a small sample tube which is then placed inside a larger 
sample tube containing a volume of anti-solvent. The assembly is sealed and kept at room 
temperature in the absence of light. As the anti-solvent diffuses into the initial solvent the 
slow change in solvent mixture will slowly decrease the solubility of the species within, 
giving a chance for crystals to form. The choice of solvent and anti-solvent can both affect 
the chance of crystallisation as well as the crystal formed (due to potential inclusion of 
solvents into the crystal lattice), with the rate of diffusion, concentration of the initial 
solution, and the ratio of solvent to anti-solvent after diffusion all potentially affecting the 
crystallisation. 
 
Figure 4.23 Initial setup of a vapour diffusion jar (left) and a similar jar after diffusion has occurred (right).  
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A closely related method is that of solvent diffusion; where the anti-solvent is carefully 
layered with the initial solution before being left to allow the two solvents to slowly mix 
with each other (Figure 4.24). This method is typically used if the anti-solvent is not 
volatile enough to readily diffuse across into the solution or if the initial solvent is more 
volatile than the anti-solvent. It can also be used in cases where the two solvents are non- 
or only slightly miscible, in which case crystallisation would be expected to occur at the 
interface of the two solvents. Vapour diffusion is typically favoured over solvent diffusion 
due to the difficulty of successfully layering solvents together and the slower rate at which 
diffusion via vapour occurs giving more time for quality crystals to form. 
 
Figure 4.24 Initial setup of a solvent diffusion jar (left) and a similar jar after diffusion has occurred (right). 
Alternatively the two compounds to be co-crystallised can be made up in different 
solutions and slowly mixed together, either by layering the two solutions, which works 
best when the solubility of the resulting co-crystallised compound is expected to be much 
less than of its component parts in either solvent used, or by placing one compound in a 
smaller sample tube within a larger sample tube containing the solution of the 
complementary compound (much like the solvent and anti-solvent in vapour diffusion 
setups) with a third solvent layered over both solutions to act both as a bridge and as an 
anti-solvent. This method allows the same solvent to be used for the initial solutions of 
both compounds but requires the third solvent to be one in which the separate 
components of the co-crystals are at least semi-soluble and the final co-crystallised species 
is not (although the third solvent can be either, miscible or non-miscible with the initial 
solutions). This method tends to require higher initial concentrations of the 
complementary species since the final concentration of the mixture is usually over a much 
larger volume and if that concentration is too low quality crystals may not form. 
The final method used was reverse vapour diffusion, where the complementary 
compounds are dissolved in a mixed solution of volatile solvent and non-volatile anti-
solvent, and the solvent is allowed to evaporate out of the mixed solution (Figure 4.25). 
This slowly changes the properties of the solution (hopefully) allowing crystal formation.  
Additionally, the complementary compounds can be dissolved together in a single solvent 
which is allowed to slowly evaporate away, giving crystals as the concentration of the 




Figure 4.25 Initial setup of a reverse vapour diffusion jar (left) and a similar jar after diffusion has occurred 
(right). 
4.2.2.2 Co-crystallisation Jars with DAD Containing Complexes 
Due to their low solubility, the series of palladium(II) diarylbiguanide complexes, 
described in Chapter 2, were not used for co-crystallisation with complementary organic 
molecules. The series of platinum(II) diarylbiguanide complexes were (in general) readily 
soluble in chloroform and solutions with both equimolar and excess amounts of dmaNaph 
were made up into vapour diffusion jars using diethyl, diisopropyl, and petroleum ethers 
as anti-solvents. Chloroform solutions of the platinum(II) diarylbiguanide complexes with 
two molar equivalents and excess amounts of barb were also made into vapour diffusion 
jars with the same collection of ethers used as anti-solvents. Crystal jars of diethyl ether 
into a chloroform solution of [Pt(ppy)(diOMebigu)] and dmaNaph; and of petroleum 
ether into a chloroform solution of [Pt(ppy)(tBubigu)] and dmaNaph; as well as 
diisopropyl ether into a chloroform solution of [Pt(ppy)(bigu)] and barb all yielded X-ray 
quality crystals. Crystal jars of diisopropyl ether into chloroform solutions of 
Pt(ppy)(Brbigu)] and dmaNaph as well as Pt(ppy)(tBubigu)] and barb yielded 
crystalline material, but no single crystals of sufficient quality to give structures were 
found during screening.  
Table 4.1 Co-crystallisation mixtures involving complexes of the type [Pt(ppy)(bigu)] and complementary 
organic molecules. 
 Vap. Diff. Evap. 
dmaNaph 
Et2O into CHCl3 
iPr2O into CHCl3 
PET into CHCl3 
CHCl3 
Barb 
Et2O into CHCl3 
iPr2O into CHCl3 
PET into CHCl3 
- 
The ruthenium(II) complex [Ru(bpy)2(BtpD)](PF6)2 and its deuterated analogue 
[Ru(bpy)2(BtpD-d3)](PF6)2 are not chloroform soluble and acetonitrile was initially used 
for co-crystallisation (since ethers into acetonitrile commonly give X-ray quality crystals of 
ruthenium(II) bis-bipyridine complexes). Acetonitrile solutions of the ruthenium(II) 
complexes with equimolar and excess amounts of dmaNaph were made up into vapour 
diffusion jars using diethyl  and diisopropyl ethers as anti-solvents. The diethyl ether into 
acetonitrile jars repeatedly gave tiny crystalline needles but none were ever found which 
were large enough to collect sufficient diffraction data. Crystal jars of diisopropyl ether 
into acetonitrile solutions of [Ru(bpy)2(BtpD)](PF6)2 and dmaNaph also gave poor quality 
crystals of the ruthenium(II) complex which gave a low quality structure very similar to 
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the structure of [Ru(bpy)2(BtpD-d3)](PF6)2 (Section 2.2.2). Vapour diffusion jars using 
mixtures of the ruthenium(II) complexes in acetonitrile and dmaNaph in either 
chloroform or dichloromethane were made up once again using diethyl  or diisopropyl 
ether as the anti-solvents. Poor quality crystals were obtained from the diethyl ether into 
the acetonitrile/chloroform jars which, on screening, had the same unit cell as the 
[Ru(bpy)2(BtpD)](PF6)2 crystals collected from the diisopropyl ether into acetonitrile 
crystal jars. No crystals of co-crystallised compounds were obtained and crystal jars with 
barb were not made up due to a limited amount of pure ruthenium(II) complexes 
synthesised, the bulk of which had been used for complex-complex co-crystallisations 
(vide infra). 
Table 4.2 Co-crystallisation mixtures involving [Ru(bpy)2(HtpD)](PF6)2 and complementary organic 
molecules. 



















The ruthenium(II) complex [Ru(bpy)2(HtpD)](PF6)2, like its BtpD counterparts, is not 
chloroform soluble, so solutions of the complex with equimolar and excess amounts of 
dmaNaph or phthalimide were made up in acetonitrile as well as in mixtures of 
acetonitrile and chloroform for vapour diffusion jars using diethyl  or diisopropyl ether as 
the anti-solvent. Reverse vapour diffusion crystal jars using [Ru(bpy)2(HtpD)](PF6)2 with 
equimolar amounts of dmaNaph or phthalimide in a solution of acetonitrile and butanol 
were also made up as well as evaporation jars using DMF or acetonitrile as the solvent. 
While no co-crystallised structures were obtained, the vapour diffusion jars regularly gave 
X-ray quality crystals which on screening gave unit cells identical to that of the 
[Ru(bpy)2(HtpD)](PF6)2·CH3CN complex (Section 2.2.2). The reverse vapour diffusion and 
slow evaporation jars failed to give any crystalline material. 
Table 4.3 Co-crystallisation mixtures involving [Ru(bpy)2(BtpD-d3)](PF6)2 and Complementary organic 
molecules. 
 Vap. Diff. Evap. 
dmaNaph 
Et2O or iPr2O into CH3CN 
Et2O or iPr2O into CHCl3/CH3CN 




No crystal jars of the iridium(III) BtpD or HtpD complexes (Section 2.2.3) with 
complementary organic molecules were made due to the bulk of the synthesised 
complexes going towards complex-complex co-crystal jars (vide infra) with the remaining 
material used for characterisation and attempts to crystallise the complexes without 
complementary hydrogen bonding molecules present.  
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4.2.2.3 Co-crystallisation Jars with ADA Containing Complexes 
Mixed acetonitrile/chloroform solutions of the ruthenium(II) complex, 
[Ru(bpy)2(pyhy)]PF6, with equimolar and excess amounts of the complementary molecule 
PhDAT were made up into vapour diffusion jars with diethyl or diisopropyl ether used as 
the anti-solvent. DMSO solutions of the same combination of species were also made up 
into vapour diffusion jars, using ethyl acetate, diisopropyl ether, or water as the anti-
solvent. Solvent diffusion jars were also made up by layering varying volumes of water on 
the DMSO solutions and reverse vapour diffusion jars using the same acetonitrile and 
butanol mixtures of solvents as the ruthenium(II) BtpD and HtpD co-crystallisation jars. 
Finally, solutions of [Ru(bpy)2(pyhy)]PF6 and PhDAT in DMF were used for slow 
evaporation crystallisation experiments. No co-crystal structures were obtained through 
any of these methods although diffusion of diisopropyl ether into the 
acetonitrile/chloroform mixed solutions gave poor quality crystals which were resolved to 
give an alternative [Ru(bpy)2(pyhy)]PF6 structure containing chloroform and diisopropyl 
ether solvent molecules rather than the acetonitrile solvents of the reported structure 
(Section 3.2.2).  
Unlike the other ruthenium(II) complexes, the neutral complex [Ru(bpy)2(orotH)] has 
limited solubility so only DMSO solutions with equimolar or excess amounts of PhDAT 
were made up into vapour diffusion jars, using ethyl acetate, diisopropyl ether, or water as 
the anti-solvent. A solvent diffusion jars were also made up using water layered with 
DMSO solutions. The iridium(III) complex nBu4N[Ir(ppy)2(orotH)] was also made up into 
solvent diffusion crystal jars with water layered on a DMSO solution of the iridium(III) 
complex with PhDAT, as well as having the aqueous, sodium salt intermediate, 
Na[Ir(ppy)2(orotH)] (which was never isolated), layered with a chloroform solution of 
PhDAT. Unfortunately, none of these jars yielded any sort of crystalline material. 
4.2.3 Dimethylaminonaphthalimde Co-crystals 
As mentioned in Subsection 4.2.2.2, X-ray quality crystals of 
[(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 were obtained from diffusion of diethyl ether into a 
mixed solution of [Pt(ppy)(tBubigu)] and dmaNaph in chloroform, while X-ray quality 
crystals of [(Pt(ppy)(diOMebigu)):dmaNaph] were obtained from diffusion of petroleum 
ether into the similar mixed solution of  [Pt(ppy)(diOMebigu)] and dmaNaph in 
chloroform. Unlike the existing co-crystal structures of biguanide and guanidine 
complexes with imide containing organic molecules, all of which form 1:2 trimer units, the 
two co-crystals obtained are discrete 1:1 dimers. 
4.2.3.1 X-ray Crystallography 
[(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 crystallises in the triclinic space group 𝑃1̅ with the 
asymmetric unit containing a single molecule of both [Pt(ppy)(tBubigu)] and dmaNaph, 
as well as a disordered chloroform solvent (Figure 4.26). As in the structure of 
[Pt(ppy)(diFbigu)]·2DMF, the platinum ion of the [Pt(ppy)(tBubigu)] molecule is square 
planar with the tBubigu ligand coordinating N^N through N1 and N3, and the  
2-phenylpyridine ligand coordinating N^C, with a substitutional disorder of the 
coordinating atoms, which upon refinement was found to have a ratio of 81:19. The 
tBubigu ligand is in the anti-anti conformation with the angle between the aryl rings 
being 83.5° and their angles relative to the PtN3C coordination plane being 54.4° and 49.2°, 
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respectively. The anti-anti conformation of the diarylbiguanide ligand exposes the 
biguanide core with a DAD type motif, to which the dmaNaph is strongly hydrogen 
bonded, with two NH···O hydrogen bonds between O1 and H4A, and O2 and H5A (H···O 
1.66 and 1.94 Å, NH···O 163° and 158° respectively), as well as a NH···N hydrogen bond 
between N2 and N7A (H···N 2.09 Å, NH···N 173°), giving a 𝑅2
2(8)𝑅2
2(8) between the two 
molecules. There is an additional weak supporting CH···O interaction from H8 to O1 (H···O 




motif. The second biguanide aryl ring is rotated too far out of plane of the biguanide for its 
ortho proton to be involved in a second supporting CH···O interaction, and instead is 
involved in a weak CH···Cl type interaction to Cl1B of the chloroform solvent (H···Cl 2.95 Å, 
CH···Cl 174°).  
 
Figure 4.26 X-ray crystal structure of [(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3. Ellipsoids are drawn at 50% and 
only major components of disorder are shown. 
[(Pt(ppy)(diOMebigu)):dmaNaph] crystallises in the monoclinic space group C 2/c with 
the asymmetric unit containing a single molecule of both [Pt(ppy)(diOMebigu)] and 
dmaNaph. The platinum ion of the [Pt(ppy)(diOMebigu)] molecule is square planar with 
the diOMebigu ligand coordinating N^N through N1 and N3, and the  2-phenylpyridine 
ligand coordinating N^C, with a substitutional disorder of the coordinating atoms, which 
upon refinement was found to have a 60:40 ratio. As in the structure of 
[(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3, the diOMebigu ligand is in the anti-anti 
conformation, although the angle between the aryl rings is less at 38.6° and their angles 
relative to the PtN3C coordination plane are 32.4° and 40.3°, respectively. The anti-anti 
conformation of the diarylbiguanide ligand once again exposes the biguanide core with a 
DAD type motif, to which the dmaNaph is strongly hydrogen bonded. There are two 
NH···O hydrogen bonds between O5 and H4A, and O6 and H5A (H···O 2.10 and 1.91 Å, 
NH···O 162° and 164° respectively), and a NH···N hydrogen bond between N2 and N7A 
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(H···N 2.28 Å, NH···N 158°), giving a 𝑅2
2(8)𝑅2
2(8) between the two molecules. In this case 
no chloroform solvent molecules were present in the structure and both aryl rings were at 
the correct angle, relative to the naphthalimide molecule, to provide supporting CH···O 
interactions from H8 to O5 and H16 to O6 (H···O 2.38 and 2.69 Å, NH···O 140° and 123° 







Figure 4.27 X-ray crystal structure of [(Pt(ppy)(diOMebigu)):dmaNaph]. Ellipsoids are drawn at 50% and 
only major component of disorder is shown. 
4.2.3.2 Packing Structures 
Hydrogen bonded [(Pt(ppy)(tBubigu)):dmaNaph] pairs stack together down the 
crystallographic b axis into ‘tetrameric’ units via three sets of π-type interactions. The C5N 
ring and the PtC3N chelate ring stack with the naphthalimide unit of an adjacent pair 
(cent···cent 3.41 Å, cent···C 3.50 Å) which in turn forms an offset π-π stacking interaction 
with a second naphthalimide unit (cent···C 3.51 Å) which again stacks with an additional 
ppy ligand of the fourth [(Pt(ppy)(tBubigu)):dmaNaph] pair to give the overall ‘tetramer’ 
(Figure 4.28). There is also a series of weak CH···N type interactions (H···N 2.74 – 2.83 Å, 
CH···N 117° - 158°) supporting the packing of these units together. The ‘tetramers’ link 
together with shared naphthalimide units as well as additional offset π-π interactions 
between the C5N of adjacent ppy ligands (cent···C 3.26 Å) to form sheets of  molecules in 
the bc crystallographic plane. Sheets are then linked together through various weak 




Figure 4.28 Packing of hydrogen bonded (blue) pairs of [(Pt(ppy)(tBubigu)):dmaNaph] into ‘tetrameric’ 
stacks through weak CH···N interactions (magenta) and π-π/π-chelate interactions (green). Chloroform 
solvent molecules and tert-butyl groups hidden for clarity. 
The methyl groups of the naphthalimide unit of [(Pt(ppy)(diOMebigu)):dmaNaph] 
facilitate the formation chains down the crystallographic a axis through weak CH···N 
hydrogen bonds (H···N 2.71 Å, CH···N 128°) and CH···Pt anagostic interactions[20] (H···Pt 
2.91 Å, CH···Pt 166°) (Figure 4.29). Chains then pack into sheets across the ac plane via 
𝑅2
2(8) motifs involving one of the methoxide substituents of the diOMebigu ligands with 
the methoxide substituents of adjacent chains (H⋯O 2.42 Å, CH⋯O 167°). Unlike in the 
structure of [(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3, there are no π-type interactions 
facilitating the packing of the molecules in the crystal (the dmaNaph molecules do not 
approach closer than 3.73 Å, with no overlap), which is interesting given that both the 
naphthalimide and the platinum complex have large π surfaces which are typically ideal 
for π-π stacking interactions.  
 
Figure 4.29 Packing of hydrogen bonded (blue) pairs of [(Pt(ppy)(diOMebigu)):dmaNaph] into chains down 
the crystallographic a axis through weak CH···N and CH···Pt interactions (magenta). 
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4.2.3.3 Hirshfeld Analysis 
Hirshfeld surfaces of [(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 were generated using not 
only the asymmetric unit where the platinum complex, dmaNaph molecule, and 
chloroform solvent are in hydrogen bonded positions but also of the structure where the 
fragments had been separated from each other. By comparing the fingerprint plots from 
these two different surfaces, the strong hydrogen bonding interactions between the 
fragments can be isolated from the interactions facilitating the packing of the hydrogen 
bonded pairs. The H···N and H···O interactions between the two surfaces are of particular 
interest (Figure 4.30). The surface generated from the asymmetric unit was observed to 
have diffuse interactions, with the H···O fingerprint plot showing no close approaches, and 
the closest approaches observed in the H···N plot being no less than 2.6 Å. This is 
consistent with the interactions observed in the packing of the crystal structure which was 
dominated by π-type interactions with supporting H···N, and H···Cl type hydrogen bonding 
interactions. In contrast, when the surface is generated from separated fragments the 
fingerprint plots of the H···N and H···O interactions (Figure 4.30) show sharp, close 
approaching interactions, which are indicative of strong directional interactions, 
consistent with the tight hydrogen bonding observed between the biguanide and 
naphthalimide moieties. The H···N and H···O interactions make up 4.6% and 5.2% of the 
total surface interactions, respectively, with the fragments of the structure separated, but 
when packing interactions are accounted for† the triple hydrogen bonding interaction only 
accounts for 0.5% and 3.9% of the intermolecular surface interactions, from H···N and 
H···O interactions respectively.  
                                                             
† By assuming the absolute amount of C···H interactions is constant between the two different surfaces 
generated, the resulting ratio‡ of 0.904 can be calculated and used to account for the 4.5% and 1.4% of H···N 
and H···O interactions present in the asymmetric unit surface, in the surface of the separated units. 
 
‡  𝑟𝑎𝑡𝑖𝑜 =  
%𝐻−𝐻 𝑖𝑛𝑡𝑒𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑠 𝑜𝑓 𝑠𝑒𝑝𝑒𝑟𝑎𝑡𝑒𝑑 𝑚𝑜𝑖𝑒𝑡𝑖𝑒𝑠








Figure 4.30 Hirshfeld fingerprint plots for H-N (left) and H-O (right) intermolecular interactions in 
[(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 calculated using the complete asymmetric unit (top) or with  
the dmaNaph molecule separate from the platinum complex (bottom) 
Hirshfeld surfaces for [(Pt(ppy)(diOMebigu)):dmaNaph] were generated in the same 
way as for [(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3. The fingerprint plots from these two 
differently generated surfaces can be compared to identify the strong hydrogen bonding 
interactions between the fragments from the interactions facilitating the packing of the 
hydrogen bonded pairs by comparing the difference in the H···N and H···O interactions 
between the two surfaces (Figure 4.31). The fingerprint plots generated from the full 
asymmetric unit contain some concentrated peaks especially in the H···O interactions 
which correspond to the CH⋯O hydrogen bonding interactions between the methoxide 
groups of the diOMebigu ligand and adjacent aromatic protons. The H···N and H···O 
interactions make up 7.0% and 9.8% of the total intermolecular surface, respectively, with 
an additional 1.6% from H···Pt interactions. The fragmented surface has more 
concentrated peaks in the H···N and H···O fingerprint plots with the closest interactions 
less than 2.3 and 2.0 Å, respectively, which is consistent with the tight hydrogen bonding 
observed between the biguanide and naphthalimide moieties. In the fragmented surface 
H···N and H···O interactions make up a significant (7.5% and 13.9% respectively) portion 
of the intermolecular interactions, although when packing interactions are accounted for 
(in the same method as above) the hydrogen bonding motif accounts for 1.2% and 5.1% of 




Figure 4.31 Hirshfeld fingerprint plots for H-N (left) and H-O (right) intermolecular interactions in 
[(Pt(ppy)(diOMebigu)):dmaNaph] calculated using the complete asymmetric unit (top) or with the  
dmaNaph molecule separate from the platinum complex (bottom) 
While these calculated interaction percentages between the full asymmetric units and the 
separated moieties might not be fully accurate, (especially when the chloroform fragment 
is present potentially complicating the calculation) they are representative of how little of 
the total surface of the molecules are involved in even a strong hydrogen bonding 
interaction. With this in mind, other intermolecular interactions need to be considered 
carefully when attempting to co-crystallise molecules through complementary hydrogen 
bonding surfaces. 
4.2.3.4 Hydrogen Bond Geometry 
Like many of the other complex:organic co-crystallised structures present in the  
literature, the structures of both [(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 and 
[(Pt(ppy)(diOMebigu)):dmaNaph] show significant deviation from a planar geometry 
between the biguanide and naphthalimide units (Table 4.4). The most significant deviation 
in the structure of [(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 was the twist, τ, of 23.8° 
between the biguanide and naphthalimide unit which is clearly visible in the crystal 
structure (Figure 4.32), where the biguanide protons H4A and H5A are bent out of the 
plane of the biguanide to achieve better hydrogen bonding interactions with O1 and O2, 
respectively. These protons were placed according to electron density and refined with 
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riding models, where possible, rather than through calculated and constrained positions, 
which tended to fix the protons into less favourable geometries. This twist is much higher 
than most of the literature structures and when compared to a structure with a similar 
degree of twisting, the structure of [(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 has a higher 
degree of bend, θ1, at 6.3° to the 2.0° of the similar structure (Figure 4.34).   
 
Figure 4.32 X-ray crystal structure of [(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 showing the geometry between 
the biguanide and naphthalimide units. Chloroform solvent and aryl groups of the tBubigu ligand hidden for 
clarity. 
In contrast, the structure of [(Pt(ppy)(diOMebigu)):dmaNaph] shows a significant bend, 
θ1, of 29.6° of the naphthalimide molecule out from the plane of the biguanide (Figure 
4.33). Both biguanide protons H4A and H5A are bent upwards to the naphthalimide and 
the aryl rings are twisted to very similar angles with H8 involved in a strong CH···O 
hydrogen bond to O5, where the twist between the molecules, which is not insignificant at 
10.0°, pulls O6 down and away from H16, weakening the supporting CH···O hydrogen 
bond. The bend of 29.6° is the second highest observed when compared to the literature 
structures and when compared to other high bend (>20°) structures has the highest twist 
(Figure 4.34). Similar to the previously reported diarylbiguanide co-crystal (Figure 4.15), 
one of the aryl rings is twisted to optimise the CH···O hydrogen bond from the ortho 
proton to the naphthalimide, while the other is involved in a less than ideal CH···O 
hydrogen bond, likely since the positioning of the naphthalimide relative to the biguanide 
would require the aryl ring to be co-planar with the biguanide which would be sterically 
unfavourable due to the proton on the closest coordinating nitrogen.  
 
Figure 4.33 X-ray crystal structure of [(Pt(ppy)(diOMebigu)):dmaNaph] showing the geometry between the 




Figure 4.34 Plot of the twists, τ, and bends, θ1, observed in the crystal structures of literature and dmaNaph 
containing co-crystallised compounds 
 
4.2.4 Barbitone Co-crystal 
As mentioned in Subsection 4.2.2.2, X-ray quality crystals of [(Pt(ppy)(biguH)):(barb-
H)]·CHCl3 were obtained by diffusion of diisopropyl ether into a 2:1 chloroform solution of 
[Pt(ppy)(bigu)] and barbitone. During crystallisation, proton transfer occurred from N7 of 
the barbitone to N2 of the biguanide. This was not observed the similar co-crystal of 
[((Cu(azaDAT)(ClO4))2-μ-I):(barb)2]ClO4 (Figure 4.4), which involves a DAT rather than a 
biguanide moiety, nor was it observed in the co-crystal structures of dmaNaph and the 
platinum(II) complexes. In theory, the pKa rule for acid-base crystalline complexes can be 
used to predict if an proton transfer will occur.[21] Barbitone is nominally more acidic than 
naphthalimide (pKa 7.98 and 9.44, respectively),[22-23] so observing a proton transfer in the 
[(Pt(ppy)(biguH)):(barb-H)]·CHCl3 co-crystal but not in either of the 
[(Pt(ppy)(bigu)):dmaNaph] co-crystals is not surprising. Not seeing proton transfer in the 
structure of [((Cu(azaDAT)(ClO4))2-μ-I):(barb)2]ClO4 suggests that the acceptor nitrogen 
of the biguanide complex is a stronger base than that of the DAT moiety, likely due to the 
proximity of the metal ion to the biguanide’s hydrogen bonding surface. The pKa’s of the 
conjugate acids of both the biguanide and DAT moieties could be estimated through the 
pKa rules, although it should be noted that pKa values are highly solvent dependent and 
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there is limited data for pKa values in solvents other than water, and are rare in mixed 
solvents. Any comparison of co-crystal structures with respect to pKa and proton transfer 
should considered carefully since crystallisation typically occurs in mixed solvent 
solutions. The DDD:AAA triple hydrogen bonding interaction in the co-crystal 
[(Pt(ppy)(biguH)):(barb-H)]·CHCl3 is unique in terms of metal containing co-crystals, 
with no similar examples found in the CSD.[1] 
4.2.4.1 X-ray Crystallography 
[(Pt(ppy)(biguH)):(barb-H)]·CHCl3 crystallises in the monoclinic space group P 21/c with 
the asymmetric unit containing a single molecule of both the protonated [Pt(ppy)(biguH)] 
and deprotonated barb-H as well as a chloroform solvent (Figure 4.26). The platinum ion 
is square planar as expected with the biguH ligand coordinating N^N through N1 and N3, 
and the 2-phenylpyridine ligand coordinating N^C with a substitutional disorder of the 
coordinating atoms, which upon refinement was found to have a ratio of 50:50. The 
biguanide moiety has alternate long and short N-C bond around the chelate ring (1.36 and 
1.36 Å, and 1.30 and 1.31 Å), like the charged complex [Pt(ppy)(tBubiguH)]OAc, which 
supported protonation of the biguanide ligand.  
 
Figure 4.35 X-ray crystal structure of [(Pt(ppy)(biguH)):(barb-H)]·CHCl3. Ellipsoids are drawn at 50% and 
only major component of disorder is shown. 
Like in the dmaNaph co-crystals, the biguH ligand is in the anti-anti conformation with 
angle between the planes of the aryl rings being 87.4° and their angles relative to the 
PtN3C coordination plane being 52.0° and 43.5°, respectively. The biguanide has a triple 
hydrogen bonding surface which is of a DDD type due to the protonation of N2. The 
deprotonated barbitone molecule is strongly hydrogen bonded to this surface through two 
NH···O hydrogen bonds between H5A and O1, and H4A and O2 (H···O 2.18 and 2.00 Å, 
NH···O 166° and 175° respectively), as well as a NH···N hydrogen bond between H2A and 
N7 (H···N 1.94 Å, NH···N 173°), giving a 𝑅2
2(8)𝑅2
2(8) motif. The ortho aryl protons H4 is 
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involved in a weak supporting CH···O hydrogen bond to O1 (H···O 2.81 Å, CH···O 135°), 
giving an overall 𝑅2
1(6)𝑅2
2(8)𝑅2
2(8) motif. The chloroform solvent is involved in a strong 
CH···O hydrogen bonding interaction with O1 (H···O 2.08 Å, CH···O 176°). The ethyl groups 
of the barbitone molecules are also secured with weak CH···O and CH···N type interactions 
from H33C to O1 (H···O 2.74 Å, CH···O 114°), H33B to O3 (H···O 2.86 Å, CH···O 113°), and 
H31B to N7 (H···O 2.89 Å, CH···O 118°). 
4.2.4.2 Packing Structure 
The barb-H molecule also contains a second, ADA type, hydrogen bonding surface which 
hydrogen bonds with an adjacent barb-H molecule in another [(Pt(ppy)(biguH)):(barb-
H)] unit to bring them together through strong NH···O hydrogen bonds between H8A and 
O2 (H···O 1.98 Å, NH···O 175°) via a 𝑅2
2(8) motif to form a tetrameric unit (Figure 4.36). 
This unit is comparable to the pseudo tetrameric unit that [((Cu(azaDAT)(ClO4))2-μ-
I):(barb)2]ClO4 forms (Figure 4.5). This interaction is supported by weaker CH···O 
interactions from H10 to O3 (H···O 2.53 Å, CH···O 154. These the hydrogen bonding 














2(8) motifs of the biguH:barb-H hydrogen bonding, the 𝑅2
2(8) motif between 
two adjacent barb-H molecules, and 𝑅3
2(10) motifs bridging between two barb-H 
molecules and a biguH complex.  
 
Figure 4.36 Hydrogen bonded tetramer formed from two [(Pt(ppy)(biguH):(barb-H)] units. Hydrogen bonds 
present within the units shown in blue while those between the units are shown in magenta. Chloroform 
solvent molecules and ethyl-groups of barb-H molecules hidden for clarity. 
Within the crystal structure, platinum complexes form zig-zag stacks through chelate-
chelate interactions (cent···cent 3.64 Å) that alternate from the biguanide to the  
2-phenylpyridine chelate rings (Figure 4.37).  These stacks are supported by weaker 
CH···O interactions from H18 to O3 and H19 to O2 (H···O 2.94 and 2.92 Å, CH···O 124° and 
161°, respectively). This stacking along with the hydrogen bonding into tetramers packs 
the units into sheets across the crystallographic bc plane (Figure 4.38). These planes then 




Figure 4.37 Zig-zag stacks of hydrogen bonded (blue) [(Pt(ppy)(biguH):(barb-H)] units  formed from 
chelate···chelate interactions (green) and weaker CH···O interactions (magenta). 
 
Figure 4.38 Packing of tetrameric units (light blue, light green, or pink) into sheets across the bc plane 
through chel···chel π interactions (green) and weak CH···O hydrogen bonds (magenta). Chloroform solvent 
molecules hidden for clarity. 
4.2.4.3 Hirshfeld Analysis 
As with the Hirshfeld analysis performed on the structures of  
[(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 and [(Pt(ppy)(diOMebigu)):dmaNaph], two 
separate surfaces from the structure  [(Pt(ppy)(biguH)):(barb-H)]·CHCl3 were examined. 
The first surface was generated from the hydrogen bonded tetramer (Figure 4.36) with its 
two corresponding chloroform solvent molecules, while the second was generated from 
three fragments, [Pt(ppy)(biguH)], barb-H, and CHCl3 which had been separated from 
each other. Once again H···N and H···O type interactions are the focus of the analysis. In the 
tetramer structure these interactions make up 3.0% and 4.5%, respectively, with 
reasonably diffuse fingerprint plots (Figure 4.39) and interactions distance of no closer 
than 2.8 Å. This is consistent with the packing of the tetrameric units through mainly 
chelate-chelate type π bonding (C-X interactions making up 30.4% of the total surface 
interactions) with weak supporting CH···O interactions. In the fragmented surface strong 
sharp peaks in the H···N and H···O fingerprint plots are observed with interaction 
distances under 2.0 Å observed in both plots (Figure 4.39). There is also a corresponding 
increase in the surface involved in these interactions to 5.0% and 11.3%, respectively. 
After accounting for the packing interactions of the tetramers (through the same method 
as in 4.2.3.3 Hirshfeld Analysis), the H···N and H···O interactions involved in the packing of 
the [Pt(ppy)(biguH)] and barb-H molecules make up approximately 3.8% and 9.4% of the 




Figure 4.39 Hirshfeld fingerprint plots for H-N (left) and H-O (right) intermolecular interactions in 
[(Pt(ppy)(biguH)):(barb-H)]·CHCl3 calculated using the complete asymmetric unit (top) or with  
the barb-H and CHCl3 molecules separate from the platinum complex (bottom) 
4.2.4.4 Hydrogen Bond Geometry 
The crystal structure of [(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 shows significant non-
planarity between the strongly hydrogen bonded units, in this case the biguanide ligand 
and the barbitone molecule, much like in the structures of  
[(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 and [(Pt(ppy)(diOMebigu)):dmaNaph], but to a 
greater extent with not only a large twist of 37.0°, but also a significant bend (θ1) of 10.8° 
(Table 4.4). When viewed side on, the twisted geometry between the two molecules is 
clearly visible (Figure 4.40) with H4A bending up towards O1 while H5A bends down out 
of the plane of the biguanide towards O2. The aryl rings of the biguanide are also rotated 
to angles that optimise the CH···O hydrogen bonding of the ortho protons to either the 
directly adjacent barbitone (in the case of H4) or to the next adjacent barbitone molecule 
(in the case of H10). In contrast, the double hydrogen bonding observed between adjacent 
barbitone molecules is mostly planar (Figure 4.40), excluding the distortion of the 
barbitone ring, with the angle between O2 and N8 through H8A being 175°. Overall 
platinum complexes related to each other through the extended hydrogen bonding are co-
planar and symmetry related within the crystal. This is also true for the barbitone 
molecules and between hydrogen bonded tetramers in the extended crystal structure.  
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Table 4.4 Deviations from planar geometry between the two triply hydrogen bonded moieties in  
co-crystallised X-ray crystal structures of the respective molecules. 
 Θ1 /° Θ2 /° τ /° Φ /Å 
[(Pt(ppy)(tBubigu)):dmaNaph] 6.3 1.7 23.8 0.13 
[(Pt(ppy)(diOMebigu)):dmaNaph] 29.6 0.7 10.0 1.05 
[(Pt(ppy)(tBubigu)):dmaNaph]·CHCl3 10.8 0.7 37.0 0.39 
 
Figure 4.40 Side on views of the hydrogen bonding between [Pt(ppy)(biguH)] and barb-H (top) and between 
two adjacent barb-H units (bottom) from the crystal structure of [(Pt(ppy)(biguH):(barb-H)]·CHCl3. 
Chloroform solvent and ethyl groups of the barbitone hidden for clarity. 
 
Figure 4.41 Plot of the twists, τ, and bends, θ1, observed in the crystal structures of literature, dmaNaph and 
barbitone containing co-crystallised compounds 
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4.3 Complex-Complex Assemblies 
4.3.1 Introduction 
As previously mentioned in Section 4.1.3, triply hydrogen bonded complex-complex co-
crystals are very rare with only the [Ni:Ni] system reported in the CSD.[9] This work 
attempted to co-crystallise 45 unique complex-complex combinations across more than 
120 different combinations of methods and solvents. When repeats and variations in 
molar ratios and concentrations are taken into account, at least 400 crystal jars were made 
up and left for weeks to months to crystallise.  From these hundreds of crystal jars, no 
single crystal X-ray diffraction structures of complex-complex co-crystal were obtained. 
The sum of the attempted complex-complex co-crystallisations are described in the 
supplemental (Section 4.5.4) along with the results of these attempts and the single 
complex crystals obtained from some of the attempted co-crystallisations. 
4.3.2 1,2-Bis(diphenylphosphino)ethane dioxide Crystals 
When attempts were made to co-crystallise the palladium(II) complex [Pd(dppe)(biuret)] 
with the platinum(II) diarylbiguanide complexes, low quality crystals were obtained 
which upon refinement showed the platinum complex with dppeo molecules, which could 
only have come from oxidation of the dppe ligand of the palladium(II) complex. 
Platinum(II) complexes have been known to catalyse the oxidation of phosphine 
containing molecules,[24] and potentially this catalytic action occurred through a hydrogen 
bonding interaction between the two complexes in solution with the crystals forming 
between the platinum(II) complex and the oxidation product. When the co-crystallisation 
solutions were de-gassed with argon and left under an atmosphere of argon, no crystals 
formed and dppeo was not present in the solution. (note, solutions of [Pd(dppe)(biuret)] 
are normally stable under the same conditions with the absence of the platinum(II) 
complex).  
4.3.2.1 [Pt(ppy)(bigu)]·dppeo·CHCl3 Crystal Structure 
More reasonable quality crystals were obtained from the diffusion of diisopropyl ether 
into the equimolar chloroform solution of [Pd(dppe)(biuret)] and [Pt(ppy)(bigu)], which 
had the molecular formula of [Pt(ppy)(bigu)]·dppeo·CHCl3. The complex crystallised in 
the triclinic space group 𝑃1̅ with the asymmetric unit containing the platinum(II) complex, 
two separate halves of 1,2-bis(diphenylphosphino)ethane dioxide molecules and a 
disordered chloroform solvent (Figure 4.42). As with the structure of 
[Pt(ppy)(diFbigu)]·2DMF, and the related palladium(II) diarylbiguanide structures, the 
aryl rings of the biguanide are up in their syn-syn conformation, with the ortho protons, H4 
and H14, involved in weak hydrogen bonds to N2 (H···N 2.48 and 2.31 Å, CH···N 112° and 
115° respectively). This syn-syn conformation closes off the DAD motif, instead exposing 
two DD hydrogen bonding motifs either side of the biguanide. On one side O1 of one dppeo 
molecule is strongly hydrogen bonded to H1A and H4A (H···O 2.23 and 2.03 Å, NH···O 152° 
and 161° respectively) via a 𝑅2
1(6) motif, with a weak supporting interaction from H24 
(H···O 2.71 Å, CH···O 165°). On the other side H3A and H5A strongly hydrogen bond to O2 
of the other dppeo molecule (H···O 2.23 and 2.16 Å, NH···O 155° and 152° respectively) 
also via a 𝑅2
1(6) motif, with a slightly stronger supporting interaction from H15 (H···O 2.53 






Figure 4.42 X-ray crystal structure of Pt(ppy)(bigu)]·dppeo·CHCl3. Ellipsoids are drawn at 50%, chloroform 
solvent is hidden for clarity and only portions of the dppeo molecules from the asymmetric unit are shown. 
The remaining portions of the dppeo molecules lay above and below the platinum 
complex, with their second oxygen atoms hydrogen bonding to adjacent complexes 
forming chains up the crystallographic ac axis (Figure 4.43). These chains then pack 
together through a variety of weak CH···N and π-π stacking interactions.  
 
Figure 4.43 Hydrogen bonded chains of [Pt(ppy)(bigu)] (light green) and dppeo molecules down the 
crystallographic ac axis. 
 
4.4 Conclusions 
The range of transition metal complexes containing ADA or DAD type hydrogen bonding 
motifs synthesised and reported in Chapters 2 and 3 were used for co-crystallisation 
experiments with complementary organic molecules, dmaNaph, barb, phthalimide, and 
PhDAT, as well as with each other, using a variety of different crystallisation techniques 
and solvent combinations. While no complex-complex co-crystals were obtained two co-
crystals of platinum(II) diarylbiguanide complexes with the complementary organic 
molecule 4-dimethylnaphthalimide, [(Pt(ppy)(tBubigu)):dmaNaph]·0.3CHCl3 and 
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[(Pt(ppy)2(diOMebigu)):dmaNaph], as well as a single co-crystal with barbitone, 
[(Pt(ppy)(biguH)):(barb-H)]·CHCl3, where a proton transfer has occurred between 
barbitone and the biguanide moiety of the platinum(II) complex giving AAA and DDD 
motifs, respectively. X-ray quality crystals of platinum(II) diarylbiguanide complexes with 
dppeo were also obtained from crystal jars of mixtures of the platinum(II) complexes with 
[Pd(dppe)(biuret)]. This AAA:DDD type metal complex containing co-crystal is believed to 
be the first of its type. 
A method for calculating the distortions from co-planar geometry between two triply 
hydrogen bonded moieties using simple trigonometric functions with angles and distances 
readily measurable from the crystal structures was developed. These calculations were 
then applied to the 22 ADA:DAD type co-crystals, which contained at least one metal 
complex component, reported in the CSD as well as to one unreported structure.[17] Of the 
24 separate triply hydrogen bonded geometries observed (Table 4.9) none were found to 
be co-planar and only one fifth had geometry components (θ1 and τ) which were no 
greater than 5°. Nearly one third of the structures were found to have one or more 
geometry components greater than 15° with deviations from co-planarity of up to 40° 
observed in some structures. Preliminary calculations[18] suggest that these deviations 
from planar geometry are (at least in part) due to optimisation of the hydrogen bonding 
interactions across the triple hydrogen bond motif. All three co-crystal structures obtained 
had their geometry components of the triple hydrogen bonding interactions calculated 
and were found to have significant deviation from planar geometry between the triply 
hydrogen bonded moieties. The calculated geometry components were found to be greater 
than those observed in the majority of the triply hydrogen bonded metal complex 
containing structures reported in the CSD.  
The platinum(II) complexes and dmaNaph molecules in the structures of both 
[(Pt(ppy)(tBubigu)):dmaNaph]·0.3CHCl3 and [(Pt(ppy)2(diOMebigu)):dmaNaph] form 
hydrogen bonded dimers through strong NH···O and NH···N hydrogen bonds between the 
biguanide and naphthalimide moieties, with weaker supporting CH···O hydrogen 









1(6) motifs, respectively. The difference of motifs is due to the 
structure of [(Pt(ppy)(tBubigu)):dmaNaph]·0.3CHCl3 lacking a second CH···O hydrogen 
bond due to the rotation of the aryl ring. While both structures form similar hydrogen 
bonded dimers, the structure of [(Pt(ppy)(tBubigu)):dmaNaph]·0.3CHCl3 was observed 
to have a significantly twisted geometry, τ = 23.8°, between the hydrogen bonded 
moieties, while only displaying a moderate bend, θ1 = 6.3°. In contrast, the structure of 
[(Pt(ppy)2(diOMebigu)):dmaNaph] was observed to have a significantly bent geometry, 
θ1 = 29.6°, while still containing a large twisting geometry component, τ = 10.3°. The two 
co-crystals are also observe to pack through different intermolecular interactions, with the 
[(Pt(ppy)(tBubigu)):dmaNaph]·0.3CHCl3 dimer units packing together into tetramers  of 
hydrogen bonded dimers, through π-stacking between two adjacent dmaNaph units and 
chelate···π stacking between from platinum complexes either side of the dmaNaph pair. In 
contrast, [(Pt(ppy)2(diOMebigu)):dmaNaph] dimers pack into chains down the 
crystallographic a axis through CH···Pt anagostic interactions and weaker CH···N hydrogen 
bonding interactions between the dimethylamino group of a dmaNaph moiety and two 
adjacent platinum(II) complexes. The chains further pack through CH···O hydrogen bonds 
between methoxide groups of adjacent platinum(II) complexes.  
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The four co-crystal structures containing nickel(II) or copper(II) complexes with 
guanibenzaimidazole, or 5-oxo-4,4-diphenylimidazol-N-phenylguanidine ligand as well as 
a fifth co-crystal structure containing a nickel(II) complex with diOMebigu ligands, co-
crystallised with either phthalimide or Naph, are similar to the 
[(Pt(ppy)(bigu)):dmaNaph] co-crystals obtained, with the imide moiety strongly 
hydrogen bonded to the guanidine or biguanide moieties through strong NH···O and 
NH···N bonds, although forming trimeric units rather than dimers. Only the 
[(Ni(diOMebigu)2):(Naph)2] shows a large deviation, θ1 = 39.4°, from co-planar while the 
other four structures show more moderate deviations,  θ1 = 3.6° – 7.8° and τ = 6.8° – 14.9°, 
with the nickel(II) guanidine co-crystals having the largest twist contributions at τ = 12.7° 
and 14.9°, respectively. 
The platinum(II) complexes and barb-H molecules in the co-crystal structure of 
[(Pt(ppy)(biguH)):(barb-H)]·CHCl3 form hydrogen bonded tetramers with each 
platinum(II) complex hydrogen bonded to a barbitone ion through strong NH···O and 




motifs. The two adjacent baritone ions are hydrogen bonded through NH···O hydrogen 
bonds via a 𝑅2
2(8) motif. A CH···O hydrogen bond from the aryl group of the biguanide 















motif linking the two platinum(II) complexes through the barbitone ions. The proton 
transfer between the biguanide and barbitone moieties, which likely occurs due to the 
more acid nature of the barbitone imide nitrogen compared to that of dmaNaph, means 
the resulting hydrogen bonding occurs between complementary AAA:DDD hydrogen 
bonding moieties, which have no reported metal containing complex analogues. Like in the 
co-crystals with dmaNaph, the triple hydrogen bonding between the biguanide motif and 
the barbitone ion is non-planar with a significant twist, τ = 37.0°, while still containing a 
large bending geometry component, θ1 = 10.8°. In contrast, the barbitone molecules 
hydrogen bonded via a 𝑅2
2(8) motif are co-planar. Adjacent platinum(II) complexes in the 
structure form zig-zag chains through chelate-chelate stacking interactions supported by 
weaker CH···O to the hydrogen bonded barbitone moieties of the adjacent complexes, 
which link the hydrogen bonded tetramers together into the overall 3D structure. 
4.4.1 Issues with Co-crystallisations 
With the distinct lack of complex-complex co-crystals, even with the great variety of 
complex combinations and conditions, the overall approach to assembling complexes 
through triple hydrogen bonds needs to be reconsidered. One of the common crystalline 
products observed was that of one complex crystallising out while the other remained in 
solution. This propensity for complexes to prefer crystallising by themselves highlights the 
importance of considering all intermolecular interactions, rather than relying on a single 
complementary interaction motif to drive assembly of different species. This can be 
observed in natural systems, where multiple different intermolecular interactions often 
work in concert to assemble multiple components into well organised systems. The 
majority of complex-complex assemblies attempted should have formed as dimers with 
the triple hydrogen bond being the major, if not only interaction between the complexes. 
Of the known complex-complex assemblies, two contain two complementary bis 
complexes forming hydrogen bonded “polymer” chains while the other is a discrete trimer 
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with additional weak hydrogen bonding interactions assisting the main triple hydrogen 
bonding interaction.  
4.4.2 Future Directions 
When planning future co-crystal systems additional interactions need to be considered. 
One approach that could be taken is by using complexes with multiple hydrogen bonding 
motifs to form hydrogen bonded “polymer” type structures. The copper(II) and zinc(II) 
bis-pyhy complexes would be ideal for these type of assemblies, and the BtpD and HtpD 
ligands should readily form complementary bis  complexes (on square planar metals) or 
tris complexes (on octahedral metals) (Figure 4.44). The diarylbiguanides are already 
known to form bis complexes and as described in subsection 4.3.2.10, initial crystal jars 
containing the nickel(II) diarylbiguanides with the copper(II) and zinc(II) hydantoin 
complexes had been made up, although no co-crystals had been obtained. Ligands similar 
to 6,6’-bimesityl-2,2’-bipyridine using either DAT or uracil type moieties in the place of the 
mesityl groups (Figure 4.45). Alternatively, ligands or complexes could be developed that 
incorporate multiple types of intermolecular interactions such as complementary π-π 
alongside the hydrogen bonding interactions. Additionally, the propensity for the triple 
hydrogen bond interactions, from complex species, to adopt non-planar geometries needs 
to be taken into consideration when designing future co-crystal systems. The wide 
variation in the geometries observed both in direction of distortion and extent to which 
the interaction is distorted from co-planar makes predictions difficult.  
 
Figure 4.44 Potential bis- (left) and tris- (right) DAT containing complexes, that could be synthesised from the 




Figure 4.45 Potential DAT (left) or uracil (right) substituted 2,2’-bipyridines for forming hydrogen bonded 





4.5 Crystallographic Supplemental 
Orange crystals of [(Pt(ppy)(tBubigu)):(dmaNaph)]·0.3CHCl3 were grown from the 
diffusion of petroleum ether into a 2:3 chloroform solution of [Pt(ppy)(tBubigu)] and 
dmaNaph. Yellow crystals of [(Pt(ppy)(diOMebigu)):(dmaNaph)] were grown from the 
diffusion of diethyl ether into a 2:3 chloroform solution of [Pt(ppy)(diOMebigu)] and 
dmaNaph. Yellow crystals of [(Pt(ppy)(biguH)):(barb-H)] were grown from the diffusion 
of diisopropyl ether into a 2:1 chloroform solution of [Pt(ppy)(bigu)] and barbitone. 
Colourless crystals of [Pt(ppy)(bigu)]·dppeo·CHCl3 were grown by diffusion of diisopropyl 
ether into 1:1 solution of [Pt(ppy)(bigu)] and [Pd(dppe)(biuret)] in chloroform. X-ray 
data for these complexes were collected at 100 K on an Agilent Technologies Supernova 
system using Cu Kα radiation with exposures over 1.0°, and data were treated using 
CrysAlisPro[25] software. The structures were solved using SHELXT[26] and weighted full-
matrix refinement on F2 was carried out using SHELXL-2014[26] running within the 
WinGX[27] package. All non-hydrogen atoms were refined anisotropically. Non N-H 
hydrogen atoms were placed in calculated positions and refined using a riding model. 
Where possible, the N-H hydrogens (those on N4 and N5 of 
[(Pt(ppy)(tBubigu)):(dmaNaph)]·0.3CHCl3, and on N1, N3-5, and N7 of 
[(Pt(ppy)(diOMebigu)):(dmaNaph)]) were assigned from electron density maps and 
refined as floating atoms.  
Crystallographic data relevant for all structures reported in this chapter are summarised 
in Table 4.5, with selected bond lengths and angles, as well as hydrogen bonding metrics 
reported in Table 4.6 and Table 2.5. Hirshfeld surfaces[28] were calculated to high 
resolution using the complete asymmetric units of the respective structures in the 
CrystalExplorer software package,[29]  and are summarised in Table 4.8 with fingerprint 
plots shown in Section 4.5.2 Hydrogen bond geometry components for co-crystal 
structures are summarised in Table 4.9 with data relating to the calculations are shown in 
Table 4.10. All structures reported have been validated using checkCIF,[30] with any and all 




4.5.1 Crystallographic Data Tables 










Formula C47.33H50.33N8O2ClPt C43H42N8O6Pt C34H35N8O3Cl3Pt C52H47N6O2P2Cl3Pt 
FW 993.78 961.93 905.14 1151.33 
Crystal System Monoclinic Triclinic Monoclinic Triclinic 
Space Group C 2/c P -1 P 21/c P -1 
a / Å 36.4566(9) 9.0399(2) 13.6217(4) 9.6668(2) 
b / Å 13.9098(2) 11.2725(2) 33.0468(9) 14.4555(3) 
c / Å 21.6407(3) 18.7721(4) 7.8130(2) 18.2290(2) 
α / ° 90 90.099(2) 90 100.335(1) 
β / ° 97.802(2) 103.059(2) 99.978(3) 94.153(1) 
γ / ° 90 90.617(2) 90 99.977(2) 
V / Å3 10872.5(3) 1863.32(7) 3463.85(17) 2453.94(8) 
Z 8 2 4 2 
T / K 100.0(2) 100.0(2) 100.0(2) 100.0(2) 
μ / mm-1 5.586 7.567 10.104 7.843 
Refls. coll. 64272 19763 39686 35820 
Ind.Refls. 
(Rint) 
11317 (0.0719) 7307 (0.0489) 7067 (0.0627) 9715 (0.0535) 
R1 (I>2σ(I))a 0.0574 0.0334 0.0378 0.0756 
wR2 (I>2σ(I))a 0.1643 0.0894 0.0899 0.1966 
R1 (all data)a 0.0630 0.0342 0.0450 0.0791 
wR2 (all data)a 0.1700 0.0929 0.0957 0.2005 














Table 4.6 Selected bond lengths (Å) and angles (°). 
[(Pt(ppy)(tBubigu)):(dmaNaph)]·0.3CHCl3 [(Pt(ppy)(diOMebigu)):(dmaNaph)] 
 C1-N1 1.318(8)  C1-N1 1.312(5) 
 C1-N2 1.353(8)  C1-N2 1.353(5) 
 C2-N2 1.359(8)  C2-N2 1.352(5) 
 C2-N3 1.305(7)  C2-N3 1.315(5) 
 C44-O1 1.199(8)  C40-O5 1.224(5) 
 C45-O2 1.250(8)  C41-O6 1.229(5) 
 Pt1-C33A 1.999(6)  Pt1-C29A 2.005(4) 
 Pt1-N1 2.012(5)  Pt1-N1 1.993(3) 
 Pt1-N3 2.048(5)  Pt1-N3 2.025(3) 
 Pt1-N6A 2.027(5)  Pt1-N6A 2.019(3) 
 N1-Pt1-N3 86.2(2)  N1-Pt1-N3 84.4(2) 
 C33A-Pt1-N6A 80.9(3)  C29A-Pt1-N6A 86.7(2) 
[(Pt(ppy)(biguH)):(barb-H)]·CHCl3 [Pt(ppy)(bigu)]·dppeo·CHCl3 
 C1-N1 1.298(6)  C1-N1 1.335(9) 
 C1-N2 1.362(6)  C1-N2 1.418(8) 
 C2-N2 1.365(6)  C2-N2 1.271(9) 
 C2-N3 1.304(6)  C2-N3 1.334(9) 
 C27-N7 1.352(6)  P1-O1 1.495(5) 
 C28-N7 1.339(6)  P2-O2 1.496(6) 
 C27-O1 1.243(6)  Pt1-C25 2.027(7) 
 C28-O2 1.248(6)  Pt1-N1 1.991(6) 
 C29-O3 1.211(6)  Pt1-N3 2.024(6) 
 Pt1-C25A 2.001(4)  Pt1-N6 2.025(8) 
 Pt1-N1 2.037(4)  N1-Pt1-N3 85.8(2) 
 Pt1-N3 2.022(4)  C25-Pt1-N6 81.0(3) 
 Pt1-N6A 2.005(5)    
 N1-Pt1-N3 86.7(2)    





Table 4.7 Hydrogen bond metrics. 
  d(H···A)/Å d(D···A)/Å <(DH···A)/° 
[(Pt(ppy)(tBubigu)):(dmaNaph)]·0.3CHCl3    
 N4-H4A···O1 1.66(9) 2.765(7) 163(7) 
 N5-H5A···O2 1.94(6) 2.898(6) 158(5) 
 N7-H7A···N2 2.09 2.946(6) 172.9 
 C8-H8···O1 2.74(1) 3.33(1) 122.2 
 C18-H18···Cl1B 2.95 3.88(3) 173.6 
 C24-H24···Cl1B#1 2.99 3.63(4) 127.6 
[(Pt(ppy)(diOMebigu)):(dmaNaph)]    
 N4-H4A···O5 2.10(5) 2.883(4) 162(5) 
 N5-H5A···O6 1.91(6) 2.824(4) 164(5) 
 N7-H7A···N2 2.28(4) 3.079(4) 158(4) 
 C8-H8···O5 2.38 3.149(5) 139.8 
 C16-H16···O6 2.69 3.287(5) 123.0 
 C12-H12···O3#2 2.41 3.327(5) 166.9 
[(Pt(ppy)(biguH)):(barb-H)]·CHCl3    
 N4-H4A···O1 2.18(6) 2.926(6) 166.6 
 N2-H2A···N7 1.94(6) 2.784(6) 173(6) 
 N5-H5A···O2 2.00(6) 2.869(5) 175(6) 
 N8-H8A···O2#3 1.98(6) 2.794(5) 175(6) 
 C50-H50···O1 2.08 3.056(6) 176.4 
 C33-H33B···O3 2.86 3.352(6) 113.2 
 C33-H33C···O1 2.74 3.265(6) 114.9 
 C4-H4···O1 2.81 3.521(6) 134.7 
 C10-H10···O3#3 2.53 3.390(6) 153.9 
[Pt(ppy)(bigu)]·dppeo·CHCl3    
 N4-H4A···O1 2.03(2) 2.885(8) 161(9) 
 N1-H1A···O1 2.23 3.017(8) 152.2 
 N3-H3A···O2#4 2.23 3.026(8) 154.8 
 N5-H5A···O2#4 2.16 2.946(9) 151.9 
 C4-H4···N2 2.48 2.956(11) 111.8 
 C14-H14···Cl2A#5 2.61 3.363(13) 138.2 
 C14-H14···N2 2.31 2.830(11) 114.8 
 C15-H15···O2#4 2.53 3.447(12) 171.0 
 C18-H18···Cl4B#6 2.94 3.62(2) 131.0 
 C45-H45···O2#7 2.61 3.351(10) 136.9 
Symmetry codes: #1 x, -y+1, z+½  #2 –x+1, -y+1, -z  #3 –x+1, -y+1, -z+2  #4 x, y, z-1  #5 x+1, y, z  #6 x+1, y+1, z  




4.5.2 Hirshfeld Surface Analysis 
Table 4.8 Percentage of total Hirshfeld surface interactions (including reciprocals) between internal and 
external atoms, for asymmetric units (top) and separated moieties (bottom) of each co-crystal structure.  
 H-H H-C H-N H-O H-X C-C C-N C-O C-X X-X Other 
[(Pt(ppy)(tBubigu)): 
(dmaNaph)]·0.3CHCl3 
42.3 14.6 4.5 1.4 10.7 3.5 2.2 1.2 1.2 0.2 18.2 
38.3 12.7 4.6 4.9 13.0 3.1 2.0 1.0 1.1 0.2 19.1 
[(Pt(ppy)(diOMebigu)): 
(dmaNaph)] 
44.4 27.5 7.0 9.8 N/A 5.0 1.9 2.2 N/A N/A 2.8 
43.4 24.8 7.5 14.0 N/A 4.6 1.8 1.8 N/A N/A 2.1 
[(Pt(ppy)(biguH)): 
(barb-H)]·CHCl3 
40.1 18.7 3.0 4.5 18.5 2.1 4.4 0.7 4.0 0.0 4.0 





Figure 4.46 Hirshfeld fingerprint plots of intermolecular interactions in the complete asymmetric unit (left) 




Figure 4.47 Hirshfeld fingerprint plots of intermolecular interactions in the complete asymmetric unit (left) 




Figure 4.48 Hirshfeld fingerprint plots of intermolecular interactions in the complete tetrameric unit (left) 




4.5.3 Hydrogen Bond Geometry Calculations 
Table 4.9 Hydrogen bond geometry metrics for literature structures 
CSD Code Θ1 /° Θ2 /° τ /° Φ /Å 
GOKXIO 12.3 1.9 5.6 0.26 
HIXKUW 4.9 1.8 1.8 0.28 
HIXLIL 14.3 4.4 4.2 0.33 
LALPAR 6.9 0.5 1.3 0.57 
LOTMUX 9.6 0.3 12.5 0.20 
LULQOY 7.8 6.2 14.9 0.62 
 0.1 2.5 1.8 0.05 
LULQIS 4.9 0.6 2.9 0.37 
LULQUE 5.0 0.3 7.9 0.35 
LUXHAN 2.4 0.8 12.7 0.06 
LUXHER 5.0 0.8 12.7 0.21 
NOMMIL 22.8 0.8 0.5 1.04 
QENXAJ 3.6 1.8 6.8 0.16 
QENXOX 4.3 0.3 8.0 0.28 
RABNUZ 0.0 1.3 4.0 0.11 
WELGAX 39.8 0.8 7.5 1.50 
YAZRAS 12.0 1.2 1.9 0.57 
YONNAQ 10.7 0.0 3.5 0.40 
YONQAT 15.0 1.2 17.3 0.63 
YONQEX 2.0 0.8 26.1 0.08 
YUNPIG 1.1 0.6 4.1 0.11 
YUNPOM 0.4 0.2 3.1 0.13 
ZOJMAM 24.6 2.0 1.8 0.51 
McMorran 
unreported[17] 





Table 4.10 Measurements of various distances (Å) for the calculation of hydrogen bond geometry terms.  
PA = PlaneA and CB = CentB. Note if B1 and B3 are opposite sides of PA, B3 is negative. 
 A1···B1 A2···B2 PA···B2 PA···CB B2···CB A1···A3 B1···B3 B1···PA B3···PA 
GOKXIO 3.017 2.867 0.260 0.544 1.331 4.495 4.550 0.084 -0.359 
HIXKUW 2.799 2.939 0.280 0.393 1.328 4.504 4.531 0.221 0.361 
HIXLIL 3.200 2.855 0.330 0.661 1.336 4.507 4.552 0.031 0.366 
LALPAR 3.211 3.175 0.571 0.713 1.185 4.567 4.543 0.611 0.510 
LOTMUC 2.875 2.896 0.199 0.425 1.351 4.571 4.849 0.584 -0.467 
LULQIS 2.785 2.836 0.367 0.248 1.381 4.851 4.493 0.355 0.584 
LULQOY 3.398 2.897 0.616 0.776 1.177 4.597 4.543 0.077 1.247 
 2.922 3.124 0.051 0.049 1.178 4.593 4.542 0.146 0.002 
LULQUE 2.879 2.906 0.354 0.473 1.369 4.605 4.514 0.064 0.684 
LUXHAN 2.888 2.950 0.057 0.001 1.331 4.555 4.532 0.005 0.094 
LUXHER 3.031 2.964 0.207 0.090 1.342 4.593 4.492 0.630 -0.356 
NOMMIL 2.942 3.004 1.043 1.553 1.317 4.568 4.484 0.951 0.990 
QENXAJ 2.798 2.941 0.163 0.249 1.368 4.557 4.516 0.098 -0.435 
QENXOX 2.883 2.857 0.277 0.380 1.376 4.618 4.529 0.649 0.019 
RABNUZ 3.215 3.114 0.105 0.105 1.169 4.517 4.542 0.079 -0.241 
WELGAX 2.898 2.868 1.500 2.375 1.367 4.551 4.510 1.730 1.138 
YAZRAS 2.847 2.937 0.566 0.842 1.325 4.486 4.505 0.627 0.476 
YONNAQ 2.997 3.000 0.396 0.614 1.180 4.514 4.589 0.326 0.607 
YONQAT 2.897 2.996 0.634 0.991 1.376 4.588 4.482 0.013 1.342 
YONQEX 2.978 2.914 0.077 0.031 1.339 4.581 4.552 0.969 -1.033 
YUNPIG 2.915 2.867 0.111 0.138 1.371 4.486 4.505 0.006 -0.318 
YUNPOM 2.925 2.906 0.132 0.140 1.097 4.480 4.463 0.249 0.011 
ZOJMAM 3.041 2.883 0.509 1.060 1.322 4.604 4.514 0.343 0.482 
[(Pt(ppy)(biguH)): 
(barb-H)]·CHCl3 
2.869 2.926 0.390 0.649 1.385 4.487 4.506 1.644 -1.068 
[(Pt(ppy)(diOMebigu)): 
(dmaNaph)] 
2.883 2.825 1.049 1.726 1.371 4.548 4.511 1.418 0.632 
[(Pt(ppy)(tBubigu)): 
(dmaNaph)]·0.3CHCl3 
2.765 2.900 0.126 0.276 1.362 4.510 4.493 0.797 -1.015 
McMorran 
unreported[17] 





4.5.4 Attempted Co-crystallisations 
Below is described the sum of the attempted complex-complex co-crystallisations along 
with the results of these attempts and the single complex crystals obtained from some of 
the attempted co-crystallisations.  
4.5.4.1 Palladium(II)-Palladium(II) Co-crystallisation Attempts 
Equimolar solutions of [Pd(dppe)(biuret)] with the palladium(II) diarylbiguanide 
complexes [Pd(ppy)(tBubigu)], [Pd(ppy)(diClbigu)], [Pd(ppy)(diFbigu)], or 
[Pd(ppy)(diOMebigu)] in DMSO were made up into vapour diffusion jars with diisopropyl 
ether, acetone, and water being used as anti-solvents. From these jars only the diisopropyl 
ether into a solution of [Pd(dppe)(biuret)] and [Pd(ppy)(diClbigu)] yielded any sort of 
crystalline material, although these were found not to be of sufficient quality for single 
crystal X-ray diffraction. Equimolar solutions of [Pd(dppe)(biuret)] with 
[Pd(ppy)(tBubigu)] or [Pd(ppy)(diOMebigu)] in varying mixtures of DMSO and 
chloroform were also made up into vapour diffusion jars with diisopropyl ether, methanol, 
and THF being used as anti-solvents. Equimolar mixtures of [Pd(dppe)(biuret)] and 
[Pd(ppy)(tBubigu)] in DMF were also left to slowly evaporate, although none of these jars 
yielded crystalline material. 
4.5.4.2 Platinum(II)-Platinum(II) Co-crystallisation Attempts 
Equimolar solutions of [Pt(dppe)(biuret)] with [Pt(ppy)(bigu)], [Pt(ppy)(Brbigu)], or 
[Pt(ppy)(diOMebigu)] in chloroform were made up into vapour diffusion jars with 
diethyl, diisopropyl, and petroleum ethers being used as anti-solvents. Diffusion of 
diisopropyl ether into the [Pt(ppy)(bigu)] containing solution and diethyl ether into the 
[Pt(ppy)(diOMebigu)] containing solution both gave semi-crystalline materials which 
insufficient for single crystal X-ray diffraction. Diffusion of diisopropyl ether into the 
[Pt(ppy)(diOMebigu)] containing solution gave crystalline material but individual crystals 
were too small to collect diffraction patterns.  
4.5.4.3 Palladium(II)-Platinum(II) Co-crystallisation Attempts 
Equimolar solutions of [Pt(dppe)(biuret)] with [Pd(ppy)(tBubigu)] and 
[Pd(ppy)(diClbigu)] in DMSO were made up into vapour diffusion jars with diisopropyl 
ether and water being used as anti-solvents. Equimolar solutions of [Pt(dppe)(biuret)] 
and [Pd(ppy)(tBubigu)] in DMF, and solutions of [Pt(dppe)(biuret)] and 
[Pd(ppy)(diClbigu)] in chloroform/DMSO and acetone/DMSO mixtures were all left to 
evaporate. No crystals were obtained from any of these jars. 
Equimolar solutions of [Pd(dppe)(biuret)] with [Pt(ppy)(bigu)], [Pt(ppy)(Brbigu)], or 
[Pt(ppy)(diOMebigu)] in chloroform were made up into vapour diffusion jars with 
diethyl, diisopropyl, and petroleum ethers being used as anti-solvents. All three 
diisopropyl ether into chloroform solutions and the diethyl ether into chloroform solution 
containing [Pt(ppy)(bigu)], gave poor quality crystals of the platinum(II) complexes with 
the oxidised  dppe ligand of the palladium(II) biuret complex (Subsection 4.3.2.1). When 
these crystal jars were repeated under Ar(g) no crystals were obtained. The diffusion of 
petroleum ether into the [Pt(ppy)(diOMebigu)] containing solution gave tiny needle 
crystals which were too small to a obtain single crystal X-ray structure.  
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4.5.4.4 Copper(II)-Palladium(II)/Platinum(II) Co-crystallisation Attempts 
Solutions of [Cu(pyhy)2] with either two equivalents or excess amounts of 
[Pd(ppy)(bigu)], [Pd(ppy)(tBubigu)], [Pd(ppy)(diFbigu)], [Pt(ppy)(bigu)], 
[Pt(ppy)(tBubigu)], [Pt(ppy)(diFbigu)], or [Pt(ppy)(diOMebigu)] in DMSO were made up 
into vapour diffusion jars with water being used as the anti-solvent and also in the 
solutions containing [Pd(ppy)(bigu)] and [Pd(ppy)(diFbigu)], and the solution containing 
[Pt(ppy)(bigu)], THF and diisopropyl ether were used as anti-solvents, respectively. 
Solutions of [Cu(pyhy)2] with two equivalents and excess amounts of [Pd(ppy)(tBubigu)] 
or [Pd(ppy)(diOMebigu)] in DMF were used for slow evaporation and the solution 
containing [Pd(ppy)(diOMebigu)] was made up into vapour diffusion jars using 
diisopropyl ether as the anti-solvent. The only jar to give crystalline material was the 
diffusion of water into a DMSO solution of [Cu(pyhy)2] and [Pt(ppy)(diOMebigu)] which 
gave X-ray quality crystals of isolated copper(II) complex (Subsection 3.2.3.2). 
4.5.4.5 Zinc(II)- Palladium(II)/Platinum(II) Co-crystallisation Attempts 
Solutions of [Cu(pyhy)2] with either two equivalents or excess amounts of 
[Pd(ppy)(bigu)], [Pd(ppy)(OMebigu)], [Pt(ppy)(bigu)], [Pt(ppy)(tBubigu)], or 
[Pt(ppy)(diOMebigu)] in DMSO were made up into vapour diffusion jars with water or 
THF being used as the anti-solvent and also in the solution containing [Pt(ppy)(bigu)], 
methanol and ethyl acetate were used as anti-solvents, while in the solutions containing 
[Pt(ppy)(tBubigu)], and [Pt(ppy)(diOMebigu)], diisopropyl ether was used as an anti-
solvent. No crystals were obtained from any of these jars.  
4.5.4.6 Ruthenium(II)-Palladium(II)/Platinum(II) Co-crystallisation Attempts 
Equimolar solutions of either [Ru(bpy)2(BtpD)](PF6)2 or [Ru(bpy)2(HtpD)](PF6)2 with 
either [Pd(dppe)(biuret)] or [Pt(dppe)(biuret)] in various mixtures of chloroform and 
acetonitrile or in nitromethane, were made up into vapour diffusion jars with diethyl, 
diisopropyl, and petroleum ethers being used as anti-solvents. Equimolar solutions of 
either [Ru(bpy)2(BtpD)](PF6)2 or [Ru(bpy)2(HtpD)](PF6)2 with [Pd(dppe)(biuret)] in 
acetonitrile/butanol mixtures were used for reverse vapour diffusion crystal jars while 
similar solutions in DMF were left to slowly evaporate. Various vapour diffusion jars 
yielded X-ray quality crystals, although they were all found to only be of the ruthenium(II) 
complexes with varying solvents (vide supra). 
4.5.4.7 Ruthenium(II)-Nickel(II) Co-crystallisation Attempts 
Two molar equivalents of either [Ru(bpy)2(BtpD)](PF6)2 or [Ru(bpy)2(HtpD)](PF6)2 in a 
solutions of acetonitrile were layered with solutions of [Ni(Brbigu)2] in DMSO. No crystals 
were obtained from any of these jars. 
4.5.4.8 Iridium(III)-Platinum(II) Co-crystallisation Attempts 
Crude aqueous solutions of Na[Ir(ppy)2(orotH)] were layered with equimolar solutions of 
[Pt(ppy)(tBubigu)], [Pt(ppy)(diClbigu)], or [Pt(ppy)(diOMebigu)] in chloroform. No 
crystals were obtained from any of these jars. 
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4.5.4.9 Iridium(III)-Ruthenium(II) Co-crystallisation Attempts 
Equimolar solutions of [Ir(ppy)2(BtpD)]PF6 with [Ru(bpy)2(pyhy)]PF6 or 
[Ru(bpy)2(orotH)] in DMSO were used in vapour diffusion jars with water, diisopropyl 
ether, and ethyl acetate being used as anti-solvents. Equimolar solutions of 
[Ir(ppy)2(HtpD)]PF6 with [Ru(bpy)2(pyhy)]PF6 or [Ru(bpy)2(orotH)] in DMSO were also 
used in vapour diffusion jars with water, diisopropyl ether, and ethyl acetate being used as 
anti-solvents. Equimolar solutions of nBu4N[Ir(ppy)2(orotH)] with 
[Ru(bpy)2(BtpD)](PF6)2 or [Ru(bpy)2(HtpD)](PF6)2 were made up into reverse vapour 
diffusion jars with various mixtures of acetonitrile and butanol. Aqueous solutions of 
crude Na[Ir(ppy)2(orotH)] were layered with solutions of [Ru(bpy)2(BtpD)](PF6)2 or 
[Ru(bpy)2(HtpD)](PF6)2 in either toluene and acetonitrile or just toluene. No crystals were 
obtained from any of these jars. 
4.5.4.10 Nickel(II)-Copper(II)/Zinc(II) Co-crystallisation Attempts 
Equimolar solutions of [Ni(Brbigu)2] with either [Cu(pyhy)2] or [Zn(pyhy)2] in DMSO 
were left to evaporate slowly. The crystal jars containing [Zn(pyhy)2] gave tiny crystalline 
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